: The AMEDEO Literature Guide

Home The Word Brain

My Amedeo

FAQ

Privacy

About

Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.

Pulmonary Hypertension, January 2022
Free Subscription

Abstracts
Retrieve all available abstracts of the following 1778 articles:
HTML format

Single Articles

BERNARDO RJ, Lu D, Ramirez RL 3rd, Hedlin H, et al
Hispanic Ethnicity and Social Determinants of Health in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
Ann Am Thorac Soc. 2022 Mar 3. doi: 10.1513/AnnalsATS.202109-1051.
Abstract

BREEN E, Yuan JX
Targeting ATP-sensitive K(+) Channels to Treat Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2022 Mar 3. doi: 10.1165/rcmb.2021-0549.
Abstract

SALGUERO MV, Chan K, Greeley SAW, Dyamenahalli U, et al
Novel KDM6A Kabuki Syndrome Mutation With Hyperinsulinemic Hypoglycemia and Pulmonary Hypertension Requiring ECMO.
J Endocr Soc. 2022;6:bvac015.
Abstract

LIU SF, Yan Y
Animal models of pulmonary hypertension due to left heart disease.
Animal Model Exp Med. 2022 Feb 9. doi: 10.1002/ame2.12214.
Abstract

MATSUI T, Kikuchi N, Serizawa N, Hagiwara N, et al
Systemic sclerosis complicated by chronic thromboembolic pulmonary hypertension treated with balloon pulmonary angioplasty: a case report.
Eur Heart J Case Rep. 2022;6:ytac080.
Abstract

CLEMENTS W, Venn G, McGiffin D, Moriarty HK, et al
Chronic Thromboembolic Pulmonary Hypertension (CTEPH) and massive hemoptysis: The rationale for bronchial artery embolization.
Respir Med. 2022 Feb 24:106784. doi: 10.1016/j.rmed.2022.106784.
Abstract

WALSH LJ, Collins C, Ibrahim H, Kerins DM, et al
Pulmonary arterial hypertension in hereditary hemorrhagic telangiectasia associated with ACVRL1 mutation: a case report.
J Med Case Rep. 2022;16:99.
Abstract

WANG Q, Sun Y, Zhao Q, Wu W, et al
Circular RNAs in pulmonary hypertension: Emerging biological concepts and potential mechanism.
Animal Model Exp Med. 2022;5:38-47.
Abstract

RUDENKO T, Kamyshova E, Vasilyeva M, Bobkova I, et al
Pulmonary Hypertension in Non-dialysis Chronic Kidney Disease: Its Prevalence and Possible Risk Factors.
Saudi J Kidney Dis Transpl. 2021;32:1184-1185.
Abstract

WERNER F, Kojonazarov B, Gassner B, Abesser M, et al
Correction to: Endothelial actions of atrial natriuretic peptide prevent pulmonary hypertension in mice.
Basic Res Cardiol. 2022;117:7.
Abstract

HOPE KD, Spinner JA
Right-Sided Heart Failure and Cor Pulmonale in the Pediatric Patient.
Pediatr Rev. 2022;43:188-190.
Abstract

HUITEMA MP, Mathijssen H, Bakker ALM, Mager JJ, et al
Four-year survival rate in pulmonary sarcoidosis with extensive pulmonary hypertension screening.
Respir Med. 2022 Feb 20:106762. doi: 10.1016/j.rmed.2022.106762.
Abstract

DIAO W, Liu G, Shi C, Jiang Y, et al
Evaluating the Effect of Circ-Sirt1 on the Expression of SIRT1 and Its Role in Pathology of Pulmonary Hypertension.
Cell Transplant. 2022;31:9636897221081479.
Abstract

VERWERFT J, Verbrugge FH, Claessen G, Herbots L, et al
Exercise Systolic Reserve and Exercise Pulmonary Hypertension Improve Diagnosis of Heart Failure With Preserved Ejection Fraction.
Front Cardiovasc Med. 2022;9:814601.
Abstract

CARTA AF, Lichtblau M, Berlier C, Saxer S, et al
The Impact of Breathing Hypoxic Gas and Oxygen on Pulmonary Hemodynamics in Patients With Pulmonary Hypertension.
Front Med (Lausanne). 2022;9:791423.
Abstract

JIA Z, Yan H, Wang S, Wang L, et al
Shufeiya Recipe Improves Monocrotaline-Induced Pulmonary Hypertension in Rats by Regulating SIRT3/FOXO3a and Its Downstream Signaling Pathways.
Dis Markers. 2022;2022:3229888.
Abstract

TZOUMAS A, Peppas S, Sagris M, Papanastasiou CA, et al
Advances in treatment of chronic thromboembolic pulmonary hypertension.
Thromb Res. 2022;212:30-37.
Abstract

GOSCINIAK P, Larysz M, Sagan L, Larysz B, et al
Effective Balloon Pulmonary Angioplasty in a Patient with Chronic Thromboembolic Complications after Ventriculoatrial Shunt for Hydrocephalus in von Hippel-Lindau Disease.
Medicina (Kaunas). 2022;58.
Abstract

AKASLAN D, Atas H, Aslanger E, Kanar BG, et al
Change in pulmonary arterial compliance and pulmonary pulsatile stress after balloon pulmonary angioplasty.
Anatol J Cardiol. 2022;26:43-48.
Abstract

FU Z, Zhang J
Molecular hydrogen is a promising therapeutic agent for pulmonary disease.
J Zhejiang Univ Sci B. 2022;23:102-122.
Abstract

STEFFES LC, Austin ED
Upfront Combination Therapy: Growing the Case to Get Ahead of Pediatric Pulmonary Arterial Hypertension.
Ann Am Thorac Soc. 2022;19:163-165.
Abstract

DOI A, Gajera J, Niewodowski D, Gangahanumaiah S, et al
Surgical management of giant pulmonary artery aneurysms in patients with severe pulmonary arterial hypertension.
J Card Surg. 2022;37:1019-1025.
Abstract

WU Y, Pan B, Zhang Z, Li X, et al
Caspase-4/11-Mediated Pulmonary Artery Endothelial Cell Pyroptosis Contributes to Pulmonary Arterial Hypertension.
Hypertension. 2022 Jan 5:HYPERTENSIONAHA12117868.
Abstract

WANG MT, Charng MJ, Chi PL, Cheng CC, et al
Gene Mutation Annotation and Pedigree for Pulmonary Arterial Hypertension Patients in Han Chinese Patients.
Glob Heart. 2021;16:70.
Abstract

ROSSI R, Coppi F, Monopoli DE, Sgura FA, et al
Pulmonary arterial hypertension and right ventricular systolic dysfunction in COVID-19 survivors.
Cardiol J. 2022;29:163-165.
Abstract

CHEN Y, Li S, Xu Z, Zhang Y, et al
Aerobic training-mediated DNA hypermethylation of Agtr1a and Mas1 genes ameliorate mesenteric arterial function in spontaneously hypertensive rats.
Mol Biol Rep. 2021;48:8033-8044.
Abstract

EILERS LF, Kyle WB, Allen HD, Qureshi AM, et al
Patent Ductus Arteriosus.
Pediatr Rev. 2021;42:632-634.
Abstract

SUNG SH, Yeh WY, Chiang CE, Huang CJ, et al
The prognostic significance of the alterations of pulmonary hemodynamics in patients with pulmonary arterial hypertension: a meta-regression analysis of randomized controlled trials.
Syst Rev. 2021;10:284.
Abstract

DUSIK M, Fingrova Z, Ambroz D, Jansa P, et al
The Role of Pulmonary Artery Wedge Pressure on the Incidence of Atrial Fibrillation and Atrial Tachycardias in Patients With Isolated Pre-capillary Pulmonary Hypertension.
Physiol Res. 2021;70:841-849.
Abstract

SU J, Simonsen U, Mellemkjaer S, Howard LS, et al
Limited value of pulse wave analysis in assessing arterial wave reflection and stiffness in the pulmonary artery.
Physiol Rep. 2021;9:e15024.
Abstract

DEWEIRDT J, Ducret T, Quignard JF, Freund-Michel V, et al
Effects of FW2 Nanoparticles Toxicity in a New In Vitro Pulmonary Vascular Cells Model Mimicking Endothelial Dysfunction.
Cardiovasc Toxicol. 2022;22:14-28.
Abstract

ZHANG Y, Tang J, Li N, Tao J, et al
Prenatal hypoxia induced ETBR activation and abnormal ROS signalling in pulmonary artery cells of rat offspring.
Reprod Toxicol. 2021;105:91-100.
Abstract

KHOURY J, Adir Y, Gayer T, Kompanietz D, et al
Veno-venous extracorporeal membrane oxygenation in pulmonary arterial hypertension - Bridging to recovery.
Respir Med Res. 2021;80:100848.
Abstract

SARZYNSKA K, Swiatoniowska-Lonc N, Dudek K, Jonas K, et al
Quality of life of patients with pulmonary arterial hypertension: a meta-analysis.
Eur Rev Med Pharmacol Sci. 2021;25:4983-4998.
Abstract

ZHAO Q, Guo N, Chen J, Parks D, et al
Comparative assessment of efficacy and safety of ambrisentan and bosentan in patients with pulmonary arterial hypertension: A meta-analysis.
J Clin Pharm Ther. 2022;47:146-156.
Abstract

DOUWES JM, Zijlstra WMH, Rosenzweig EB, Ploegstra MJ, et al
Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, Combine.
Ann Am Thorac Soc. 2022;19:227-237.
Abstract

SARANGARM P, Elwood K
Transition from IV epoprostenol to oral treprostinil in a patient with group 1 pulmonary arterial hypertension.
Am J Health Syst Pharm. 2021;78:2110-2115.
Abstract

YILMAZ ES, Uzun O
Low-dose thrombolysis for submassive pulmonary embolism.
J Investig Med. 2021;69:1439-1446.
Abstract

LYU DM, Goff RR, Chan KM
The Lung Allocation Score and Its Relevance.
Semin Respir Crit Care Med. 2021;42:346-356.
Abstract

ROMANIELLO A, Rubattu S, Vaiarello V, Gigante A, et al
Circulating NT-proANP level is a predictor of mortality for systemic sclerosis: a retrospective study of an Italian cohort.
Expert Rev Clin Immunol. 2021;17:661-666.
Abstract

ATEF H, Abdeen H
Effect of exercise on sleep and cardiopulmonary parameters in patients with pulmonary artery hypertension.
Sleep Breath. 2021;25:1953-1960.
Abstract

DUNMORE BJ, Jones RJ, Toshner MR, Upton PD, et al
Approaches to treat pulmonary arterial hypertension by targeting BMPR2: from cell membrane to nucleus.
Cardiovasc Res. 2021;117:2309-2325.
Abstract

KUSAKA K, Nakano K, Fukuyo S, Miyazaki Y, et al
A Case of Mixed Connective Tissue Disease Complicated by Pulmonary Hypertension and Ascites After Addition of Pulmonary Vasodilators.
Mod Rheumatol Case Rep. 2022 Mar 11. pii: 6547077. doi: 10.1093.
Abstract

MIZUNO T, Sasaki K, Suzuki S, Nagao I, et al
Case Report: Tricuspid Annuloplasty for Right-Sided Congestive Heart Failure Secondary to Pulmonary Hypertension in a Dog.
Front Vet Sci. 2022;9:843792.
Abstract

SANTOS-MARTINEZ LE
[Pulmonary hypertension. Defining the structure and the departmental function based on risk].
Rev Med Inst Mex Seguro Soc. 2021;60:59-66.
Abstract

MELZIG C, Do TD, Egenlauf B, Partovi S, et al
Diagnostic accuracy of automated 3D volumetry of cardiac chambers by CT pulmonary angiography for identification of pulmonary hypertension due to left heart disease.
Eur Radiol. 2022 Mar 10. pii: 10.1007/s00330-022-08663.
Abstract

RAWLINGS GH, Beail N, Armstrong I, Thompson AR, et al
Self-help cognitive behavioural therapy for anxiety in pulmonary hypertension: pilot randomised controlled trial.
ERJ Open Res. 2022;8.
Abstract

GARCIA MVF, Souza R, Caruso P
External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension.
ERJ Open Res. 2022;8.
Abstract

CONDLIFFE R, Bauchmuller K, Southern J, Kiely DG, et al
Reply: External validation of the OPALS prediction model for in-hospital mortality in patients with acute decompensated pulmonary hypertension.
ERJ Open Res. 2022;8.
Abstract

TROFIMOV NA, Rodionov AL, Egorov DV, Surkova TV, et al
Histological Justification for the Need of Radiofrequency Ablation of Pulmonary Arteries in Patients with High-Grade Secondary Pulmonary Hypertension.
Sovrem Tekhnologii Med. 2021;13:56-62.
Abstract

LECHARTIER B, Chaouat A, Aubert JD, Schwitter J, et al
Magnetic resonance imaging in pulmonary hypertension: an overview of current applications and future perspectives.
Swiss Med Wkly. 2022;152:w30055.
Abstract

SLAWEK-SZMYT S, Araszkiewicz A, Grygier M, Zielinski D, et al
Chronic thromboembolic pulmonary hypertension complicated by left main compression syndrome.
Kardiol Pol. 2022 Mar 8. pii: VM/OJS/J/88903. doi: 10.33963/KP.a2022.0067.
Abstract

CALVIER L, Herz J, Hansmann G
Interplay of Low-Density Lipoprotein Receptors, LRPs, and Lipoproteins in Pulmonary Hypertension.
JACC Basic Transl Sci. 2022;7:164-180.
Abstract

WANG J, Niu Y, Luo L, Lu Z, et al
Decoding ceRNA regulatory network in the pulmonary artery of hypoxia-induced pulmonary hypertension (HPH) rat model.
Cell Biosci. 2022;12:27.
Abstract

YOGESWARAN A, Kuhnert S, Gall H, Faber M, et al
Relevance of Cor Pulmonale in COPD With and Without Pulmonary Hypertension: A Retrospective Cohort Study.
Front Cardiovasc Med. 2022;9:826369.
Abstract

ZHANG Y, Li X, Luo Q, Zhao Q, et al
Heart-Rate Recovery at 1 Min After Exercise Predicts Response to Balloon Pulmonary Angioplasty in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension.
Front Cardiovasc Med. 2022;9:795420.
Abstract

MAI AS, Lim OZH, Ho YJ, Kong G, et al
Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis.
Front Med (Lausanne). 2022;9:765461.
Abstract

BENMESSAOUD FA, Bendagha N, Soufiani A, Konate L, et al
[Percutaneous dilation of mitral stenosis in patients with severe pulmonary hypertension during pregnancy].
Pan Afr Med J. 2021;40:265.
Abstract

FUNK-HILSDORF TC, Behrens F, Grune J, Simmons S, et al
Dysregulated Immunity in Pulmonary Hypertension: From Companion to Composer.
Front Physiol. 2022;13:819145.
Abstract

WANG Q, Tian J, Li X, Liu X, et al
Upregulation of Endothelial DKK1 (Dickkopf 1) Promotes the Development of Pulmonary Hypertension Through the Sp1 (Specificity Protein 1)/SHMT2 (Serine Hydroxymethyltransferase 2) Pathway.
Hypertension. 2022 Mar 7:HYPERTENSIONAHA12118672.
Abstract

KAWAI M, Zhang E, Kabwe JC, Okada A, et al
Lung damage created by high tidal volume ventilation in rats with monocrotaline-induced pulmonary hypertension.
BMC Pulm Med. 2022;22:78.
Abstract

SLIVNICK J, Zareba KM, Varghese J, Truong V, et al
Prevalence and haemodynamic profiles of pulmonary hypertension in cardiac amyloidosis.
Open Heart. 2022;9.
Abstract

MOHRI T, Goda A, Takeuchi K, Kikuchi H, et al
High prevalence of occult left ventricular diastolic dysfunction detected by exercise stress test in systemic sclerosis.
Sci Rep. 2022;12:2423.
Abstract

KOLSTAD KD, Khatri A, Donato M, Chang SE, et al
Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension.
Arthritis Res Ther. 2022;24:39.
Abstract

DAI HL, Zhang WH, Guang XF
A 49-Year-Old Woman With Progressive Dyspnea.
JAMA Cardiol. 2022;7:e214920.
Abstract

COSTAGUTA A, Gutierrez MG, Costaguta G, Reyes N, et al
Long term remission of portopulmonary hypertension with liver transplantation in a patient with cirrhosis associated to autoimmune hepatitis.
Arch Argent Pediatr. 2022;120:e17-e20.
Abstract

SHOJI H, Yoshida Y, Sanada TJ, Naito A, et al
The Isoquinoline-Sulfonamide Compound H-1337 Attenuates SU5416/Hypoxia-Induced Pulmonary Arterial Hypertension in Rats.
Cells. 2021;11.
Abstract

TORBIC H, Hohlfelder B, Krishnan S, Tonelli AR, et al
A Review of Pulmonary Arterial Hypertension Treatment in Extracorporeal Membrane Oxygenation: A Case Series of Adult Patients.
J Cardiovasc Pharmacol Ther. 2022;27:10742484211069005.
Abstract

TIAN F, Song W, Wang L, Zeng Q, et al
NT-pro BNP in AECOPD-PH: old biomarker, new insights-based on a large retrospective case-controlled study.
Respir Res. 2021;22:321.
Abstract

XIONG J, Yu S, Liu R, Fang X, et al
The Role of Conjunctival Microvasculation Combined with Echocardiography in Evaluating Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus.
Dis Markers. 2021;2021:2135942.
Abstract

BRENT MB
A review of the skeletal effects of exposure to high altitude and potential mechanisms for hypobaric hypoxia-induced bone loss.
Bone. 2022;154:116258.
Abstract

SARZYNSKA K, Polanski J, Kopec G, Mroczek E, et al
Cultural adaptation and validation of the Polish version of the Pulmonary Arterial Hypertension-Symptoms and Impact (PAH-SYMPACT) questionnaire.
Kardiol Pol. 2021;79:1372-1374.
Abstract

GALIE N, Gaine S, Channick R, Coghlan JG, et al
Long-Term Survival, Safety and Tolerability with Selexipag in Patients with Pulmonary Arterial Hypertension: Results from GRIPHON and its Open-Label Extension.
Adv Ther. 2022;39:796-810.
Abstract

TARIQ S, Tervaert JWC, Osman M
Diagnosis of pulmonary arterial hypertension preceding the confirmation of systemic sclerosis in a patient with Raynaud's phenomenon.
Microvasc Res. 2022;139:104267.
Abstract

KUMAR S, Frid MG, Zhang H, Li M, et al
Complement-containing small extracellular vesicles from adventitial fibroblasts induce proinflammatory and metabolic reprogramming in macrophages.
JCI Insight. 2021;6.
Abstract

ALFONSO F, Garcia-Guimaraes M, Alvarado T, Sanz-Ruiz R, et al
Clinical implications of arterial hypertension in patients with spontaneous coronary artery dissection.
Coron Artery Dis. 2022;33:75-80.
Abstract

GIERHARDT M, Pak O, Sydykov A, Kraut S, et al
Genetic deletion of p66shc and/or cyclophilin D results in decreased pulmonary vascular tone.
Cardiovasc Res. 2022;118:305-315.
Abstract

PENUMATSA KC, Singhal AA, Warburton RR, Bear MD, et al
Vascular smooth muscle ROCK1 contributes to hypoxia-induced pulmonary hypertension development in mice.
Biochem Biophys Res Commun. 2022;604:137-143.
Abstract

WALSH KF, Lui JK
Post-tuberculosis pulmonary hypertension: a case of global disparity in health care.
Lancet Glob Health. 2022;10:e476.
Abstract

PUGLIESE NR, Mazzola M, Madonna R, Gargani L, et al
Exercise-induced pulmonary hypertension in HFpEF and HFrEF: Different pathophysiologic mechanism behind similar functional impairment.
Vascul Pharmacol. 2022 Mar 14:106978. doi: 10.1016/j.vph.2022.106978.
Abstract

LYSSENS A, Lekane M, Gommeren K, Merveille AC, et al
Focused Cardiac Ultrasound to Detect Pre-capillary Pulmonary Hypertension.
Front Vet Sci. 2022;9:830275.
Abstract

DING XH, Chai X, Zheng J, Chang H, et al
Baseline Ratio of Soluble Fas/FasL Predicts Onset of Pulmonary Hypertension in Elder Patients Undergoing Maintenance Hemodialysis: A Prospective Cohort Study.
Front Physiol. 2022;13:847172.
Abstract

SHIBAYAMA J, Tada H, Morita M, Yoshida S, et al
A Case of Pulmonary Hypertension in a 67-Year-Old Woman with Thiamine Deficiency Following Partial Gastrectomy and Exacerbated by Diuretics.
Am J Case Rep. 2022;23:e935308.
Abstract

ZENG QX, Yang T, Xi QY, Zhao ZH, et al
Bilateral pulmonary artery stenosis with pulmonary hypertension due to Takayasu's arteritis, examined using quantitative flow ratio during revascularization.
Eur Heart J Case Rep. 2021;6:ytab495.
Abstract

KARPOV AA, Vaulina DD, Smirnov SS, Moiseeva OM, et al
Rodent models of pulmonary embolism and chronic thromboembolic pulmonary hypertension.
Heliyon. 2022;8:e09014.
Abstract

NEDER JA, Berton DC, O'Donnell DE
Breathing too much! Ventilatory inefficiency and exertional dyspnea in pulmonary hypertension.
J Bras Pneumol. 2022;48:e20220037.
Abstract

BIKOU O, Tharakan S, Yamada K, Kariya T, et al
Endo-bronchial aerosolized AAV1.SERCA2a gene therapy in a pulmonary hypertension pig model: addressing the lung delivery bottleneck.
Hum Gene Ther. 2022 Mar 16. doi: 10.1089/hum.2021.
Abstract

BONNET D, Szezepanski I, Delacourt C, Malkezadeh-Milani S, et al
Multifactorial pulmonary hypertension in infantile scimitar syndrome.
Arch Cardiovasc Dis. 2022 Mar 4. pii: S1875-2136(22)00044.
Abstract

AURANGABADKAR GM, Lanjewar AV, Jadhav US, Ali SN, et al
Evaluation of Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease.
Cureus. 2022;14:e21828.
Abstract

AN J, Nam Y, Cho H, Chang J, et al
Acute Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension: Clinical and Serial CT Pulmonary Angiographic Features.
J Korean Med Sci. 2022;37:e76.
Abstract

WU XG, Shi YJ, Wang XH, Yu XW, et al
Diagnostic value of computed tomography-based pulmonary artery to aorta ratio measurement in chronic obstructive pulmonary disease with pulmonary hypertension: A systematic review and meta-analysis.
Clin Respir J. 2022 Mar 14. doi: 10.1111/crj.13485.
Abstract

SAKARIN S, Rungsipipat A, Surachetpong SD
Expression of apoptotic proteins in the pulmonary artery of dogs with pulmonary hypertension secondary to degenerative mitral valve disease.
Res Vet Sci. 2022;145:238-247.
Abstract

CHIU SN, Lu CW, Lin MT, Chen CA, et al
Pulmonary Hypertension in Adult Congenital Heart Disease in Asia: A Distinctive Feature of Complex Congenital Heart Disease.
J Am Heart Assoc. 2022 Mar 14:e022596. doi: 10.1161/JAHA.121.022596.
Abstract

HE W, Liu C, Liao J, Liu F, et al
TIMP-1: A Circulating Biomarker for Pulmonary Hypertension Diagnosis Among Chronic Obstructive Pulmonary Disease Patients.
Front Med (Lausanne). 2022;8:774623.
Abstract

YAMAGATA Y, Ikeda S, Kojima S, Ueno Y, et al
Right Ventricular Dyssynchrony in Patients With Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension.
Circ J. 2022 Mar 12. doi: 10.1253/circj.CJ-21-0849.
Abstract

SINGH SP, Raju SN, Singh A
In response to the article "Main pulmonary artery-to-descending aorta ratio in computed tomography: cut-off value to diagnose pulmonary hypertension in children". Pol J Radiol 2021; 86: e87-e125.
Pol J Radiol. 2022;87:e125.
Abstract

CHAI T, Qiu C, Xian Z, Lu Y, et al
A narrative review of research advances in hypoxic pulmonary hypertension.
Ann Transl Med. 2022;10:230.
Abstract

LEPSY N, Dering MR, Fuge J, Meltendorf T, et al
Childhood Maltreatment, Mental Well-Being, and Healthy Lifestyle in Patients With Chronic Thromboembolic Pulmonary Hypertension.
Front Psychiatry. 2022;13:821468.
Abstract

ZHANG RY, Liu J, Sun Y, Wang W, et al
[Metabolic reprogramming in pulmonary hypertension].
Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:313-317.
Abstract

CHEN YL, Zhang TT, Chen YQ, Wang J, et al
[Progress on the pathogenesis of chronic thromboembolic pulmonary hypertension].
Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:304-308.
Abstract

YANG L, Zhang L, Chen S, Li M, et al
Efficacy of interatrial shunt devices: an opening window to acute pulmonary hypertensive crisis and chronic pulmonary arterial hypertension.
J Thromb Thrombolysis. 2022 Mar 13. pii: 10.1007/s11239-022-02635.
Abstract

YI J, Wang X, Song K, Ren J, et al
Integrated metabolomics and mechanism to reveal the protective effect of kaempferol on pulmonary arterial hypertension.
J Pharm Biomed Anal. 2022;212:114662.
Abstract

MLECZKO M, Gerkowicz A, Krasowska D
Chronic Inflammation as the Underlying Mechanism of the Development of Lung Diseases in Psoriasis: A Systematic Review.
Int J Mol Sci. 2022;23.
Abstract

AJAM M, Drake M, Ran R, Mukundan S, et al
Approach to echocardiography in ARDS patients in the prone position: A systematic review.
Echocardiography. 2022;39:330-338.
Abstract

KASSIS-GEORGE H, Raina A
Normal resting and exercise hemodynamics in pulmonary arterial hypertension: The roadmap to prostacyclin withdrawal?
Int J Cardiol. 2022;350:109-110.
Abstract

ZHANG W, Qi Y, Wu B
MicroRNA-146-5p Promotes Pulmonary Artery Endothelial Cell Proliferation under Hypoxic Conditions through Regulating USP3.
Dis Markers. 2021;2021:3668422.
Abstract

PAN Y, Sun Y, He L
Predictive factors for concomitant pulmonary arterial hypertension at diagnosis of systemic lupus erythematosus in a Chinese population.
Int J Rheum Dis. 2022;25:76-82.
Abstract

LI N, Zhu L, Zhu C, Zhou H, et al
BMPR2 promoter methylation and its expression in valvular heart disease complicated with pulmonary artery hypertension.
Aging (Albany NY). 2021;13:24580-24604.
Abstract

KACPRZAK A, Burakowska B, Kurzyna M, Fijalkowska A, et al
Predictive value of chest HRCT for survival in idiopathic pulmonary arterial hypertension.
Respir Res. 2021;22:293.
Abstract

DING Y, Tu P, Chen Y, Huang Y, et al
CYP2J2 and EETs protect against pulmonary arterial hypertension with lung ischemia-reperfusion injury in vivo and in vitro.
Respir Res. 2021;22:291.
Abstract

XANTHOULI P, Theobald V, Benjamin N, Marra AM, et al
Prognostic impact of hypochromic erythrocytes in patients with pulmonary arterial hypertension.
Respir Res. 2021;22:288.
Abstract

BERTOLIZIO G, Engelhardt T, Veyckemans F
Congenital interstitial lung diseases: What the anaesthesiologist needs to know.
Paediatr Anaesth. 2021 Nov 5. doi: 10.1111/pan.14325.
Abstract

RAMPA DR, Murugesan P, Chao H, Feng H, et al
Reversal of pulmonary arterial hypertension and neointimal formation by kinin B1 receptor blockade.
Respir Res. 2021;22:281.
Abstract

UMEI M, Saito A, Soma K, Inaba T, et al
Clinical Outcome of Closure of a Small Atrial Septal Defect in a Patient with Pulmonary Arterial Hypertension.
Intern Med. 2022;61:851-855.
Abstract

LI P, Song J, Du H, Lu Y, et al
MicroRNA-663 prevents monocrotaline-induced pulmonary arterial hypertension by targeting TGF-beta1/smad2/3 signaling.
J Mol Cell Cardiol. 2021;161:9-22.
Abstract

MIGLANI M, Pasha Q, Gupta A, Priyadarshini A, et al
Seeding drug discovery: Telomeric tankyrase as a pharmacological target for the pathophysiology of high-altitude hypoxia.
Drug Discov Today. 2021;26:2774-2781.
Abstract

VLACHOU M, Fayed H, Dawson A, Reddecliffe S, et al
Intravenous prostanoids in systemic sclerosis-associated pulmonary arterial hypertension: a single-centre experience.
Rheumatology (Oxford). 2022;61:1106-1114.
Abstract

LAI J, Guo X, Zhao J, Wang H, et al
Interventricular systolic asynchrony predicts prognosis in patients with systemic sclerosis-associated pulmonary arterial hypertension.
Rheumatology (Oxford). 2022;61:983-991.
Abstract

LEE C, Hamlyn J, Porcelli J, Schmit A, et al
Practical considerations in the management of inhaled prostacyclin therapy for pulmonary hypertension associated with interstitial lung disease (WHO group 3).
Respir Med. 2022;196:106806.
Abstract

WU XH, Ma JL, Ding D, Ma YJ, et al
Experimental animal models of pulmonary hypertension: Development and challenges.
Animal Model Exp Med. 2022 Mar 25. doi: 10.1002/ame2.12220.
Abstract

BOXHAMMER E, Mirna M, Baz L, Bacher N, et al
Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
Life (Basel). 2022;12.
Abstract

JIANG R, Wang L, Zhao QH, Wu C, et al
Echocardiography Nomogram for Predicting Survival among Chronic Lung Disease Patients with Severe Pulmonary Hypertension.
J Clin Med. 2022;11.
Abstract

RUARO B, Salton F, Baratella E, Confalonieri P, et al
An Overview of Different Techniques for Improving the Treatment of Pulmonary Hypertension Secondary in Systemic Sclerosis Patients.
Diagnostics (Basel). 2022;12.
Abstract

SIEFKES H, Sunderji S, Vaughn J, Sankaran D, et al
Factors to Consider to Study Preductal Oxygen Saturation Targets in Neonatal Pulmonary Hypertension.
Children (Basel). 2022;9.
Abstract

KUROPATKINA T, Pavlova O, Gulyaev M, Pirogov Y, et al
Sex-Dependent Protective Effect of Combined Application of Solubilized Ubiquinol and Selenium on Monocrotaline-Induced Pulmonary Hypertension in Wistar Rats.
Antioxidants (Basel). 2022;11.
Abstract

REYES-GARCIA J, Carbajal-Garcia A, Di Mise A, Zheng YM, et al
Important Functions and Molecular Mechanisms of Mitochondrial Redox Signaling in Pulmonary Hypertension.
Antioxidants (Basel). 2022;11.
Abstract

DALEN ML, Vigerust NF, Hammarstrom C, Holmstrom H, et al
Neonatal interstitial lung disease in a girl with Jacobsen syndrome: a case report.
J Med Case Rep. 2022;16:117.
Abstract

LE PENNEC R, Tromeur C, Orione C, Robin P, et al
Lung Ventilation/Perfusion Scintigraphy for the Screening of Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Which Criteria to Use?
Front Med (Lausanne). 2022;9:851935.
Abstract

CASTILLO-GALAN S, Arenas GA, Iturriaga R
CONTRIBUTION OF STIM-ACTIVATED TRPC-ORAI CHANNELS IN PULMONARY HYPERTENSION INDUCED BY CHRONIC SUSTAINED AND INTERMITTENT HYPOXIA.
Curr Vasc Pharmacol. 2022 Mar 21. pii: CVP-EPUB-121749.
Abstract

YOSHIDA T, Nagaoka T, Nagata Y, Suzuki Y, et al
Periostin-related progression of different types of experimental pulmonary hypertension: A role for M2 macrophage and FGF-2 signalling.
Respirology. 2022 Mar 22. doi: 10.1111/resp.14249.
Abstract

GUPTA R, Baughman RP, Nathan SD, Wells AU, et al
The six-minute walk test in sarcoidosis associated pulmonary hypertension: Results from an international registry.
Respir Med. 2022;196:106801.
Abstract

MCNAMARA PJ, Giesinger RE, Lakshminrusimha S
Dopamine and Neonatal Pulmonary Hypertension - Pressing Need for a Better Pressor?
J Pediatr. 2022 Mar 18. pii: S0022-3476(22)00207.
Abstract

BALDI BG, Souza R
Pulmonary Hypertension in Interstitial Lung Disease.
Arch Bronconeumol. 2022 Feb 12. pii: S0300-2896(22)00092.
Abstract

BLANCO I, Torres-Castro R, Barbera JA
Exercise tolerance in pulmonary hypertension.
Arch Bronconeumol. 2021 Dec 6. pii: S0300-2896(21)00388.
Abstract

JOHNSON SW, Gillmeyer KR, Bolton RE, McCullough MB, et al
Variable Monitoring of Veterans with Group 3 Pulmonary Hypertension Treated with Off-Label Pulmonary Vasodilator Therapy.
Ann Am Thorac Soc. 2022 Mar 21. doi: 10.1513/AnnalsATS.202110-1168.
Abstract

SANG P, Kucherenko MM, Yao J, Li Q, et al
A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats.
J Vis Exp. 2022;.
Abstract

GARCIA-GONZALEZ MA, Vallejo-Ruiz V, Atonal-Flores F, Flores-Hernandez J, et al
Sildenafil prevents right ventricular hypertrophy and improves heart rate variability in rats with pulmonary hypertension secondary to experimental diabetes.
Clin Exp Hypertens. 2022 Mar 20:1-11. doi: 10.1080/10641963.2022.2050743.
Abstract

WANG S, Yan Y, Xu WJ, Gong SG, et al
The Role of Glutamine and Glutaminase in Pulmonary Hypertension.
Front Cardiovasc Med. 2022;9:838657.
Abstract

DERING MR, Lepsy N, Fuge J, Meltendorf T, et al
Prevalence of Mental Disorders in Patients With Chronic Thromboembolic Pulmonary Hypertension.
Front Psychiatry. 2022;13:821466.
Abstract

GOMES MT, Bai Y, Potje SR, Zhang L, et al
Signal Transduction during Metabolic and Inflammatory Reprogramming in Pulmonary Vascular Remodeling.
Int J Mol Sci. 2022;23.
Abstract

CHEN J, Tian Z, Zhang H, Shi L, et al
Risks of postoperative respiratory failure in elderly patients after hip surgery: a retrospective study.
J Orthop Surg Res. 2022;17:140.
Abstract

WANG J, Uddin MN, Li Q, Aierken A, et al
Identifying Potential Mitochondrial Proteome Signatures Associated with the Pathogenesis of Pulmonary Arterial Hypertension in the Rat Model.
Oxid Med Cell Longev. 2022;2022:8401924.
Abstract

KRAUTER C, Reiter U, Kovacs G, Reiter C, et al
Automated vortical blood flow-based estimation of mean pulmonary arterial pressure from 4D flow MRI.
Magn Reson Imaging. 2022 Feb 18. pii: S0730-725X(22)00032.
Abstract

HEERDT PM, Singh I, Elassal A, Kheyfets V, et al
Pressure-based estimation of right ventricular ejection fraction.
ESC Heart Fail. 2022;9:1436-1443.
Abstract

BAUMANN P, Greco F, Wiegert S, Wellmann S, et al
Macitentan attenuates cardiovascular remodelling in infant rats with chronic lung disease.
J Transl Med. 2022;20:77.
Abstract

ALVAREZ P, Briasoulis A
Innovations and challenges across the heart failure spectrum.
Rev Cardiovasc Med. 2022;23:35.
Abstract

PANT S, Sizarov A, Knepper A, Gossard G, et al
Multiscale modelling of Potts shunt as a potential palliative treatment for suprasystemic idiopathic pulmonary artery hypertension: a paediatric case study.
Biomech Model Mechanobiol. 2022;21:471-511.
Abstract

WATANABE T, Ishikawa M, Abe K, Ishikawa T, et al
Increased Lung Uric Acid Deteriorates Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2021;10:e022712.
Abstract

H CANBEYLI F, Atasayan V, Tokgoz S, Tunaoglu FS, et al
Health-related quality of life and parental depression in children with pulmonary arterial hypertension.
Pediatr Pulmonol. 2022;57:544-550.
Abstract

ZHANG Y, Zervopoulos SD, Boukouris AE, Lorenzana-Carrillo MA, et al
SNPs for Genes Encoding the Mitochondrial Proteins Sirtuin3 and Uncoupling Protein 2 Are Associated With Disease Severity, Type 2 Diabetes, and Outcomes in Patients With Pulmonary Arterial Hypertension and This Is Recapitulated in a New Mouse Model La
J Am Heart Assoc. 2021;10:e020451.
Abstract

MIRTAJADDINI M, Naderi N, Chenaghlou M, Taghavi S, et al
The prediction of right atrial pressure using electrocardiogram: a novel approach.
ESC Heart Fail. 2021;8:5040-5044.
Abstract

ROSENKRANZ S, Feldman J, McLaughlin VV, Rischard F, et al
Selonsertib in adults with pulmonary arterial hypertension (ARROW): a randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet Respir Med. 2022;10:35-46.
Abstract

JANKOWICH M, Maron BA, Choudhary G
Mildly elevated pulmonary artery systolic pressure on echocardiography: bridging the gap in current guidelines.
Lancet Respir Med. 2021;9:1185-1191.
Abstract

LIU Y, Hu R, Zhu J, Nie X, et al
The lncRNA PAHRF functions as a competing endogenous RNA to regulate MST1 expression by sponging miR-23a-3p in pulmonary arterial hypertension.
Vascul Pharmacol. 2021;139:106886.
Abstract

HODGSON J, Ruiz-Llorente L, McDonald J, Quarrell O, et al
Homozygous GDF2 nonsense mutations result in a loss of circulating BMP9 and BMP10 and are associated with either PAH or an "HHT-like" syndrome in children.
Mol Genet Genomic Med. 2021;9:e1685.
Abstract

GLOWACKI K, Grabka M, Myszor J, Maciejewski T, et al
Pregnant 30-year-old with idiopathic pulmonary arterial hypertension.
Ginekol Pol. 2021;92:252-253.
Abstract

DENG H, Tian X, Sun H, Liu H, et al
Calpain-1 mediates vascular remodelling and fibrosis via HIF-1alpha in hypoxia-induced pulmonary hypertension.
J Cell Mol Med. 2022 Apr 1. doi: 10.1111/jcmm.17295.
Abstract

YEO J, Shin N, Ahn KJ, Seo M, et al
Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension.
Clin Hypertens. 2022;28:10.
Abstract

ZHONG XJ, Jiang R, Yang L, Yuan P, et al
Peak oxygen uptake is a strong prognostic predictor for pulmonary hypertension due to left heart disease.
BMC Cardiovasc Disord. 2022;22:137.
Abstract

SHAHIN Y, Alabed S, Rehan Quadery S, Lewis RA, et al
CMR Measures of Left Atrial Volume Index and Right Ventricular Function Have Prognostic Value in Chronic Thromboembolic Pulmonary Hypertension.
Front Med (Lausanne). 2022;9:840196.
Abstract

HUANG Z, Wang M, Hu F, Liu X, et al
Long-Term Outcomes After Percutaneous Transluminal Pulmonary Angioplasty in Patients With Takayasu Arteritis and Pulmonary Hypertension.
Front Immunol. 2022;13:828863.
Abstract

GOO HW, Park SH
Prediction of pulmonary hypertension using central-to-peripheral pulmonary vascular volume ratio on three-dimensional cardiothoracic CT in patients with congenital heart disease.
Jpn J Radiol. 2022 Mar 31. pii: 10.1007/s11604-022-01272.
Abstract

WOOD JC
Pulmonary hypertension in thalassemia: a call to action.
Blood. 2022;139:1937-1938.
Abstract

XIONG A, Liu Q, Zhong J, Cao Y, et al
Increased risk of mortality in systemic sclerosis-associated pulmonary hypertension: a systemic review and meta-analysis.
Adv Rheumatol. 2022;62:10.
Abstract

LI LX, Wei B, Yang M, Li M, et al
Efficacy and safety of bosentan in the treatment of persistent pulmonary hypertension of the newborn: a Metaanalysis.
Zhongguo Dang Dai Er Ke Za Zhi. 2022;24:319-325.
Abstract

HERESI GA, Dean BB, Castillo H, Lee HF, et al
Identifying Patients with Group 3 Pulmonary Hypertension Associated with COPD or ILD Using an Administrative Claims Database.
Lung. 2022 Mar 29. pii: 10.1007/s00408-022-00521.
Abstract

QUTRIO BALOCH Z, Abbas SA, Prasad RM, Elamin AM, et al
Potential Role of Cardiopulmonary Exercise Testing as an Early Screening Tool for Patients With Suspected Pulmonary Hypertension Including Exercise-Induced Pulmonary Hypertension: Results From a Retrospective Analysis.
Perm J. 2021;25.
Abstract

SOLINC J, Raimbault-Machado J, Dierick F, El Bernoussi L, et al
Platelet-Derived Growth Factor Receptor Type alpha Activation Drives Pulmonary Vascular Remodeling Via Progenitor Cell Proliferation and Induces Pulmonary Hypertension.
J Am Heart Assoc. 2022 Mar 29:e023021. doi: 10.1161/JAHA.121.023021.
Abstract

CUETO-ROBLEDO G, Roldan-Valadez E, Graniel-Palafox LE, Garcia-Cesar M, et al
Chronic thromboembolic pulmonary hypertension (CTEPH): a review of another sequel of severe post-Covid-19 pneumonia.
Curr Probl Cardiol. 2022 Mar 25:101187. doi: 10.1016/j.cpcardiol.2022.101187.
Abstract

QIN X, Gao A, Hou X, Xu X, et al
Connexins may play a critical role in cigarette smoke-induced pulmonary hypertension.
Arch Toxicol. 2022 Mar 27. pii: 10.1007/s00204-022-03274.
Abstract

SRNKOVA P, Brucknerova J, Brucknerova I
Is inhaled nitric oxide a miraculous molecule? The analysis of nitric oxide use in newborns with persistent pulmonary hypertension of the newborn.
Bratisl Lek Listy. 2022;123:153-159.
Abstract

BUTT MU, Jabri A, Hamade H, Abdouh AA, et al
Predicting the Severity and Outcome of Persistent Pulmonary Hypertension of the Newborn Using New Echocardiography Parameters.
Curr Probl Cardiol. 2022 Mar 24:101181. doi: 10.1016/j.cpcardiol.2022.101181.
Abstract

XU ZY, Zhang HS, Li QQ, Zhang C, et al
[Impact of composite clinical worsening events on outcome of patients with pulmonary arterial hypertension associated with congenital heart disease].
Zhonghua Xin Xue Guan Bing Za Zhi. 2022;50:282-288.
Abstract

BENZA RL, Farber HW, Frost AE, Ghofrani HA, et al
Application of the REVEAL risk score calculator 2.0 in the CHEST study.
Respir Med. 2022;195:106783.
Abstract

VIZCARRA-VIZCARRA CA, Alcos-Mamani AL
High Altitude Pulmonary Edema in a Chronic Kidney Disease Patient-Is Peritoneal Dialysis A Risk Factor?
High Alt Med Biol. 2022;23:96-99.
Abstract

ZEREN M, Demir R, Sinan UY, Mustafaoglu R, et al
Prevalence of musculoskeletal pain and its impact on quality of life and functional exercise capacity in patients with pulmonary arterial hypertension.
Respir Med. 2022;193:106759.
Abstract

KHAN A, White RJ, Meyer G, Pulido Zamudio TR, et al
Oral treprostinil improves pulmonary vascular compliance in pulmonary arterial hypertension.
Respir Med. 2022;193:106744.
Abstract

WEN-TING L, Chang-Wei W, De-Jian B, Wei S, et al
Arterial partial pressure of oxygen and procalcitonin levels correlate with pulmonary artery systolic pressure in patients with active pulmonary tuberculosis.
Int J Infect Dis. 2022;117:87-92.
Abstract

WANG M, Su L, Sun J, Cai L, et al
FGF21 attenuates pulmonary arterial hypertension via downregulation of miR-130, which targets PPARgamma.
J Cell Mol Med. 2022;26:1034-1049.
Abstract

CHI PL, Cheng CC, Hung CC, Wang MT, et al
MMP-10 from M1 macrophages promotes pulmonary vascular remodeling and pulmonary arterial hypertension.
Int J Biol Sci. 2022;18:331-348.
Abstract

XU X, Wang X, Yang GC, Liu Q, et al
Identification of a novel mutation in the BMPR2 gene in a pulmonary arterial hypertension patient using next-generation sequencing.
J Clin Lab Anal. 2022;36:e24183.
Abstract

DIMARCO KG, Beasley KM, Shah K, Speros JP, et al
No effect of patent foramen ovale on acute mountain sickness and pulmonary pressure in normobaric hypoxia.
Exp Physiol. 2022;107:122-132.
Abstract

CHEN J, Rathinasabapathy A, Luo J, Yang X, et al
Differential serum lipid distribution in IPAH and CHD-PAH patients.
Respir Med. 2022;191:106711.
Abstract

ROSENKRANZ S, Channick R, Chin KM, Jenner B, et al
The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study.
Eur J Heart Fail. 2022;24:205-214.
Abstract

DYMEK P, Kielbowski K, Sienkiewicz S, Blaszkowski T, et al
Leiomyosarcoma in adrenal gland.
Endokrynol Pol. 2021;72:674-675.
Abstract

MEY JT, Rath MC, McLaughlin K, Galang M, et al
The breath print represents a novel biomarker of malnutrition in pulmonary arterial hypertension: a proof-of-concept study.
JPEN J Parenter Enteral Nutr. 2021 Oct 11. doi: 10.1002/jpen.2277.
Abstract

GE X, Zhang W, Zhu T, Huang N, et al
Hypoxia-activated platelets stimulate proliferation and migration of pulmonary arterial smooth muscle cells by phosphatidylserine/LOX-1 signaling-impelled intercellular communication.
Cell Signal. 2021;87:110149.
Abstract

ZHANG H, He H, Cui Y, Yu S, et al
Regulatory effects of HIF-1alpha and HO-1 in hypoxia-induced proliferation of pulmonary arterial smooth muscle cells in yak.
Cell Signal. 2021;87:110140.
Abstract

FUKUDA S, Nabetani M, Goldman RD, Shinomoto T, et al
Experience of cases with inhaled nitric oxide and therapeutic hypothermia.
Pediatr Int. 2022;64:e14901.
Abstract

YILDIZ M, Kahraman S, Surgit O, Zencirkiran Agus H, et al
Acute effects of inhaled iloprost on intracardiac conduction in patients with pulmonary arterial hypertension.
Herz. 2022;47:158-165.
Abstract

BELLAFRONTE NT, de Queiros Mattoso Ono A, Chiarello PG
Sarcopenic Obesity in Chronic Kidney Disease: Challenges in Diagnosis Using Different Diagnostic Criteria.
Med Princ Pract. 2021;30:477-486.
Abstract

AKKUS NI, Rajpal S, Hilbun J, Dwary A, et al
Troponin Elevation in Sickle Cell Disease.
Med Princ Pract. 2021;30:437-442.
Abstract

SHARMA K, Mishra A, Singh HN, Parashar D, et al
High-altitude pulmonary edema is aggravated by risk loci and associated transcription factors in HIF-prolyl hydroxylases.
Hum Mol Genet. 2021;30:1734-1749.
Abstract

SILVA AF, Sousa-Nunes F, Faria-Costa G, Rodrigues I, et al
Effects of chronic moderate alcohol consumption on right ventricle and pulmonary remodelling.
Exp Physiol. 2021;106:1359-1372.
Abstract

NARIAI R, Mafune R, Ide K, Nishimura N, et al
Pulmonary hypertension caused by vitamin C deficiency in a 2-year-old girl.
Pediatr Int. 2022;64:e14971.
Abstract

KABWE JC, Sawada H, Mitani Y, Oshita H, et al
CRISPR-mediated Bmpr2 point mutation exacerbates late pulmonary vasculopathy and reduces survival in rats with experimental pulmonary hypertension.
Respir Res. 2022;23:87.
Abstract

IKUBO Y, Sanada TJ, Hosomi K, Park J, et al
Altered gut microbiota and its association with inflammation in patients with chronic thromboembolic pulmonary hypertension: a single-center observational study in Japan.
BMC Pulm Med. 2022;22:138.
Abstract

KOIKE H, Sueyoshi E, Uetani M
Diagnosis of Chronic Thromboembolic Pulmonary Hypertension Using Quantitative Lung Perfusion Parameters Extracted From Dual-energy Computed Tomography Images.
J Thorac Imaging. 2022 Apr 11. pii: 00005382-990000000-00006.
Abstract

ALICI G, Waberi MM, Mohamud MA, Bashir AM, et al
Pulmonary hypertension among maintenance hemodialysis patients in Somalia: a hospital-based observational study.
Egypt Heart J. 2022;74:24.
Abstract

GERTZ RJ, Gerhardt F, Kroger JR, Shahzad R, et al
Spectral Detector CT-Derived Pulmonary Perfusion Maps and Pulmonary Parenchyma Characteristics for the Semiautomated Classification of Pulmonary Hypertension.
Front Cardiovasc Med. 2022;9:835732.
Abstract

MUTO Y, Sekine A, Hagiwara E, Komatsu S, et al
Clinical characteristics of pulmonary hypertension in patients with pleuroparenchymal fibroelastosis.
Respir Investig. 2022 Apr 3. pii: S2212-5345(22)00021.
Abstract

KANNEY M, Hsu D
Pulmonary hypertension in children with severe OSA: can CO2 provide a clue?
J Clin Sleep Med. 2022 Apr 8. doi: 10.5664/jcsm.10034.
Abstract

ALANDEJANI F, Alabed S, Garg P, Goh ZM, et al
Training and clinical testing of artificial intelligence derived right atrial cardiovascular magnetic resonance measurements.
J Cardiovasc Magn Reson. 2022;24:25.
Abstract

RONG W, Liu C, Li X, Wan N, et al
Caspase-8 Promotes Pulmonary Hypertension by Activating Macrophage-Associated Inflammation and IL-1beta (Interleukin 1beta) Production.
Arterioscler Thromb Vasc Biol. 2022 Apr 7:101161ATVBAHA121317168.
Abstract

YOUNGER J, Fayed M, Chauhan G, Mantel N, et al
Intrathecal Fentanyl With a Paracervical Block Is Safe and Effective for Elective Termination of Pregnancy in a Patient With Primary Pulmonary Hypertension.
Cureus. 2022;14:e22699.
Abstract

GUAN YT, Zhang R, Wang TY, Wei A, et al
[Chronic active Epstein-Barr virus infection complicated with pulmonary arterial hypertension in a child].
Zhonghua Er Ke Za Zhi. 2022;60:355-357.
Abstract

OKADA N, Takiguchi H, Suzuki W, Okazaki E, et al
ANCA-Associated Vasculitis in a Patient with Chronic Thromboembolic Pulmonary Hypertension.
Tokai J Exp Clin Med. 2022;47:26-30.
Abstract

AKCABELEN YM, Kaya Dincel G, Ece I, Cinel G, et al
Idiopathic Hypereosinophilic Syndrome Associated With Pulmonary Hypertension in an Infant.
J Pediatr Hematol Oncol. 2022 Apr 1. pii: 00043426-990000000-00005.
Abstract

SHARIF-KASHANI B, Serati A, Shafaghi S, Behzadnia N, et al
Curable Syncope in Primary Pulmonary Hypertension with Novel Atrial Flow Regulator.
Tanaffos. 2021;20:287-290.
Abstract

WESTHOFF M, Litterst P, Kreppein U
[Pulmonary Hypertension and Polycythemia vera].
Pneumologie. 2022 Apr 5. doi: 10.1055/a-1775-6424.
Abstract

ZHANG Y, Wang Y
Cell-to-Cell Crosstalk: A New Insight into Pulmonary Hypertension.
Rev Physiol Biochem Pharmacol. 2022 Apr 6. doi: 10.1007/112_2022.
Abstract

LIU S, Zhang Q, Liu W, Zheng L, et al
Hereditary haemorrhagic telangiectasia with atrial septal defect and pulmonary hypertension during advanced pregnancy: a case report and literature review.
J Int Med Res. 2022;50:3000605221085427.
Abstract

PEREIRA AR, Cale R, Ferreira F, Pereira H, et al
Balloon pulmonary angioplasty in inoperable chronic thromboembolic pulmonary hypertension.
BMJ Case Rep. 2022;15.
Abstract

SAGRIS M, Kokkinidis DG, Bakoyiannis C
Contemporary Management of Deep Vein Thrombosis, Pulmonary Embolism and Chronic Thromboembolic Pulmonary Hypertension.
Curr Pharm Des. 2022;28:511.
Abstract

BOULATE D, Amsallem M, Menager JB, Dang Van S, et al
Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension.
J Vis Exp. 2022;.
Abstract

JASTANIA EI, Alqarni MS, Abukhodair AW, Bukhari ZM, et al
Risk Factors of Persistent Pulmonary Hypertension in Neonate in A Tertiary Care Referral Center.
Cureus. 2022;14:e22416.
Abstract

CASTILLO-GALAN S, Riquelme B, Iturriaga R
Crucial Role of Stromal Interaction Molecule-Activated TRPC-ORAI Channels in Vascular Remodeling and Pulmonary Hypertension Induced by Intermittent Hypoxia.
Front Physiol. 2022;13:841828.
Abstract

CHEN X, He Y, Yu Z, Zuo J, et al
Polydatin Glycosides Improve Monocrotaline-Induced Pulmonary Hypertension Injury by Inhibiting Endothelial-To-Mesenchymal Transition.
Front Pharmacol. 2022;13:862017.
Abstract

JING X, Wu S, Liu Y, Wang H, et al
Circular RNA Sirtuin1 represses pulmonary artery smooth muscle cell proliferation, migration and autophagy to ameliorate pulmonary hypertension via targeting microRNA-145-5p/protein kinase-B3 axis.
Bioengineered. 2022;13:8759-8771.
Abstract

LEONG K, Howard L, Lo Giudice F, Pavey H, et al
MRI Feature Tracking Strain in Pulmonary Hypertension: Utility of Combined Left Atrial Volumetric and Deformation Assessment in Distinguishing Post- From Pre-capillary Physiology.
Front Cardiovasc Med. 2022;9:787656.
Abstract

YANG DP, Dong WP, Yang YC, Zeng YY, et al
Tetramethylpyrazine Improves Monocrotaline-Induced Pulmonary Hypertension through the ROS/iNOS/PKG-1 Axis.
J Healthc Eng. 2022;2022:1890892.
Abstract

SU JY, Chen HF, Wang SM
Pregnancy outcome analysis of 94 patients with pulmonary arterial hypertension during pregnancy.
Eur Rev Med Pharmacol Sci. 2022;26:1970-1977.
Abstract

GUILLEN-DEL-CASTILLO A, Meseguer ML, Fonollosa-Pla V, Gimenez BS, et al
Impact of interstitial lung disease on the survival of systemic sclerosis with pulmonary arterial hypertension.
Sci Rep. 2022;12:5289.
Abstract

EICHSTAEDT CA, Sassmannshausen Z, Shaukat M, Cao D, et al
Gene panel diagnostics reveals new pathogenic variants in pulmonary arterial hypertension.
Respir Res. 2022;23:74.
Abstract

ZOZAYA N, Abdalla F, Casado Moreno I, Crespo-Diz C, et al
The economic burden of pulmonary arterial hypertension in Spain.
BMC Pulm Med. 2022;22:105.
Abstract

YE C, Lian G, Wang T, Chen A, et al
The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways.
BMC Pulm Med. 2022;22:111.
Abstract

KOBAYASHI T, Kim JD, Naito A, Yanagisawa A, et al
Multiomics analysis of right ventricles in rat models of pulmonary arterial hypertension: Consideration of mitochondrial biogenesis by chrysin.
Int J Mol Med. 2022;49.
Abstract

TORRES PPTES, Rabahi MF, Mancano AD, Santos SHRD, et al
Frequency of spontaneous detection of pulmonary arterial thrombi in unenhanced chest computed tomography in patients diagnosed with pulmonary embolism.
J Bras Pneumol. 2022;48:e20210128.
Abstract

JANG SY, Kim EK, Huh J, Song J, et al
A Retrospective Population-Based Survival Study of Idiopathic Pulmonary Arterial Hypertension in Korea.
J Korean Med Sci. 2022;37:e80.
Abstract

SCHAFER M, Frank BS, Ivy DD, Mitchell MB, et al
Repolarization Dispersion Is Associated With Diastolic Electromechanical Discoordination in Children With Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2022;11:e024787.
Abstract

WELCH CL, Chung WK
Channelopathy Genes in Pulmonary Arterial Hypertension.
Biomolecules. 2022;12.
Abstract

XIANG Y, Zheng F, Zhang Q, Zhang R, et al
Tanreqing Injection Regulates Cell Function of Hypoxia-Induced Human Pulmonary Artery Smooth Muscle Cells (HPASMCs) through TRPC1/CX3CL1 Signaling Pathway.
Oxid Med Cell Longev. 2022;2022:3235102.
Abstract

CHANG WT, Wu CC, Lin YW, Shih JY, et al
Dynamic Changes in miR-21 Regulate Right Ventricular Dysfunction in Congenital Heart Disease-Related Pulmonary Arterial Hypertension.
Cells. 2022;11.
Abstract

CHOWDHURY UK, Anderson RH, Spicer DE, Sankhyan LK, et al
A review of the therapeutic management of multiple ventricular septal defects.
J Card Surg. 2022;37:1361-1376.
Abstract

ALDRED MA
Food for Thought: The Emerging Role of Intestinal Microbiota in Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2022;66:361-362.
Abstract

MPRAH R, Ma Y, Adzika GK, Ndzie Noah ML, et al
Metabotropic glutamate receptor 5 blockade attenuates pathological cardiac remodelling in pulmonary arterial hypertension.
Clin Exp Pharmacol Physiol. 2022;49:558-566.
Abstract

WU Y, Liu HM, Gu L, Li QW, et al
Prostacyclins and pulmonary arterial hypertension in children.
Eur Rev Med Pharmacol Sci. 2022;26:37-45.
Abstract

LOVERING AT, Kelly TS, DiMarco KG, Bradbury KE, et al
Implications of a patent foramen ovale for environmental physiology and pathophysiology: do we know the 'hole' story?
J Physiol. 2022;600:1541-1553.
Abstract

PINTO VM, Musallam KM, Derchi G, Graziadei G, et al
Mortality in beta-thalassemia patients with confirmed pulmonary arterial hypertension on right heart catheterization.
Blood. 2022;139:2080-2083.
Abstract

HE W, Su X, Chen L, Liu C, et al
Potential biomarkers and therapeutic targets of idiopathic pulmonary arterial hypertension.
Physiol Rep. 2022;10:e15101.
Abstract

CONSTANTINE A, Dimopoulos K, Jenkins P, Tulloh RMR, et al
Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United Kingdom.
J Am Heart Assoc. 2022;11:e023035.
Abstract

REHMEL J, Ferguson-Sells L, Morse BL, Li B, et al
Physiologically based pharmacokinetic modeling of tadalafil to inform pediatric dose selection in children with pulmonary arterial hypertension.
CPT Pharmacometrics Syst Pharmacol. 2022;11:173-184.
Abstract

HATAI E, Muneuchi J, Sugitani Y, Doi H, et al
Pulmonary vascular resistance and compliance in individuals with trisomy 18.
Am J Med Genet A. 2022;188:534-539.
Abstract

FURUKAWA A, Tamura Y, Yamada K, Taniguchi H, et al
Liver fibrosis index as a novel prognostic factor in patients with pulmonary arterial hypertension.
Heart Vessels. 2022;37:601-608.
Abstract

MINHAS J, Shou H, Hershman S, Zamanian R, et al
Physical Activity and Its Association with Traditional Outcome Measures in Pulmonary Arterial Hypertension.
Ann Am Thorac Soc. 2022;19:572-582.
Abstract

SEDHOM R, Megaly M, Gupta E, Amanullah A, et al
Use of direct oral anticoagulants in chronic thromboembolic pulmonary hypertension: a systematic review.
J Thromb Thrombolysis. 2022;53:51-57.
Abstract

ROBLEDO GC, Palafox LEG, Hernandez MYJ, Paez YAC, et al
Tricuspid Atresia with Persistent Left Superior Vena Cava and Pulmonary Arterial Hypertension. Case Report.
Curr Probl Cardiol. 2022;47:100837.
Abstract

RICHTER MJ, Yogeswaran A, Husain-Syed F, Vadasz I, et al
A novel non-invasive and echocardiography-derived method for quantification of right ventricular pressure-volume loops.
Eur Heart J Cardiovasc Imaging. 2022;23:498-507.
Abstract

ROGULA SP, Mutwil HM, Gasecka A, Kurzyna M, et al
Antiplatelet effects of prostacyclin analogues: Which one to choose in case of thrombosis or bleeding?
Cardiol J. 2021;28:954-961.
Abstract

SUN W, Ota H, Sato H, Yamamoto S, et al
Systemic-pulmonary collateral supply associated with clinical severity of chronic thromboembolic pulmonary hypertension: a study using intra-aortic computed tomography angiography.
Eur Radiol. 2022 Apr 14. pii: 10.1007/s00330-022-08768.
Abstract

KASSA B, Lee MH, Kumar R, Mickael C, et al
Experimental Schistosoma japonicum-induced pulmonary hypertension.
PLoS Negl Trop Dis. 2022;16:e0010343.
Abstract

HE T, Zhang J, Qiao T, Zhang Z, et al
Compensatory roles of Protein Related to DAN and Cerberus (PRDC) decrease in pulmonary arterial hypertension.
Int J Biol Sci. 2022;18:2372-2391.
Abstract

TANG Y, Tan S, Li M, Tang Y, et al
Dapagliflozin, sildenafil and their combination in monocrotaline-induced pulmonary arterial hypertension.
BMC Pulm Med. 2022;22:142.
Abstract

RUOPP NF, Cockrill BA
Diagnosis and Treatment of Pulmonary Arterial Hypertension: A Review.
JAMA. 2022;327:1379-1391.
Abstract

BAHADORAN S, Teymouri Y, Hassanpour H, Mohebbi A, et al
Effect of sage (Salvia officinalis L.) extract in antioxidant status and intestinal morphology of pulmonary hypertensive chickens.
Vet Med Sci. 2022 Apr 11. doi: 10.1002.
Abstract

PARAJULI N, Kosanovic D
Editorial: Oxidative Stress in Cardiovascular Diseases and Pulmonary Hypertension.
Front Cardiovasc Med. 2022;9:868988.
Abstract

WANG R, Pan J, Han J, Gong M, et al
Melatonin Attenuates Dasatinib-Aggravated Hypoxic Pulmonary Hypertension via Inhibiting Pulmonary Vascular Remodeling.
Front Cardiovasc Med. 2022;9:790921.
Abstract

DONG L, Liu X, Wu B, Li C, et al
Mxi1-0 Promotes Hypoxic Pulmonary Hypertension Via ERK/c-Myc-dependent Proliferation of Arterial Smooth Muscle Cells.
Front Genet. 2022;13:810157.
Abstract

AFIFY H, Kong A, Bernal J, Elgendy IY, et al
Pulmonary Hypertension in Pregnancy: Challenges and Solutions.
Integr Blood Press Control. 2022;15:33-41.
Abstract

SUZUKI S, Aoki Y, Anezaki H, Wakuda C, et al
Association Between the Presence of Pulmonary Hypertension Before Cardiovascular Surgery and the Nephroprotective Effect of Carperitide: A Retrospective Cohort Study.
Cureus. 2022;14:e22891.
Abstract

HUANG Y, Su D, Ye B, Huang Y, et al
Expression and clinical significance of circular RNA hsa_circ_0003416 in pediatric pulmonary arterial hypertension associated with congenital heart disease.
J Clin Lab Anal. 2022;36:e24273.
Abstract

PREDESCU DN, Mokhlesi B, Predescu SA
The Impact of Sex Chromosomes in the Sexual Dimorphism of Pulmonary Arterial Hypertension.
Am J Pathol. 2022;192:582-594.
Abstract

WENCHENG H, Zhang W, An Y, Huang L, et al
Impact of Pulmonary Arterial Hypertension on Systemic Inflammation, Cardiac Injury and Hemodynamics in Sepsis: A retrospective study from MIMIC-III.
Am J Med Sci. 2022 Jan 14. pii: S0002-9629(22)00005.
Abstract

AGGARWAL M, Li M, Bhardwaj A, Wallace WD, et al
Predictors of survival in portopulmonary hypertension: a 20-year experience.
Eur J Gastroenterol Hepatol. 2022;34:449-456.
Abstract

HIRJI SA, Vinholo TF, Rinewalt DE
Commentary: Measurement of Right Heart Hemodynamics After Pulmonary Hromboendarterectomy-A Step in the Right Direction.
Semin Thorac Cardiovasc Surg. 2022;34:90-91.
Abstract

CAIN MT, Joyce D, Lahr BD, Day CN, et al
Do Right Heart Hemodynamic Improvements Persist After Pulmonary Thromboendarterectomy?
Semin Thorac Cardiovasc Surg. 2022;34:80-89.
Abstract

MILLER RJH, Hedman K, Amsallem M, Tulu Z, et al
Donor and Recipient Size Matching in Heart Transplantation With Predicted Heart and Lean Body Mass.
Semin Thorac Cardiovasc Surg. 2022;34:158-167.
Abstract

COCHIUS-DEN OTTER S, de Hoog M, Koch BCP, de Winter BCM, et al
RE: Efficacy and safety of IV sildenafil in the treatment of newborn infants with or at risk of persistent pulmonary hypertension of the newborn.
J Pediatr. 2022 Apr 18. pii: S0022-3476(22)00333.
Abstract

GOKNAR N, Kelesoglu E, Kasap N, Uckardes D, et al
A case of chronic kidney disease with pulmonary hypertension, hyperuricemia, immunodeficiency and other extrarenal findings: Answers.
Pediatr Nephrol. 2022 Apr 20. pii: 10.1007/s00467-022-05560.
Abstract

GOKNAR N, Kelesoglu E, Kasap N, Uckardes D, et al
A case of chronic kidney disease with pulmonary hypertension, hyperuricemia, immunodeficiency and other extrarenal findings: Questions.
Pediatr Nephrol. 2022 Apr 20. pii: 10.1007/s00467-022-05548.
Abstract

LODHI SH, Nandavaram S, Malyala R, Anstead M, et al
Double Lung Transplantation Bridged With Direct Central Ambulatory Veno-Arterial Extracorporeal Membrane Oxygenation in a Pulmonary Hypertension Patient With Extreme Mediastinal Shift.
Cureus. 2022;14:e23070.
Abstract

KUMARI N, Mallick RK, Suchi S, Sahu RS, et al
Prevalence of Pulmonary Hypertension in Chronic Kidney Disease.
J Assoc Physicians India. 2022;70:11-12.
Abstract

CHINTALAPATI A, Babu S, Cs C
Study of Pulmonary Function Tests in Diabetic Nephropathy.
J Assoc Physicians India. 2022;70:11-12.
Abstract

MICHALSKI TA, Pszczola J, Lisowska A, Knapp M, et al
ECG in the clinical and prognostic evaluation of patients with pulmonary arterial hypertension: an underestimated value.
Ther Adv Respir Dis. 2022;16:17534666221087846.
Abstract

HEIDARI A, Elkhodary KI, Pop C, Badran M, et al
Patient-specific finite element analysis of heart failure and the impact of surgical intervention in pulmonary hypertension secondary to mitral valve disease.
Med Biol Eng Comput. 2022 Apr 20. pii: 10.1007/s11517-022-02556.
Abstract

WANG G, Wen B, Deng Z, Zhang Y, et al
Endothelial progenitor cells stimulate neonatal lung angiogenesis through FOXF1-mediated activation of BMP9/ACVRL1 signaling.
Nat Commun. 2022;13:2080.
Abstract

LI X, Zhang Y, Su L, Cai L, et al
FGF21 alleviates pulmonary hypertension by inhibiting mTORC1/EIF4EBP1 pathway via H19.
J Cell Mol Med. 2022 Apr 19. doi: 10.1111/jcmm.17318.
Abstract

HEATH-FREUDENTHAL A, Toledo-Jaldin L, von Alvensleben I, Lazo-Vega L, et al
Vascular Disorders of Pregnancy Increase Susceptibility to Neonatal Pulmonary Hypertension in High-Altitude Populations.
Hypertension. 2022 Apr 19:101161HYPERTENSIONAHA12219078.
Abstract

JANO E, Vaz MJ, Mally PV, Wachtel E, et al
Pilot study investigating brain natriuretic peptide, troponin, galectin-3 and miRNA-126a-5p as biomarkers of persistent pulmonary hypertension in neonates with hypoxic-ischemic injury receiving therapeutic hypothermia.
Am J Perinatol. 2022 Apr 18. doi: 10.1055/a-1827-7518.
Abstract

YANG Y, Xu J, Zhou J, Xue J, et al
High Betaine and Dynamic Increase of Betaine Levels Are Both Associated With Poor Prognosis of Patients With Pulmonary Hypertension.
Front Cardiovasc Med. 2022;9:852009.
Abstract

ESPINOLA-ZAVALETA N, Antonio-Villa NE, Guerra EC, Nanda NC, et al
Right Heart Chambers Longitudinal Strain Provides Enhanced Diagnosis and Categorization in Patients With Pulmonary Hypertension.
Front Cardiovasc Med. 2022;9:841776.
Abstract

RIETH AJ, Grun D, Zarogiannis G, Kriechbaum SD, et al
Prognostic Power of Pulmonary Arterial Compliance Is Boosted by a Hemodynamic Unloading Test With Glyceryl Trinitrate in Heart Failure Patients With Post-capillary Pulmonary Hypertension.
Front Cardiovasc Med. 2022;9:838898.
Abstract

DAI HL, Wang D, Guang XF, Zhang WH, et al
Pulmonary Hypertension in a Patient With Kartagener's Syndrome and a Novel Homozygous Nonsense Mutation in CCDC40 Gene: A Case Report.
Front Med (Lausanne). 2022;9:860684.
Abstract

LOPEZ-GUDE MJ, Blanco I, Benito-Arnaiz V, Castella M, et al
Pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension: the Spanish experience.
Ann Cardiothorac Surg. 2022;11:151-160.
Abstract

VERBELEN T, Godinas L, Maleux G, Coolen J, et al
Chronic thromboembolic pulmonary hypertension: diagnosis, operability assessment and patient selection for pulmonary endarterectomy.
Ann Cardiothorac Surg. 2022;11:82-97.
Abstract

GODINAS L, Verbelen T, Delcroix M
Residual pulmonary hypertension after pulmonary thromboendarterectomy: incidence, pathogenesis and therapeutic options.
Ann Cardiothorac Surg. 2022;11:163-165.
Abstract

JAMIESON S, Pomar J
Surgical treatment for chronic thromboembolic pulmonary hypertension: an historical perspective.
Ann Cardiothorac Surg. 2022;11:98-105.
Abstract

DE PERROT M, McRae K, Donahoe L, Abdelnour-Berchtold E, et al
Pulmonary endarterectomy in severe chronic thromboembolic pulmonary hypertension: the Toronto experience.
Ann Cardiothorac Surg. 2022;11:133-142.
Abstract

BROOKES JDL, Li C, Chung STW, Brookes EM, et al
Pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension: a systematic review.
Ann Cardiothorac Surg. 2022;11:68-81.
Abstract

FACCIOLI E, Dell'Amore A
End-stage chronic thromboembolic pulmonary hypertension: is there still room for lung transplantation?-the past, the present and the future.
Ann Cardiothorac Surg. 2022;11:161-162.
Abstract

SIMONNEAU G, Dorfmuller P, Guignabert C, Mercier O, et al
Chronic thromboembolic pulmonary hypertension: the magic of pathophysiology.
Ann Cardiothorac Surg. 2022;11:106-119.
Abstract

MARTIN-SUAREZ S, Loforte A, Cavalli GG, Gliozzi G, et al
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team.
Ann Cardiothorac Surg. 2022;11:120-127.
Abstract

QAMAR F, Attar RH, Nabi F
Paravalvular Leak.
Methodist Debakey Cardiovasc J. 2022;18:7-9.
Abstract

ADACHI S, Nakano Y, Furusawa K
Right Ventricular Dyssynchrony Casts New Light on the Risk Stratification and Prediction of Prognosis in Patients With Pulmonary Hypertension.
Circ J. 2022 Apr 16. doi: 10.1253/circj.CJ-22-0145.
Abstract

FANG X, Xie M, Liu X, He Y, et al
REDD1 gene knockout alleviates vascular smooth muscle cell remodeling in pulmonary hypertension.
Am J Transl Res. 2022;14:1578-1591.
Abstract

ROSCOE AJ, Hwang NC
Pulmonary thromboendarterectomy and pulmonary haemorrhage.
Ann Card Anaesth. 2022;25:200-201.
Abstract

COOL CJ, Fathini F, Adams I, Saboe A, et al
Eisenmenger syndrome with left main compression syndrome: a case report.
BMC Cardiovasc Disord. 2022;22:89.
Abstract

MARON BA, Humbert M
Finding Pulmonary Arterial Hypertension-Switching to Offense to Mitigate Disease Burden.
JAMA Cardiol. 2022;7:369-370.
Abstract

ZHU Y, Shu D, Gong X, Lu M, et al
Platelet-Derived TGF (Transforming Growth Factor)-beta1 Enhances the Aerobic Glycolysis of Pulmonary Arterial Smooth Muscle Cells by PKM2 (Pyruvate Kinase Muscle Isoform 2) Upregulation.
Hypertension. 2022;79:932-945.
Abstract

TAKEMORI W, Yamamura K, Tomita Y, Egami N, et al
Pediatric pulmonary veno-occlusive disease associated with a novel BMPR2 variant.
Pediatr Pulmonol. 2022;57:1366-1369.
Abstract

HIGANO NS, Bates AJ, Gunatilaka CC, Hysinger EB, et al
Bronchopulmonary dysplasia from chest radiographs to magnetic resonance imaging and computed tomography: adding value.
Pediatr Radiol. 2022 Feb 5. pii: 10.1007/s00247-021-05250.
Abstract

ZAROGOULIDIS P, Petridis D, Sardeli C, Kosmidis C, et al
Modification Tadalafil and Macitentan tablets to aerosol.
Front Biosci (Landmark Ed). 2022;27:19.
Abstract

KIM D, Chang D, Kim G
Congenital portosystemic shunt concurrent with an atrial septal defect in a Maltese dog.
Open Vet J. 2021;11:724-727.
Abstract

NAKANO Y, Adachi S, Nishiyama I, Yasuda K, et al
Usefulness of a refined computed tomography imaging method to assess the prevalence of residual pulmonary thrombi in patients 1 year after acute pulmonary embolism: The Nagoya PE study.
J Thromb Haemost. 2022;20:888-898.
Abstract

ANDERSON JH, Cabalka AK, Frantz RP, Cajigas HR, et al
Transcatheter Nonductal Reverse Potts Shunt Creation in Pulmonary Arterial Hypertension.
Circ Cardiovasc Interv. 2021 Dec 21:CIRCINTERVENTIONS121011315.
Abstract

ISSAPOUR A, Frank B, Crook S, Hite MD, et al
Safety and tolerability of combination therapy with ambrisentan and tadalafil for the treatment of pulmonary arterial hypertension in children: Real-world experience.
Pediatr Pulmonol. 2022;57:724-733.
Abstract

WANG Z, Li J, Wang X, Liu M, et al
Evaluation of pulmonary arterial pressure in patients with connective tissue disease-associated pulmonary arterial hypertension by myocardial perfusion imaging.
Ann Noninvasive Electrocardiol. 2022;27:e12927.
Abstract

FANG H, Zhang M, Zhao C, Yao X, et al
Characteristics of length of stay and cardiovascular pharmacotherapy advice among chronic obstructive pulmonary disease patients.
Sci Prog. 2021;104:368504211066003.
Abstract

HALAWA S, Pullamsetti SS, Bangham CRM, Stenmark KR, et al
Potential long-term effects of SARS-CoV-2 infection on the pulmonary vasculature: a global perspective.
Nat Rev Cardiol. 2022;19:314-331.
Abstract

SCHRANZ D, Schrewe R, Esmaeili A
Life-threatening PPHN refractory to NO: therapeutic algorithm.
Eur J Pediatr. 2022;181:423.
Abstract

FORTAS F, Di Nardo M, Yousef N, Humbert M, et al
Response to: Life-threatening PPHN refractory to NO: therapeutic algorithm.
Eur J Pediatr. 2022;181:425-426.
Abstract

LI Y, Tung M, Xu J, Pan G, et al
Perioperative Use of Pituitrin after Cardiac Defect Repair in Adult Patients with Severe Pulmonary Hypertension.
Heart Surg Forum. 2022;25:E277-E283.
Abstract

VALERIO L, Mavromanoli AC, Barco S, Abele C, et al
Chronic thromboembolic pulmonary hypertension and impairment after pulmonary embolism: the FOCUS study.
Eur Heart J. 2022 Apr 28. pii: 6575686. doi: 10.1093.
Abstract

LI T, Liu B, Luo XJ, Peng J, et al
VPO1/HOCl/ERK pathway mediates the right ventricular remodeling in rats with hypoxic pulmonary hypertension.
Arch Biochem Biophys. 2022 Apr 25:109267. doi: 10.1016/j.abb.2022.109267.
Abstract

LAMBERT L, Michalek P, Burgetova A
The diagnostic performance of CT pulmonary angiography in the detection of chronic thromboembolic pulmonary hypertension-systematic review and meta-analysis.
Eur Radiol. 2022 Apr 28. pii: 10.1007/s00330-022-08804.
Abstract

WANG RR, Yuan TY, Chen D, Chen YC, et al
Dan-Shen-Yin Granules Prevent Hypoxia-Induced Pulmonary Hypertension via STAT3/HIF-1alpha/VEGF and FAK/AKT Signaling Pathways.
Front Pharmacol. 2022;13:844400.
Abstract

SUTO H, Suto M, Inui Y, Okamura A, et al
Difficulty in Distinguishing Pulmonary Arterial Intimal Sarcoma from Pulmonary Thromboembolism Using FDG PET/CT.
In Vivo. 2022;36:1519-1522.
Abstract

STUBBS H, MacLellan A, McGettrick M, Jani B, et al
Predicting Group II pulmonary hypertension: diagnostic accuracy of the H2FPEF and OPTICS scores in Scotland.
Open Heart. 2022;9.
Abstract

SATOH K
Caspase-8 Promotes the Development of Pulmonary Hypertension.
Arterioscler Thromb Vasc Biol. 2022 Apr 28:101161ATVBAHA122317727.
Abstract

LIU B, Wei YP, Fan X, Hu X, et al
Calcium Sensing Receptor Variants Increase Pulmonary Hypertension Susceptibility.
Hypertension. 2022 Apr 28:101161HYPERTENSIONAHA12118399.
Abstract

YAMADA K, Matsukuma S, Tokumitsu Y, Shindo Y, et al
Surgical shunt ligation for a congenital extrahepatic portosystemic shunt with pulmonary hypertension: A case report.
Int J Surg Case Rep. 2022;93:107024.
Abstract

PFEUFFER-JOVIC E, Joa F, Halank M, Krannich JH, et al
Anxiety, Depression and Quality of Life in Pulmonary Hypertension: A Comparison of Incident and Prevalent Cases.
Respiration. 2022 Apr 27:1-9. doi: 10.1159/000524369.
Abstract

CHANG KY, Duval S, Badesch DB, Bull TM, et al
Mortality in Pulmonary Arterial Hypertension in the Modern Era: Early Insights From the Pulmonary Hypertension Association Registry.
J Am Heart Assoc. 2022 Apr 27:e024969. doi: 10.1161/JAHA.121.024969.
Abstract

HASHIMOTO H, Oka T, Nakanishi R, Mizumura S, et al
Evaluation of balloon pulmonary angioplasty using lung perfusion SPECT in patients with chronic thromboembolic pulmonary hypertension.
J Nucl Cardiol. 2022 Apr 26. pii: 10.1007/s12350-022-02971.
Abstract

RYAN A, Miah N, Saleh M
Portopulmonary hypertension: a patient with shortness of breath.
BMJ Case Rep. 2022;15.
Abstract

RAWAT M, Lakshminrusimha S, Vento M
Pulmonary hypertension and oxidative stress: Where is the link?
Semin Fetal Neonatal Med. 2022 Apr 19:101347. doi: 10.1016/j.siny.2022.101347.
Abstract

SUN Y, Wan W, Zhao X, Han X, et al
Chronic Sigma 1 receptor activation alleviates right ventricular dysfunction secondary to pulmonary arterial hypertension.
Bioengineered. 2022;13:10843-10856.
Abstract

ZHANG J, Du L, Qin X, Guo X, et al
Effect of Sacubitril/Valsartan on the Right Ventricular Function and Pulmonary Hypertension in Patients With Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis of Observational Studies.
J Am Heart Assoc. 2022 Apr 26:e024449. doi: 10.1161/JAHA.121.024449.
Abstract

MILLER TF, Kaiser A, Schmelter T, Lippert J, et al
Using real-world data in pediatric clinical trials: Lessons learned and future applications in studies of persistent pulmonary hypertension of the newborn.
Semin Fetal Neonatal Med. 2022 Apr 8:101331. doi: 10.1016/j.siny.2022.101331.
Abstract

SURESH S, Charlton D, Snell EK, Laffoon M, et al
Over one-third of Th/To antibody positive scleroderma patients develop pulmonary hypertension in long-term follow-up.
Arthritis Rheumatol. 2022 Apr 25. doi: 10.1002/art.42152.
Abstract

JIAN Y, Zhou H, Wang Y, Zhang Z, et al
Echocardiography-defined pulmonary hypertension is an adverse prognostic factor for newly diagnosed multiple myeloma patients.
Cancer Med. 2022 Apr 24. doi: 10.1002/cam4.4770.
Abstract

NISHIYAMA A, Kawata N, Yokota H, Hayano K, et al
Heterogeneity of Lung Density in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
Acad Radiol. 2022 Apr 21. pii: S1076-6332(22)00141.
Abstract

MARRA AM, Benjamin N, Cittadini A, Bossone E, et al
When Pulmonary Hypertension Complicates Heart Failure.
Cardiol Clin. 2022;40:191-198.
Abstract

PICCARI L, Wort SJ, Meloni F, Rizzo M, et al
The Effect of Borderline Pulmonary Hypertension on Survival in Chronic Lung Disease.
Respiration. 2022 Apr 22:1-11. doi: 10.1159/000524263.
Abstract

ROZQIE R, Satwiko MG, Anggrahini DW, Sadewa AH, et al
NKX2-5 variants screening in patients with atrial septal defect in Indonesia.
BMC Med Genomics. 2022;15:91.
Abstract

ASSAGGAF H, Yoo C, Lucchini RG, Black SM, et al
Polychlorinated Biphenyls and Pulmonary Hypertension.
Int J Environ Res Public Health. 2022;19.
Abstract

WU Z, Zhou G, Wang H, Yao P, et al
Inhibition of KIF23 Alleviates IPAH by Targeting Pyroptosis and Proliferation of PASMCs.
Int J Mol Sci. 2022;23.
Abstract

LOOKIN O, Mukhlynina E, Protsenko Y
Contractile Behavior of Right Atrial Myocardium of Healthy Rats and Rats with the Experimental Model of Pulmonary Hypertension.
Int J Mol Sci. 2022;23.
Abstract

KARYOFYLLIS P, Demerouti E, Giannakoulas G, Anthi A, et al
Balloon Pulmonary Angioplasty in Patients with Chronic Thromboembolic Pulmonary Hypertension in Greece: Data from the Hellenic Pulmonary Hypertension Registry.
J Clin Med. 2022;11.
Abstract

BOXHAMMER E, Berezin AE, Paar V, Bacher N, et al
Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement.
J Pers Med. 2022;12.
Abstract

TSUTSUMI Y, Adachi S, Nakano Y, Iwano S, et al
End-Systolic Eccentricity Index Obtained by Enhanced Computed Tomography Is a Predictor of Pulmonary Vascular Resistance in Patients with Chronic Thromboembolic Pulmonary Hypertension.
Life (Basel). 2022;12.
Abstract

RUDIENE V, Kapleriene L, Jancauskaite D, Meskene E, et al
Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension-A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare Professionals.
Medicina (Kaunas). 2022;58.
Abstract

XU J, Linneman J, Zhong Y, Yin H, et al
MicroRNAs in Pulmonary Hypertension, from Pathogenesis to Diagnosis and Treatment.
Biomolecules. 2022;12.
Abstract

SANTOS-GOMES J, Le Ribeuz H, Bras-Silva C, Antigny F, et al
Role of Ion Channel Remodeling in Endothelial Dysfunction Induced by Pulmonary Arterial Hypertension.
Biomolecules. 2022;12.
Abstract

REDDY C, Kaskar A, Karthick E, Siddaiah S, et al
Surgical Management of Aortopulmonary Window and its Associated Cardiac Lesions.
World J Pediatr Congenit Heart Surg. 2022;13:334-340.
Abstract

MIYAKI R, Yamamura A, Kawade A, Fujiwara M, et al
SKF96365 activates calcium-sensing receptors in pulmonary arterial smooth muscle cells.
Biochem Biophys Res Commun. 2022;607:44-48.
Abstract

OLIVEIRA SD
Insights on the Gut-Mesentery-Lung Axis in Pulmonary Arterial Hypertension: A Poorly Investigated Crossroad.
Arterioscler Thromb Vasc Biol. 2022;42:516-526.
Abstract

SI L, Wang H, Jiang Y, Yi Y, et al
MIR17HG polymorphisms contribute to high-altitude pulmonary edema susceptibility in the Chinese population.
Sci Rep. 2022;12:4346.
Abstract

WANG J, Liu W, Lu W, Luo X, et al
Sodium tanshinone IIA sulfonate enhances the BMP9-BMPR2-Smad1/5/9 signaling pathway in rat pulmonary microvascular endothelial cells and human embryonic stem cell-derived endothelial cells.
Biochem Pharmacol. 2022;199:114986.
Abstract

LI M, Tian Z, Qian J, Huang C, et al
Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review.
Lupus Sci Med. 2022;9.
Abstract

KIMMIG LM, Stutz MR, Husain AN, Bag R, et al
Identification of a Novel EIF2AK Variant and Genetics-Assisted Approach to Diagnosis of Pulmonary Capillary Hemangiomatosis.
Lung. 2022;200:217-219.
Abstract

SHAO B, Hoover C, Shi H, Kondo Y, et al
Deletion of platelet CLEC-2 decreases GPIbalpha-mediated integrin alphaIIbbeta3 activation and decreases thrombosis in TTP.
Blood. 2022;139:2523-2533.
Abstract

LIU A, Li B, Yang M, Shi Y, et al
Targeted treprostinil delivery inhibits pulmonary arterial remodeling.
Eur J Pharmacol. 2022;923:174700.
Abstract

HU L, Zhao C, Chen Z, Hu G, et al
An emerging strategy for targeted therapy of pulmonary arterial hypertension: Vasodilation plus vascular remodeling inhibition.
Drug Discov Today. 2022;27:1457-1463.
Abstract

HUANG CX, Jiang ZX, Du DY, Zhang ZM, et al
The MFF-SIRT1/3 axis, regulated by miR-340-5p, restores mitochondrial homeostasis of hypoxia-induced pulmonary artery smooth muscle cells.
Lab Invest. 2022;102:515-523.
Abstract

FETANAT M, Stevens M, Jain P, Hayward C, et al
Fully Elman Neural Network: A Novel Deep Recurrent Neural Network Optimized by an Improved Harris Hawks Algorithm for Classification of Pulmonary Arterial Wedge Pressure.
IEEE Trans Biomed Eng. 2022;69:1733-1744.
Abstract

FERGUSON-SELLS L, Velez de Mendizabal N, Li B, Small D, et al
Population Pharmacokinetics of Tadalafil in Pediatric Patients with Pulmonary Arterial Hypertension: A Combined Adult/Pediatric Model.
Clin Pharmacokinet. 2022;61:249-262.
Abstract

ZHANG F, Chen A, Pan Y, Wang X, et al
Research Progress on Pulmonary Arterial Hypertension and the Role of the Angiotensin Converting Enzyme 2-Angiotensin-(1-7)-Mas Axis in Pulmonary Arterial Hypertension.
Cardiovasc Drugs Ther. 2022;36:363-370.
Abstract

SAADI S, Masmoudi T, Ben Daly A, Jedidi M, et al
Pulmonary alveolar capillary dysplasia in infants: A rare and deadly missed diagnosis.
Ann Cardiol Angeiol (Paris). 2022;71:112-114.
Abstract

GAVELA J, Sharma S, Thompson D, Cocca A, et al
Presentation of cardiogenic shock with pulmonary hypertension and arrhythmia secondary to foramen magnum stenosis in a patient with achondroplasia.
J Paediatr Child Health. 2022 May 5. doi: 10.1111/jpc.16005.
Abstract

DAI LL, Jiang TC, Li PF, Shao H, et al
Predictors of Maternal Death Among Women With Pulmonary Hypertension in China From 2012 to 2020: A Retrospective Single-Center Study.
Front Cardiovasc Med. 2022;9:814557.
Abstract

GUO J, Liu B, Thorikay M, Yu M, et al
Crystal structures of BMPRII extracellular domain in binary and ternary receptor complexes with BMP10.
Nat Commun. 2022;13:2395.
Abstract

HU L, Wang J, Lin D, Shen Y, et al
Mesenchymal Stem Cell-Derived Nanovesicles as a Credible Agent for Therapy of Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2022 May 4. doi: 10.1165/rcmb.2021-0415.
Abstract

JANSA P, Ambroz D, Kuhn M, Dytrych V, et al
Epidemiology of chronic thromboembolic pulmonary hypertension (CTEPH) in the Czech Republic.
Pulm Circ. 2022;12:e12038.
Abstract

APPENZELLER P, Lichtblau M, Berlier C, Aubert JD, et al
Disease characteristics and clinical outcome over two decades from the Swiss pulmonary hypertension registry.
Pulm Circ. 2022;12:e12001.
Abstract

SAITO S, Ikeda N, Iijima R, Hara H, et al
Evaluation of the effect of nitric oxide inhalation in the patients with chronic thromboembolic pulmonary hypertension or pulmonary disease during balloon pulmonary angioplasty.
Pulm Circ. 2022;12:e12032.
Abstract

FROST AE, Moore LW, Valdivia E Alvarado M, Obi C, et al
The echocardiographic course of pretransplant pulmonary hypertension following kidney transplantation and associated outcomes.
Pulm Circ. 2022;12:e12030.
Abstract

STERNBERG ME, Grinnan D, Gertz ZM
Utility of plasma volume status in ambulatory patients with pulmonary hypertension.
Pulm Circ. 2022;12:e12045.
Abstract

COOK DP, Xu M, Martucci VL, Annis JS, et al
Clinical insights into pulmonary hypertension in chronic obstructive pulmonary disease.
Pulm Circ. 2022;12:e12006.
Abstract

BOULATE D, Loisel F, Coblence M, Provost B, et al
Pulsatile pulmonary artery pressure in a large animal model of chronic thromboembolic pulmonary hypertension: Similarities and differences with human data.
Pulm Circ. 2022;12:e12017.
Abstract

SULLIVAN RT, Lo C, Martin E, Kameny RJ, et al
A case of acquired von Willebrand disease in severe pediatric pulmonary hypertension contributing to bleeding following reverse Potts shunt.
Pulm Circ. 2022;12:e12042.
Abstract

LUO D, Xie N, Yang Z, Zhang C, et al
Association of nutritional status and mortality risk in patients with primary pulmonary hypertension.
Pulm Circ. 2022;12:e12018.
Abstract

WIJERATNE DT, Housin A, Lajkosz K, Lougheed MD, et al
Using health administrative data to identify patients with pulmonary hypertension: A single center, proof of concept validation study in Ontario, Canada.
Pulm Circ. 2022;12:e12040.
Abstract

MITROUSKA I, Bolaki M, Vaporidi K, Georgopoulos D, et al
Respiratory system as the main determinant of dyspnea in patients with pulmonary hypertension.
Pulm Circ. 2022;12:e12060.
Abstract

RABIH F, Holden RL, Vasanth P, Pastan SO, et al
Effect of pulmonary hypertension on 5-year outcome of kidney transplantation.
Pulm Circ. 2022;12:e12010.
Abstract

KOZITZA CJ, Dharmavaram N, Tao R, Tabima DM, et al
Pulmonary vascular distensibility with passive leg raise is comparable to exercise and predictive of clinical outcomes in pulmonary hypertension.
Pulm Circ. 2022;12:e12029.
Abstract

OROZCO-LEVI M, Caneva J, Fernandes C, Restrepo-Jaramillo R, et al
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America.
Pulm Circ. 2022;12:e12012.
Abstract

STEVENS L, Colglazier E, Parker C, Amin EK, et al
Genetics dictating therapeutic decisions in pediatric pulmonary hypertension? A case report suggesting we are getting closer.
Pulm Circ. 2022;12:e12033.
Abstract

OLIVEIRA AC, Yang T, Li J, Sharma RK, et al
Fecal matter transplant from Ace2 overexpressing mice counteracts chronic hypoxia-induced pulmonary hypertension.
Pulm Circ. 2022;12:e12015.
Abstract

KING NE, Brittain E
Emerging therapies: The potential roles SGLT2 inhibitors, GLP1 agonists, and ARNI therapy for ARNI pulmonary hypertension.
Pulm Circ. 2022;12:e12028.
Abstract

SIMPSON CE, Kolb TM, Hsu S, Zimmerman SL, et al
Ventricular mass discriminates pulmonary arterial hypertension as redefined at the Sixth World Symposium on Pulmonary Hypertension.
Pulm Circ. 2022;12:e12005.
Abstract

WARDLE M, Nair A, Saunders S, Armstrong I, et al
Elective lower limb orthopedic arthroplasty surgery in patients with pulmonary hypertension.
Pulm Circ. 2022;12:e12019.
Abstract

MARON BA, Choudhary G, Goldstein RL, Garshick E, et al
Tadalafil for veterans with chronic obstructive pulmonary disease-pulmonary hypertension: A multicenter, placebo-controlled randomized trial.
Pulm Circ. 2022;12:e12043.
Abstract

HANDLER SS, Varghese NP, Rosenzweig EB, Yung D, et al
Building a dedicated pediatric pulmonary hypertension program: A consensus statement from the pediatric pulmonary hypertension network.
Pulm Circ. 2022;12:e12031.
Abstract

CHEN T, Sun MR, Zhou Q, Guzman AM, et al
Extracellular vesicles derived from endothelial cells in hypoxia contribute to pulmonary artery smooth muscle cell proliferation in-vitro and pulmonary hypertension in mice.
Pulm Circ. 2022;12:e12014.
Abstract

BESHAY S, Humbert M, Barrios R, Sahay S, et al
Progression of pulmonary veno-occlusive disease without pulmonary hypertension.
Pulm Circ. 2022;12:e12046.
Abstract

GOYA S, Yoshida T, Sennba S, Uchide T, et al
Adjunct ambrisentan therapy had clinical benefits in 5 dogs with sildenafil-refractory pulmonary hypertension.
Can Vet J. 2022;63:497-503.
Abstract

BURMEISTER C, Ghazaleh S, Beran A, Patel N, et al
Head-to-head comparison between direct oral anticoagulants and vitamin K antagonists for chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.
Curr Probl Cardiol. 2022 Apr 29:101232. doi: 10.1016/j.cpcardiol.2022.101232.
Abstract

GADIOLI LP, Costa FA, Moreira HT, Crescencio JC, et al
Use of Cardiopulmonary Exercise Testing to Assess Pulmonary Hypertension in Patients with Rheumatic Mitral Valve Disease: A Comparative Study with Echocardiography.
Curr Probl Cardiol. 2022 Apr 29:101230. doi: 10.1016/j.cpcardiol.2022.101230.
Abstract

HAJRA A, Safiriyu I, Balasubramanian P, Gupta R, et al
Recent Advances and Future Prospects of Treatment of Pulmonary Hypertension.
Curr Probl Cardiol. 2022 Apr 29:101236. doi: 10.1016/j.cpcardiol.2022.101236.
Abstract

SUZUKI R, Yuchi Y, Saito T, Teshima T, et al
Investigation of Beraprost Sodium on Cardiac Function and Hemodynamics in Canine Models of Chronic Pulmonary Hypertension.
Front Vet Sci. 2022;9:876178.
Abstract

BOYLE TA, Daimee UA, Simpson CE, Kolb TM, et al
Left atrial ablation for the management of atrial tachyarrhythmias in patients with pulmonary hypertension: A case series.
HeartRhythm Case Rep. 2022;8:275-279.
Abstract

YANAKA K, Nakayama K, Taniguchi Y, Onishi H, et al
RC time (resistance x compliance) is related to residual symptom after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.
Int J Cardiol Heart Vasc. 2022;40:101031.
Abstract

WATANABE M, Higuchi R, Nanasato M, Iguchi N, et al
Thromboembolic Pulmonary Hypertension Induced Myocardial Ischemia in a Patient With Anomalous Right Coronary Artery.
Circ J. 2022 Apr 29. doi: 10.1253/circj.CJ-22-0115.
Abstract

ADEOTI AO, Nadar A, Channa ML
Targeting Apoptosis Signal-Regulating Kinase-1 (ASK-1) As a Biomarker of Monocrotaline-Induced Pulmonary Hypertension following Administration of Antiretroviral Medications in Rat Model.
West Afr J Med. 2022;39:394-398.
Abstract

HIGUCHI S, Ota H, Yaoita N, Kamada H, et al
Update on the roles of imaging in the management of chronic thromboembolic pulmonary hypertension.
J Cardiol. 2022 Apr 27. pii: S0914-5087(22)00053.
Abstract

JIANG XK, Xiao YY, Ye Q, Meng XF, et al
[Risk factors for syncope in children with severe idiopathic pulmonary arterial hypertension].
Zhonghua Er Ke Za Zhi. 2022;60:442-446.
Abstract

MIAO R, Gong J, Guo X, Guo D, et al
Diagnostic value of miRNA expression and right ventricular echocardiographic functional parameters for chronic thromboembolic pulmonary hypertension with right ventricular dysfunction and injury.
BMC Pulm Med. 2022;22:171.
Abstract

MADDEN BA, Conaway MR, Zanelli SA, McCulloch MA, et al
Screening Echocardiography Identifies Risk Factors for Pulmonary Hypertension at Discharge in Premature Infants with Bronchopulmonary Dysplasia.
Pediatr Cardiol. 2022 Apr 29. pii: 10.1007/s00246-022-02911.
Abstract

CHARTERS PFP, Rossdale J, Brown W, Burnett TA, et al
Diagnostic accuracy of an automated artificial intelligence derived right ventricular to left ventricular diameter ratio tool on CT pulmonary angiography to predict pulmonary hypertension at right heart catheterisation.
Clin Radiol. 2022 Apr 26. pii: S0009-9260(22)00163.
Abstract

MICKAEL C, Kheyfets VO, Langouet-Astrie C, Lee MH, et al
Peripheral Blood Inflammation Profile of Patients with Pulmonary Arterial Hypertension Using the High-Throughput Olink Proteomics Platform.
Am J Respir Cell Mol Biol. 2022;66:580-581.
Abstract

ZHANG F, Zheng Z, Gong T, Zhu Z, et al
Anesthesia Management of a Premature Neonate with Congenital Heart Disease during Emergency Diaphragmatic Hernia Surgery: A Case Report.
Heart Surg Forum. 2022;25:E273-E276.
Abstract

TENNOE AH, Murbraech K, Didriksen H, Ueland T, et al
Serum markers of cardiac complications in a systemic sclerosis cohort.
Sci Rep. 2022;12:4661.
Abstract

VALASARAJAN C, Karger A, Savai R, Pullamsetti SS, et al
Long Noncoding RNAs: Emerging Regulators of Platelet-derived Growth Factor Signaling.
Am J Respir Cell Mol Biol. 2022;66:473-475.
Abstract

DE GROOTE P, Delobelle M, Hebbar E, Mercier T, et al
Right heart catheterization in advanced systolic heart failure. What are the most useful haemodynamic parameters for risk stratification?
Arch Cardiovasc Dis. 2022;115:169-178.
Abstract

YATES AR, Berger JT, Reeder RW, Banks R, et al
Characterization of Inhaled Nitric Oxide Use for Cardiac Indications in Pediatric Patients.
Pediatr Crit Care Med. 2022;23:245-254.
Abstract

MARWICK TH
Peripheral Venous Pressure: An Important but Neglected Contributor to Echocardiographic Estimation of Pulmonary Artery Pressure With Exercise.
Circ Heart Fail. 2022 Feb 22:CIRCHEARTFAILURE121009383.
Abstract

LE RIBEUZ H, Masson B, Capuano V, Dutheil M, et al
SUR1 As a New Therapeutic Target for Pulmonary Arterial Hypertension.
Am J Respir Cell Mol Biol. 2022;66:539-554.
Abstract

DJOKOVIC A, Stojanovich L, Stanisavljevic N, Djokic S, et al
Cardiac manifestations in primary antiphospholipid syndrome and their association to antiphospholipid antibodies' types and titers-cross-sectional study of Serbian cohort.
Clin Rheumatol. 2022;41:1447-1455.
Abstract

UMEMOTO S, Abe K, Hosokawa K, Horimoto K, et al
Increased Pulmonary Arterial Compliance after Balloon Pulmonary Angioplasty Predicts Exercise Tolerance Improvement in Inoperable CTEPH Patients with Lower Pulmonary Arterial Pressure.
Heart Lung. 2022;52:8-15.
Abstract

HAN Z, Li X, Cui X, Yuan H, et al
The roles of immune system and autoimmunity in pulmonary arterial hypertension: A review.
Pulm Pharmacol Ther. 2022;72:102094.
Abstract

WELLER K, Peters NCJ, van Rosmalen J, Cochius-Den Otter SCM, et al
Prenatal stomach position and volume in relation to postnatal outcomes in left-sided congenital diaphragmatic hernia.
Prenat Diagn. 2022;42:338-347.
Abstract

HOCQ C, Vanhoutte L, Guilloteau A, Massolo AC, et al
Early diagnosis and targeted approaches to pulmonary vascular disease in bronchopulmonary dysplasia.
Pediatr Res. 2022;91:804-815.
Abstract

BALIEVA I, Chauke L, Wise A, Voors AA, et al
Pregnancy in women with cardiac disease: a one-year retrospective review of management and maternal and neonatal outcomes in a tertiary hospital in Johannesburg, South Africa.
Cardiovasc J Afr. 2021;32:301-307.
Abstract

SANTOS JG, Ferreira F, Alegria S, Pereira H, et al
Anomalous origin of the left pulmonary artery from the ascending thoracic aorta and a right patent ductus arteriosus associated with pulmonary hypertension in a woman of childbearing age: an unprecedented approach.
BMJ Case Rep. 2022;15.
Abstract

SPILIMBERGO FB, Assmann TS, Bellon M, Hoscheidt LM, et al
Soluble Guanylate Cyclase Stimulators (Riociguat) in Pulmonary Hypertension: Data from Real-Life Clinical Practice in a 3-Year Follow-Up.
Arq Bras Cardiol. 2022 May 9. pii: S0066-782X2022005006202.
Abstract

SMITS AJ, Arkani M, In 't Veld SGJG, Huis In 't Veld AE, et al
Distinct Platelet RNA Signatures in Patients with Pulmonary Hypertension.
Ann Am Thorac Soc. 2022 May 10. doi: 10.1513/AnnalsATS.202201.
Abstract

TSUJIMOTO Y, Kumasawa J, Shimizu S, Nakano Y, et al
Doppler trans-thoracic echocardiography for detection of pulmonary hypertension in adults.
Cochrane Database Syst Rev. 2022;5:CD012809.
Abstract

PILIERO N, Thony F, Guillien A, Rousseau J, et al
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: Evaluation of haemodynamic effects, complication rates and radiation exposure over time.
Arch Cardiovasc Dis. 2022 Apr 21. pii: S1875-2136(22)00055.
Abstract

HONG C, Lu J, Wu X, Guo W, et al
Bilateral versus unilateral balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension.
Respir Res. 2022;23:117.
Abstract

MANDURINO-MIRIZZI A, Munafo A, Raineri C, Magrini G, et al
Response to acute vasodilator challenge and haemodynamic modifications after MitraClip in patients with functional mitral regurgitation and pulmonary hypertension.
Eur Heart J Acute Cardiovasc Care. 2022 May 7. pii: 6582251.
Abstract

XIANG G, Ying K, Jiang P, Jia M, et al
Growth differentiation factor 11 induces skeletal muscle atrophy via a STAT3-dependent mechanism in pulmonary arterial hypertension.
Skelet Muscle. 2022;12:10.
Abstract

GONCHAROVA EA, Farkas L
Stem Cell-Derived Nanovesicles for the Treatment of Pulmonary Hypertension: Are We There Yet?
Am J Respir Cell Mol Biol. 2022 May 6. doi: 10.1165/rcmb.2022-0078.
Abstract

LI Q, Zhang C, Wang R, Keller BB, et al
Pulmonary hypertensive crisis in children with pulmonary arterial hypertension undergoing cardiac catheterization.
Pulm Circ. 2022;12:e12067.
Abstract

SCHMIDT C, Monteiro M, Furtado I, Carvalho L, et al
Physical activity and its clinical correlates in chronic thromboembolic pulmonary hypertension.
Pulm Circ. 2022;12:e12048.
Abstract

NIES MK, Yang J, Griffiths M, Damico R, et al
Proteomics discovery of pulmonary hypertension biomarkers: Insulin-like growth factor binding proteins are associated with disease severity.
Pulm Circ. 2022;12:e12039.
Abstract

SINKALA E, Ahmed HY, Sibomana JP, Lee MH, et al
Rationale and design of a screening study to detect schistosomiasis-associated pulmonary hypertension in Ethiopia and Zambia.
Pulm Circ. 2022;12:e12072.
Abstract

RAWLINGS GH, Beail N, Condliffe R, Kiely DG, et al
Examining the impact of pulmonary hypertension on nonprofessional caregivers: A mixed-methods systematic review.
Pulm Circ. 2022;12:e12077.
Abstract

RAHAGHI FF, Balasubramanian VP, Bourge RC, Burger CD, et al
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.
Pulm Circ. 2022;12:e12055.
Abstract

BLANCO I, Torres-Castro R, Barbera JA
[Translated article] Exercise Tolerance in Pulmonary Hypertension.
Arch Bronconeumol. 2022 May 2. pii: S0300-2896(22)00306.
Abstract

PADREZ Y, Golubewa L, Kulahava T, Vladimirskaja T, et al
Quantitative and qualitative analysis of pulmonary arterial hypertension fibrosis using wide-field second harmonic generation microscopy.
Sci Rep. 2022;12:7330.
Abstract

RHEE SJ, Shin SH, Oh J, Jung YH, et al
Population pharmacokinetic analysis of sildenafil in term and preterm infants with pulmonary arterial hypertension.
Sci Rep. 2022;12:7393.
Abstract

PEREIRA MC, Lima LNG, Moreira MM, Mendes FAR, et al
One minute sit-to-stand test as an alternative to measure functional capacity in patients with pulmonary arterial hypertension.
J Bras Pneumol. 2022;48:e20210483.
Abstract

ZHANG Y, Hernandez M, Gower J, Winicki N, et al
JAGGED-NOTCH3 signaling in vascular remodeling in pulmonary arterial hypertension.
Sci Transl Med. 2022;14:eabl5471.
Abstract

ZHANG Y, Michelakis ED
Changing cell fate in the wall of pulmonary arteries.
Sci Transl Med. 2022;14:eabq1908.
Abstract

JARABICOVA I, Horvath C, Velasova E, Bies Pivackova L, et al
Analysis of necroptosis and its association with pyroptosis in organ damage in experimental pulmonary arterial hypertension.
J Cell Mol Med. 2022;26:2633-2645.
Abstract

THOMEAS-MCEWING V, Psotka MA, Gamazon ER, Friedman P, et al
Two polymorphic gene loci associated with treprostinil dose in pulmonary arterial hypertension.
Pharmacogenet Genomics. 2022;32:144-151.
Abstract

STUBBE B, Halank M, Seyfarth HJ, Obst A, et al
[Risk Stratification in Patients with Pulmonary Arterial Hypertension under Treatment - Results of Four German Centers].
Pneumologie. 2022;76:330-339.
Abstract

HUANG Z, Gao D, Liu Z, Liu X, et al
Long-term outcomes and prognostic predictors of patients with Takayasu's arteritis along with pulmonary artery involvement.
Clin Exp Rheumatol. 2022;40:765-771.
Abstract

CRUZ-UTRILLA A, Gallego N, Torrent-Vernetta A, Guillen I, et al
Prevalence of genetic variants in pediatric pulmonary arterial hypertension associated with corrected D-transposition of the great arteries. The REHIPED registry.
Rev Esp Cardiol (Engl Ed). 2022;75:448-450.
Abstract

SAMEEMA VV, Soni K, Deora S, Sharma JB, et al
Assessment of preoperative and postoperative cardiac function in children with adenotonsillar hypertrophy: a prospective cohort study.
Eur Arch Otorhinolaryngol. 2022;279:3013-3019.
Abstract

BAYRAM Z, Dogan C, Efe SC, Guvendi B, et al
Ischaemic versus non-ischaemic: how does heart failure aetiology affect pulmonary arterial capacitance and pulmonary artery pulsatility index in end-stage heart failure?
Acta Cardiol. 2022;77:204-210.
Abstract

SPIERINGS J, Nihtyanova SI, Derrett-Smith E, Clark KEN, et al
Outcomes linked to eligibility for stem cell transplantation trials in diffuse cutaneous systemic sclerosis.
Rheumatology (Oxford). 2022;61:1948-1956.
Abstract

KAMELY M, Karimi Torshizi MA, West J, Niewold T, et al
Impacts of caffeine on resistant chicken's performance and cardiovascular gene expression.
J Anim Physiol Anim Nutr (Berl). 2022;106:566-574.
Abstract

SHI B, Zhou T, Lv S, Wang M, et al
An evolutionary machine learning for pulmonary hypertension animal model from arterial blood gas analysis.
Comput Biol Med. 2022;146:105529.
Abstract

OKAMURA M, Konishi M, Saigusa Y, Ando S, et al
Impact of grip strength and gait speed on exercise tolerance in patients with pulmonary hypertension without left heart disease.
Heart Vessels. 2022 May 20. pii: 10.1007/s00380-022-02091.
Abstract

CODINA P, Domingo M, Barcelo E, Gastelurrutia P, et al
Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension.
ESC Heart Fail. 2022 May 19. doi: 10.1002/ehf2.13952.
Abstract

RUIGROK D, Handoko ML, Meijboom LJ, Nossent EJ, et al
Noninvasive follow-up strategy after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
ERJ Open Res. 2022;8.
Abstract

ALKHANFAR D, Shahin Y, Alandejani F, Dwivedi K, et al
Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative computed tomography.
ERJ Open Res. 2022;8.
Abstract

BIER EA, Alenezi F, Lu J, Wang Z, et al
Noninvasive diagnosis of pulmonary hypertension with hyperpolarised (129)Xe magnetic resonance imaging and spectroscopy.
ERJ Open Res. 2022;8.
Abstract

WADA TT, Yokota K, Iida S, Kanno Y, et al
Transition from epoprostenol to selexipag in a patient with systemic sclerosis and pulmonary hypertension during the postoperative period of colon cancer surgery: A case report.
J Scleroderma Relat Disord. 2022;7:NP4-NP8.
Abstract

JOHNY D, Subramanyam K, Bhandary RM, Rao A, et al
Non-surgical treatment of Lutembacher syndrome: combined percutaneous transcatheter therapy.
BMJ Case Rep. 2022;15.
Abstract

RANGEL BSDS, Biselli B, Quintanilha NR, Avila MS, et al
Early reduction of pulmonary arterial hypertension in patients using a long-term mechanical ventricular assistance device: a cross-sectional study.
Sao Paulo Med J. 2022;140:505-508.
Abstract

SCOTT JV, Tembulkar TU, Lee ML, Faliks BT, et al
Right ventricular myocardial energetic model for evaluating right heart function in pulmonary arterial hypertension.
Physiol Rep. 2022;10:e15136.
Abstract

YU M, Wu X, Wang J, He M, et al
Paeoniflorin attenuates monocrotaline-induced pulmonary arterial hypertension in rats by suppressing TAK1-MAPK/NF-kappaB pathways.
Int J Med Sci. 2022;19:681-694.
Abstract

D'ADDARIO CA, Lanier GM, Jacob C, Bauer N, et al
Differences in the expression of DNA methyltransferases and demethylases in leukocytes and the severity of pulmonary arterial hypertension between ethnic groups.
Physiol Rep. 2022;10:e15282.
Abstract

LIM MX, Ismail AJ, Yeap TB
Challenges in managing a critically ill patient with decompensated Eisenmenger syndrome.
BMJ Case Rep. 2022;15.
Abstract

LV GJ, Li AL, Tao XC, Zhai YN, et al
The accuracy and influencing factors of Doppler echocardiography in estimating pulmonary artery systolic pressure: comparison with right heart catheterization: a retrospective cross-sectional study.
BMC Med Imaging. 2022;22:91.
Abstract

STEPNIEWSKI J, Magon W, Waligora M, Jonas K, et al
Hemodynamic effects of balloon pulmonary angioplasty for the treatment of total and subtotal pulmonary artery occlusions in inoperable chronic thromboembolic pulmonary hypertension.
Int J Cardiol. 2022 May 13. pii: S0167-5273(22)00738.
Abstract

CHAKRABORTY S, Das SK, Lorente-Ros M, Patel N, et al
Impact of pulmonary hypertension in patients with hypertrophic cardiomyopathy presented with cardiogenic shock/acute decompensated heart failure.
Curr Probl Cardiol. 2022 May 13:101251. doi: 10.1016/j.cpcardiol.2022.101251.
Abstract

SHANG ST, Chang YL, Ho WJ, Liu CY, et al
Quality of Life in Patients With Pulmonary Hypertension.
Clin Nurs Res. 2022 May 16:10547738221096558. doi: 10.1177/10547738221096558.
Abstract

BERTERO T, Lu Y, Annis S, Hale A, et al
Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.
J Clin Invest. 2022;132.
Abstract

UDOMKIATTIKUL J, Kirdratanasak N, Siritianwanitchakul P, Worapunyaanun W, et al
Factors related to survival time in dogs with pulmonary hypertension secondary to degenerative mitral valve disease stage C.
Int J Vet Sci Med. 2022;10:25-32.
Abstract

WU S, Peng G, Xu C, Li X, et al
The outcome of lung transplantation for end-stage pulmonary diseases with pulmonary hypertension: a single-center experience.
J Thorac Dis. 2022;14:1020-1030.
Abstract

VAN UDEN D, Koudstaal T, van Hulst JAC, van den Bosch TPP, et al
Evidence for a Role of CCR6+ T Cells in Chronic Thromboembolic Pulmonary Hypertension.
Front Immunol. 2022;13:861450.
Abstract

BENAVIDES-CORDOBA V, Spruit MA
Muscle training in patients with pulmonary hypertension. a narrative review.
Colomb Med (Cali). 2021;52:e2015163.
Abstract

RUBACKOVA POPELOVA J, Tomkova M, Tomek J, Zivna R, et al
Long-Term Survival of Adult Patients With Atrial Septal Defect With Regards to Defect Closure and Pulmonary Hypertension.
Front Cardiovasc Med. 2022;9:867012.
Abstract

SIMAKOVA MA, Zlobina IS, Berezina AV, Marukyan NV, et al
Cardiopulmonary exercise testing for treatment effect assessment in chronic thromboembolic pulmonary hypertension patients.
Kardiologiia. 2022;62:44-54.
Abstract

MULLER BA, Diab KA
Pulmonary hypertension in pregnancy and its effects on the fetus.
Semin Fetal Neonatal Med. 2022 Apr 22:101348. doi: 10.1016/j.siny.2022.101348.
Abstract

ZHOU Y, Panda A, Jokerst CE
Editorial for "Evaluation of Pulmonary Hypertension Using 4D Flow MRI".
J Magn Reson Imaging. 2022 May 14. doi: 10.1002/jmri.28235.
Abstract

MADONNA R, Fabiani S, Morganti R, Forniti A, et al
Exercise-Induced Pulmonary Hypertension Is Associated with High Cardiovascular Risk in Patients with HIV.
J Clin Med. 2022;11.
Abstract

MAGON W, Stepniewski J, Waligora M, Jonas K, et al
Changes in Inflammatory Markers in Patients with Chronic Thromboembolic Pulmonary Hypertension Treated with Balloon Pulmonary Angioplasty.
Cells. 2022;11.
Abstract

GONZALES J, Holbert K, Czysz K, George J, et al
Hemin-Induced Endothelial Dysfunction and Endothelial to Mesenchymal Transition in the Pathogenesis of Pulmonary Hypertension Due to Chronic Hemolysis.
Int J Mol Sci. 2022;23.
Abstract

BARILLI M, Tavera MC, Valente S, Palazzuoli A, et al
Structural and Hemodynamic Changes of the Right Ventricle in PH-HFpEF.
Int J Mol Sci. 2022;23.
Abstract

WANG M, Li X, Chen L
An enhance multimodal multiobjective optimization genetic algorithm with special crowding distance for pulmonary hypertension feature selection.
Comput Biol Med. 2022;146:105536.
Abstract

LIN S, Hua X, Li J, Li Y, et al
Novel Compound Heterozygous PKLR Mutation Induced Pyruvate Kinase Deficiency With Persistent Pulmonary Hypertension in a Neonate: A Case Report.
Front Cardiovasc Med. 2022;9:872172.
Abstract

TAS S, Antal A, Durusoy AF, Yanartas M, et al
Pulmonary Endarterectomy in Patients with Antiphospholipid Syndrome-Associated Chronic Thromboembolic Pulmonary Hypertension.
Anatol J Cardiol. 2022;26:394-400.
Abstract

AKGUN AE, Yaylali YT, Secme M, Dodurga Y, et al
Kynurenine-PARP-1 Link Mediated by MicroRNA 210 May Be Dysregulated in Pulmonary Hypertension.
Anatol J Cardiol. 2022;26:388-393.
Abstract

EROL C
Focus on Micro RNAs and Pulmonary Hypertension.
Anatol J Cardiol. 2022;26:345.
Abstract

JOSHI SR, Liu J, Bloom T, Karaca Atabay E, et al
Sotatercept analog suppresses inflammation to reverse experimental pulmonary arterial hypertension.
Sci Rep. 2022;12:7803.
Abstract

BAPTISTA DE BARROS RIBEIRO DOU, Santos M, Moreira-Goncalves D
Nets, pulmonary arterial hypertension, and thrombo-inflammation.
J Mol Med (Berl). 2022;100:713-722.
Abstract

FUKUMITSU M, Groeneveldt JA, Braams NJ, Bayoumy AA, et al
When right ventricular pressure meets volume: The impact of arrival time of reflected waves on right ventricle load in pulmonary arterial hypertension.
J Physiol. 2022;600:2327-2344.
Abstract

DING J, Chu C, Mao Z, Yang J, et al
Metabolomics-based mechanism exploration of pulmonary arterial hypertension pathogenesis: novel lessons from explanted human lungs.
Hypertens Res. 2022;45:990-1000.
Abstract

YANG C, Rong R, Li Y, Cheng M, et al
Decrease in LINC00963 attenuates the progression of pulmonary arterial hypertension via microRNA-328-3p/profilin 1 axis.
J Clin Lab Anal. 2022;36:e24383.
Abstract

THOMAS S, Manivannan S, Garg V, Lilly B, et al
Single-Cell RNA Sequencing Reveals Novel Genes Regulated by Hypoxia in the Lung Vasculature.
J Vasc Res. 2022;59:163-175.
Abstract

KHALILIAN MR, Ziaratban M, Alizadeh P, Norouzi AR, et al
Comparison of QT dispersion before and after PDA device closure in pediatrics.
Ann Noninvasive Electrocardiol. 2022;27:e12945.
Abstract

SOMEYA Y, Koyasu S, Ohnishi Y, Ohno T, et al
Pancreatic enlargement in a patient receiving therapy with vasodilators for pulmonary arterial hypertension: a case report.
Abdom Radiol (NY). 2022;47:1948-1953.
Abstract

WANG J, Jiang R, Tan Y, Cheng K, et al
Human pulmonary artery smooth muscle cell dysfunction is regulated by miR-509-5p in hypoxic environment.
Cell Cycle. 2022;21:1212-1221.
Abstract

ZHANG G, Kang Y, Cathey D, LeBlanc AJ, et al
Sulforaphane Does Not Protect Right Ventricular Systolic and Diastolic Functions in Nrf2 Knockout Pulmonary Artery Hypertension Mice.
Cardiovasc Drugs Ther. 2022;36:425-436.
Abstract

ZHANG Y, Qin D, Qin L, Yang X, et al
Answer to Simopoulou et al. "On the diagnostic test accuracy of N-terminal pro-brain natriuretic peptide (NT-proBNP) for pulmonary arterial hypertension in patients with systemic sclerosis". Joint Bone Spine 2021;89:105317.
Joint Bone Spine. 2022;89:105323.
Abstract

SAGONAS I, Daoussis D
Serotonin and systemic sclerosis. An emerging player in pathogenesis.
Joint Bone Spine. 2022;89:105309.
Abstract

PALASSIN P, Maria ATJ, Ladhari C, Quantin X, et al
Pulmonary hypertension reported with immune checkpoint inhibitors: a pharmacovigilance study.
Cancer Immunol Immunother. 2022 May 26. pii: 10.1007/s00262-022-03208.
Abstract

GELPI RJ
A New Therapeutic Alternative for the Treatment of Pulmonary Hypertension?
Arq Bras Cardiol. 2021;117:1113-1114.
Abstract

WANG G, Tao X, Peng L
miR-155-5p regulates hypoxia-induced pulmonary artery smooth muscle cell function by targeting PYGL.
Bioengineered. 2022;13:12985-12997.
Abstract

ASSERI AA, Asiri IA, Alwabel HH, Asiri AM, et al
Severe acute reentry high altitude pulmonary edema in pediatric patients: report of three cases and literature review.
Turk J Pediatr. 2022;64:400-407.
Abstract

PARK MH, Lee MJ, Kim JS, Park SH, et al
Veno-venous extracorporeal membrane oxygenation rescue for pulmonary hypertension and hypoxemic respiratory failure to obesity hypoventilation syndrome: a case report.
Ann Palliat Med. 2022 May 12. pii: apm-22-178. doi: 10.21037.
Abstract

ZHOU F, Zheng Z, Pan Y
Pulmonary artery dissection secondary to pulmonary hypertension due to patent ductus arteriosus: echocardiography and computed tomography findings.
Acta Cardiol. 2022 May 24:1-2. doi: 10.1080/00015385.2022.2054496.
Abstract

BURKI T
Pulmonary hypertension in Europe: a call to action.
Lancet Respir Med. 2022 May 20. pii: S2213-2600(22)00190.
Abstract

BROOKS BA, Krishnan A, d'Udekem Y, Yurasek GK, et al
Transposition With Hypertrophic Cardiomyopathy and Persistent Pulmonary Hypertension of the Newborn.
World J Pediatr Congenit Heart Surg. 2022 May 23:21501351221098135.
Abstract

CROQUETTE M, Puyade M, Montani D, Jutant EM, et al
Diagnostic Performance of Pulsed Doppler Ultrasound of the Common Femoral Vein to Detect Elevated Right Atrial Pressure in Pulmonary Hypertension.
J Cardiovasc Transl Res. 2022 May 23. pii: 10.1007/s12265-022-10276.
Abstract

GONZALEZ-GARCIA M, Aguirre-Franco CE, Vargas-Ramirez L, Barrero M, et al
Effect of pulmonary hypertension on exercise capacity and gas exchange in patients with chronic obstructive pulmonary disease living at high altitude.
Chron Respir Dis. 2022;19:14799731221104095.
Abstract

MA X, Wang XE, Xie LX, Lu S, et al
The Levels of TNF-alpha, Tissue Factor, and Coagulation Function in Rats with Pulmonary Hypertension and the Intervention Effect of Sildenafil Encapsulated by Targeted Nanocarriers.
Comput Math Methods Med. 2022;2022:8619092.
Abstract

WU P, Zhu T, Tan Z, Chen S, et al
Role of Gut Microbiota in Pulmonary Arterial Hypertension.
Front Cell Infect Microbiol. 2022;12:812303.
Abstract

BOLT MA, MaWhinney S, Pattee JW, Erlandson KM, et al
Inference following multiple imputation for generalized additive models: an investigation of the median p-value rule with applications to the Pulmonary Hypertension Association Registry and Colorado COVID-19 hospitalization data.
BMC Med Res Methodol. 2022;22:148.
Abstract

PANAKALA S, Anumolu AR, Khatri M
Prevalence of sexual dysfunction in women with pulmonary hypertension and associated variables.
Heart Lung. 2022;55:146-147.
Abstract

COOPER TJ, Cleland JG, Guazzi M, Pellicori P, et al
Effects of sildenafil on symptoms and exercise capacity for heart failure with reduced ejection fraction and pulmonary hypertension (The SilHF study): A randomised placebo-controlled multicentre trial.
Eur J Heart Fail. 2022 May 21. doi: 10.1002/ejhf.2527.
Abstract

AZZO L, Ali YS, Vaqar S, Yildiz Bolukbasi E, et al
Do paternal deletions involving the FOXF1 locus on chromosome 16q24.1 manifest with more severe non-lung anomalies?
Eur J Med Genet. 2022;65:104519.
Abstract

YE B, Peng X, Su D, Liu D, et al
Effects of YM155 on the proliferation and apoptosis of pulmonary artery smooth muscle cells in a rat model of high pulmonary blood flow-induced pulmonary arterial hypertension.
Clin Exp Hypertens. 2022 May 4:1-10. doi: 10.1080/10641963.2022.2071919.
Abstract

TANI C, Elefante E, Arnaud L, Barreira SC, et al
Rare clinical manifestations in systemic lupus erythematosus: a review on frequency and clinical presentation.
Clin Exp Rheumatol. 2022;40 Suppl 134:93-102.
Abstract

KYNTA RL, Rawat S, Mandal M, Saikia MK, et al
Pulmonary Thromboendarterectomy Without Circulatory Arrest.
Braz J Cardiovasc Surg. 2022;37:394-400.
Abstract

GUREL DURMUS Z, Bulbul Y, Tekinbas C, Seyis KN, et al
Frequency and Predictors of Pulmonary Arterial Stump Thrombosis following Pneumonectomy or Lobectomy.
Med Princ Pract. 2022;31:174-179.
Abstract

AL-YAARUBI S, Al-Abri AS, Al-Kindi H, Al-Abri M, et al
Sanjad Sakati syndrome and sleep-disordered breathing: an undisclosed association.
Sleep Breath. 2022;26:815-821.
Abstract

YU S, Wang Y, Fan Y, Ma R, et al
Pulmonary hypertension in patients with pneumoconiosis with progressive massive fibrosis.
Occup Environ Med. 2022 Jun 2. pii: oemed-2021-108095.
Abstract

BUTLER O, Ju S, Hoernig S, Vogtlander K, et al
Assessment for residual disease after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension.
ERJ Open Res. 2022;8.
Abstract

ZHOU S, Shi S, Xie C, Chen G, et al
Association between smoking and postoperative delirium in surgical patients with pulmonary hypertension: a secondary analysis of a cohort study.
BMC Psychiatry. 2022;22:371.
Abstract

RICCARDI M, Pagnesi M, Sciatti E, Lombardi CM, et al
Combined pre- and post-capillary pulmonary hypertension in left heart disease.
Heart Fail Rev. 2022 Jun 1. pii: 10.1007/s10741-022-10251.
Abstract

WANG M, Hu Y, Guo B, Tang H, et al
Simulation of Acute Pulmonary Hypertension in Beagle Dogs.
Int Heart J. 2022;63:612-622.
Abstract

MATTHEWS CR, Madison M, Zhang C, Waters J, et al
Trousseau Syndrome in a 25-Year-Old Woman with Occult Colon Malignancy, Lynch Syndrome, and Chronic Thromboembolic Pulmonary Hypertension.
Tex Heart Inst J. 2022;49.
Abstract

MONG DA, Guillerman RP, Weinman JP
Computed tomography evaluation of pediatric pulmonary hypertension.
Pediatr Radiol. 2022 Jun 1. pii: 10.1007/s00247-022-05385.
Abstract

Erratum: Characteristics of Children with Bronchopulmonary Dysplasia with Prolonged and/or Later-Onset Pulmonary Hypertension.
Ann Am Thorac Soc. 2022;19:1080.
Abstract

NAKAMURA J, Tsujino I, Ohira H, Nakaya T, et al
Various factors contribute to death in patients with different types of pulmonary hypertension: A retrospective pilot study from a single tertiary center.
Respir Investig. 2022 May 26. pii: S2212-5345(22)00053.
Abstract

QIAN AM, Zhu W, Yang Y, Lu KY, et al
[Early risk factors for death in neonates with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide].
Zhongguo Dang Dai Er Ke Za Zhi. 2022;24:507-513.
Abstract

TEERAPUNCHAROEN K, Bag R
Chronic Thromboembolic Pulmonary Hypertension.
Lung. 2022 May 29. pii: 10.1007/s00408-022-00539.
Abstract

CUI L, Yuan T, Zeng Z, Liu D, et al
Mechanistic and therapeutic perspectives of baicalin and baicalein on pulmonary hypertension: A comprehensive review.
Biomed Pharmacother. 2022;151:113191.
Abstract

LI Q, Gu Y, Gao X, Guo X, et al
Preparation of polyclonal antibody against phosphatidylethanolamine binding protein 1 recombinant protein and its functional verification in pulmonary hypertension syndrome in broilers.
Int J Biol Macromol. 2022;213:19-26.
Abstract

MORIYAMA H, Endo J, Kataoka M, Shimanaka Y, et al
Omega-3 fatty acid epoxides produced by PAF-AH2 in mast cells regulate pulmonary vascular remodeling.
Nat Commun. 2022;13:3013.
Abstract

LEVY PT, Levin J, Leeman KT, Mullen MP, et al
Diagnosis and management of pulmonary hypertension in infants with bronchopulmonary dysplasia.
Semin Fetal Neonatal Med. 2022 May 26:101351. doi: 10.1016/j.siny.2022.101351.
Abstract

LI C, Zhu H, Zhang S, Meng F, et al
Astragaloside IV ameliorates pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension by restraining the T follicular helper cell response and expanding T follicular regulatory cell response.
Phytomedicine. 2022;102:154171.
Abstract

KRZYZEWSKA A, Baranowska-Kuczko M, Jastrzab A, Kasacka I, et al
Cannabidiol Improves Antioxidant Capacity and Reduces Inflammation in the Lungs of Rats with Monocrotaline-Induced Pulmonary Hypertension.
Molecules. 2022;27.
Abstract

BUTANE L, Spilva-Ekerte L, Skride A, Smite D, et al
Individually Tailored Remote Physiotherapy Program Improves Participation and Autonomy in Activities of Everyday Life along with Exercise Capacity, Self-Efficacy, and Low-Moderate Physical Activity in Patients with Pulmonary Arterial Hypertension: A R
Medicina (Kaunas). 2022;58.
Abstract

UGAWA S, Akagi S, Ejiri K, Nakamura K, et al
Quantification of Lung Perfusion Blood Volume in Dual-Energy Computed Tomography in Patients with Pulmonary Hypertension.
Life (Basel). 2022;12.
Abstract

SCHNEIDER SR, Lichtblau M, Furian M, Mayer LC, et al
Cardiorespiratory Adaptation to Short-Term Exposure to Altitude vs. Normobaric Hypoxia in Patients with Pulmonary Hypertension.
J Clin Med. 2022;11.
Abstract

SLAWEK-SZMYT S, Araszkiewicz A, Jankiewicz S, Grygier M, et al
Prognostic Value of Pulmonary Artery Pulsatility Index in Right Ventricle Failure-Related Mortality in Inoperable Chronic Thromboembolic Pulmonary Hypertension.
J Clin Med. 2022;11.
Abstract

CROWE LA, Genecand L, Hachulla AL, Noble S, et al
Non-Invasive Cardiac Output Determination Using Magnetic Resonance Imaging and Thermodilution in Pulmonary Hypertension.
J Clin Med. 2022;11.
Abstract

VANDERPOOL RR, Gorelova A, Ma Y, Alhamaydeh M, et al
Reversal of Right Ventricular Hypertrophy and Dysfunction by Prostacyclin in a Rat Model of Severe Pulmonary Arterial Hypertension.
Int J Mol Sci. 2022;23.
Abstract

GALLEGO-ZAZO N, Cruz-Utrilla A, Del Cerro MJ, Ochoa Parra N, et al
Description of Two New Cases of AQP1 Related Pulmonary Arterial Hypertension and Review of the Literature.
Genes (Basel). 2022;13.
Abstract

THEOBALD V, Benjamin N, Seyfarth HJ, Halank M, et al
Reduction of BMPR2 mRNA Expression in Peripheral Blood of Pulmonary Arterial Hypertension Patients: A Marker for Disease Severity?
Genes (Basel). 2022;13.
Abstract

VRIGKOU E, Tsantes A, Konstantonis D, Rapti E, et al
Platelet, Fibrinolytic and Other Coagulation Abnormalities in Newly-Diagnosed Patients with Chronic Thromboembolic Pulmonary Hypertension.
Diagnostics (Basel). 2022;12.
Abstract

TRUONG L, Zheng YM, Wang YX
The Potential Important Role of Mitochondrial Rieske Iron-Sulfur Protein as a Novel Therapeutic Target for Pulmonary Hypertension in Chronic Obstructive Pulmonary Disease.
Biomedicines. 2022;10.
Abstract

LAGGNER M, Oberndorfer F, Golabi B, Bauer J, et al
EGR1 Is Implicated in Right Ventricular Cardiac Remodeling Associated with Pulmonary Hypertension.
Biology (Basel). 2022;11.
Abstract

CHETAN C, Suryawanshi P, Patnaik S, Soni NB, et al
Oral versus intravenous sildenafil for pulmonary hypertension in neonates: a randomized trial.
BMC Pediatr. 2022;22:311.
Abstract

OGBOMO A, Tsang Y, Mallampati R, Panjabi S, et al
The direct and indirect health care costs associated with pulmonary arterial hypertension among commercially insured patients in the United States.
J Manag Care Spec Pharm. 2022;28:608-616.
Abstract

FANG X, He C, Ni X, Zhang T, et al
A potential model of systemic sclerosis with pulmonary hypertension induced by monocrotaline plus bleomycin.
Clin Exp Hypertens. 2022 May 27:1-7. doi: 10.1080/10641963.2022.2079665.
Abstract

JIANG C, Fang X, Fu W
The Association of Body Mass Index With Mortality Among Pulmonary Hypertension Patients: A Systematic Review and Meta-Analysis of Cohort Studies.
Front Public Health. 2022;10:761904.
Abstract

AZZO L, Ali YS, Vaqar S, Wang RR, et al
Immunity and inflammation in pulmonary arterial hypertension: From pathophysiology mechanisms to treatment perspective.
Pharmacol Res. 2022;180:106238.
Abstract

JERJES-SANCHEZ C, Glenn-Valdez H, Zayas N, Cueto-Robledo G, et al
Riociguat in the Treatment of Pulmonary Arterial Hypertension.
Arch Med Res. 2022;53:352-358.
Abstract

PHAM T, Tran K, Taberner AJ, Loiselle DS, et al
Cross-bridge thermodynamics in pulmonary arterial hypertensive right-ventricular failure.
J Appl Physiol (1985). 2022;132:1338-1349.
Abstract

ALVES-SILVA JM, Zuzarte M, Marques C, Viana S, et al
1,8-Cineole ameliorates right ventricle dysfunction associated with pulmonary arterial hypertension by restoring connexin43 and mitochondrial homeostasis.
Pharmacol Res. 2022;180:106151.
Abstract

IWAYA Y, Muneuchi J, Sugitani Y, Watanabe M, et al
Pulmonary vascular resistance and compliance in pulmonary blood flow alterations in children with congenital heart disease.
Heart Vessels. 2022;37:1283-1289.
Abstract

HAYAMA H, Moroi M, Adachi-Akahane S, Uejima T, et al
A Novel Non-Invasive Method for Estimating Elevated Pulmonary Vascular Resistance Based on Echocardiographic Assessment of Pulmonary Artery Wave Reflection.
Circ J. 2022;86:947-955.
Abstract

COLALILLO A, Grimaldi MC, Vaiarello V, Pellicano C, et al
In systemic sclerosis, the TAPSE/sPAP ratio can be used in addition to the DETECT algorithm for pulmonary arterial hypertension diagnosis.
Rheumatology (Oxford). 2022;61:2450-2456.
Abstract

ZHAO C, Hu L, He X, Li L, et al
TPN171H alleviates pulmonary hypertension via inhibiting inflammation in hypoxia and monocrotaline-induced rats.
Vascul Pharmacol. 2022 Jun 6:107017. doi: 10.1016/j.vph.2022.107017.
Abstract

LUI JK, Gillmeyer KR, Sangani RA, Smyth RJ, et al
A Multimodal Prediction Model for Diagnosing Pulmonary Hypertension in Systemic Sclerosis.
Arthritis Care Res (Hoboken). 2022 Jun 9. doi: 10.1002/acr.24969.
Abstract

DADLANI A, Eiswerth M, Bosch A, Sharpe T, et al
Pulmonary Hypertension as a Rare Complication After Orthotopic Liver Transplant in a Patient With Non-alcoholic Steatohepatitis (NASH) Cirrhosis Complicated by Hepatopulmonary Syndrome.
Cureus. 2022;14:e24740.
Abstract

CHELLADURAI P, Kuenne C, Bourgeois A, Gunther S, et al
Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension.
Sci Transl Med. 2022;14:eabe5407.
Abstract

CHEN B, Jin Y, Pool CM, Liu Y, et al
Hypoxic pulmonary endothelial cells release epidermal growth factor leading to vascular smooth muscle cell arginase-2 expression and proliferation.
Physiol Rep. 2022;10:e15342.
Abstract

ZHANG X, Liu S, Sun Y, Li G, et al
[Tanshinone IIA alleviates monocrotaline-induced pulmonary hypertension in rats through the PI3K/Akt-eNOS signaling pathway].
Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:718-723.
Abstract

HONORE PM, Redant S, Djimafo P, Blackman S, et al
Endarterectomy treatment for patients suffering from a new episode of pulmonary embolism, after screening for chronic thromboembolic pulmonary hypertension.
Crit Care. 2022;26:165.
Abstract

DHOBLE S, Patravale V
SIRT 1 Activator Loaded Inhaled Antiangiogenic Liposomal Formulation Development for Pulmonary Hypertension.
AAPS PharmSciTech. 2022;23:158.
Abstract

TSENG V, Collum S, Allawzi A, Crotty K, et al
3'UTR shortening of HAS2 promotes hyaluronan hyper-synthesis and bioenergetic dysfunction in pulmonary hypertension.
Matrix Biol. 2022 Jun 4. pii: S0945-053X(22)00075.
Abstract

PATEL JK, Ramkishun CA, Haw A, Mehta K, et al
Association of Pulmonary Hypertension with Survival and Neurologic Outcomes in Adults with In-Hospital Cardiac Arrest.
Resuscitation. 2022 Jun 4. pii: S0300-9572(22)00171.
Abstract

PETHO A, Szebeni J
Pulmonary hypertension in a hemodialysis porcine model: possible unforeseen causes?
Ren Fail. 2022;44:693.
Abstract

ANDERSEN MO, Diederichsen S, Svendsend JH, Carlsen J, et al
Continuous cardiac monitoring in a patient with terminal pulmonary hypertension and eventual bilateral lung transplantation.
BMJ Case Rep. 2022;15.
Abstract

TU J, Jin J, Chen X, Sun L, et al
Altered Cellular Immunity and Differentially Expressed Immune-Related Genes in Patients With Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
Front Immunol. 2022;13:868983.
Abstract

ALBABA I, Medarov BI
A case of severe cancer-related pulmonary hypertension; An unexpected resolution.
Respir Med Case Rep. 2022;38:101671.
Abstract

HAYASHI H, Oda S, Emoto T, Kidoh M, et al
Myocardial extracellular volume quantification by cardiac CT in pulmonary hypertension: Comparison with cardiac MRI.
Eur J Radiol. 2022;153:110386.
Abstract

STAPEL JR, Speed JS, Clemmer JS
Endothelin antagonism reduces hemoglobin A1c in patients with pulmonary hypertension.
Can J Physiol Pharmacol. 2022 Jun 3. doi: 10.1139/cjpp-2022-0132.
Abstract

XIAO XH, Luo FM, Wang EL, Fu MY, et al
Magnolol alleviates hypoxia-induced pulmonary vascular remodeling through inhibition of phenotypic transformation in pulmonary arterial smooth muscle cells.
Biomed Pharmacother. 2022;150:113060.
Abstract

XU J, Zhong Y, Wang Z
Decrease in Tripartite Motif Containing 24 suppresses hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/mammalian target of rapamycin complex 1 pathway.
Bioengineered. 2022;13:13596-13606.
Abstract

ZANI A, Chung WK, Deprest J, Harting MT, et al
Congenital diaphragmatic hernia.
Nat Rev Dis Primers. 2022;8:37.
Abstract

KHANGOORA VS, King CS, Shlobin OA
Managing pulmonary arterial hypertension: how to select and facilitate successful transplantation.
Curr Opin Organ Transplant. 2022;27:169-176.
Abstract

MONOSILIO S, Filomena D, Cimino S, Birtolo LI, et al
Prognostic value of systemic inflammatory response syndrome after transcatheter aortic valve implantation.
J Cardiovasc Med (Hagerstown). 2022;23:394-398.
Abstract

SCHULER KP, Hemnes AR, Annis J, Farber-Eger E, et al
An algorithm to identify cases of pulmonary arterial hypertension from the electronic medical record.
Respir Res. 2022;23:138.
Abstract

ALQARNI AA, Brand OJ, Pasini A, Alahmari M, et al
Imbalanced prostanoid release mediates cigarette smoke-induced human pulmonary artery cell proliferation.
Respir Res. 2022;23:136.
Abstract

AZZO L, Ali YS, Vaqar S, Dhoble S, et al
Comprehensive review on novel targets and emerging therapeutic modalities for pulmonary arterial Hypertension.
Int J Pharm. 2022;621:121792.
Abstract

ZHAO H, Yan Y, Liu Y, Long L, et al
Bedside critical ultrasound as a key to the diagnosis of obstructive atelectasis complicated with acute cor pulmonale and differentiation from pulmonary embolism: A case report.
J Clin Ultrasound. 2022;50:611-617.
Abstract

USTA DY, Timur B, Teksin ZS
Formulation development, optimization by Box-Behnken design, characterization, in vitro, ex-vivo, and in vivo evaluation of bosentan-loaded self-nanoemulsifying drug delivery system: A novel alternative dosage form for pulmonary arterial hypertension
Eur J Pharm Sci. 2022;174:106159.
Abstract

VRAKA A, Yerly P, Aubert JD
Comparison of Risk Stratification Scores in Pulmonary Arterial Hypertension: A Monocentric Retrospective Study at Lausanne University Hospital.
Respiration. 2022;101:565-576.
Abstract

MIN J, Appleby DH, McClelland RL, Minhas J, et al
Secular and Regional Trends among Pulmonary Arterial Hypertension Clinical Trial Participants.
Ann Am Thorac Soc. 2022;19:952-961.
Abstract

SUDA T, Zoshima T, Ito K, Mizushima I, et al
Successful Early Immunosuppressive Therapy for Pulmonary Arterial Hypertension Due to Takayasu arteritis: Two Case Reports and a Review of Similar Case Reports in the English Literature.
Intern Med. 2022;61:1767-1774.
Abstract

PFANNMUELLER B, Budde LM, Noack T, Marin-Cuartas M, et al
Is the pulmonary pressure directly correlated with the operative risk in patients with isolated tricuspid valve surgery?
J Cardiovasc Surg (Torino). 2022;63:376-381.
Abstract

XIE Y, Liu N, Xiao Z, Yang F, et al
The progress of pulmonary artery denervation.
Cardiol J. 2022;29:381-387.
Abstract

WANG L, Zhang Z, Zhao Z, Yan C, et al
(68)Ga-FAPI right heart uptake in a patient with idiopathic pulmonary arterial hypertension.
J Nucl Cardiol. 2022;29:1475-1477.
Abstract

SUNAGAWA G, Kehara H, Mangukia C, Brann S, et al
Single Lung Transplant Remains a Viable Option for Patients With Severe Secondary Pulmonary Hypertension.
Transplantation. 2022 Jun 6. pii: 00007890-990000000-00069.
Abstract

EBERLEIN M, Reed RM
A New Look at an Old Problem: Is Single Lung Transplantation an Option in Candidates With Significant Secondary Pulmonary Hypertension?
Transplantation. 2022 Jun 6. pii: 00007890-990000000-00070.
Abstract

ALENCAR AKN
Should we Consider the Stimulation of Soluble Guanylyl Cyclase as Beneficial for Treating Pre-Capillary Pulmonary Hypertension?
Arq Bras Cardiol. 2022;118:1067-1068.
Abstract

YASAR S, Koksal O, Eski S, Asil S, et al
Incidentally Diagnosed Double Inferior Vena Cava While Being Investigated for Pulmonary Hypertension.
Anatol J Cardiol. 2022;26:E8-E9.
Abstract

BRIEGER D, Rye EE, Hungerford SL
Editorial for "Risk Stratification and Outcomes in Patients with Pulmonary Hypertension: Insights into Right Ventricular Strain by MRI Feature-Tracking".
J Magn Reson Imaging. 2022 Jun 14. doi: 10.1002/jmri.28289.
Abstract

JOSHI S, Quinones Cardona V, Menkiti OR
Use of vasopressin in persistent pulmonary hypertension of the newborn: A case series.
SAGE Open Med Case Rep. 2022;10:2050313X221102289.
Abstract

CHEN J, Ding S, Zhang C, Li R, et al
Clinical value of echocardiography in evaluating hemodynamics and right ventricular function in patients with chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty.
J Thorac Dis. 2022;14:1401-1410.
Abstract

COOKSON MW, Abman SH, Kinsella JP, Mandell EW, et al
Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension.
Semin Fetal Neonatal Med. 2022 Jun 3:101367. doi: 10.1016/j.siny.2022.101367.
Abstract

PEREZ JM, Melvin PR, Berry JG, Mullen MP, et al
Outcomes for Children With Pulmonary Hypertension Undergoing Tracheostomy Placement: A Multi-Institutional Analysis.
Pediatr Crit Care Med. 2022 Jun 10. pii: 00130478-990000000-00045.
Abstract

HONG C, Lu J, Chen R, Liu H, et al
CXCL10 levels in diagnosis and improved hemodynamics in patients with chronic thromboembolic pulmonary hypertension undergoing balloon pulmonary angioplasty.
Pulm Circ. 2022;12:e12091.
Abstract

ARVANITAKI A, Vrana E, Boutsikou M, Anthi A, et al
The impact of cardiovascular comorbidities associated with risk for left heart disease on idiopathic pulmonary arterial hypertension: Data from the Hellenic Pulmonary Hypertension Registry (HOPE).
Pulm Circ. 2022;12:e12086.
Abstract

AKATLI AN, Ulutas H, Turkmen Samdanci E, Celik MR, et al
Bronchiectasis: Retrospective Analysis of Clinical and Pathological Findings in a Tertiary-Care Hospital.
Int J Clin Pract. 2022;2022:8773204.
Abstract

LI Y, Qiu H, Zhao Q, He J, et al
The Different Effects of Direct Bilirubin on Portopulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension.
Int J Clin Pract. 2022;2022:7021178.
Abstract

NKOKE C, Makoge C
Prolapsing left atrial mass causing severe pulmonary hypertension in a new cardiac service in a rural hospital in Cameroon: a case report.
Pan Afr Med J. 2022;41:196.
Abstract

SU D, Huang Y, Liu D, Huang Y, et al
Bioinformatic analysis of dysregulated circular RNAs in pediatric pulmonary hypertension linked congenital heart disease.
Transl Pediatr. 2022;11:715-727.
Abstract

AGNIHOTRI V, Agrawal Y, Goyal S, Sharma C, et al
An Update on Advancements and Challenges in Inhalational Drug Delivery for Pulmonary Arterial Hypertension.
Molecules. 2022;27.
Abstract

KIPFMUELLER F, Akkas S, Pugnaloni F, Bo B, et al
Echocardiographic Assessment of Pulmonary Hypertension in Neonates with Congenital Diaphragmatic Hernia Using Pulmonary Artery Flow Characteristics.
J Clin Med. 2022;11.
Abstract

FLORES K, Siques P, Brito J, Arribas SM, et al
AMPK and the Challenge of Treating Hypoxic Pulmonary Hypertension.
Int J Mol Sci. 2022;23.
Abstract

PENG Q, Shan D, Cui K, Li K, et al
The Role of Endothelial-to-Mesenchymal Transition in Cardiovascular Disease.
Cells. 2022;11.
Abstract

SUZUKI S, Asano R, Aoki T, Nakayama S, et al
Prognostic impact of follow-up pulmonary vascular resistance in pulmonary arterial hypertension.
Open Heart. 2022;9.
Abstract

JAIN PP, Hosokawa S, Babicheva A, Zhao T, et al
In Vivo and Ex Vivo Experimental Approach for Studying Functional Role of Notch in Pulmonary Vascular Disease.
Methods Mol Biol. 2022;2472:209-220.
Abstract

DE CARVALHO NUNES G, Grenier K, Maedler Kron C, Kitzler T, et al
Pulmonary lymphangiectasia in myotubular myopathy: a novel unrecognized association?
Neuromuscul Disord. 2022;32:512-515.
Abstract

BERGER MM, Sareban M, Schiefer LM, Swenson KE, et al
Effects of acetazolamide on pulmonary artery pressure and prevention of high-altitude pulmonary edema after rapid active ascent to 4,559 m.
J Appl Physiol (1985). 2022;132:1361-1369.
Abstract

BUXTON RB, Prisk GK, Hopkins SR
A novel nonlinear analysis of blood flow dynamics applied to the human lung.
J Appl Physiol (1985). 2022;132:1546-1559.
Abstract

HASHIMOTO R, Gupte SA
G6PD is a critical enabler of hypoxia-induced accumulation of macrophages and platelets in mice lungs and contributor to lung inflammation.
Vascul Pharmacol. 2022;144:106976.
Abstract

BADAGLIACCA R, Mercurio V, Romeo E, Correale M, et al
Beta-blockers in pulmonary arterial hypertension: Time for a second thought?
Vascul Pharmacol. 2022;144:106974.
Abstract

GAUTHIER-LOISELLE M, Tsang Y, Lefebvre P, Agron P, et al
Development and evaluation of a predictive algorithm for unsatisfactory response among patients with pulmonary arterial hypertension using health insurance claims data.
Curr Med Res Opin. 2022;38:1019-1030.
Abstract

SAFAI ZADEH E, Dietrich CF, Kmoth L, Trenker C, et al
Peripheral Pulmonary Lesions in Confirmed Pulmonary Arterial Embolism: Follow-up Study of B-Mode Ultrasound and of Perfusion Patterns Using Contrast-Enhanced Ultrasound (CEUS).
J Ultrasound Med. 2022;41:1713-1721.
Abstract

CARAVACA PEREZ P, Aurtenetxe Perez A, Escribano Subias P
Giant pulmonary artery aneurysm in pulmonary arterial hypertension.
Arch Bronconeumol. 2021;57:541.
Abstract

HU Y, Jin L, Pan Y, Zou J, et al
Apela gene therapy alleviates pulmonary hypertension in rats.
FASEB J. 2022;36:e22431.
Abstract

APPENZELLER P, Gautschi F, Muller J, Lichtblau M, et al
Prediction of maximal oxygen uptake from 6-min walk test in pulmonary hypertension.
ERJ Open Res. 2022;8.
Abstract

KIMURO K, Hosokawa K, Abe K, Masaki K, et al
Beneficial Effects of Pulmonary Vasodilators on Pre-Capillary Pulmonary Hypertension in Patients with Chronic Kidney Disease on Hemodialysis.
Life (Basel). 2022;12.
Abstract

RODRIGUEZ-RAMALLO H, Baez-Gutierrez N, Otero-Candelera R, Martin LA, et al
Subgroup Analysis in Pulmonary Hypertension-Specific Therapy Clinical Trials: A Systematic Review.
J Pers Med. 2022;12.
Abstract

LEE JH, Park JH, Hwang IC, Park JJ, et al
Decreased Peak Left Atrial Longitudinal Strain Is Associated with Persistent Pulmonary Hypertension Associated with Left Heart Disease.
J Clin Med. 2022;11.
Abstract

DENG L, Han X, Wang Z, Nie X, et al
The Landscape of Noncoding RNA in Pulmonary Hypertension.
Biomolecules. 2022;12.
Abstract

SUN Y, Tang C, Jin H, Du J, et al
Implications of Hydrogen Sulfide in Development of Pulmonary Hypertension.
Biomolecules. 2022;12.
Abstract

JI D, Qiao Y, Guan X, Zhang T, et al
Serum miR-204 and miR-451 Expression and Diagnostic Value in Patients with Pulmonary Artery Hypertension Triggered by Congenital Heart Disease.
Comput Math Methods Med. 2022;2022:9430708.
Abstract

BENALDO FA, Araya-Quijada C, Ebensperger G, Herrera EA, et al
Cinaciguat (BAY-582667) Modifies Cardiopulmonary and Systemic Circulation in Chronically Hypoxic and Pulmonary Hypertensive Neonatal Lambs in the Alto Andino.
Front Physiol. 2022;13:864010.
Abstract

TABUCHI I, Ogawa A, Shigetoshi M, Shimokawahara H, et al
Low incidence of restenosis after successful balloon pulmonary angioplasty in patients with chronic thromboembolic pulmonary hypertension.
Cardiovasc Interv Ther. 2022 Jun 22. pii: 10.1007/s12928-022-00866.
Abstract

FLORENTIN J, Zhao J, Tai YY, Sun W, et al
Loss of Amphiregulin drives inflammation and endothelial apoptosis in pulmonary hypertension.
Life Sci Alliance. 2022;5.
Abstract

DE SMALEN PP, Stoutjesdijk MJ
Vascular anomaly diagnosis by central venous catheter misplacement: a case report.
J Med Case Rep. 2022;16:259.
Abstract

WANG D, Huang S, Xu G, Wu S, et al
Abnormal Liver Function Tests Were Related to Short- and Long-Term Prognosis in Critically Ill Patients With Primary Pulmonary Hypertension.
Front Cardiovasc Med. 2022;9:897040.
Abstract

LIN K, Sarnari R, Pathrose A, Gordon DZ, et al
Cine magnetic resonance imaging detects shorter cardiac rest periods in postcapillary pulmonary hypertension.
Eur Heart J Cardiovasc Imaging. 2022 Jun 20. pii: 6611497.
Abstract

MORE K, Soni R, Gupta S
The role of bedside functional echocardiography in the assessment and management of pulmonary hypertension.
Semin Fetal Neonatal Med. 2022 Jun 14:101366. doi: 10.1016/j.siny.2022.101366.
Abstract

MURTA MS, Duarte RLM, Waetge D, Gozal D, et al
Sleep-Disordered Breathing in Adults with Precapillary Pulmonary Hypertension: Prevalence and Predictors of Nocturnal Hypoxemia.
Lung. 2022 Jun 18. pii: 10.1007/s00408-022-00547.
Abstract

MUKHERJEE D, Rana U, Kriegel AJ, Liu P, et al
Fetal pulmonary hypertension: dysregulated microRNA-34c-Notch1 axis contributes to impaired angiogenesis in an ovine model.
Pediatr Res. 2022 Jun 18. pii: 10.1038/s41390-022-02151.
Abstract

ZHOU D, Li X, Yin G, Li S, et al
Risk Stratification and Outcomes in Patients With Pulmonary Hypertension: Insights into Right Ventricular Strain by MRI Feature tracking.
J Magn Reson Imaging. 2022 Jun 17. doi: 10.1002/jmri.28291.
Abstract

HU X, Wang Q, Zhao H, Wu W, et al
Role of miR-21-5p/FilGAP axis in estradiol alleviating the progression of monocrotaline-induced pulmonary hypertension.
Animal Model Exp Med. 2022 Jun 17. doi: 10.1002/ame2.12253.
Abstract

LIU Y, Shi JZ, Jiang R, Liu SF, et al
Regulatory T Cell-Related Gene Indicators in Pulmonary Hypertension.
Front Pharmacol. 2022;13:908783.
Abstract

RAO S, Daines B, Hosseini O, Test V, et al
The Utility of Brain Natriuretic Peptide in Patients Undergoing an Initial Evaluation for Pulmonary Hypertension.
J Community Hosp Intern Med Perspect. 2022;12:48-52.
Abstract

ZHANG L, Liu Y, Zhao S, Wang Z, et al
The Incidence and Prevalence of Pulmonary Hypertension in the COPD Population: A Systematic Review and Meta-Analysis.
Int J Chron Obstruct Pulmon Dis. 2022;17:1365-1379.
Abstract

TANG S, Liu Y, Liu B
Integrated bioinformatics analysis reveals marker genes and immune infiltration for pulmonary arterial hypertension.
Sci Rep. 2022;12:10154.
Abstract

WU XH, Chen ZR, He ZY, Dong Y, et al
[Gene expression signature analysis of peripheral blood mononuclear cells from patients with for high altitude pulmonary hypertension and value for potential drug selection].
Zhonghua Xin Xue Guan Bing Za Zhi. 2022;50:577-584.
Abstract

HYDER SN, Chatterjee S, Aggarwal V
Percutaneous Treatments for Pulmonary Hypertension: Reviewing the Growing Procedural Role for Interventional Cardiology.
Interv Cardiol Clin. 2022;11:293-305.
Abstract

SAGRIS M, Bakoyiannis C
Venous Thromboembolism and Chronic Thromboembolic Pulmonary Hypertension: Novel Clinical Insights.
Curr Pharm Des. 2022;28:769-770.
Abstract

QIN Y, Qiao Y, Wang D, Li L, et al
Target Nuclear Factor Erythroid 2-Related Factor 2 in Pulmonary Hypertension: Molecular Insight into Application.
Oxid Med Cell Longev. 2022;2022:7845503.
Abstract

JIN T, Lu H, Zhang Z, Wang Y, et al
CYP2S1 gene methylation among High-altitude pulmonary edema.
Gene. 2022;834:146590.
Abstract

HENDRIKS PM, van de Groep LD, Veen KM, van Thor MCJ, et al
Prognostic value of brain natriuretic peptides in patients with pulmonary arterial hypertension: a systematic review and meta-analysis.
Am Heart J. 2022 May 6. pii: S0002-8703(22)00093.
Abstract

SANNA L, Todea A
Risk assessment tools for survival prognosis: An era of new surrogacy endpoints for clinical outcome measurement in pulmonary arterial hypertension clinical trials?
Respir Med Res. 2022;81:100893.
Abstract

KELLY TD, Meier M, Weinman JP, Ivy D, et al
High-Altitude Pulmonary Edema in Colorado Children: A Cross-Sectional Survey and Retrospective Review.
High Alt Med Biol. 2022;23:119-124.
Abstract

QIU C, Li QW, Zhang L, Liu XL, et al
X-linked osteogenesis imperfecta accompanied by patent ductus arteriosus: a case with a novel splice variant in PLS3.
World J Pediatr. 2022;18:515-519.
Abstract

QUAN R, Zhang G, Yu Z, Zhang C, et al
Characteristics, goal-oriented treatments and survival of pulmonary arterial hypertension in China: Insights from a national multicentre prospective registry.
Respirology. 2022;27:517-528.
Abstract

LEFEBVRE B, Kyheng M, Giordano J, Lamblin N, et al
Dual-energy CT lung perfusion characteristics in pulmonary arterial hypertension (PAH) and pulmonary veno-occlusive disease and/or pulmonary capillary hemangiomatosis (PVOD/PCH): preliminary experience in 63 patients.
Eur Radiol. 2022;32:4574-4586.
Abstract

LUNA-LOPEZ R, Ruiz Martin A, Escribano Subias P
Pulmonary arterial hypertension.
Med Clin (Barc). 2022;158:622-629.
Abstract

SALVADOR ML, Rodriguez-Padial L, Soto Abanades C, Cruz Utrilla A, et al
Management and prognosis of HIV-associated pulmonary arterial hypertension: 20 Years of evidence from the REHAP registry.
J Intern Med. 2022;292:116-126.
Abstract

SMITH A, Bussmann N, Breatnach C, Levy PT, et al
The Relationship Between Postnatal Pulmonary Arterial Pressure and Altered Diastolic Function in Neonates with Down Syndrome.
J Pediatr. 2022 Feb 14. pii: S0022-3476(22)00113.
Abstract

HADDAD F, Ataam JA, Amsallem M, Cauwenberghs N, et al
Insulin Growth Factor Phenotypes in Heart Failure with Preserved Ejection Fraction, an INSPIRE Registry and CATHGEN Study: IGF axis in HFpEF.
J Card Fail. 2021 Dec 31. pii: S1071-9164(21)00526.
Abstract

NGUYEN-THU H, Ohyama Y, Taketomi-Takahashi A, Nguyen-Cong T, et al
Pulmonary Artery Diameter (PAD) and the Pulmonary Artery to Aorta Ratio (PAD/AAD) as Assessed by Non-contrast Cardiac CT: The Association with Left Ventricular (LV) Remodeling and the LV Function.
Intern Med. 2022;61:1809-1815.
Abstract

BHOSLE KN, Paul S, Nagre SW
Proposition of quantitative parameters for pre- and early post-operative assessment in pulmonary thromboendarterectomy - An Indian prospective study.
Asian Cardiovasc Thorac Ann. 2022;30:549-554.
Abstract

SHETTY V, Punnen J, Natarajan P, Orathi S, et al
Experience with pulmonary endarterectomy: Lessons learned across 17 years.
Asian Cardiovasc Thorac Ann. 2022;30:532-539.
Abstract

JELLIS CL, Park MM, Abidov A, Borlaug BA, et al
Comprehensive echocardiographic evaluation of the right heart in patients with pulmonary vascular diseases: the PVDOMICS experience.
Eur Heart J Cardiovasc Imaging. 2022;23:958-969.
Abstract

JUNG YH, Ren X, Suffredini G, Dodd-O JM, et al
Right ventricular diastolic dysfunction and failure: a review.
Heart Fail Rev. 2022;27:1077-1090.
Abstract

MELIOTA G, Vairo U, Ficarella R, Milella L, et al
Cardiovascular, Brain, and Lung Involvement in a Newborn With a Novel FLNA Mutation: A Case Report and Literature Review.
Adv Neonatal Care. 2022;22:125-131.
Abstract

WILLIAMS EE, Nanjundappa M, Babla K, Wong J, et al
Pericardial effusion and pulmonary vein stenosis in severe bronchopulmonary dysplasia.
Arch Dis Child Fetal Neonatal Ed. 2022;107:447.
Abstract

JOGA S, Bansal A, Talwar V, Bothra SJ, et al
Spontaneous pulmonary arterial embolization: A rare complication of the silicon-based peripherally inserted central venous catheter (PICC).
J Vasc Access. 2022;23:471-473.
Abstract

TAHA F, Southgate L
Molecular genetics of pulmonary hypertension in children.
Curr Opin Genet Dev. 2022;75:101936.
Abstract

RUEDA DA, Aguirre RA, Fonzo HD, Mazzei ME, et al
Severe arterial pulmonary hypertension in a 34-year-old patient.
Arch Cardiol Mex. 2022;92:418-419.
Abstract

Erratum: Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
Ann Am Thorac Soc. 2022;19:1243-1244.
Abstract

Erratum: Obesity in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
Ann Am Thorac Soc. 2022;19:1242.
Abstract

WOLTERS AEP, Wolters AJP, van Kraaij TDA, Kietselaer BLJH, et al
Echocardiographic estimation of pulmonary hypertension in COVID-19 patients.
Neth Heart J. 2022 Jun 30. pii: 10.1007/s12471-022-01702.
Abstract

CARAVITA S, Picariello C, Garascia A, Misuraca L, et al
[Pulmonary hypertension: pre- or post-capillary? The role of provocative tests in the cath lab].
G Ital Cardiol (Rome). 2022;23:533-541.
Abstract

MALIGIREDDY AR, Shore S, Sreenivas Kumar A, Harikrishnan S, et al
Current status and barriers in pulmonary hypertension care delivery in India: A qualitative analysis.
Pulm Circ. 2022;12:e12094.
Abstract

WANG N, Guo Z, Gong X, Kang S, et al
A Nomogram for Predicting the Risk of Pulmonary Hypertension for Patients with Chronic Obstructive Pulmonary Disease.
Int J Gen Med. 2022;15:5751-5762.
Abstract

CHANG S, Wu J, Jin J, Shi H, et al
Aldehyde Dehydrogenase 2 (ALDH2) Elicits Protection against Pulmonary Hypertension via Inhibition of ERK1/2-Mediated Autophagy.
Oxid Med Cell Longev. 2022;2022:2555476.
Abstract

WANG CH, Chen JJ, Ge JJ, Ma XL, et al
[Risk factors and short-term prognosis of early pulmonary hypertension in preterm infants].
Zhonghua Er Ke Za Zhi. 2022;60:682-687.
Abstract

CULLIVAN S, Lennon D, Meghani S, Minnock C, et al
Incidence and outcomes of pulmonary hypertension in the Ireland.
BMJ Open Respir Res. 2022;9.
Abstract

FERNANDES CJCDS, Ota-Arakaki JS, Campos FTAF, Correa RA, et al
Brazilian Thoracic Society recommendations for the diagnosis and treatment of chronic thromboembolic pulmonary hypertension.
J Bras Pneumol. 2022;46:e20200204.
Abstract

PARK J, Banerjee S, Hong J, Umar S, et al
Response by Park et al to Letter Regarding Article, "Transcriptomic Analysis of Right Ventricular Remodeling in Two Rat Models of Pulmonary Hypertension: Identification and Validation of Epithelial-to-Mesenchymal Transition in Human Right Ventricular
Circ Heart Fail. 2022 Jun 29:101161CIRCHEARTFAILURE122008632.
Abstract

NAING P, Kangaharan N, Scalia GM, Strange G, et al
Pulmonary Hypertension in Remote and Disadvantaged Population: Overcoming Unique Challenges for Improved Outcomes.
Intern Med J. 2022 Jun 28. doi: 10.1111/imj.15860.
Abstract

SURAYA R, Nagano T, Ryanto GRT, Effendi WI, et al
Budesonide/glycopyrronium/formoterol fumarate triple therapy prevents pulmonary hypertension in a COPD mouse model via NFkappaB inactivation.
Respir Res. 2022;23:173.
Abstract

SHARMA M, Bellio MA, Benny M, Kulandavelu S, et al
Mesenchymal Stem Cell-derived Extracellular Vesicles Prevent Experimental Bronchopulmonary Dysplasia Complicated By Pulmonary Hypertension.
Stem Cells Transl Med. 2022 Jun 27. pii: 6618502. doi: 10.1093.
Abstract

DUAN A, Li X, Jin Q, Zhang Y, et al
Prognostic implication of noninvasive right ventricle-to-pulmonary artery coupling in chronic thromboembolic pulmonary hypertension.
Ther Adv Chronic Dis. 2022;13:20406223221102803.
Abstract

TABELING C, Gonzalez Calera CR, Lienau J, Hoppner J, et al
Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension.
Front Immunol. 2022;13:895501.
Abstract

BAO C, He Q, Wang H, Sun Y, et al
Artemisinin and Its Derivate Alleviate Pulmonary Hypertension and Vasoconstriction in Rodent Models.
Oxid Med Cell Longev. 2022;2022:2782429.
Abstract

RUBACKOVA POPELOVA J, Tomek J, Tomkova M, Zivna R, et al
Normalization of Four Different Types of Pulmonary Hypertension After Atrial Septal Defect Closure.
Front Cardiovasc Med. 2022;9:876755.
Abstract

BUFFONI I, Buratti S, Mallamaci MF, Pezzato S, et al
Sudden Onset of Severe Pulmonary Hypertension in a Preterm Infant: A Case Report on the Role of Maternal Use of Serotonin Re-Uptake Inhibitors During Pregnancy and Concurrent Risk Factors.
Front Pediatr. 2022;10:855419.
Abstract

REHMAN A, Darira J, Ahmed MS, Hamid K, et al
Evaluating Signs of Pulmonary Hypertension on Computed Tomography and Correlating With Echocardiography: A Study at a Tertiary Care Hospital.
Cureus. 2022;14:e25319.
Abstract

INOUE N, Morikawa S
Unusual case of cerebral embolism after initiation of selexipag for sarcoidosis-related pulmonary hypertension: a case report.
Radiol Case Rep. 2022;17:3009-3014.
Abstract

SCHIMMELPENNINK MC, Meek DB, Vorselaars ADM, Langezaal LCM, et al
Characterization of the PF-ILD phenotype in patients with advanced pulmonary sarcoidosis.
Respir Res. 2022;23:169.
Abstract

SUN X, Shi X, Cao Y, Zhu H, et al
Variation of PetCO2 during incremental exercise and severity of IPAH and CTEPH.
BMC Pulm Med. 2022;22:249.
Abstract

XU D, Hu YH, Gou X, Li FY, et al
Oxidative Stress and Antioxidative Therapy in Pulmonary Arterial Hypertension.
Molecules. 2022;27.
Abstract

VAN UDEN D, Koudstaal T, van Hulst JAC, Vink M, et al
Peripheral Blood T Cells of Patients with IPAH Have a Reduced Cytokine-Producing Capacity.
Int J Mol Sci. 2022;23.
Abstract

JIANG Y, Hei B, Hao W, Lin S, et al
Clinical value of lncRNA SOX2-OT in pulmonary arterial hypertension and its role in pulmonary artery smooth muscle cell proliferation, migration, apoptosis, and inflammatory.
Heart Lung. 2022;55:16-23.
Abstract

YANG EL, Levy PT, Critser PJ, Dukhovny D, et al
The clinical and cost utility of cardiac catheterizations in infants with bronchopulmonary dysplasia.
J Pediatr. 2022 Apr 14. pii: S0022-3476(22)00323.
Abstract

NI S, Ji T, Dong J, Chen F, et al
Immune Cells in Pulmonary Arterial Hypertension.
Heart Lung Circ. 2022;31:934-943.
Abstract

SAIKI C, Kashiwado Y, Yokoyama T, Ayano M, et al
Successful transition from intravenous epoprostenol to oral selexipag and inhaled iloprost in a case of severe pulmonary arterial hypertension associated with systemic lupus erythematosus.
Mod Rheumatol Case Rep. 2022;6:183-188.
Abstract

MICHAUD E, Pan M, Aggarwal V
Catheter-based therapies in acute and chronic pulmonary embolism.
Curr Opin Cardiol. 2021;36:704-710.
Abstract

BASURTO D, Maria Russo F, Papastefanou I, Bredaki E, et al
Pulmonary hypertension in congenital diaphragmatic hernia: ANTENATAL PREDICTION AND IMPACT ON NEONATAL MORTALITY.
Prenat Diagn. 2022 Jul 7. doi: 10.1002/pd.6207.
Abstract

ABOZEED M, Conic S, Bullen J, Rizk A, et al
Dual energy CT based scoring in chronic thromboembolic pulmonary hypertension and correlation with clinical and hemodynamic parameters: a retrospective cross-sectional study.
Cardiovasc Diagn Ther. 2022;12:305-313.
Abstract

RUOSS JL, Moronta SC, Bazacliu C, Giesinger RE, et al
Management of cardiac dysfunction in neonates with pulmonary hypertension and the role of the ductus arteriosus.
Semin Fetal Neonatal Med. 2022 Jun 11:101368. doi: 10.1016/j.siny.2022.101368.
Abstract

STONE A, Poulik J, Koussa S, Xin Y, et al
Early histological changes of bronchopulmonary dysplasia and pulmonary hypertension may precede clinical diagnosis in preterm infants.
Early Hum Dev. 2022;171:105612.
Abstract

OMOTE K, Sorimachi H, Obokata M, Reddy YNV, et al
Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
Eur Heart J. 2022 Jul 7. pii: 6633254. doi: 10.1093.
Abstract

HOEPER MM, Rosenkranz S
Was Paul Wood wrong about pre-capillary pulmonary hypertension protecting against pulmonary congestion in left heart disease?
Eur Heart J. 2022 Jul 7. pii: 6633248. doi: 10.1093.
Abstract

ZHANG Z, Liu C, Bai Y, Li X, et al
Pipersentan: A De Novo Synthetic Endothelin Receptor Antagonist that Inhibits Monocrotaline- and Hypoxia-Induced Pulmonary Hypertension.
Front Pharmacol. 2022;13:920222.
Abstract

KOSANOVICH CM, Pi H, Handen A, Schikowski E, et al
Improved hospitalization rates in a specialty center for heart failure with preserved ejection fraction and pulmonary hypertension.
Pulm Circ. 2022;12.
Abstract

JACOBS JA, Jahangir E, Ryan JJ
Differentiating pulmonary hypertension associated with protein kinase inhibitors.
Pulm Circ. 2022;12:e12075.
Abstract

KALLONEN J, Korsholm K, Bredin F, Corbascio M, et al
Association of residual pulmonary hypertension with survival after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension.
Pulm Circ. 2022;12:e12093.
Abstract

FORFIA P, Ferraro B, Vaidya A
Recognizing pulmonary hypertension following pulmonary thromboendarterectomy: A practical guide for clinicians.
Pulm Circ. 2022;12:e12073.
Abstract

FUKAMACHI D, Okumura Y
Pulmonary Circulation with Chronic Thromboembolic Pulmonary Hypertension.
Intern Med. 2022 Jul 5. doi: 10.2169/internalmedicine.0017.
Abstract

YAGMUR B, Nalbantgil S, Kayikcioglu M
Two Case Reports of Progressive Pulmonary Hypertension with Type-1 Gaucher Disease: Efficient PAH-Specific Therapy and 1-Year Follow-Up.
Anatol J Cardiol. 2022;26:584-588.
Abstract

SHI Y, Dong X, Hu X, Weng L, et al
Cross-cultural validation of the Chinese version of the EmPHasis-10 questionnaire in connective tissue disease patients with pulmonary arterial hypertension and its relationship with risk stratification.
BMC Pulm Med. 2022;22:264.
Abstract

KJELLSTROM B, Bouzina H, Bjorklund E, Beaudet A, et al
Five year risk assessment and treatment patterns in patients with chronic thromboembolic pulmonary hypertension.
ESC Heart Fail. 2022 Jul 4. doi: 10.1002/ehf2.14033.
Abstract

JONES CB, Crossland DS
The interplay between pressure, flow, and resistance in neonatal pulmonary hypertension.
Semin Fetal Neonatal Med. 2022 Jun 18:101371. doi: 10.1016/j.siny.2022.101371.
Abstract

GIACOMAZZI F, Mazzaccaro D, Schiaffino S, Giannetta M, et al
Radiologic evolution of pulmonary arterial thrombosis associated with SARS-CoV-2 pneumonia.
Vasa. 2022;51:263-264.
Abstract

DONG J, Jiang XM, Zhang J, Xie DJ, et al
Pulmonary artery denervation significantly improves right ventricular longitudinal strain in pulmonary hypertension induced by dehydromonocrotaline.
Minerva Med. 2022 Jul 5. pii: S0026-4806.22.08259.
Abstract

WU J, Huang Q, Li Q, Gu Y, et al
Increased Methyl-CpG-Binding Domain Protein 2 Promotes Cigarette Smoke-Induced Pulmonary Hypertension.
Front Oncol. 2022;12:879793.
Abstract

MURALI S, Khanal S, Banerjee S, Christie O, et al
Pause at Your Own Peril: A Case Series on Rebound Pulmonary Hypertension.
Cureus. 2022;14:e25552.
Abstract

XU W, Sun X, Tao X, Wang D, et al
Characteristics of Right Ventricular Blood Flow in Patients With Chronic Thromboembolic Pulmonary Hypertension: An Analysis With 4-Dimensional Flow Cardiovascular Magnetic Resonance Imaging.
Front Cardiovasc Med. 2022;9:900301.
Abstract

KUSUNOSE K, Hirata Y, Yamaguchi N, Kosaka Y, et al
Deep Learning for Detection of Exercise-Induced Pulmonary Hypertension Using Chest X-Ray Images.
Front Cardiovasc Med. 2022;9:891703.
Abstract

RODERBURG C, Loosen SH, Hippe HJ, Luedde T, et al
Pulmonary hypertension is associated with an increased incidence of cancer diagnoses.
Pulm Circ. 2022;12:e12000.
Abstract

MINHAS J, Narasimmal SP, Bull TM, De Marco T, et al
Corrigendum for health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: And analysis from the Pulmonary Hypertension Association Registry.
Pulm Circ. 2022;12:e12085.
Abstract

WATANABE H
[Role of NO-cGMP-PKG axis in pulmonary arterial hypertension].
Nihon Yakurigaku Zasshi. 2022;157:221-225.
Abstract

VEIGA OLIVEIRA P, Madeira M, Ranchordas S, Nolasco T, et al
Triple valve surgery: long-term follow-up from a single centre.
Port J Card Thorac Vasc Surg. 2022;29:23-29.
Abstract

JENTZER JC
Under pressure: pulmonary hypertension and right ventricular dysfunction in cardiac arrest.
Resuscitation. 2022 Jun 29. pii: S0300-9572(22)00584.
Abstract

DE BIE FR, Halline CG, Kotzur T, Hayes K, et al
Prenatal treprostinil reduces the pulmonary hypertension phenotype in the rat model of congenital diaphragmatic hernia.
EBioMedicine. 2022;81:104106.
Abstract

LI C, Zhu H, Zhang S, Meng F, et al
Corrigendum to "Astragaloside IV ameliorates pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension by restraining the T follicular helper cell response and expanding T follicular regulatory cell response".
Phytomedicine. 2022;104:154267.
Abstract

ATA F, Khan AA, Yousaf Z, Choudry H, et al
The clinical characteristics and outcomes of patients with pulmonary hypertension in association with hyperthyroid state: A systematic review.
Medicine (Baltimore). 2022;101:e29832.
Abstract

YAMAGUCHI K, Ogihara Y, Fujimoto N, Nomura Y, et al
Histopathological Findings of Pulmonary Hypertension With Elevated Pulmonary Arterial Wedge Pressure in Hereditary Hemorrhagic Telangiectasia.
Circ Rep. 2022;4:287-288.
Abstract

AL-NAAMANI N
Let's Talk about Sex: Sexual Health in Pulmonary Arterial Hypertension.
Ann Am Thorac Soc. 2022;19:1097-1099.
Abstract

FRIEDMAN SH, Veglia M, Gregg D, Argula RG, et al
Progressive Dyspnea in a Woman with Congenital Heart Disease and Pulmonary Arterial Hypertension.
Ann Am Thorac Soc. 2022;19:1221-1225.
Abstract

HEINONEN E, Forsberg L, Norby U, Wide K, et al
Neonatal morbidity after fetal exposure to antipsychotics: a national register-based study.
BMJ Open. 2022;12:e061328.
Abstract

GUO T, He C, Venado A, Zhou Y, et al
Extracellular Matrix Stiffness in Lung Health and Disease.
Compr Physiol. 2022;12:3523-3558.
Abstract

LIN QF, Rao JH, Luo SM, Wang QM, et al
Relation between endothelial nitric oxide synthase genetic polymorphisms and pulmonary arterial hypertension in newborns with congenital heart disease.
Clin Exp Hypertens. 2022 Jun 14:1-6. doi: 10.1080/10641963.2022.2085736.
Abstract

CIURZYNSKI M, Kurzyna M, Kopec G, Blaszczak P, et al
An expert opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation on screening for chronic thromboembolic pulmonary hypertension patients after acute pulmonary embolism: Update.
Kardiol Pol. 2022;80:723-732.
Abstract

BADEA R, Dorobantu DM, Sharabiani MTA, Predescu LM, et al
Left main coronary artery compression by dilated pulmonary artery in pulmonary arterial hypertension: a systematic review and meta-analysis.
Clin Res Cardiol. 2022;111:816-826.
Abstract

YEE DC, Banerjee D, Vargas SE, Allahua M, et al
Sexual Health-related Quality of Life in Women with Pulmonary Arterial Hypertension: Compensating for Loss.
Ann Am Thorac Soc. 2022;19:1122-1129.
Abstract

HE YY, Yan Y, Chen JW, Liu S, et al
Plasma metabolomics in the perioperative period of defect repair in patients with pulmonary arterial hypertension associated with congenital heart disease.
Acta Pharmacol Sin. 2022;43:1710-1720.
Abstract

YUGUCHI T, Sano H, Nakajima K, Ikura Y, et al
Pulmonary Tumor Thrombotic Microangiopathy Caused by Recurrent Gastric Cancer 26 Years After Total Gastrectomy.
Intern Med. 2022;61:1969-1972.
Abstract

RAMIREZ-RAMOS CF, Saldarriaga-Giraldo C, Yepes-Calderon M, Castilla-Agudelo G, et al
Clinical and hemodynamic outcomes and mortality risk factors in patients undergoing pulmonary thromboendarterectomy.
Arch Cardiol Mex. 2022;92:312-319.
Abstract

WAXMAN AB, Elia D, Adir Y, Humbert M, et al
Recent advances in the management of pulmonary hypertension with interstitial lung disease.
Eur Respir Rev. 2022;31.
Abstract

MURUGESAN P, Zhang Y, Youn JY, Cai H, et al
Novel and robust treatment of pulmonary hypertension with netrin-1 and netrin-1-derived small peptides.
Redox Biol. 2022;55:102348.
Abstract

ZAPATA-SUDO G
Riociguat: An Alternative to Treat Pulmonary Hypertension.
Arq Bras Cardiol. 2022;119:111-112.
Abstract

BOXHAMMER E, Paar V, Jirak P, Koller C, et al
Main pulmonary artery diameter in combination with cardiovascular biomarkers. New possibilities to identify pulmonary hypertension in patients with severe aortic valve stenosis?
Minerva Med. 2022 Jul 13. pii: S0026-4806.22.08167.
Abstract

RODRIGUEZ-ARIAS JJ, Garcia-Alvarez A
Sex Differences in Pulmonary Hypertension.
Front Aging. 2021;2:727558.
Abstract

SILVA VBC, Froes TR, Wolf M, Lucina SB, et al
Characterization of Doppler spectrum of hepatic veins in dogs with pulmonary hypertension.
Res Vet Sci. 2022;150:131-136.
Abstract

SHAHIN Y, Alabed S, Alkhanfar D, Tschirren J, et al
Quantitative CT Evaluation of Small Pulmonary Vessels Has Functional and Prognostic Value in Pulmonary Hypertension.
Radiology. 2022 Jul 12:210482. doi: 10.1148/radiol.210482.
Abstract

MOORE JE, Cerne JW, Pathrose A, Veer M, et al
Quantitative Assessment of Regional Pulmonary Transit Times in Pulmonary Hypertension.
J Magn Reson Imaging. 2022 Jul 9. doi: 10.1002/jmri.28343.
Abstract

ARRIAZA K, Cuevas C, Pena E, Siques P, et al
Impact of Zinc on Oxidative Signaling Pathways in the Development of Pulmonary Vasoconstriction Induced by Hypobaric Hypoxia.
Int J Mol Sci. 2022;23.
Abstract

LI Y, Zhang Y, Jiang G, Wang Y, et al
Case report: novel mutations of NDUFS6 and NHLRC2 genes potentially cause the quick postnatal death of a Chinese Hani minority neonate with mitochondrial complex I deficiency and FINCA syndrome.
Medicine (Baltimore). 2022;101:e29239.
Abstract

HU P, Xu Y, Jiang Y, Huang J, et al
The mechanism of the imbalance between proliferation and ferroptosis in pulmonary artery smooth muscle cells based on the activation of SLC7A11.
Eur J Pharmacol. 2022;928:175093.
Abstract

TANIZAWA K, Handa T, Nagai S, Ikezoe K, et al
Lung function decline in sarcoidosis.
Respir Investig. 2022;60:551-561.
Abstract

REZAEI-KALANTARI K, Samimi K, Zomorodian H, Bakhshandeh H, et al
Pulmonary Blood Volume Measured by Dual-Energy Computed Tomography Can Help Distinguish Patients With Pulmonary Hypertension.
Front Cardiovasc Med. 2022;9:835655.
Abstract

HANDLER SS, Jin J, Ogawa MT, Feinstein JA, et al
Abnormal platelet aggregation in pediatric pulmonary hypertension.
Pulm Circ. 2022;12:e12104.
Abstract

LIU R, Xu C, Zhang W, Cao Y, et al
FUNDC1-mediated mitophagy and HIF1alpha activation drives pulmonary hypertension during hypoxia.
Cell Death Dis. 2022;13:634.
Abstract

LI Y, Cai H, Wei J, Zhu L, et al
Dihydroartemisinin Attenuates Hypoxic Pulmonary Hypertension via the Downregulation of miR-335 Targeting Vangl2.
DNA Cell Biol. 2022 Jul 19. doi: 10.1089/dna.2021.1113.
Abstract

LUTSEY PL, Evensen LH, Thenappan T, Prins KW, et al
Incidence and Risk Factors of Pulmonary Hypertension After Venous Thromboembolism: An Analysis of a Large Health Care Database.
J Am Heart Assoc. 2022;11:e024358.
Abstract

GLUSCHKE H, Siegert E, Minich WB, Hackler J, et al
Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension.
Front Immunol. 2022;13:935787.
Abstract

CAI Z, Tian S, Klein T, Tu L, et al
Kynurenine metabolites predict survival in pulmonary arterial hypertension: A role for IL-6/IL-6Ralpha.
Sci Rep. 2022;12:12326.
Abstract

DANDEL M, Hetzer R
Particular Challenges in the Use of Pulmonary Vasodilating Therapy for Patients with Pulmonary Hypertension Secondary to Left Heart Diseases.
Eur J Heart Fail. 2022 Jul 19. doi: 10.1002/ejhf.2622.
Abstract

NAGATA J, Sekine A, Tanabe N, Taniguchi Y, et al
Mixed venous oxygen tension is a crucial prognostic factor in pulmonary hypertension: a retrospective cohort study.
BMC Pulm Med. 2022;22:282.
Abstract

ABU T, Levi A, Hasdai D, Kramer MR, et al
Correction to: Preoperative evaluation of pulmonary hypertension in lung transplant candidates: echocardiography versus right heart catheterization.
BMC Cardiovasc Disord. 2022;22:324.
Abstract

CAO N, Aikeremu N, Shi WY, Tang XC, et al
Inhibition of KIR2.1 decreases pulmonary artery smooth muscle cell proliferation and migration.
Int J Mol Med. 2022;50.
Abstract

REMES A, Korbelin J, Arnold C, Rohwedder C, et al
AAV-mediated gene transfer of inducible nitric oxide synthase (iNOS) to an animal model of pulmonary hypertension.
Hum Gene Ther. 2022 Jul 19. doi: 10.1089/hum.2021.
Abstract

NEZAMI N, Garg T
Editorial for "Quantitative Assessment of Regional Pulmonary Transit Times in Pulmonary Hypertension".
J Magn Reson Imaging. 2022 Jul 18. doi: 10.1002/jmri.28361.
Abstract

XU J, Zhong Y, Yin H, Linneman J, et al
Methylation-mediated silencing of PTPRD induces pulmonary hypertension by promoting pulmonary arterial smooth muscle cell migration via the PDGFRB/PLCgamma1 axis.
J Hypertens. 2022 Jul 14. pii: 00004872-990000000-00040.
Abstract

CHAN RK, Horrigan M, Goh NSL, Khor YH, et al
Clinical Assessment for Pulmonary Hypertension in Interstitial Lung Disease.
Intern Med J. 2022 Jul 18. doi: 10.1111/imj.15887.
Abstract

LI Q, Xin W, Ding H, Zhang Y, et al
Total flavones from Sceptridium ternatum alleviate pulmonary hypertension through inhibiting the proliferation of vascular endothelial cells.
Ann Transl Med. 2022;10:677.
Abstract

HASAN H, Chouvarine P, Diekmann F, Diedrich N, et al
Validation of the New Pediatric Pulmonary Hypertension Risk Score by CMR and Speckle Tracking Echocardiography.
Eur J Clin Invest. 2022 Jul 17:e13835. doi: 10.1111/eci.13835.
Abstract

JI L, Su S, Xin M, Zhang Z, et al
Luteolin ameliorates hypoxia-induced pulmonary hypertension via regulating HIF-2alpha-Arg-NO axis and PI3K-AKT-eNOS-NO signaling pathway.
Phytomedicine. 2022;104:154329.
Abstract

JIANG DT, Tuo L, Bai X, Bing WD, et al
Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha.
Stem Cell Res Ther. 2022;13:316.
Abstract

RAMARAJ AB, Rice-Townsend SE, Foster CL, Yung D, et al
Trends in use of prostacyclin analogs for management of CDH-associated pulmonary hypertension.
Pediatr Surg Int. 2022 Jul 16. pii: 10.1007/s00383-022-05176.
Abstract

DONG C, Li Y
Exercise Rehabilitation Training in Patients with Pulmonary Hypertension: A Review.
Heart Lung Circ. 2022 Jul 12. pii: S1443-9506(22)00937.
Abstract

MA G, Wang D, Xu X, Liang L, et al
Case report: apatinib plus selexipag as a novel therapy for pulmonary tumor thrombotic microangiopathy accompanied by pulmonary hypertension associated with gastric carcinoma.
Medicine (Baltimore). 2022;101:e29412.
Abstract

JIANG L, Goncharov DA, Shen Y, Lin D, et al
Akt-Dependent Glycolysis-Driven Lipogenesis Supports Proliferation and Survival of Human Pulmonary Arterial Smooth Muscle Cells in Pulmonary Hypertension.
Front Med (Lausanne). 2022;9:886868.
Abstract

NGUYEN MC, Po-Yu Chiang T, Massie AB, Bae S, et al
Kidney Transplantation Confers Survival Benefit for Candidates With Pulmonary Hypertension.
Transplant Direct. 2021;7:e738.
Abstract

ZHAI YN, Li AL, Tao XC, Xie WM, et al
A simpler noninvasive method of predicting markedly elevated pulmonary vascular resistance in patients with chronic thromboembolic pulmonary hypertension.
Pulm Circ. 2022;12:e12102.
Abstract

CASTILLO JP, Robledo AM, Torres-Canchala L, Roa-Saldarriaga L, et al
Gigantomastia as a Cause of Pulmonary Hypertension.
Arch Plast Surg. 2022;49:369-372.
Abstract

NAKANO Y, Adachi S, Nishiyama I, Yasuda K, et al
Right ventricular pressure overload related to residual thrombotic burden in patients 1 year after acute pulmonary embolism: From the Nagoya PE study.
Thromb Res. 2022;216:113-119.
Abstract

XU Y, Guo X, Ning S, He Q, et al
Inhibition of IP3R3 attenuates endothelial to mesenchymal transition induced by TGF-beta1 through restoring mitochondrial function.
Biochem Biophys Res Commun. 2022;619:144-150.
Abstract

BAUER-RUSEK S, Samra N, Moore SS, Arnon S, et al
Paracetamol Treatment for Patent Ductus Arteriosus, an Apparent Association with Acute Hemolysis in Three Preterm Infants: Case Series.
Neonatology. 2022 Jun 21:1-5. doi: 10.1159/000525128.
Abstract

KARVASARSKI E, Zarathus-Cook M, Wright SP
Catching the wave at the wrong time: Arrival timing provides additional insight into right ventricular afterload in pulmonary arterial hypertension.
J Physiol. 2022;600:3225-3226.
Abstract

KOSTURA M, Smalley C, Koyfman A, Long B, et al
Right heart failure: A narrative review for emergency clinicians.
Am J Emerg Med. 2022;58:106-113.
Abstract

ELCIOGLU BC, Baydar O, Helvaci F, Karatas C, et al
Evaluation of pulmonary arterial stiffness and comparison with right ventricular functions in patients with cirrhosis preparing for liver transplantation.
J Clin Ultrasound. 2022;50:749-755.
Abstract

SHIMBO M, Hatano M, Ishii S, Saito A, et al
Renal replacement therapy as a therapeutic option for right heart failure in severe pulmonary arterial hypertension.
ESC Heart Fail. 2022;9:2728-2731.
Abstract

RAFIKOV R, Rischard F, Vasilyev M, Varghese MV, et al
Cytokine profiling in pulmonary arterial hypertension: the role of redox homeostasis and sex.
Transl Res. 2022;247:1-18.
Abstract

OISHI H, Matsuda Y, Ejima Y, Toyama H, et al
Changes in haemodynamics during single lung transplantation under venovenous extracorporeal membrane oxygenation.
Interact Cardiovasc Thorac Surg. 2022;35.
Abstract

AWAD A, Elnemr S, Hodeib H, El Amrousy D, et al
Platelet Activation Markers in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease.
Pediatr Cardiol. 2022;43:1264-1270.
Abstract

MING Y, Wu Z, Wu Z, Chu S, et al
Effects of different anesthesia methods on maternal and neonatal outcomes in pregnant patients with pulmonary arterial hypertension: a meta-analysis.
Arch Gynecol Obstet. 2022;306:7-15.
Abstract

BRIDA M, Chessa M, Celermajer D, Li W, et al
Atrial septal defect in adulthood: a new paradigm for congenital heart disease.
Eur Heart J. 2022;43:2660-2671.
Abstract

CAETANO J, Batista F, Amaral MC, Oliveira S, et al
Acute hospitalization in a cohort of patients with systemic sclerosis: a 10-year retrospective cohort study.
Rheumatol Int. 2022;42:1393-1402.
Abstract

PRASAD CS, Kumar S, Sumathy S, Kunjukutty R, et al
Pregnancy and pulmonary arterial hypertension-improving surveillance and outcomes with multidisciplinary care and N terminal pro-brain natriuretic peptide trends.
J Matern Fetal Neonatal Med. 2022;35:3533-3539.
Abstract

JILANI D, Abuzahra M, Ali MB
Cardiac Papillary Fibroelastoma: Pulmonic Valve Involvement With Pulmonary Embolism and Pulmonary Hypertension.
Cureus. 2022;14:e26302.
Abstract

SELLE J, Dinger K, Jentgen V, Zanetti D, et al
Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life.
Nat Commun. 2022;13:4352.
Abstract

CHEN YL, Yang XF, Chen J, Shi SW, et al
[Application of extracorporeal membrane oxygenation in the treatment of persistent pulmonary hypertension of the newborn].
Zhongguo Dang Dai Er Ke Za Zhi. 2022;24:786-791.
Abstract

ADAMOPOULOS D, Pagoulatou S, Rovas G, Bikia V, et al
Prognostic Implications of the Novel Pulmonary Hypertension Definition in Patients with Aortic Stenosis after Transcatheter Valve Replacement.
J Clin Med. 2022;11.
Abstract

CHEN T, Sun MR, Zhou Q, Guzman AM, et al
MicroRNA-212-5p, an anti-proliferative miRNA, attenuates hypoxia and sugen/hypoxia-induced pulmonary hypertension in rodents.
Mol Ther Nucleic Acids. 2022;29:204-216.
Abstract

MAARMAN GJ
Pulmonary hypertension in developing countries: Limiting factors in time to diagnosis, specialised medications and contextualised recommendations.
Afr J Thorac Crit Care Med. 2022;28.
Abstract

ZARAMBAITE E, Ramantauskaite G, Krivickiene A, Siudikas A, et al
The Treatment Strategy for the Atrial Septal Defect in the Presence of Severe Pulmonary Hypertension.
Medicina (Kaunas). 2022;58.
Abstract

OPITZ I, Patella M, Lauk O, Inci I, et al
Acute on Chronic Thromboembolic Pulmonary Hypertension: Case Series and Review of Management.
J Clin Med. 2022;11.
Abstract

MAMZER A, Waligora M, Kopec G, Ptaszynska-Kopczynska K, et al
Impact of the COVID-19 Pandemic on Pulmonary Hypertension Patients: Insights from the BNP-PL National Database.
Int J Environ Res Public Health. 2022;19.
Abstract

WIETESKA-MILEK M, Szmit S, Florczyk M, Witowicz A, et al
Physical Activity in Pulmonary Arterial Hypertension during Pandemic COVID-19 and the Potential Impact of Mental Factors.
Int J Environ Res Public Health. 2022;19.
Abstract

CHEN IC, Chen HL, Liu YC, Wu YH, et al
Unique Pulmonary Hypertension in Young Children: A Case Series Study.
Children (Basel). 2022;9.
Abstract

GOJEVIC T, Van Ryckeghem L, Jogani S, Frederix I, et al
Pulmonary hypertension during exercise underlies unexplained exertional dyspnea in patients with type 2 diabetes.
Eur J Prev Cardiol. 2022 Jul 26. pii: 6650274. doi: 10.1093.
Abstract

HE Z, Dai L, Zuo Y, Chen Y, et al
Hotspots and frontiers in pulmonary arterial hypertension research: a bibliometric and visualization analysis from 2011 to 2020.
Bioengineered. 2022;13:14667-14680.
Abstract

CRUNKHORN S
Inhibiting IgE in pulmonary hypertension.
Nat Rev Drug Discov. 2022 Jul 25. pii: 10.1038/d41573-022-00131.
Abstract

ZHANG J, Zheng XZ, Wu XC
Perinatal changes of right ventricle-pulmonary artery coupling and its value in predicting persistent pulmonary hypertension of the newborn.
Clin Physiol Funct Imaging. 2022 Jul 19. doi: 10.1111/cpf.12782.
Abstract

PI H, Rayner SG, Ralph DD, Nolley S, et al
Thyroid-stimulating hormone and mortality in pulmonary arterial hypertension.
BMJ Open Respir Res. 2022;9.
Abstract

OTHMAN F, Bailey B, Collins N, Lau E, et al
Platypnea-Orthodeoxia Syndrome in the Setting of Patent Foramen Ovale Without Pulmonary Hypertension or Major Lung Disease.
J Am Heart Assoc. 2022 Jul 25:e024609. doi: 10.1161/JAHA.121.024609.
Abstract

JEONG I, Alotaibi M, Fernandes TM, Kim S, et al
Direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension and the presence of recent thrombus during pulmonary endarterectomy.
Pulm Circ. 2022;12:e12110.
Abstract

ZHAO Y, Tian LG, Zhang LX, Ma T, et al
The comparative effects of sacubitril/valsartan versus enalapril on pulmonary hypertension due to heart failure with a reduced ejection fraction.
Pulm Circ. 2022;12:e12034.
Abstract

GU S, Mickael C, Kumar R, Lee MH, et al
The role of macrophages in right ventricular remodeling in experimental pulmonary hypertension.
Pulm Circ. 2022;12:e12105.
Abstract

TSOI SM, Jones K, Colglazier E, Parker C, et al
Persistence of persistent pulmonary hypertension of the newborn: A case of de novo TBX4 variant.
Pulm Circ. 2022;12:e12108.
Abstract

HSU CH, Huang WC, Chang WT
Future Perspectives of Pulmonary Hypertension Treatment.
Acta Cardiol Sin. 2022;38:435-442.
Abstract

ZHOU J, Chou OHI, Wong KHG, Lee S, et al
Development of an Electronic Frailty Index for Predicting Mortality and Complications Analysis in Pulmonary Hypertension Using Random Survival Forest Model.
Front Cardiovasc Med. 2022;9:735906.
Abstract

CERSOSIMO A, Arabia G, Vizzardi E, Metra M, et al
Rapid progression of pulmonary artery dilatation in pulmonary hypertension.
Monaldi Arch Chest Dis. 2022 Jul 20. doi: 10.4081/monaldi.2022.2369.
Abstract

LAO TT
The obstetric implications of pulmonary hypertension and lung transplant.
Best Pract Res Clin Obstet Gynaecol. 2022 Jun 26. pii: S1521-6934(22)00093.
Abstract

XANTHOULI P, Miazgowski J, Benjamin N, Gordjani O, et al
Prognostic meaning of right ventricular function and output reserve in patients with systemic sclerosis.
Arthritis Res Ther. 2022;24:173.
Abstract

FARKAS L, Goncharova EA
Circling In on Pulmonary Arterial Hypertension: Is It Time to Consider Circular RNA circ_0016070 as a Biomarker and Target for Therapy?
J Am Heart Assoc. 2022;11:e026798.
Abstract

PI H, Carlson SD, Barros LM, Hogl L, et al
Risk Prediction and Right Ventricular Dilation in a Single-Institution Pulmonary Arterial Hypertension Cohort.
J Am Heart Assoc. 2022;11:e025521.
Abstract

HUANG CX, Jiang ZX, Du DY, Zhang ZM, et al
Hsa_circ_0016070/micro-340-5p Axis Accelerates Pulmonary Arterial Hypertension Progression by Upregulating TWIST1 Transcription Via TCF4/beta-Catenin Complex.
J Am Heart Assoc. 2022;11:e024147.
Abstract

TAI C, Hsieh A, Moon-Grady AJ, Keller RL, et al
Pulmonary artery acceleration time in young children is determined by heart rate and transpulmonary gradient but not by pulmonary blood flow: A simultaneous echocardiography-cardiac catheterization study.
Echocardiography. 2022;39:895-905.
Abstract

ILIADIS C, Kalbacher D, Lurz P, Petrescu AM, et al
Left atrial volume index and outcome after transcatheter edge-to-edge valve repair for secondary mitral regurgitation.
Eur J Heart Fail. 2022;24:1282-1292.
Abstract

COBER ND, VandenBroek MM, Ormiston ML, Stewart DJ, et al
Evolving Concepts in Endothelial Pathobiology of Pulmonary Arterial Hypertension.
Hypertension. 2022 May 18:101161HYPERTENSIONAHA12218261.
Abstract

CLAEYS M, Petit T, La Gerche A, Herbots L, et al
Impaired biventricular contractile reserve in patients with diastolic dysfunction: insights from exercise stress echocardiography.
Eur Heart J Cardiovasc Imaging. 2022;23:1042-1052.
Abstract

AHMED AS, Divani GK, Gupta S
A curious case of pulmonary hypertension in a child.
Egypt Heart J. 2022;74:58.
Abstract

GONG JN, Chen BX, Xing HQ, Huo L, et al
Pulmonary artery imaging with (68) Ga-FAPI-04 in patients with chronic thromboembolic pulmonary hypertension.
J Nucl Cardiol. 2022 Aug 4. pii: 10.1007/s12350-022-03069.
Abstract

KAWAKAMI T, Matsubara H, Shinke T, Abe K, et al
Balloon pulmonary angioplasty versus riociguat in inoperable chronic thromboembolic pulmonary hypertension (MR BPA): an open-label, randomised controlled trial.
Lancet Respir Med. 2022 Aug 1. pii: S2213-2600(22)00171.
Abstract

JAIS X, Brenot P, Bouvaist H, Jevnikar M, et al
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up study.
Lancet Respir Med. 2022 Aug 1. pii: S2213-2600(22)00214.
Abstract

BONAFIGLIA QA, Zhou YQ, Hou G, Saha R, et al
Deficiency in DDR1 Induces Pulmonary Hypertension and Impaired Alveolar Development.
Am J Respir Cell Mol Biol. 2022 Aug 4. doi: 10.1165/rcmb.2022-0124.
Abstract

XU X, Zhang J, Wang R, Zhang W, et al
[Study on the effect of Xiaoqinglong decoction on vascular endothelin inpulmonary hypertension rat based on Jiebiaokuoluo method].
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022;34:597-601.
Abstract

ITAGAKI T, Miura T, Kasai T, Ikeda U, et al
Symptomatic and severe pulmonary hypertension due to hyperthyroidism.
BMJ Case Rep. 2022;15.
Abstract

WU Q, Zhou X, Wang Y, Hu Y, et al
LncRNA GAS5 promotes spermidineinduced autophagy through the miRNA315p/NAT8L axis in pulmonary artery endothelial cells of patients with CTEPH.
Mol Med Rep. 2022;26.
Abstract

CARLSEN J, Henriksen HH, Marin de Mas I, Johansson PI, et al
An explorative metabolomic analysis of the endothelium in pulmonary hypertension.
Sci Rep. 2022;12:13284.
Abstract

XINTIAN, Zhang X, Feng Y, Gao X, et al
Astragaloside IV in Hypoxic Pulmonary Hypertension: an In Vivo and In Vitro Experiments.
Appl Biochem Biotechnol. 2022 Aug 2. pii: 10.1007/s12010-022-04027.
Abstract

YILMAZ F, Tuncez A, Onner H, Gedik GK, et al
Diagnostic compatibility of V/Q SPECT and CTPA, which are non-invasive diagnostic methods, for the detection of CTEPH, which is a treatable cause of pulmonary hypertension.
Hell J Nucl Med. 2022 Aug 3. pii: s002449912478. doi: 10.1967/s002449912478.
Abstract

HANSMANN G, Sabiniewicz A, Sabiniewicz R
Atrial Flow Regulator for Postcapillary Pulmonary Hypertension: First-in-Human Transcatheter AFR Device Implantations in RCM.
JACC Case Rep. 2022;4:878-884.
Abstract

SCHWEINTZGER S, Kurath-Koller S, Burmas A, Grangl G, et al
Normal Echocardiographic Reference Values of the Right Ventricular to Left Ventricular Endsystolic Diameter Ratio and the Left Ventricular Endsystolic Eccentricity Index in Healthy Children and in Children With Pulmonary Hypertension.
Front Cardiovasc Med. 2022;9:950765.
Abstract

MAK S, Kolker S, Girdharry NR, Bentley RF, et al
The role of exercise right heart catheterization to guide pulmonary hypertension therapy in older adults.
Pulm Circ. 2022;12:e12103.
Abstract

ANDERSEN A, Hansen JV, Dragsbaek SJ, Maeng M, et al
Balloon pulmonary angioplasty for patients with chronic thromboembolic pulmonary hypertension previously operated by pulmonary endarterectomy.
Pulm Circ. 2022;12:e12115.
Abstract

YU W, Dujiang X, Yi W, Guanwen D, et al
Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure.
Pulm Circ. 2022;12:e12096.
Abstract

GRINNAN D, Kang L, DeWilde C, Badesch D, et al
Prediction of patient outcomes through social determinants of health: The Pulmonary Hypertension Association Registry (PHAR) evaluation.
Pulm Circ. 2022;12:e12120.
Abstract

OJO OE, Akintomide AO, Adebayo RA, Akinyele OA, et al
Lutembacher syndrome presenting as heart failure in a young Nigerian at Obafemi Awolowo University Teaching Hospitals Complex (OAUTHC), Ile-Ife: a case report.
Pan Afr Med J. 2022;41:342.
Abstract

DACHS TM, Duca F, Rettl R, Binder-Rodriguez C, et al
Riociguat in pulmonary hypertension and heart failure with preserved ejection fraction: the haemoDYNAMIC trial.
Eur Heart J. 2022 Aug 1. pii: 6652608. doi: 10.1093.
Abstract

BAUERSACHS J, Olsson KM
Targeting pulmonary hypertension in patients with heart failure and preserved ejection fraction: rather static than DYNAMIC development?
Eur Heart J. 2022 Aug 1. pii: 6652609. doi: 10.1093.
Abstract

DONG X, Shi Y, Xia Y, Zhang X, et al
Diversity of hemodynamic types in connective tissue disease associated pulmonary hypertension: more than a subgroup of pulmonary arterial hypertension.
BMC Pulm Med. 2022;22:295.
Abstract

VAN DER BIJL P, Bax JJ
Using deep learning to diagnose pulmonary hypertension.
Eur Heart J Cardiovasc Imaging. 2022 Jul 30. pii: 6652181.
Abstract

LI WJ, Wen ZP, Xing Y, Yang JP, et al
HMGB1 Upregulates RAGE to Trigger the Expression of Inflammatory Factors in the Lung Tissue in a Hypoxic Pulmonary Hypertension Rat Model.
Comput Math Methods Med. 2022;2022:6823743.
Abstract

AKINCIOGLU C, Mehta S
Nuclear imaging in chronic thromboembolic pulmonary hypertension: increasingly central to diagnosis and management.
J Nucl Cardiol. 2022 Jul 18. pii: 10.1007/s12350-022-03056.
Abstract

DANDEL M
Pathophysiological insights with relevant impact on the prognostic assessment and clinical management of patients with pulmonary arterial hypertension.
J Physiol. 2022;600:3633-3634.
Abstract

FUKUMITSU M, Vonk Noordegraaf A, Westerhof BE
Reply from Masafumi Fukumitsu, Anton Vonk Noordegraaf and Berend E. Westerhof.
J Physiol. 2022;600:3635.
Abstract

WANG Z, Ding N, Yi H, Zhu Y, et al
Prognosis and related risk factors analysis of total anomalous pulmonary venous connection correction.
J Card Surg. 2022;37:2524-2535.
Abstract

PUJITHA V, Shaw M, Kumar S, Narang R, et al
Delayed presentation of aorto-pulmonary window, double outlet right ventricle with pulmonary arterial hypertension: Illustration of uncommon association on dual-energy CT.
J Card Surg. 2022;37:2852-2853.
Abstract

BOGAARD HJ, Aman J
Tyrosine Kinases and Endothelial Homeostasis in Pulmonary Arterial Hypertension: Too Hot to Handle?
Am J Respir Cell Mol Biol. 2022;67:147-149.
Abstract

LE VELY B, Phan C, Berrebeh N, Thuillet R, et al
Loss of cAbl Tyrosine Kinase in Pulmonary Arterial Hypertension Causes Dysfunction of Vascular Endothelial Cells.
Am J Respir Cell Mol Biol. 2022;67:215-226.
Abstract

CIRULIS MM, Knox DB, Stoddard GJ, Brown LM, et al
The CTEPH Trajectories Study: Assessment of Follow-Up after Acute Pulmonary Embolism to Identify Missed Opportunities for Chronic Thromboembolic Pulmonary Hypertension Diagnosis.
Ann Am Thorac Soc. 2022;19:1428-1432.
Abstract

LIU Y, Han J, Li B, Xiao J, et al
Risk factors associated with pulmonary arterial hypertension among HIV-infected adults: A meta-analysis and systematic review.
AIDS Rev. 2022;24:59-68.
Abstract

LI WT, Wu CW, Liu JM
Association of changes in NT-proBNP, hsTnT and uric acid levels with haemodynamic changes after targeted medical therapies in patients with idiopathic pulmonary arterial hypertension.
Cardiovasc J Afr. 2022;33:10-14.
Abstract

MARTIN CALDERON L, Chaudhary M, Pope JE
Healthcare utilization and economic burden in systemic sclerosis: a systematic review.
Rheumatology (Oxford). 2022;61:3123-3131.
Abstract

SALEH D, Fisher JH, Provencher S, Liang Z, et al
A Systematic Evaluation of the Quality, Accuracy, and Reliability of Internet Websites about Pulmonary Arterial Hypertension.
Ann Am Thorac Soc. 2022;19:1404-1413.
Abstract

LIU J, Yang P, Tian H, Zhen K, et al
Right Ventricle Remodeling in Chronic Thromboembolic Pulmonary Hypertension.
J Transl Int Med. 2022;10:125-133.
Abstract

WEI R, Chen L, Li P, Lin C, et al
IL-13 alleviates idiopathic pulmonary hypertension by inhibiting the proliferation of pulmonary artery smooth muscle cells and regulating macrophage infiltration.
Am J Transl Res. 2022;14:4573-4590.
Abstract

DUAN M, Shu T, Zhao B, Xiang T, et al
Explainable machine learning models for predicting 30-day readmission in pediatric pulmonary hypertension: A multicenter, retrospective study.
Front Cardiovasc Med. 2022;9:919224.
Abstract

XU W, Deng M, Meng X, Sun X, et al
The alterations in molecular markers and signaling pathways in chronic thromboembolic pulmonary hypertension, a study with transcriptome sequencing and bioinformatic analysis.
Front Cardiovasc Med. 2022;9:961305.
Abstract

PORTO RIBEIRO T, Barbeau S, Baudrimont I, Vacher P, et al
Piezo1 Channel Activation Reverses Pulmonary Artery Vasoconstriction in an Early Rat Model of Pulmonary Hypertension: The Role of Ca(2+) Influx and Akt-eNOS Pathway.
Cells. 2022;11.
Abstract

CRAGER SE, Humphreys C
Right Ventricular Failure and Pulmonary Hypertension.
Emerg Med Clin North Am. 2022;40:519-537.
Abstract

SUN X, Nakajima E, Norbrun C, Sorkhdini P, et al
Chitinase 3-like-1 contributes to the development of pulmonary vascular remodeling in pulmonary hypertension.
JCI Insight. 2022 Aug 11. pii: 159578. doi: 10.1172/jci.insight.159578.
Abstract

TSAROVA K, Morgan AE, Melendres-Groves L, Ibrahim MM, et al
Imaging in Pulmonary Vascular Disease-Understanding Right Ventricle-Pulmonary Artery Coupling.
Compr Physiol. 2022;12:1-26.
Abstract

LARSON KF, Malik A, Brozovich FV
Aging and Heart Failure with Preserved Ejection Fraction.
Compr Physiol. 2022;12:1-10.
Abstract

KISHI K, Jarutach J, Ooi YK, Wong NL, et al
High haemoglobin levels at the time of occlusion predict worse outcome for patients with patent ductus arteriosus and pulmonary hypertension.
Cardiol Young. 2022 Aug 11:1-8. doi: 10.1017/S104795112200244.
Abstract

PITRE T, Su J, Cui S, Scanlan R, et al
Medications for the treatment of pulmonary arterial hypertension: a systematic review and network meta-analysis.
Eur Respir Rev. 2022;31.
Abstract

RAWLINGS GH, Thompson AR, Armstrong I, Novakova B, et al
Coping styles associated with depression, health anxiety and health-related quality of life in pulmonary hypertension: cross-sectional analysis.
BMJ Open. 2022;12:e062564.
Abstract

GONZALEZ-HERMOSILLO LM, Cueto-Robledo G, Roldan-Valadez E, Graniel-Palafox LE, et al
Right Heart Catheterization (RHC): A comprehensive review of provocation tests and hepatic hemodynamics in patients with pulmonary hypertension (PH).
Curr Probl Cardiol. 2022 Aug 7:101351. doi: 10.1016/j.cpcardiol.2022.101351.
Abstract

SPARKS AT, Kawabori M, Chen FY, Couper GS, et al
Use of Mechanical Circulatory Support to Demonstrate Pulmonary Hypertension Reversibility in Mitral Stenosis.
ASAIO J. 2022 Aug 5. pii: 00002480-990000000-00076.
Abstract

HIRAISHI K, Kurahara LH, Ishikawa K, Go T, et al
Potential of the TRPM7 channel as a novel therapeutic target for pulmonary arterial hypertension.
J Smooth Muscle Res. 2022;58:50-62.
Abstract

CHEN J, Luo J, Qiu H, Tang Y, et al
Apolipoprotein A5 ameliorates MCT induced pulmonary hypertension by inhibiting ER stress in a GRP78 dependent mechanism.
Lipids Health Dis. 2022;21:69.
Abstract

TURHAN K, Alan E, Yetik-Anacak G, Sevin G, et al
H2S releasing sodium sulfide protects against pulmonary hypertension by improving vascular responses in monocrotaline-induced pulmonary hypertension.
Eur J Pharmacol. 2022 Aug 5:175182. doi: 10.1016/j.ejphar.2022.175182.
Abstract

UMEI TC, Kishino Y, Kawakami T, Fukuda K, et al
Recurrent pulmonary thrombosis after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
Eur Heart J. 2022 Aug 8. pii: 6658235. doi: 10.1093.
Abstract

WEI R, Lv X, Fang C, Liu C, et al
Silencing TUFM Inhibits Development of Monocrotaline-Induced Pulmonary Hypertension by Regulating Mitochondrial Autophagy via AMPK/mTOR Signal Pathway.
Oxid Med Cell Longev. 2022;2022:4931611.
Abstract

DANIYAN O, Ezeanosike O, Obu D, Ujunwa F, et al
Use of off-label compounded oral sildenafil in the management of persistent pulmonary hypertension of the newborn: A case report.
J Cardiovasc Thorac Res. 2022;14:141-143.
Abstract

WANG C, Ma X, Xu Y, Chen Z, et al
A prediction model of pulmonary hypertension in preterm infants with bronchopulmonary dysplasia.
Front Pediatr. 2022;10:925312.
Abstract

HONG AW, Toppen W, Lee J, Wilhalme H, et al
Outcomes and Prognostic Factors of Pulmonary Hypertension Patients Undergoing Emergent Endotracheal Intubation.
J Intensive Care Med. 2022 Aug 8:8850666221118839.
Abstract

ARJAANS S, Fries MWF, Schoots MH, Schilte CFM, et al
Clinical significance of early Pulmonary Hypertension in Preterm Infants.
J Pediatr. 2022 Aug 4. pii: S0022-3476(22)00700.
Abstract

YANG L, Zhang L, Chen S, Li M, et al
Correction to: Efficacy of interatrial shunt devices: an opening window to acute pulmonary hypertensive crisis and chronic pulmonary arterial hypertension.
J Thromb Thrombolysis. 2022 Aug 6. pii: 10.1007/s11239-022-02683.
Abstract

ZHU ZQ, Sun XL, Chen X, Anniwaer A, et al
[Advances in genome-wide association study of pulmonary arterial hypertension].
Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:813-818.
Abstract

LI Q, Liu S, Ma X, Yu J, et al
Fetal endoscopic tracheal occlusion for moderate and severe congenital diaphragmatic hernia: a systematic review and meta-analysis of randomized controlled trials.
Pediatr Surg Int. 2022 Jul 15. pii: 10.1007/s00383-022-05170.
Abstract

BARBERATO SH, Bruneto EG, Reis GS, Oliveira PRF, et al
Abnormal Echocardiographic Findings in Hospitalized Patients with Covid-19: A Systematic Review and Meta-analysis.
Arq Bras Cardiol. 2022;119:267-279.
Abstract

CHEN GB, Lu HZ
Brain abscess due to Aggregatibacter aphrophilus in association with atrial septal defectCase report and literature review.
Clin Neurol Neurosurg. 2022;219:107337.
Abstract

VIZZA CD, Ghio S, Badagliacca R, Manzi G, et al
Gaps of evidence in pulmonary arterial hypertension.
Int J Cardiol. 2022;364:119-123.
Abstract

CUETO-ROBLEDO G, Tapia-Paredes A, Garcia-Cesar M, Torres-Rojas MB, et al
Evaluation of Hepatic Hemodynamics (Hepatic Venous Pressure Gradient) During Right Heart Catheterization: A Comprehensive Review.
Curr Probl Cardiol. 2022;47:101278.
Abstract

BARRAGAN-MARTINEZ MD, Cueto-Robledo G, Roldan-Valadez E, Puebla-Aldama D, et al
A Brief Review on Gender Differences in Mexican-Mestizo Patients with Pulmonary Arterial Hypertension (PAH) at a Tertiary-Level Hospital.
Curr Probl Cardiol. 2022;47:101275.
Abstract

HAN SW, Puelz C, Rusin CG, Penny DJ, et al
Computer simulation of surgical interventions for the treatment of refractory pulmonary hypertension.
Math Med Biol. 2022 Aug 19. pii: 6671730. doi: 10.1093.
Abstract

LIN Y, Pang L, Huang S, Shen J, et al
The prevalence and survival of pulmonary hypertension due to left heart failure: A retrospective analysis of a multicenter prospective cohort study.
Front Cardiovasc Med. 2022;9:908215.
Abstract

TU L, Thuillet R, Perrot J, Ottaviani M, et al
Mineralocorticoid Receptor Antagonism by Finerenone Attenuates Established Pulmonary Hypertension in Rats.
Hypertension. 2022 Aug 18:101161HYPERTENSIONAHA12219207.
Abstract

ZUO W, Liu N, Xiao Y, Xie Y, et al
Meta-Analysis of Pulmonary Artery Denervation for Treatment of Pulmonary Hypertension.
Braz J Cardiovasc Surg. 2022;37:554-565.
Abstract

LIU P, Zhang A, Ding Z, Dai D, et al
m6A Modification-Mediated GRAP Regulates Vascular Remodeling in Hypoxic Pulmonary Hypertension.
Am J Respir Cell Mol Biol. 2022 Aug 16. doi: 10.1165/rcmb.2021-0429.
Abstract

RUBIN R
New Device Okayed for Treating Pulmonary Hypertension in Newborns.
JAMA. 2022;328:612.
Abstract

KAWAI Y, Hayakawa M, Tanaka T, Yamada Y, et al
Pulmonary hypertension with bronchopulmonary dysplasia: Aichi cohort study.
Pediatr Int. 2022;64:e15271.
Abstract

GUPTA S, Donn SM
Pulmonary hypertension in the newborn - Towards precision medicine.
Semin Fetal Neonatal Med. 2022 Aug 10:101382. doi: 10.1016/j.siny.2022.101382.
Abstract

CATALTEPE S, Cox LA
DDR1 deficiency in mice: A spontaneous model of bronchopulmonary-associated pulmonary hypertension?
Am J Respir Cell Mol Biol. 2022 Aug 15. doi: 10.1165/rcmb.2022-0312.
Abstract

SANGES S, Guerrier T, Duhamel A, Guilbert L, et al
Soluble markers of B cell activation suggest a role of B cells in the pathogenesis of systemic sclerosis-associated pulmonary arterial hypertension.
Front Immunol. 2022;13:954007.
Abstract

SANKARAN D, Lakshminrusimha S
Pulmonary hypertension in the newborn- etiology and pathogenesis.
Semin Fetal Neonatal Med. 2022 Aug 7:101381. doi: 10.1016/j.siny.2022.101381.
Abstract

JIN T, Lu J, Lv Q, Gong Y, et al
Farnesyl diphosphate synthase regulated endothelial proliferation and autophagy during rat pulmonary arterial hypertension induced by monocrotaline.
Mol Med. 2022;28:94.
Abstract

ROSTAGNO C, Cartei A, Rubbieri G, Ceccofiglio A, et al
Hip Fracture Surgery in Severe Aortic Stenosis: A Study of Factors Affecting Mortality.
Clin Interv Aging. 2022;17:1163-1171.
Abstract

CURRAN L, Nah G, Marcus GM, Tseng Z, et al
Clinical Correlates and Outcomes of Methamphetamine-Associated Cardiovascular Diseases in Hospitalized Patients in California.
J Am Heart Assoc. 2022;11:e023663.
Abstract

SINHA M, Zabini D, Guntur D, Nagaraj C, et al
Chloride channels in the lung: Challenges and perspectives for viral infections, pulmonary arterial hypertension, and cystic fibrosis.
Pharmacol Ther. 2022;237:108249.
Abstract

CHEN T, Su S, Yang Z, Zhang D, et al
Srolo Bzhtang reduces inflammation and vascular remodeling via suppression of the MAPK/NF-kappaB signaling pathway in rats with pulmonary arterial hypertension.
J Ethnopharmacol. 2022;297:115572.
Abstract

SHARMA D, Shah RJ, Sreenivasan J, Kafle P, et al
The role of serial right heart catheterization in risk stratification and management of pulmonary arterial hypertension.
Expert Rev Cardiovasc Ther. 2022;20:543-547.
Abstract

DURMUS S, Atahan E, Avci Kilickiran B, Onal B, et al
Significance of Cyclooxgenase-2 gene polymorphism and related miRNAs in pulmonary arterial hypertension.
Clin Biochem. 2022;107:33-39.
Abstract

KAMP JC, Neubert L, Ackermann M, Stark H, et al
A Morphomolecular Approach to Alveolar Capillary Dysplasia.
Am J Pathol. 2022;192:1110-1121.
Abstract

HRFI A, Ismail M, Mohammed MHA, Hamadah HK, et al
Outcome of truncus arteriosus repair: 20 years of single-center experience comparing early versus late surgical repair.
Cardiol Young. 2022;32:1289-1295.
Abstract

CUETO-ROBLEDO G, Guerrero-Velazquez JF, Roldan-Valadez E, Graniel-Palafox LE, et al
Pulmonary hypertension or pulmonary arterial hypertension in idiopathic pleuroparenchymal fibroelastosis: An updated comprehensive review.
Curr Probl Cardiol. 2022 Aug 23:101368. doi: 10.1016/j.cpcardiol.2022.101368.
Abstract

HOPPER RK, Abman SH, Elia EG, Avitabile CM, et al
Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network Registry.
J Pediatr. 2022 Aug 23. pii: S0022-3476(22)00762.
Abstract

YAROVOY S, Chazova I, Danilov N, Matchin Y, et al
POSITIVE PULMONARY ARTERY REMODELING AFTER A SERIES OF BALLOON PULMONARY ANGIOPLASTIES IN A PATIENT WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION.
J Hypertens. 2022;40.
Abstract

KRAMER T, Hoenemann J, Weis H, Jordan J, et al
EFFECTS OF ACUTE NORMOBARIC HYPOXIA-INDUCED PULMONARY HYPERTENSION ON ELECTROCARDIGRAPHIC MEASURES IN POST-MYOCARDIAL INFARCTION PATIENTS.
J Hypertens. 2022;40.
Abstract

BILALOVA D, Nigmatullina R, Mustafin A
ROLE OF SEROTONIN AND ITS METABOLITE 5-HIAA IN THE DEVELOPMENT OF PULMONARY HYPERTENSION. NEW APPROACHES TO TREATMENT AND NON-INVASIVE DIAGNOSTICS?
J Hypertens. 2022;40.
Abstract

FAUCHE A, Presles E, Sanchez O, Jais X, et al
Frequency and Predictors for Chronic Thromboembolic Pulmonary Hypertension after a first Unprovoked Pulmonary Embolism: results from PADIS studies.
J Thromb Haemost. 2022 Aug 26. doi: 10.1111/jth.15866.
Abstract

HUMBERT M, Kovacs G, Hoeper MM, Badagliacca R, et al
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Eur Heart J. 2022 Aug 26. pii: 6673929. doi: 10.1093.
Abstract

JIN W, Yang S, Yu C, Zhu T, et al
Variables associated with pulmonary hypertension screened by echocardiography in chronic myeloid leukemia patients on dasatinib therapy.
Front Cardiovasc Med. 2022;9:960531.
Abstract

DUAL SA, Verdonk C, Amsallem M, Pham J, et al
Elucidating tricuspid Doppler signal interpolation and its implication for assessing pulmonary hypertension.
Pulm Circ. 2022;12:e12125.
Abstract

NIKKHO SM, Richter MJ, Shen E, Abman SH, et al
Clinical significance of pulmonary hypertension in interstitial lung disease: A consensus statement from the Pulmonary Vascular Research Institute's innovative drug development initiative-Group 3 pulmonary hypertension.
Pulm Circ. 2022;12:e12127.
Abstract

OVCHINNIKOV A, Potekhina A, Belyavskiy E, Ageev F, et al
Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors.
Pharmaceuticals (Basel). 2022;15.
Abstract

RUARO B, Confalonieri P, Caforio G, Baratella E, et al
Chronic Thromboembolic Pulmonary Hypertension: An Observational Study.
Medicina (Kaunas). 2022;58.
Abstract

MIWA K, Taniguchi Y, Fujii H, Matsuoka Y, et al
Microvasculopathy Evaluated by Dual-Energy Computed Tomography in Patients with Chronic Thromboembolic Pulmonary Hypertension and Pulmonary Arterial Hypertension.
Life (Basel). 2022;12.
Abstract

YANG F, Ren W, Wang D, Yan Y, et al
The Variation in the Diastolic Period with Interventricular Septal Displacement and Its Relation to the Right Ventricular Function in Pulmonary Hypertension: A Preliminary Cardiac Magnetic Resonance Study.
Diagnostics (Basel). 2022;12.
Abstract

SUZUKI R, Yuchi Y, Saito T, Yasumura Y, et al
Beraprost Sodium for Pulmonary Hypertension in Dogs: Effect on Hemodynamics and Cardiac Function.
Animals (Basel). 2022;12.
Abstract

ZHAO Y, Yang XX, Huang C, Zhao JL, et al
[Systemic lupus erythematosus complicated with type pulmonary hypertension: a case report].
Zhonghua Nei Ke Za Zhi. 2022;61:1049-1052.
Abstract

KRAJEWSKI P, Turczynska M, Golebiewska J, Roik M, et al
Optical coherence tomography angiography findings in patients with chronic thromboembolic pulmonary hypertension.
Retina. 2022 Aug 23. pii: 00006982-990000000-00134.
Abstract

CHAN JCY, Chang SH
Commentary: Another tool for the chronic thromboembolic pulmonary hypertension toolbox.
JTCVS Open. 2022;10:73-74.
Abstract

WONG MKL, Hsin M
Commentary: The proinflammatory soluble CD40 ligand is associated with worse outcomes after pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension.
JTCVS Open. 2021;8:631-632.
Abstract

NISHIDA K, Ikawa Y, Nakamura T, Ohta K, et al
Severe pulmonary hypertension with fibrodysplasia ossificans progressiva.
Pediatr Int. 2022;64:e15250.
Abstract

BHOMBAL S, Patel N
Diagnosis & management of pulmonary hypertension in congenital diaphragmatic hernia.
Semin Fetal Neonatal Med. 2022 Aug 12:101383. doi: 10.1016/j.siny.2022.101383.
Abstract

ZHANG Y, Zhang N, Sun X, Liu Q, et al
Prognostic Significance of Small Pulmonary Vessel Alteration Measured by Chest Computed Tomography in Connective Tissue Diseases With Pulmonary Arterial Hypertension.
J Thorac Imaging. 2022;37:336-343.
Abstract

SHANG P, Sun SB, Liu BH
[Umbelliferone improves chronic hypoxia-induced pulmonary hypertension by inhibiting the RhoA/ROCK signaling pathway and autophagy].
Sheng Li Xue Bao. 2022;74:555-562.
Abstract

VAN DER LAARSE WJ, Bogaards SJP, Schalij I, Noordegraaf AV, et al
Work and oxygen consumption of isolated right ventricular papillary muscle in experimental pulmonary hypertension.
J Physiol. 2022 Aug 22. doi: 10.1113/JP282991.
Abstract

HOSSEINI O, Daines B, Rao S, Yang S, et al
Correlation between echocardiographic measurements and right heart hemodynamic parameters in patients undergoing evaluation for pulmonary hypertension.
Proc (Bayl Univ Med Cent). 2022;35:587-590.
Abstract

REITER G, Kovacs G, Reiter C, Schmidt A, et al
Left atrial acceleration factor as a magnetic resonance 4D flow measure of mean pulmonary artery wedge pressure in pulmonary hypertension.
Front Cardiovasc Med. 2022;9:972142.
Abstract

RODRIGUEZ-IRIZARRY VJ, Schneider AC, Ahle D, Smith JM, et al
Mice with humanized immune system as novel models to study HIV-associated pulmonary hypertension.
Front Immunol. 2022;13:936164.
Abstract

DOLKAR T, Chaudry A, Salauddin F, Nway N, et al
Warfarin Failure in a Patient With Chronic Thromboembolic Pulmonary Hypertension: A Case Report and Literature Review.
Cureus. 2022;14:e27007.
Abstract

LIU H, Zhang S, Liu Y, Ma J, et al
Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway.
Respir Res. 2022;23:209.
Abstract

KIM YJ, Shin SH, Park HW, Kim EK, et al
Risk factors of early pulmonary hypertension and its clinical outcomes in preterm infants: a systematic review and meta-analysis.
Sci Rep. 2022;12:14186.
Abstract

CHEN J, Miao J, Zhou D, Liao J, et al
Upregulation of mechanosensitive channel Piezo1 involved in high shear stress-induced pulmonary hypertension.
Thromb Res. 2022;218:52-63.
Abstract

DI SCALA L, Bacchi M, Bayer B, Turricchia S, et al
Adjusting Overall Survival Estimates of Macitentan in Pulmonary Arterial Hypertension After Treatment Switching: Results from the SERAPHIN Study.
Adv Ther. 2022;39:4346-4358.
Abstract

CAO R, Guo Z
Comment on "Predictive factors for concomitant pulmonary arterial hypertension at diagnosis of systemic lupus erythematosus in a Chinese population".
Int J Rheum Dis. 2022;25:966-967.
Abstract

SOUZA R, Delcroix M, Galie N, Jansa P, et al
Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension.
Adv Ther. 2022;39:4374-4390.
Abstract

KOLB M, Orfanos SE, Lambers C, Flaherty K, et al
The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD.
Adv Ther. 2022;39:3881-3895.
Abstract

FALCON-CORDON Y, Tvarijonaviciute A, Montoya-Alonso JA, Munoz-Prieto A, et al
Evaluation of acute phase proteins, adiponectin and endothelin-1 to determine vascular damage in dogs with heartworm disease (Dirofilaria immitis), before and after adulticide treatment.
Vet Parasitol. 2022;309:109759.
Abstract

GOTO A, Kambayashi R, Hagiwara-Nagasawa M, Izumi-Nakaseko H, et al
Impact of head-up tilt on expiratory negative airway pressure ventilation-induced cardiovascular hemodynamics in the halothane-anesthetized intact microminipigs.
Heart Vessels. 2022;37:1808-1815.
Abstract

SINIARSKI A, Gasecka A, Starczynski M, Banaszkiewicz M, et al
Prostacyclin analogues decrease platelet aggregation but have no effect on thrombin generation, fibrin clot structure, and fibrinolysis in pulmonary arterial hypertension: PAPAYA coagulation.
Platelets. 2022;33:1065-1074.
Abstract

RODRIGUEZ-GOMEZ I, Sanchez-Martin C, Garcia-Garcia FJ, Garcia-Esquinas E, et al
The medium-term consequences of a COVID-19 lockdown on lifestyle among Spanish older people with hypertension, pulmonary disease, cardiovascular disease, musculoskeletal disease, depression, and cancer.
Epidemiol Health. 2022;44:e2022026.
Abstract

DAS P, Thandavarayan RA, Watanabe K, Velayutham R, et al
Right ventricular failure: a comorbidity or a clinical emergency?
Heart Fail Rev. 2022;27:1779-1793.
Abstract

URBANOWICZ RJ, Holmes JH, Appleby D, Narasimhan V, et al
A Semi-Automated Term Harmonization Pipeline Applied to Pulmonary Arterial Hypertension Clinical Trials.
Methods Inf Med. 2022;61.
Abstract

GRIMMER B, Krauszman A, Hu X, Kabir G, et al
Pannexin 1: a novel regulator of acute hypoxic pulmonary vasoconstriction.
Cardiovasc Res. 2022;118:2535-2547.
Abstract

RODOR J, Chen SH, Scanlon JP, Monteiro JP, et al
Single-cell RNA sequencing profiling of mouse endothelial cells in response to pulmonary arterial hypertension.
Cardiovasc Res. 2022;118:2519-2534.
Abstract

MACHADO RD, Welch CL, Haimel M, Bleda M, et al
Biallelic variants of ATP13A3 cause dose-dependent childhood-onset pulmonary arterial hypertension characterised by extreme morbidity and mortality.
J Med Genet. 2022;59:906-911.
Abstract

ASSMUS B, Angermann CE, Alkhlout B, Asselbergs FW, et al
Effects of remote haemodynamic-guided heart failure management in patients with different subtypes of pulmonary hypertension: Insights from the MEMS-HF study.
Eur J Heart Fail. 2022 Aug 23. doi: 10.1002/ejhf.2656.
Abstract

NINAGAWA K, Kato M, Kikuchi Y, Sugimori H, et al
Predicting the response to pulmonary vasodilator therapy in systemic sclerosis with pulmonary hypertension by using quantitative chest CT.
Mod Rheumatol. 2022 Sep 2. pii: 6687422. doi: 10.1093.
Abstract

VILLAFRANCO N, Chartan C, Varghese NP, Coleman RD, et al
Tracheostomy in Pulmonary Hypertension: Not for the Faint of Heart.
Pediatr Crit Care Med. 2022;23:754-756.
Abstract

CHUANG KH, Yao RH, Jiang YN, Gui LX, et al
Attenuating effect of magnesium on pulmonary arterial calcification in rodent models of pulmonary hypertension.
J Hypertens. 2022;40:1979-1993.
Abstract

KIGITOVICA D, Rusa E, Rudzitis A, Skride A, et al
Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension incidence in Latvia in 2021 according to the new definition.
Eur J Intern Med. 2022 Aug 29. pii: S0953-6205(22)00308.
Abstract

SANCHEZ-AGUILERA SANCHEZ-PAULE, Lazaro Salvador M, Berenguel Senen A, Mendez Perles C, et al
Role of cardiopulmonary exercise test in early diagnosis of pulmonary hypertension in scleroderma patients.
Med Clin (Barc). 2022 Aug 29. pii: S0025-7753(22)00418.
Abstract

LEE SK, Choi J
Caudal pulmonary artery to vein ratio on radiography can predict pulmonary hypertension in dogs with mitral regurgitation.
Vet Radiol Ultrasound. 2022 Sep 1. doi: 10.1111/vru.13145.
Abstract

PALAKEEL JJ, Ali M, Chaduvula P, Chhabra S, et al
An Outlook on the Etiopathogenesis of Pulmonary Hypertension in HIV.
Cureus. 2022;14:e27390.
Abstract

TAN ML, Willis CG
Beriberi: A Reversible Cause of Acute Severe Pulmonary Hypertension.
Cureus. 2022;14:e27376.
Abstract

BHATIA T, Gupta GD, Kurmi BD, Singh D, et al
Role of solid lipid nanoparticle for the delivery of Lipophilic Drugs and Herbal Medicines in the treatment of pulmonary hypertension.
Pharm Nanotechnol. 2022 Aug 31. pii: PNT-EPUB-126042.
Abstract

SHIKHARE S, Balki I, Shi Y, Kavanagh J, et al
Right-to-left ventricle ratio determined by machine learning algorithms on CT pulmonary angiography images predicts prolonged ICU length of stay in operated chronic thromboembolic pulmonary hypertension.
Br J Radiol. 2022 Aug 31:20210722. doi: 10.1259/bjr.20210722.
Abstract

HILTON LR, Ratsep MT, Vandenbroek MM, Jafri S, et al
Impaired IL (Interleukin)-15 Signaling via BMPR2 Loss Drives Natural Killer Cell Deficiency and Pulmonary Hypertension.
Hypertension. 2022 Aug 31:101161HYPERTENSIONAHA12219178.
Abstract

BILIK MZ, Oylumlu M, Oylumlu M, Acun B, et al
Novel predictor of pulmonary arterial hypertension: Monocyte to HDL cholesterol ratio.
Medicine (Baltimore). 2022;101:e29973.
Abstract

ZHOU J, Li F, Yang Y
Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension.
Respir Res. 2022;23:223.
Abstract

LEIKIN JB
Foreword: Pulmonary hypertension in Scleroderma-Evaluation and management.
Dis Mon. 2022 Aug 27:101467. doi: 10.1016/j.disamonth.2022.101467.
Abstract

BIKOU O, Ishikawa K
Endobronchial Gene Delivery for Pulmonary Hypertension in a Large Animal Model.
Methods Mol Biol. 2022;2573:279-289.
Abstract

BISSERIER M, Boucherat O, Bonnet S, Hadri L, et al
Intra-Airway Gene Delivery for Pulmonary Hypertension in Rodent Models.
Methods Mol Biol. 2022;2573:263-278.
Abstract

ZHANG ZQ, Zhu SK, Wang M, Wang XA, et al
New progress in diagnosis and treatment of pulmonary arterial hypertension.
J Cardiothorac Surg. 2022;17:216.
Abstract

MAHMOOD B
Persistent pulmonary hypertension of newborn.
Semin Pediatr Surg. 2022;31:151202.
Abstract

SIMONSON JL, Pandya D, Khan S, Greenberg HE, et al
Comparison of obstructive sleep apnoea prevalence and severity across WHO pulmonary hypertension groups.
BMJ Open Respir Res. 2022;9.
Abstract

MACLEAN MR, Fanburg B, Hill N, Lazarus HM, et al
Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho.
Compr Physiol. 2022;12:1-16.
Abstract

LONG GM, Troutman AD, Gray DA, Fisher AJ, et al
Skeletal Muscle Blood Flow during Exercise is Reduced in a Rat Model of Pulmonary Hypertension.
Am J Physiol Regul Integr Comp Physiol. 2022.
Abstract

KLINKOVA AS, Kamenskaya OV, Loginova IY, Porotnikova SS, et al
[Features of psychoemotional status in patients with chronic thromboembolic pulmonary hypertension after cardiac surgery during the COVID-19 pandemic].
Zh Nevrol Psikhiatr Im S S Korsakova. 2022;122:80-87.
Abstract

TANG HT, Mu WH, Xiang YJ, An Y, et al
Effect of hepatocyte growth factor on mice with hypoxic pulmonary arterial hypertension: a preliminary study.
Zhongguo Dang Dai Er Ke Za Zhi. 2022;24:936-941.
Abstract

LIN Y, Pang L, Huang S, Shen J, et al
Impact of borderline pulmonary hypertension due to left heart failure on mortality in a multicenter registry study: A 3-year survivorship analysis.
Front Cardiovasc Med. 2022;9:983803.
Abstract

ALMAN K, Sadd CJ, Ravel A, Raza F, et al
Prevalence of aortic stenosis and TAVR outcomes in patients with systemic sclerosis-associated pulmonary hypertension.
Pulm Circ. 2022;12:e12118.
Abstract

CHINAWA JM, Duru CO, Chinawa AT, Chukwu BF, et al
A comparative analysis on risk of pulmonary hypertension in children with Atrio-ventricular (AV) canal defect: a multi-centre study.
Afr Health Sci. 2022;22:220-226.
Abstract

DURWARD A, Macrae D
Long term outcome of babies with pulmonary hypertension.
Semin Fetal Neonatal Med. 2022 Aug 12:101384. doi: 10.1016/j.siny.2022.101384.
Abstract

SHAFIQ M, Lone ZR, Bharati P, Mahapatra S, et al
Pyrroloquinoline quinone (PQQ) improves pulmonary hypertension by regulating mitochondrial and metabolic functions.
Pulm Pharmacol Ther. 2022;76:102156.
Abstract

LI T, Liu B, Li NS, Luo XJ, et al
Vascular peroxidase 1 promotes phenotypic transformation of pulmonary artery smooth muscle cells via ERK pathway in hypoxia-induced pulmonary hypertensive rats.
Life Sci. 2022;307:120910.
Abstract

RICCI F, Khanji MY, Garg P
Editorial for "Corrected MRI Pulmonary Transit Time for Identification of Combined Pre and PostCapillary Pulmonary Hypertension in Patients With Left Heart Disease".
J Magn Reson Imaging. 2022 Aug 27. doi: 10.1002/jmri.28411.
Abstract

EARASI K, Mihaltses J, Kennedy JLW, Rao S, et al
Intensive ultrafiltration strategy restores kidney transplant candidacy for patients with echocardiographic evidence of pulmonary hypertension.
Clin Transplant. 2022 Aug 27:e14799. doi: 10.1111/ctr.14799.
Abstract

MORAL-SANZ J, Lewis SA, MacMillan S, Meloni M, et al
AMPK deficiency in smooth muscles causes persistent pulmonary hypertension of the new-born and premature death.
Nat Commun. 2022;13:5034.
Abstract

SONG S, Park KH, Lee H, Lee NH, et al
Veno-arterial extracorporeal membrane oxygenation for treatment of persistent pulmonary hypertension of the newborn.
Asian J Surg. 2022 Aug 23. pii: S1015-9584(22)01145.
Abstract

BART NK, Liu K, Kotlyar E, Keogh AM, et al
Portopulmonary Hypertension: The Interplay Between the Liver and Pulmonary Arteries.
Heart Lung Circ. 2022;31:1185-1187.
Abstract

ASSADI H, Alabed S, Maiter A, Salehi M, et al
The Role of Artificial Intelligence in Predicting Outcomes by Cardiovascular Magnetic Resonance: A Comprehensive Systematic Review.
Medicina (Kaunas). 2022;58.
Abstract

LIU X, Zhou H, Hu Z
Resveratrol attenuates chronic pulmonary embolism-related endothelial cell injury by modulating oxidative stress, inflammation, and autophagy.
Clinics (Sao Paulo). 2022;77:100083.
Abstract

JAYASEKERA G, Macdonald A, Mccomb C, Orchard V, et al
Left ventricular dysfunction and intra-ventricular dyssynchrony in idiopathic pulmonary arterial hypertension.
Int J Cardiol. 2022;365:131-139.
Abstract

PEPPAS S, Nagraj S, Koutsias G, Kladas M, et al
Portopulmonary Hypertension: A Review of the Current Literature.
Heart Lung Circ. 2022;31:1191-1202.
Abstract

SAHA AK, Sardar SK, Majhi B, Chatterjee S, et al
Clinical and echocardiographic characteristics associated with evolution of patent ductus arteriosus in preterm neonates: A prospective cohort study.
J Neonatal Perinatal Med. 2022;15:537-544.
Abstract

HIRAKAWA K, Aoki T, Tsuji A, Ogo T, et al
Pulmonary arterial hypertension sensitive to calcium channel blocker, but not advanced pulmonary hypertension treatment: a case report.
Eur Heart J Case Rep. 2022;6:ytac351.
Abstract

ISMAT FA, Usansky HH, Villa R, Zou J, et al
Safety, Tolerability, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder for Pulmonary Hypertension: A Phase 1, Randomized, Double-Blind, Single- and Multiple-Dose Study.
Adv Ther. 2022 Sep 7. pii: 10.1007/s12325-022-02296.
Abstract

CHAN KH, Rizvi SH, De Jesus-Rojas W, Stark JM, et al
Pulmonary hypertension screening in children with sickle cell disease.
Pediatr Blood Cancer. 2022 Sep 7:e29980. doi: 10.1002/pbc.29980.
Abstract

BEGNIS M, Chaar Y, Savoldelli A, Scaburri A, et al
A patient-specific image-based approach to estimate pulmonary artery stiffness based on vessel constitutive model.
Med Eng Phys. 2022;107:103851.
Abstract

CHAKKARAPANI AA, Gupta S, Jamil A, Yadav SK, et al
Effects of inhaled nitric oxide (iNO) in pulmonary hypertension secondary to arteriovenous malformations: a retrospective cohort study from the European iNO registry.
Eur J Pediatr. 2022 Sep 6. pii: 10.1007/s00431-022-04602.
Abstract

FERREIRA F
Therapeutic options for thromboembolic pulmonary hypertension: An overview of the situation in Portugal.
Rev Port Cardiol. 2022;41:749-750.
Abstract

SAMOUCO G, Fonseca M, Batista Correia J, Santos-Ferreira C, et al
Chronic thromboembolic pulmonary hypertension: A 10-year analysis from a Portuguese referral center.
Rev Port Cardiol. 2022;41:741-748.
Abstract

SHILIN DS, Shapovalov KG
Changes in Some Vascular Biomarkers in Patients with Severe COVID-19 with Various Degrees of Pulmonary Hypertension.
Bull Exp Biol Med. 2022 Sep 5. pii: 10.1007/s10517-022-05581.
Abstract

CUETO-ROBLEDO G, Narvaez-Oriani C, Roldan-Valadez E
Patent Ductus Arteriosus Can Coexist With Pulmonary Sequestration in Adults, Conditioning Pulmonary Hypertension.
Mayo Clin Proc. 2022;97:1752-1753.
Abstract

ANSA VO, Inyama MA, Mpama EA, Uhegbu VM, et al
Cardiovascular Findings in Adult Patients with Sickle Cell Anaemia in Steady State seen in Calabar, Nigeria.
West Afr J Med. 2022;39:844-851.
Abstract

GUO Z, Liu YX, Qi J, Xian XH, et al
[Effects of exogenous hydrogen sulfide on pulmonary hypertension in rabbits with endotoxic shock].
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2022;38:264-269.
Abstract

RYAN JJ, Gomberg-Maitland M
Right Heart Catheterization-To Do or Not To Do? Introducing a New Diagnostic Algorithm for Pulmonary Hypertension.
J Am Heart Assoc. 2022 Sep 5:e026589. doi: 10.1161/JAHA.122.026589.
Abstract

ASMARATS L, Bethencourt A, Rodriguez A, Noris M, et al
Ruptured sinus of Valsalva aneurysm: A reversible cause of suprasystemic pulmonary hypertension.
Rev Port Cardiol. 2022;41:177.
Abstract

FREITAS P
Be mindful when evaluating a patient with chest pain and pulmonary hypertension.
Rev Port Cardiol. 2022;41:81-82.
Abstract

SUN Y, Wu W, Zhao Q, Jiang R, et al
CircGSAP regulates the cell cycle of pulmonary microvascular endothelial cells via the miR-942-5p sponge in pulmonary hypertension.
Front Cell Dev Biol. 2022;10:967708.
Abstract

XIAO X, Luo F, Fu M, Jiang Y, et al
Evaluating the therapeutic role of selected active compounds in Plumula Nelumbinis on pulmonary hypertension via network pharmacology and experimental analysis.
Front Pharmacol. 2022;13:977921.
Abstract

LUIJTEN D, Meijer FMM, Boon GJAM, Ende-Verhaar YM, et al
Diagnostic efficacy of ECG-derived ventricular gradient for the detection of chronic thromboembolic pulmonary hypertension in patients with acute pulmonary embolism.
J Electrocardiol. 2022;74:94-100.
Abstract

SAKAMOTO H, Goda A, Tobita K, Takeuchi K, et al
EmPHasis-10 Health-Related Quality of Life and Exercise Capacity in Chronic Thromboembolic Pulmonary Hypertension After Balloon Angioplasty.
J Am Heart Assoc. 2022;11:e026400.
Abstract

STEENHORST JJ, Hirsch A, Verzijl A, Wielopolski P, et al
Exercise and hypoxia unmask pulmonary vascular disease and right ventricular dysfunction in a 10- to 12-week-old swine model of neonatal oxidative injury.
J Physiol. 2022;600:3931-3950.
Abstract

LIU L, Wei Y, Giunta S, He Q, et al
Potential role of cellular senescence in pulmonary arterial hypertension.
Clin Exp Pharmacol Physiol. 2022;49:1042-1049.
Abstract

DING Y, Qian J, Zhang S, Xu D, et al
Immunosuppressive therapy in patients with connective tissue disease-associated pulmonary arterial hypertension: A systematic review.
Int J Rheum Dis. 2022;25:982-990.
Abstract

OLASINSKA-WISNIEWSKA A, Grodecki K, Urbanowicz T, Perek B, et al
Pulmonary artery systolic pressure at 1-month predicts 1-year survival after transcatheter aortic valve implantation.
Kardiol Pol. 2022;80.
Abstract

FERNANDO RJ, Johnson SD, Richardson K
Intraoperative Transesophageal Echocardiographic Detection of a Gerbode Defect in a Patient Referred for Aortic Valve Endocarditis: A Case Report.
Semin Cardiothorac Vasc Anesth. 2022;26:245-252.
Abstract

LEI Q, Yu Z, Li H, Cheng J, et al
Fatty acid-binding protein 5 aggravates pulmonary artery fibrosis in pulmonary hypertension secondary to left heart disease via activating wnt/beta-catenin pathway.
J Adv Res. 2022;40:197-206.
Abstract

ABMAN SH
Characterization of Early Pulmonary Hypertension in Preterm Infants: A Key Step Towards Improving Outcomes.
J Pediatr. 2022 Sep 10. pii: S0022-3476(22)00801.
Abstract

DING Y, He N
HIV and pulmonary hypertension: CD4 and viral load matter.
Lancet Healthy Longev. 2021;2:e389-e390.
Abstract

YANG QF, Du M, Li XY, He WJ, et al
[Progress in the development of treprostinil for the treatment of pulmonary hypertension].
Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:930-935.
Abstract

[Consensus on the operation of pulmonary artery catheterization].
Zhonghua Jie He He Hu Xi Za Zhi. 2022;45:855-864.
Abstract

KANG M, Hart CM, Kempker JA, Veeraraghavan S, et al
Pulmonary Hypertension Mortality Trends in United States 1999-2019.
Ann Epidemiol. 2022 Sep 8. pii: S1047-2797(22)00225.
Abstract

BRENNAN M, Breen D
Sarcoidosis in the older person: diagnostic challenges and treatment consideration.
Age Ageing. 2022;51.
Abstract

LIU X, Zhang L, Zhang W
Metabolic reprogramming: A novel metabolic model for pulmonary hypertension.
Front Cardiovasc Med. 2022;9:957524.
Abstract

JOHNSON SW, Finlay L, Mathai SC, Goldstein RH, et al
Real-world use of inhaled treprostinil for lung disease-pulmonary hypertension: A protocol for patient evaluation and prescribing.
Pulm Circ. 2022;12:e12126.
Abstract

MURPHY G, Jayasekera G, Mullin J, Gallagher L, et al
Exploring the failing right ventricle in pulmonary hypertension by cardiac magnetic resonance: An in vivo study utilizing Macitentan.
Pulm Circ. 2022;12:e12124.
Abstract

PEREZ-VIZCAINO F, Mondejar-Parreno G
Antiproliferative miR-212-5p: Promising RNA therapy for pulmonary hypertension.
Mol Ther Nucleic Acids. 2022;29:689-690.
Abstract

KANIA K, Ahmed A, Ahmed S, Radegran G, et al
Elevated plasma WIF-1 levels are associated with worse prognosis in heart failure with pulmonary hypertension.
ESC Heart Fail. 2022 Sep 9. doi: 10.1002/ehf2.14148.
Abstract

HUANG Z, Duan A, Hu M, Zhao Z, et al
Implication of prolonged nocturnal hypoxemia and obstructive sleep apnea for pulmonary hemodynamics in patients being evaluated for pulmonary hypertension: a retrospective study.
J Clin Sleep Med. 2022 Sep 9. doi: 10.5664/jcsm.10286.
Abstract

DEUX JF, Crowe LA, Genecand L, Hachulla AL, et al
Correlation between Pulmonary Artery Pressure and Vortex Duration Determined by 4D Flow MRI in Main Pulmonary Artery in Patients with Suspicion of Chronic Thromboembolic Pulmonary Hypertension (CTEPH).
J Clin Med. 2022;11.
Abstract

ZEIDAN EM, Hossain MA, El-Daly M, Abourehab MAS, et al
Mitochondrial Regulation of the Hypoxia-Inducible Factor in the Development of Pulmonary Hypertension.
J Clin Med. 2022;11.
Abstract

SHAH AJ, Vorla M, Kalra DK
Molecular Pathways in Pulmonary Arterial Hypertension.
Int J Mol Sci. 2022;23.
Abstract

WANG JL, Liu H, Jing ZC, Zhao F, et al
18beta-Glycyrrhetinic acid ameliorates endoplasmic reticulum stress-induced inflammation in pulmonary arterial hypertension through PERK/eIF2alpha/NF-kappaB signaling.
Chin J Physiol. 2022;65:187-198.
Abstract

WEI RQ, Zhang WM, Liang Z, Piao C, et al
Identification of Signal Pathways and Hub Genes of Pulmonary Arterial Hypertension by Bioinformatic Analysis.
Can Respir J. 2022;2022:1394088.
Abstract

YU M, Wu X, Peng L, Yang M, et al
Inhibition of Bruton's Tyrosine Kinase Alleviates Monocrotaline-Induced Pulmonary Arterial Hypertension by Modulating Macrophage Polarization.
Oxid Med Cell Longev. 2022;2022:6526036.
Abstract

OKNINSKA M, Mackiewicz U, Zajda K, Kieda C, et al
New potential treatment for cardiovascular disease through modulation of hemoglobin oxygen binding curve: Myo-inositol trispyrophosphate (ITPP), from cancer to cardiovascular disease.
Biomed Pharmacother. 2022;154:113544.
Abstract

TAN Z, Wu PY, Zhu TT, Su W, et al
Efficacy and safety of sequential combination therapy for pulmonary arterial hypertension: A meta-analysis of Randomized-Controlled Trials.
Pulm Pharmacol Ther. 2022;76:102144.
Abstract

ULRICH S, Lichtblau M, Schneider SR, Saxer S, et al
Clinician's Corner: Counseling Patients with Pulmonary Vascular Disease Traveling to High Altitude.
High Alt Med Biol. 2022 Jul 18. doi: 10.1089/ham.2022.0051.
Abstract

ANTONIO T, Soares-da-Silva P, Pires NM, Gomes P, et al
Salt-inducible kinases: new players in pulmonary arterial hypertension?
Trends Pharmacol Sci. 2022;43:806-819.
Abstract

AK K, Arslanhan G, Tire Y, Tosun S, et al
Transatrial balloon atrial septostomy to facilitate weaning off venoarterial ECMO after pulmonary endarterectomy.
Int J Artif Organs. 2022;45:883-885.
Abstract

LAN M, Wu S, Fernandes TM
Iron deficiency and pulmonary arterial hypertension.
Nutr Clin Pract. 2022;37:1059-1073.
Abstract

OKOYE HC, Ezekekwu C, Nwagha TU, Korubo K, et al
Prevalence of venous thromboembolism and its associations in a large racially homogenous population of sickle cell disease patients.
Eur J Haematol. 2022;109:321-326.
Abstract

TURNER JM, Russo F, Deprest J, Mol BW, et al
Phosphodiesterase-5 inhibitors in pregnancy: Systematic review and meta-analysis of maternal and perinatal safety and clinical outcomes.
BJOG. 2022;129:1817-1831.
Abstract

XIAO R, Liu J, Luo S, Yu Z, et al
Orally-administrated mitochondria attenuate pulmonary hypertension with the aid of erythrocytes as carriers.
Clin Transl Med. 2022;12:e1033.
Abstract

KASLIWAL N, Yang C, Martinez EJ, Hebeler RF, et al
Combined Tricuspid Valve Repair and Orthotopic Liver Transplantation in a Patient With Severe Tricuspid Regurgitation and Pulmonary Hypertension.
Cureus. 2022;14:e28146.
Abstract

CHACKO SR, Ram P, Fox T, Sooknanan N, et al
Impact of achieving euthyroidism on pulmonary artery systolic pressures in hyperthyroidism-associated pulmonary hypertension - a systematic review.
Am J Cardiovasc Dis. 2022;12:212-223.
Abstract

REMISZEWSKI P, Malinowska B
Why Multitarget Vasodilatory (Endo)cannabinoids Are Not Effective as Antihypertensive Compounds after Chronic Administration: Comparison of Their Effects on Systemic and Pulmonary Hypertension.
Pharmaceuticals (Basel). 2022;15.
Abstract

ILIUTA L, Rac-Albu M, Rac-Albu ME, Andronesi A, et al
Impact of Pulmonary Hypertension on Mortality after Surgery for Aortic Stenosis.
Medicina (Kaunas). 2022;58.
Abstract

DUMITROF LC, Nedelciuc I, Roca M, Crisan-Dabija R, et al
The Evolution of Pulmonary Hypertension and Its Prognostic Implications Post-TAVI-Single Center Experience.
Medicina (Kaunas). 2022;58.
Abstract

KOSMAS K, Michael Z, Papathanasiou AE, Spyropoulos F, et al
Skeletal Muscle Dysfunction in Experimental Pulmonary Hypertension.
Int J Mol Sci. 2022;23.
Abstract

ZHANG X, Ruan B, Qiao Z, Yang M, et al
The Balance between the Left and Right Ventricular Deformation Evaluated by Speckle Tracking Echocardiography Is a Great Predictor of the Major Adverse Cardiac Event in Patients with Pulmonary Hypertension.
Diagnostics (Basel). 2022;12.
Abstract

MATOS JI, Falcon-Cordon Y, Garcia-Rodriguez SN, Costa-Rodriguez N, et al
Evaluation of Pulmonary Hypertension in Dogs with Heartworm Disease Using the Computed Tomographic Pulmonary Trunk to Aorta Diameter Ratio.
Animals (Basel). 2022;12.
Abstract

GARCIA MVF, Souza R, Caruso P
Long-term survival after acute decompensated pulmonary hypertension: A propensity-score matched study.
Med Intensiva (Engl Ed). 2022 Sep 19. pii: S2173-5727(22)00205.
Abstract

WU Y, Hu S, Yan XX, Peng FH, et al
Chronic Thromboembolic Pulmonary Hypertension in Females: Clinical Features and Survival.
J Cardiovasc Dev Dis. 2022;9.
Abstract

BOXHAMMER E, Gharibeh SX, Wernly B, Kelm M, et al
Conundrum of Classifying Subtypes of Pulmonary Hypertension-Introducing a Novel Approach to Classify "Borderline" Patients in a Population with Severe Aortic Stenosis Undergoing TAVI.
J Cardiovasc Dev Dis. 2022;9.
Abstract

JOOSTEN A, Carrier FM, Menioui A, Van der Linden P, et al
Incidental finding of elevated pulmonary arterial pressures during liver transplantation and postoperative pulmonary complications.
BMC Anesthesiol. 2022;22:300.
Abstract

SAMMUT MA, Condliffe R, Elliot C, Hameed A, et al
Atrial flutter and fibrillation in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension in the ASPIRE registry: Comparison of rate versus rhythm control approaches.
Int J Cardiol. 2022 Sep 18. pii: S0167-5273(22)01341.
Abstract

CREA F
Pulmonary hypertension, sarcoidosis, and inflammatory and dilated cardiomyopathy: new light shed on prevalence, mechanisms, and treatment.
Eur Heart J. 2022;43:3371-3375.
Abstract

NISHIYAMA M, Inoue Y, Sasaki H, Seike Y, et al
Long-term outcomes of combined pulmonary endarterectomy and additional balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
Gen Thorac Cardiovasc Surg. 2022 Sep 21. pii: 10.1007/s11748-022-01872.
Abstract

KANE CJ, Salama AA, Pislaru C, Kane GC, et al
Low Pulmonary Artery Pulsatility Index by Echocardiography is Associated with Increased Mortality in Pulmonary Hypertension.
J Am Soc Echocardiogr. 2022 Sep 17. pii: S0894-7317(22)00457.
Abstract

GONG JN, Chen BX, Xing HQ, Huo L, et al
Correction: Pulmonary artery imaging with (68) Ga-FAPI-04 in patients with chronic thromboembolic pulmonary hypertension.
J Nucl Cardiol. 2022 Sep 19. pii: 10.1007/s12350-022-03104.
Abstract

GUO X, Meng Y, Wang Y, Nan S, et al
Mice lacking 1,4,5-triphosphate inositol type III receptor demonstrate inhibition of hypoxic pulmonary hypertension.
Biochem Biophys Res Commun. 2022;629:165-170.
Abstract

NIHTYANOVA SI, Schreiber BE, Ong VH, Wells AU, et al
Dynamic prediction of pulmonary hypertension in systemic sclerosis using landmark analysis.
Arthritis Rheumatol. 2022 Sep 19. doi: 10.1002/art.42349.
Abstract

REMISZEWSKI P, Pedzinska-Betiuk A, Minczuk K, Schlicker E, et al
Effects of the peripheral CB1 receptor antagonist JD5037 in mono- and polytherapy with the AMPK activator metformin in a monocrotaline-induced rat model of pulmonary hypertension.
Front Pharmacol. 2022;13:965613.
Abstract

OLEYNIKOV DA, Yi M
Pre- and postcapillary pulmonary hypertension in dogs: Circulating biomarkers.
Open Vet J. 2022;12:469-480.
Abstract

ZHU YH, Cai Y, Jiang YD, Deng WC, et al
[Progress of researches on schistosomiasis-associated pulmonary arterial hypertension].
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2022;34:432-437.
Abstract

GRANTON J, Teijeiro-Paradis R
Management of the Critically Ill Patient with Pulmonary Arterial Hypertension and Right Heart Failure.
Clin Chest Med. 2022;43:425-439.
Abstract

NASEEM M, Alkassas A, Alaarag A
Tricuspid annular plane systolic excursion/pulmonary arterial systolic pressure ratio as a predictor of in-hospital mortality for acute heart failure.
BMC Cardiovasc Disord. 2022;22:414.
Abstract

COOPER TJ, Pellicori P, Ushakova A, Dickstein K, et al
Reply to the letter "Particular Challenges in the Use of Pulmonary Vasodilating Therapy for Patients with Pulmonary Hypertension Secondary to Left Heart Diseases".
Eur J Heart Fail. 2022 Sep 17. doi: 10.1002/ejhf.2690.
Abstract

LIU YY, Zhang WY, Zhang ML, Wang YJ, et al
DNA-PKcs participated in hypoxic pulmonary hypertension.
Respir Res. 2022;23:246.
Abstract

KAKIUCHI T, Baba Y, Minematsu N, Doi H, et al
Progress of pulmonary hypertension and high manganese levels through congenital portosystemic shunt closure.
Clin Case Rep. 2022;10:e6318.
Abstract

NAN X, Yang Z, Su S, Huang Z, et al
The Mechanism of Volatile Oil of Rhodiola tangutica against Hypoxia-Induced Pulmonary Hypertension in Rats Based on RAS Pathway.
Biomed Res Int. 2022;2022:9650650.
Abstract

FISHWICK D, Kiely DG
Vascular compression and pulmonary hypertension: the occupational context.
Occup Environ Med. 2022 Sep 14. pii: oemed-2022-108474.
Abstract

POTT J, Grafin Zu Reventlow P, Simon M, Steurer S, et al
[Intimal pulmonary sarcoma: A case report of a rare differential diagnosis of chronic thromboembolic pulmonary hypertension].
Pneumologie. 2022;76:633-638.
Abstract

LI X, Duan A, Jin Q, Zhang Y, et al
Exercise feature and predictor of prognosis in patients with pulmonary artery stenosis-associated pulmonary hypertension.
ESC Heart Fail. 2022 Sep 13. doi: 10.1002/ehf2.14154.
Abstract

DEMIR M, Akdag S, Deniz MA, Simsek H, et al
An isolated congenital absence of right pulmonary artery associated with pulmonary hypertension with coronary collaterals: A case report.
Echocardiography. 2022 Sep 13. doi: 10.1111/echo.15450.
Abstract

JANSEN SMA, Huis In 't Veld AE, Tolen PHCG, Jacobs W, et al
Clinical Characteristics of Patients Undergoing Right Heart Catheterizations in Community Hospitals.
J Am Heart Assoc. 2022;11:e025143.
Abstract

AL ZAIDI M, Pizarro C, Bley C, Repges E, et al
ER-stress-induced secretion of circulating glucose-regulated protein 78kDa (GRP78) ameliorates pulmonary artery smooth muscle cell remodelling.
Cell Stress Chaperones. 2022;27:561-572.
Abstract

LI YE, Ren J
Association between obstructive sleep apnea and cardiovascular diseases.
Acta Biochim Biophys Sin (Shanghai). 2022;54:882-892.
Abstract

RAO P, Charki S, Aradhya AS, Diggikar S, et al
Prediction score for prolonged hospital stay in Meconium aspiration syndrome: A Multicentric collaborative cohort of South India.
Pediatr Pulmonol. 2022 Jun 27. doi: 10.1002/ppul.26044.
Abstract

MAZZOLA M, Madonna R, Badagliacca R, Caterina R, et al
Porto-pulmonary arterial hypertension: Translation of pathophysiological concepts to the bedside.
Vascul Pharmacol. 2022;145:107022.
Abstract

MANZI G, Papa S, Mariani MV, Scoccia G, et al
Telehealth: A winning weapon to face the COVID-19 outbreak for patients with pulmonary arterial hypertension.
Vascul Pharmacol. 2022;145:107024.
Abstract

TANG L, Wang N, Wei X, Huang S, et al
Cysteine and glycine-rich protein 2 promotes hypoxic pulmonary vascular smooth muscle cell proliferation through the Wnt3alpha-beta-catenin/lymphoid enhancer-binding factor 1 pathway.
J Biochem Mol Toxicol. 2022;36:e23122.
Abstract

LANG IM, Artner T
FOCUS on sequelae of acute pulmonary embolism: does it pay off?
Eur Heart J. 2022;43:3399-3401.
Abstract

MEHRA P, Mehta V, Yusuf J, Mukhopadhyay S, et al
Gender Differences in Genotypic Distribution of Endothelin-1 Gene and Endothelin receptor A gene in Pulmonary Hypertension associated with Rheumatic Mitral Valve Disease.
Indian Heart J. 2022 Sep 27. pii: S0019-4832(22)00143.
Abstract

SCHIKOWSKI EM, Swabe G, Chan SY, Magnani JW, et al
Association between income and likelihood of right heart catheterization in individuals with pulmonary hypertension: A US claims database analysis.
Pulm Circ. 2022;12:e12132.
Abstract

LIAO LC, Shyu TC, Chuang CM, Fu YC, et al
Staged Treatment of Ruptured Sinus of Valsalva Aneurysm and Ventricular Septal Defect with Pulmonary Hypertension.
Acta Cardiol Sin. 2022;38:639-641.
Abstract

CHANG WT, Su CC, Chang YC, Cheng CL, et al
The Impact of Sildenafil on Ischemic Outcomes in Patients with Pulmonary Hypertension - A Nationwide Cohort Study.
Acta Cardiol Sin. 2022;38:623-630.
Abstract

LIN YB, Xia B, Cao J, Tang ZJ, et al
Ultrasound findings in neonates with alveolar capillary dysplasia with misalignment of the pulmonary veins: report of two cases.
J Int Med Res. 2022;50:3000605221126876.
Abstract

DAWES TJW, McCabe C, Dimopoulos K, Stewart I, et al
Phosphodiesterase 5 inhibitor treatment and survival in interstitial lung disease pulmonary hypertension: A Bayesian retrospective observational cohort study.
Respirology. 2022 Sep 29. doi: 10.1111/resp.14378.
Abstract

WU J, Liu T, Shi S, Fan Z, et al
Dapagliflozin reduces the vulnerability of rats with pulmonary arterial hypertension-induced right heart failure to ventricular arrhythmia by restoring calcium handling.
Cardiovasc Diabetol. 2022;21:197.
Abstract

FELDHUTTER EK, Domenech O, Vezzosi T, Tognetti R, et al
Right ventricular size and function evaluated by various echocardiographic indices in dogs with pulmonary hypertension.
J Vet Intern Med. 2022 Sep 28. doi: 10.1111/jvim.16496.
Abstract

GOKCEN T, Inci K, Inci EE, Sevgen O, et al
Allopurinol treatment reduced vascular remodeling and improved vascular functions in monocrotaline-induced pulmonary hypertensive rats.
Pulm Pharmacol Ther. 2022;77:102166.
Abstract

OKTAVIONO YH, Mulia EPB, Luke K, Nugraha D, et al
Right ventricular dysfunction and pulmonary hypertension in COVID-19: a meta-analysis of prevalence and its association with clinical outcome.
Arch Med Sci. 2021;18:1169-1180.
Abstract

CHENNAKESAVULU PV, Uppaluri S, Koyi J, Jhaveri S, et al
Pulmonary Hypertension in Scleroderma- Evaluation and Management.
Dis Mon. 2022 Sep 23:101468. doi: 10.1016/j.disamonth.2022.101468.
Abstract

LIU TX, Du LZ, Ma XL, Chen Z, et al
Giant omphalocele associated pulmonary hypertension: A retrospective study.
Front Pediatr. 2022;10:940289.
Abstract

FRIEDMAN SH, Tedford RJ
Are you Coupled? Hemodynamic Phenotyping in Pulmonary Hypertension.
Function (Oxf). 2022;3:zqac036.
Abstract

TAI IH, Shyu TC, Hsieh KS, Chen KW, et al
Case report: The impact of percutaneous atrial septal defect closure in pulmonary hypertension with co-existing cor triatriatum sinister and multiple cardiac comorbidities.
Front Cardiovasc Med. 2022;9:913391.
Abstract

ZHANG L, Qie G, Yin X, Zhao H, et al
Pregnant outcomes of critically ill pregnant patients with pulmonary hypertension: A multicenter retrospective study.
Front Cardiovasc Med. 2022;9:872833.
Abstract

BANERJEE S, Hong J, Umar S
Comparative analysis of right ventricular metabolic reprogramming in pre-clinical rat models of severe pulmonary hypertension-induced right ventricular failure.
Front Cardiovasc Med. 2022;9:935423.
Abstract

SANTOS SD, Lopes Sousa D, Cristina Martins A, Rua J, et al
Cor Pulmonale Secondary to Severe Pulmonary Hypertension As the First Manifestation of Graves' Disease.
Cureus. 2022;14:e28115.
Abstract

ZHANG A, De Gala V, Lementowski PW, Cvetkovic D, et al
Veno-Arterial Extracorporeal Membrane Oxygenation Rescue in a Patient With Pulmonary Hypertension Presenting for Revision Total Hip Arthroplasty: A Case Report and Narrative Review.
Cureus. 2022;14:e28234.
Abstract

YAMIN M, Faisal E, Putranto R, Shatri H, et al
Major Depressive Disorder in a Patient with Systemic Lupus Erythematous, Pulmonary Hypertension, and Hypercoagulation: A Case Report.
Acta Med Indones. 2022;54:459-466.
Abstract

BOYD SM, Chatmethakul T, McNamara PJ
How to diagnose and treat acute pulmonary hypertension when you have no cardiology support.
Early Hum Dev. 2022;174:105668.
Abstract

AMANO M, Nakagawa S, Moriuchi K, Nishimura H, et al
Substitute parameters of exercise-induced pulmonary hypertension and usefulness of low workload exercise stress echocardiography in mitral regurgitation.
Sci Rep. 2022;12:15977.
Abstract

NAKAMURA M, Wada M
[Current Management of Congenital Diaphragmatic Hernia].
Kyobu Geka. 2022;75:864-871.
Abstract

CRUZ-UTRILLA A, Gallego-Zazo N, Tenorio-Castano JA, Guillen I, et al
Clinical Implications of the Genetic Background in Pediatric Pulmonary Arterial Hypertension: Data from the Spanish REHIPED Registry.
Int J Mol Sci. 2022;23.
Abstract

YEN TA, Huang HC, Wu ET, Chou HW, et al
Microrna-486-5P Regulates Human Pulmonary Artery Smooth Muscle Cell Migration via Endothelin-1.
Int J Mol Sci. 2022;23.
Abstract

DE BIE FR, Basurto D, Kumar S, Deprest J, et al
Sildenafil during the 2nd and 3rd Trimester of Pregnancy: Trials and Tribulations.
Int J Environ Res Public Health. 2022;19.
Abstract

BOUCHET C, Cardouat G, Douard M, Coste F, et al
Inflammation and Oxidative Stress Induce NGF Secretion by Pulmonary Arterial Cells through a TGF-beta1-Dependent Mechanism.
Cells. 2022;11.
Abstract

DOLLIVER WR, Wang W, Nardelli P, Rahaghi FN, et al
Pulmonary arterial pruning is associated with CT-derived bronchiectasis progression in smokers.
Respir Med. 2022;202:106971.
Abstract

DOUSCHAN P, Kovacs G, Sassmann T, Stadlbauer V, et al
Pulmonary vascular disease and exercise hemodynamics in chronic liver disease.
Respir Med. 2022;202:106987.
Abstract

DUARTE AG, Hoang V, Boroumand N, Campbell G, et al
Immunohistochemical profile of the pulmonary vasculature in subjects with cirrhosis and histopathologic evidence of pulmonary vascular disease: An autopsy study.
Respir Med. 2022;202:106969.
Abstract

LYHNE MD, Witkin AS, Dasegowda G, Tanayan C, et al
Evaluating cardiopulmonary function following acute pulmonary embolism.
Expert Rev Cardiovasc Ther. 2022;20:747-760.
Abstract

THODIKA FMSA, Dimitrova S, Nanjundappa M, Davenport M, et al
Prediction of survival in infants with congenital diaphragmatic hernia and the response to inhaled nitric oxide.
Eur J Pediatr. 2022 Jul 28. pii: 10.1007/s00431-022-04568.
Abstract

ALABED S, Alandejani F, Dwivedi K, Karunasaagarar K, et al
Validation of Artificial Intelligence Cardiac MRI Measurements: Relationship to Heart Catheterization and Mortality Prediction.
Radiology. 2022 Jun 14:212929. doi: 10.1148/radiol.212929.
Abstract

KAZIMIERCZYK R, Szumowski P, Nekolla S, Malek L, et al
Platelet sTWEAK and plasma IL-6 are associated with 18F-fluorodeoxyglucose uptake in right ventricles of patients with pulmonary arterial hypertension: A pilot study.
Adv Clin Exp Med. 2022;31:991-998.
Abstract

BECKER CU, Sartorio CL, Campos-Carraro C, Siqueira R, et al
Exercise training decreases oxidative stress in skeletal muscle of rats with pulmonary arterial hypertension.
Arch Physiol Biochem. 2022;128:1330-1338.
Abstract

LAWRIE A, Hamilton N, Wood S, Exposto F, et al
Healthcare resource utilization and quality of life in patients with sarcoidosis-associated pulmonary hypertension.
Pulm Circ. 2022;12:e12136.
Abstract

NORELL PN, Ivarsson B, Selin M, Kjellstrom B, et al
Prevalence of potential drug-drug interactions with disease-specific treatments in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension: A registry study.
Pulm Circ. 2022;12:e12114.
Abstract

Prevalence of sexual dysfunction in women with pulmonary hypertension and associated factors. Prevalence of sexual dysfunction in women with pulmonary hypertension and associated factors: A reponse letter.
Heart Lung. 2022 Oct 3. pii: S0147-9563(22)00214.
Abstract

CHEN J, Zhou D, Miao J, Zhang C, et al
Microbiome and metabolome dysbiosis of the gut-lung axis in pulmonary hypertension.
Microbiol Res. 2022;265:127205.
Abstract

PATEL SN
Pulmonary Hypertension and Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity-Is There a Link?
JAMA Ophthalmol. 2022 Oct 6. pii: 2797008. doi: 10.1001/jamaophthalmol.2022.3824
Abstract

NITKIN CR, Bamat NA, Lagatta J, DeMauro SB, et al
Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.
JAMA Ophthalmol. 2022 Oct 6:1-10. doi: 10.1001/jamaophthalmol.2022.3788.
Abstract

AKASLAN D, Aslanger E, Atas H, Kanar BG, et al
The Effects of Iron Replacement on Functional Capacity in Patients with Group 1 and Group 4 Pulmonary Hypertension.
Turk Kardiyol Dern Ars. 2022;50:492-497.
Abstract

ROBERTS DS, Sherlock LG, Posey JN, Archambault JL, et al
Serotonin-deficient neonatal mice are not protected against the development of experimental bronchopulmonary dysplasia or pulmonary hypertension.
Physiol Rep. 2022;10:e15482.
Abstract

GHAZARIAN A, King M, Premyodhin N, Gradus-Pizlo I, et al
Pulmonary hypertension in an adult with unilateral absence of left pulmonary artery.
SAGE Open Med Case Rep. 2022;10:2050313X221127667.
Abstract

BENZA RL, Langleben D, Hemnes AR, Vonk Noordegraaf A, et al
Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
Eur Respir Rev. 2022;31.
Abstract

KAYMAZ C, Tanyeri S, Tokgoz HC, Akbal OY, et al
The Consistent Effectiveness and Safety of Macitentan Therapies Across Idiopathic and Congenital Heart Disease-Associated PulmonaryArterial Hypertension: A Single-Center Experience.
Anatol J Cardiol. 2022;26:778-787.
Abstract

EROL C
Endocarditis, Leptin, Pulmonary Hypertension....
Anatol J Cardiol. 2022;26:742.
Abstract

BEYHAN SAGMEN S, Fidan A
Can FVC/DLCO predict pulmonary hypertension in patients with chronic obstructive pulmonary disease?
Eur Rev Med Pharmacol Sci. 2022;26:6658-6664.
Abstract

HUANG L, Pang L, Gu Q, Yang T, et al
Prevalence, risk factors, and survival associated with pulmonary hypertension and heart failure among patients with underlying coronary artery disease: a national prospective, multicenter registry study in China.
Chin Med J (Engl). 2022;135:1837-1845.
Abstract

BOWCOCK EM, Gerhardy B, Huang S, Orde S, et al
Right ventricular outflow tract Doppler flow analysis and pulmonary arterial coupling by transthoracic echocardiography in sepsis: a retrospective exploratory study.
Crit Care. 2022;26:303.
Abstract

VASUDEVA R, Challa A, Tuck N, Pothuru S, et al
Hospital outcomes for patients with pulmonary arterial hypertension in sepsis and septic shock.
BMC Pulm Med. 2022;22:374.
Abstract

HONG C, Hu L, Liu H, Wu X, et al
Learning curve and analysis of curative effects after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension.
Chin Med J (Engl). 2022 Oct 4. pii: 00029330-990000000-00177.
Abstract

HIGUCHI S, Horinouchi H, Aoki T, Nishii T, et al
Balloon Pulmonary Angioplasty in the Management of Chronic Thromboembolic Pulmonary Hypertension.
Radiographics. 2022;42:1881-1896.
Abstract

WILLIAMS K, Kime NA, Kronmal RA, Al-Naamani N, et al
On errata and corrigenda-The Pulmonary Hypertension Association Registry (PHAR).
Pulm Circ. 2022;12:e12131.
Abstract

CHEN Y, Zhong B, Jiang Q, Chen Y, et al
The impact of the COVID-19 pandemic on the care of pulmonary hypertension patients outside the Hubei province in China.
Pulm Circ. 2022;12:e12130.
Abstract

HUANG CY, Lu MJ, Tian JH, Liu DS, et al
Pulmonary hypertension secondary to seronegative rheumatoid arthritis overlapping antisynthetase syndrome: A case report.
World J Clin Cases. 2022;10:9851-9858.
Abstract

LEIVA O, Ren S, Neuberg D, Bhatt A, et al
Pulmonary hypertension is associated with poor cardiovascular and hematologic outcomes in patients with myeloproliferative neoplasms and cardiovascular disease.
Int J Hematol. 2022 Oct 2. pii: 10.1007/s12185-022-03454.
Abstract

BECKER-PELSTER EM, Hahn MG, Delbeck M, Dietz L, et al
Inhaled mosliciguat (BAY 1237592): targeting pulmonary vasculature via activating apo-sGC.
Respir Res. 2022;23:272.
Abstract

DONG Y, Li Y, Song L
Evaluation of right ventricular function in patients with pulmonary arterial hypertension by different right ventricular-pulmonary artery coupling methods.
Medicine (Baltimore). 2022;101:e30873.
Abstract

SHARMA K, Mishra A, Singh H, Thinlas T, et al
Differential methylation in EGLN1 associates with blood oxygen saturation and plasma protein levels in high-altitude pulmonary edema.
Clin Epigenetics. 2022;14:123.
Abstract

HOEPER MM, Vonk-Noordegraaf A, Kiely DG
Phenotypes of idiopathic pulmonary arterial hypertension - Authors' reply.
Lancet Respir Med. 2022;10:e90-e91.
Abstract

BADAGLIACCA R, Benza RL, Manzi G, Tello K, et al
Phenotypes of idiopathic pulmonary arterial hypertension.
Lancet Respir Med. 2022;10:e89.
Abstract

EL-KERSH K, Nathan SD
Phenotypes of idiopathic pulmonary arterial hypertension.
Lancet Respir Med. 2022;10:e88.
Abstract

CRUZ-UTRILLA A, Perez-Olivares C, Martinez-Menaca A, Lopez-Meseguer M, et al
Phenotypes of idiopathic pulmonary arterial hypertension.
Lancet Respir Med. 2022;10:e87.
Abstract

ZHAI C, Zhang N, Wang J, Cao M, et al
Activation of Autophagy Induces Monocrotaline-Induced Pulmonary Arterial Hypertension by FOXM1-Mediated FAK Phosphorylation.
Lung. 2022;200:619-631.
Abstract

CHEN S, Sun P, Li Y, Shen W, et al
Melatonin activates the Mst1-Nrf2 signaling to alleviate cardiac hypertrophy in pulmonary arterial hypertension.
Eur J Pharmacol. 2022 Sep 10:175262. doi: 10.1016/j.ejphar.2022.175262.
Abstract

MARUYAMA H, Sakai S, Ieda M
Endothelin-1 alters BMP signaling to promote proliferation of pulmonary artery smooth muscle cells.
Can J Physiol Pharmacol. 2022;100:1018-1027.
Abstract

GHOFRANI HA, Kim NH
Medical and interventional therapies for inoperable CTEPH: a necessary combination?
Lancet Respir Med. 2022;10:926-927.
Abstract

HOEPER MM, Dwivedi K, Pausch C, Lewis RA, et al
Phenotyping of idiopathic pulmonary arterial hypertension: a registry analysis.
Lancet Respir Med. 2022;10:937-948.
Abstract

SUGIYAMA Y, Matsubara H, Shimokawahara H, Ogawa A, et al
Outcome of mean pulmonary arterial pressure-based intensive treatment for patients with pulmonary arterial hypertension.
J Cardiol. 2022;80:432-440.
Abstract

PLYWACZEWSKA M, Pruszczyk P, Kostrubiec M
Does kidney function matter in pulmonary thromboembolism management?
Cardiol J. 2022;29:858-865.
Abstract

HINOJOSA W, Cristo-Ropero MJ, Cruz-Utrilla A, Segura de la Cal T, et al
The impact of COVID-19 pandemic on pulmonary hypertension: What have we learned?
Pulm Circ. 2022;12:e12142.
Abstract

SANGANI RA, Lui JK, Gillmeyer KR, Trojanowski MA, et al
Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity.
Pulm Circ. 2022;12:e12117.
Abstract

FU Z, Tao X, Xie W, Yang P, et al
Different response of the oxygen pathway in patients with chronic thromboembolic pulmonary hypertension treated with pulmonary endarterectomy versus balloon pulmonary angioplasty.
Front Cardiovasc Med. 2022;9:990207.
Abstract

ZHU Y, Jiang Q, Zhang W, Hu R, et al
Outcomes and occurrence of post-operative pulmonary hypertension crisis after late referral truncus arteriosus repair.
Front Cardiovasc Med. 2022;9:999032.
Abstract

ORFANOS SE, Giannakoulas G
Pulmonary Hypertension: Current Diagnosis, Approach and Treatment at the Dawn of the New European Guidelines.
J Clin Med. 2022;11.
Abstract

BRAKSATOR M, Jachymek M, Witkiewicz K, Piatek P, et al
Echocardiographic Probability of Pulmonary Hypertension in Cardiac Surgery Patients-Occurrence and Association with Respiratory Adverse Events-An Observational Prospective Single-Center Study.
J Clin Med. 2022;11.
Abstract

FU B, Li Y, Shi X, Liu P, et al
NCAPG Promotes Pulmonary Artery Smooth Muscle Cell Proliferation as a Promising Therapeutic Target of Idiopathic Pulmonary Hypertension: Bioinformatics Analysis and Experiment Verification.
Int J Mol Sci. 2022;23.
Abstract

DYLA A, Mielnicki W, Waszak J, Szurmiak H, et al
A Successful Heart Transplantation Coupled with Temporary Right Ventricular Assist Device Implantation in a Patient with (ir)Reversible Pulmonary Hypertension.
Int J Environ Res Public Health. 2022;19.
Abstract

SYDYKOV A, Petrovic A, Maripov AM, Gredic M, et al
Circulating Microparticles Are Differentially Increased in Lowlanders and Highlanders with High Altitude Induced Pulmonary Hypertension during the Cold Season.
Cells. 2022;11.
Abstract

ZHOU DS, Xu L, Zhang Y, Zhang TT, et al
[Establishment and effect evaluation of nomogram model for diagnosis and prediction of pulmonary hypertension in patients with chronic obstructive pulmonary disease].
Zhonghua Yi Xue Za Zhi. 2022;102:3019-3025.
Abstract

BARATI S, Amini H, Ahmadi ZH, Dastan A, et al
Assessing the efficacy and safety of rivaroxaban as a warfarin alternative in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy: A randomized clinical trial.
Rev Port Cardiol. 2022 Oct 10. pii: S0870-2551(22)00458.
Abstract

PARIKH R, Konstantinidis I, O'Sullivan DM, Farber HW, et al
Pulmonary hypertension in patients with interstitial lung disease: a tool for early detection.
Pulm Circ. 2022;12:e12141.
Abstract

GARCIA M, Souza R, Caruso P
Renal Replacement Therapy in Patients With Acute Decompensated Pulmonary Hypertension Admitted to the Intensive Care Unit.
Cureus. 2022;14:e28792.
Abstract

GU L, Liu CJ, Xie L, Gu L, et al
[Pulmonary Vascular Remodeling Characteristics of Pulmonary Arterial Hypertension Mouse Model Induced by Left Pneumonectomy and Jugular Vein Injection of Monocrotaline Pyrrole].
Sichuan Da Xue Xue Bao Yi Xue Ban. 2022;53:821-827.
Abstract

SUN H, Liu J, Su Y, Li F, et al
The role and mechanism of NDST1/NULP1 regulating right ventricular hypertrophy in hypoxic pulmonary hypertension.
Gen Physiol Biophys. 2022;41:407-416.
Abstract

LI C, Liu P, Yao H, Zhu H, et al
Regulatory B cells protect against chronic hypoxia-induced pulmonary hypertension by modulating the Tfh/Tfr immune balance.
Immunology. 2022 Oct 11. doi: 10.1111/imm.13589.
Abstract

PAN J, Wang R, Pei Y, Wang D, et al
Sulforaphane alleviated vascular remodeling in hypoxic pulmonary hypertension via inhibiting inflammation and oxidative stress.
J Nutr Biochem. 2022 Oct 8:109182. doi: 10.1016/j.jnutbio.2022.109182.
Abstract

SCHROEDER L, Kuelshammer M, Dolscheid-Pommerich R, Holdenrieder S, et al
NT-proBNP and Zlog-transformed NT-proBNP values predict extubation failure in critically ill neonates with pulmonary hypertension and ventricular dysfunction.
Pediatr Pulmonol. 2022 Oct 10. doi: 10.1002/ppul.26193.
Abstract

ABEDI F, Omidkhoda N, Arasteh O, Ghavami V, et al
The Therapeutic Role of Rho Kinase Inhibitor, Fasudil, on Pulmonary Hypertension; a Systematic Review and Meta-Analysis.
Drug Res (Stuttg). 2022 Oct 10. doi: 10.1055/a-1879-3111.
Abstract

MOHD KORI AM, Alias A, Daud M, Yahaya NA, et al
A rare association of Down syndrome with Dandy -Walker variant, pulmonary hypertension and childhood interstitial lung disease: A case report of a prognostic dilemma.
J Taibah Univ Med Sci. 2022;17:950-953.
Abstract

XIONG J, Li J, Huang Y, Yang F, et al
The Role of Pulmonary Function Test for Pulmonary Arterial Hypertension in Patients with Connective Tissue Disease.
Dis Markers. 2022;2022:6066291.
Abstract

DIDRIKSEN H, Molberg O, Mehta A, Jordan S, et al
Target organ expression and biomarker characterization of chemokine CCL21 in systemic sclerosis associated pulmonary arterial hypertension.
Front Immunol. 2022;13:991743.
Abstract

MOLES VM, Grafton G
Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction.
Cardiol Clin. 2022;40:533-540.
Abstract

HAN XY, Selesner LT, Butler MW
Congenital Diaphragmatic Hernia: Considerations for the Adult General Surgeon.
Surg Clin North Am. 2022;102:739-757.
Abstract

WANG Y, Lin L, Cao J, Li X, et al
[The application value of cardiac magnetic resonance quantitative T1 mapping technique for risk stratification in patients with pulmonary arterial hypertension].
Zhonghua Yi Xue Za Zhi. 2022;102:2963-2968.
Abstract

HAMZA M, Siddiqui MD, Shahid M, Sathyanarayanan SP, et al
A Case of Pulmonary Tumor Thrombotic Microangiopathy: A Rare and Fatal Phenomenon.
S D Med. 2022;75:274-277.
Abstract

MAZUR ES, Mazur VV, Bazhenov ND, Nilova OV, et al
Left Atrial Strain as a Predictor of Diastolic Stress Test Results in Patients With Arterial Hypertension.
Kardiologiia. 2022;62:9-17.
Abstract

AHMED S, Ahmed A, Radegran G
[Structured evaluation of unclear dyspnea - of great importance to early identify patients with PAH and CTEPH and improve prognosis].
Lakartidningen. 2022;119.
Abstract

IKEDA K
[Myeloproliferative neoplasms and vascular diseases].
Rinsho Ketsueki. 2022;63:1107-1114.
Abstract

LIPPMANN MR, Maron BA
The Right Ventricle: From Embryologic Development to RV Failure.
Curr Heart Fail Rep. 2022;19:325-333.
Abstract

RANASINGHE ADCU, Schwarz MA
Integrating epigenetics and metabolomics to advance treatments for pulmonary arterial hypertension.
Biochem Pharmacol. 2022;204:115245.
Abstract

BADAGLIACCA R, Vizza CD, Lang I, Sadushi-Kolici R, et al
Pulmonary pressure recovery in idiopathic, hereditary and drug and toxin-induced pulmonary arterial hypertension: determinants and clinical impact.
Vascul Pharmacol. 2022;146:107099.
Abstract

LAZO REL, Mengarda M, Almeida SL, Caldonazo A, et al
Advanced formulations and nanotechnology-based approaches for pulmonary delivery of sildenafil: A scoping review.
J Control Release. 2022;350:308-323.
Abstract

YOSHIDA Y, Uchida K, Kodo K, Shibata H, et al
Genetic and functional analyses of TBX4 reveal novel mechanisms underlying pulmonary arterial hypertension.
J Mol Cell Cardiol. 2022;171:105-116.
Abstract

YILDIZ BOLUKBASI E, Karolak JA, Szafranski P, Gambin T, et al
Variable expressivity in a four-generation ACDMPV family with a non-coding hypermorphic SNV in trans to the frameshifting FOXF1 variant.
Eur J Hum Genet. 2022;30:1182-1186.
Abstract

NAWAYTOU H, Springston C, Lazar A, Keller S, et al
A Measurement-Based Protocol Improves Interrater Agreement and Accuracy of Right Ventricular Systolic Pressure Assessment by Echocardiography in Children: A Call for Quality Improvement.
J Am Soc Echocardiogr. 2022;35:1091-1100.
Abstract

WANG Q, Chai L, Zhang Q, Wang J, et al
Induction of GLI1 by miR-27b-3p/FBXW7/KLF5 pathway contributes to pulmonary arterial hypertension.
J Mol Cell Cardiol. 2022;171:16-29.
Abstract

ABERG M, Bjorklund E, Wikstrom G, Christersson C, et al
Platelet-leukocyte aggregate formation and inflammation in patients with pulmonary arterial hypertension and CTEPH.
Platelets. 2022;33:1199-1207.
Abstract

TRIPOSKIADIS F, Xanthopoulos A, Skoularigis J, Starling RC, et al
Therapeutic augmentation of NO-sGC-cGMP signalling: lessons learned from pulmonary arterial hypertension and heart failure.
Heart Fail Rev. 2022;27:1991-2003.
Abstract

TRITTMANN JK, Almazroue H, Nelin LD, Shaffer TA, et al
PATET ratio by Doppler echocardiography: noninvasive detection of pediatric pulmonary arterial hypertension.
Pediatr Res. 2022;92:631-636.
Abstract

MIRDAMADI A, Shirzad M, Abrishamkar R, Behjati M, et al
Flow-Mediated Dilation, a Marker of Endothelial Cell Dysfunction, in Patients with Pulmonary Hypertension.
Tanaffos. 2021;20:332-336.
Abstract

MCINNIS M
Imaging Advances in Chronic Thromboembolic Pulmonary Hypertension.
Semin Roentgenol. 2022;57:324-334.
Abstract

MOCERI P, Duchateau N, Baudouy D, Squara F, et al
Additional prognostic value of echocardiographic follow-up in pulmonary hypertension-role of 3D right ventricular area strain.
Eur Heart J Cardiovasc Imaging. 2022;23:1562-1572.
Abstract

SINDHU TG, Rajesh TV, Ajithkumar VT, Muneer K, et al
Thiamine-Responsive Acute Pulmonary Hypertension in an Exclusively Breastfed Infant.
Indian Pediatr. 2022;59:814-815.
Abstract

JANG AY, Park SJ, Chung WJ
Pulmonary Hypertension in Heart Failure.
Int J Heart Fail. 2021;3:147-159.
Abstract

COLLINS N, Sugito S, Davies A, Boyle A, et al
Prevalence and survival associated with pulmonary hypertension after mitral valve replacement: National echocardiography database of Australia study.
Pulm Circ. 2022;12:e12140.
Abstract

KITAHARA S, Kasai H, Sugiura T, Akimoto Y, et al
Chronic Expanding Haematoma Causing Stenosis of the Right Ventricular Outflow Tract and Pulmonary Hypertension.
Intern Med. 2022 Oct 19. doi: 10.2169/internalmedicine.0433.
Abstract

SLEGG OG, Willis JA, Wilkinson F, Sparey J, et al
IMproving PULmonary hypertension Screening by Echocardiography: IMPULSE.
Echo Res Pract. 2022;9:9.
Abstract

LATTANZIO M, Ferrari M, Martini S, Ceriani F, et al
Pharmacological counseling in hepatotoxicity induced by macitentan and selexipag: a case report.
J Med Case Rep. 2022;16:385.
Abstract

WEISS TJ, Rosen Ramey D, Yang L, Liu X, et al
Medication use by US patients with pulmonary hypertension associated with chronic obstructive pulmonary disease: a retrospective study of administrative data.
BMC Pulm Med. 2022;22:383.
Abstract

NANDULA PS, Shah SD, Held M, Weiner S, et al
[Functional characterization of patients with isolated post-capillary or combined post-capillary and pre-capillary pulmonary hypertension].
Pneumologie. 2022;76:689-696.
Abstract

SCHROEDER L, Monno P, Unger M, Ackerl J, et al
Heart rate control with landiolol hydrochloride in infants with ventricular dysfunction and pulmonary hypertension.
ESC Heart Fail. 2022 Oct 18. doi: 10.1002/ehf2.14202.
Abstract

TIAN X, Zhang X, Feng Y, Gao X, et al
Correction to: Astragaloside IV in Hypoxic Pulmonary Hypertension: In Vivo and In Vitro Experiments.
Appl Biochem Biotechnol. 2022 Oct 18. pii: 10.1007/s12010-022-04195.
Abstract

SALAUNKEY K, Jenkins D, Roscoe A
The use of ketamine as an induction agent for anesthesia in pulmonary thromboendarterectomy surgery: A case series.
Ann Card Anaesth. 2022;25:528-530.
Abstract

SU Y, Tan R, Sun M, Yuan L, et al
MiR-1249 on Endothelial Extracellular Vesicles Mediates Cigarette Smoke-Induced Pulmonary Hypertension by Inhibiting HDAC10 (Histone Deacetylase 10)-NFkappaB (Nuclear Factor kappaB)-CaSR (Calcium Sensitive Receptors) Cascade.
Hypertension. 2022 Oct 12. doi: 10.1161/HYPERTENSIONAHA.122.19560.
Abstract

KUSAKA K, Miyagawa I, Kosaka S, Matsunaga S, et al
A case of glucocorticoid-resistant adult Still's disease complicated by pulmonary hypertension and interstitial lung disease.
Mod Rheumatol Case Rep. 2022 Oct 17. pii: 6762011. doi: 10.1093.
Abstract

WANG X, Chen A, Hu R, Zhang F, et al
Salusin-beta, a TOR2A gene product, promotes proliferation, migration, fibrosis, and calcification of smooth muscle cells and accelerates the imbalance of vasomotor function and vascular remodeling in monocrotaline-induced pulmonary hypertensive rats.
Front Pharmacol. 2022;13:928834.
Abstract

QU LH, Luo WJ, Yan ZG, Liu WP, et al
FAM171B as a Novel Biomarker Mediates Tissue Immune Microenvironment in Pulmonary Arterial Hypertension.
Mediators Inflamm. 2022;2022:1878766.
Abstract

MA H, Ye P, Zhang AK, Yu WD, et al
Upregulation of miR-335-5p Contributes to Right Ventricular Remodeling via Calumenin in Pulmonary Arterial Hypertension.
Biomed Res Int. 2022;2022:9294148.
Abstract

MAO X, Li Y, Yang R, Wei J, et al
Single-Cell RNA-Sequencing Reveals the Active Involvement of Macrophage Polarizations in Pulmonary Hypertension.
Dis Markers. 2022;2022:5398157.
Abstract

KLEB C, Aggarwal M, Tonelli AR, White M, et al
Liver Transplant Outcomes in Patients With Postcapillary Pulmonary Hypertension.
Transplant Direct. 2022;8:e1372.
Abstract

LI X, Zhang Y, Jin Q, Zhao Z, et al
Diagnostic and prognostic value of ventilatory power in pulmonary hypertension.
Respir Res. 2022;23:285.
Abstract

PUIGRENIER S, Giovannelli J, Lamblin N, De Groote P, et al
Mild pulmonary hemodynamic alterations in patients with systemic sclerosis: relevance of the new 2022 ESC/ERS definition of pulmonary hypertension and impact on mortality.
Respir Res. 2022;23:284.
Abstract

KHANDAGALE A, Corcoran P, Nikpour M, Isaksson A, et al
MircoRNA in Extracellular Vesicles from Patients with Pulmonary Arterial Hypertension Alters Endothelial Angiogenic Response.
Int J Mol Sci. 2022;23.
Abstract

LU YY, Lin FJ, Chen YC, Kao YH, et al
Role of Endothelin-1 in Right Atrial Arrhythmogenesis in Rabbits with Monocrotaline-Induced Pulmonary Arterial Hypertension.
Int J Mol Sci. 2022;23.
Abstract

XIONG CM
[Improve the understanding of hepatic disease related pulmonary vascular disease].
Zhonghua Yi Xue Za Zhi. 2022;102:2984-2987.
Abstract

MORAIS F, Nogueira-Ferreira R, Rocha H, Duarte JA, et al
Exercise training counteracts the cardiac metabolic remodelling induced by experimental pulmonary arterial hypertension.
Arch Biochem Biophys. 2022;730:109419.
Abstract

PAN Y, Chen A, Wang X, Bao C, et al
Saluisn-beta contributes to endothelial dysfunction in monocrotaline-induced pulmonary arterial hypertensive rats.
Biomed Pharmacother. 2022;155:113748.
Abstract

SONG K, Duan Q, Ren J, Yi J, et al
Targeted metabolomics combined with network pharmacology to reveal the protective role of luteolin in pulmonary arterial hypertension.
Food Funct. 2022;13:10695-10709.
Abstract

QUARTUCCIO L, Sonaglia A, Casarotto L, McGonagle D, et al
Clinical, laboratory and immunohistochemical characterization of in situ pulmonary arterial thrombosis in fatal COVID-19.
Thromb Res. 2022;219:95-101.
Abstract

LI H, Li X, Hao Y, Wu C, et al
Maresin 1 intervention reverses experimental pulmonary arterial hypertension in mice.
Br J Pharmacol. 2022;179:5132-5147.
Abstract

FAVOINO E, Catacchio G, Mininni A, Ruscitti P, et al
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients.
Clin Exp Rheumatol. 2022;40:1956-1963.
Abstract

LEWIS L, Sinha I, Kang SL, Lim J, et al
Long term outcomes in CDH: Cardiopulmonary outcomes and health related quality of life.
J Pediatr Surg. 2022;57:501-509.
Abstract

REMY-JARDIN M, Hutt A, Remy J
Chronic Thromboembolic Pulmonary Disease and Chronic Thromboembolic Pulmonary Hypertension.
Semin Respir Crit Care Med. 2022 Oct 28. doi: 10.1055/s-0042-1755570.
Abstract

CELIK M, Yilmaz Y, Kup A, Kahyaoglu M, et al
Predictors of pulmonary hypertension after atrial septal defect closure: Impact of atrial fibrillation.
Turk Gogus Kalp Damar Cerrahisi Derg. 2022;30:344-353.
Abstract

SHAH SS, Dhalait S, Fursule A, Khandare J, et al
Use of Vasopressin as Rescue therapy in refractory hypoxia and refractory systemic hypotension in term neonates with severe persistent pulmonary hypertension - prospective observational study.
Am J Perinatol. 2022 Oct 27. doi: 10.1055/a-1969-1119.
Abstract

SIUBA MT, Bhardwaj A, Kirincich J, Perez O, et al
Does veno-arterial carbon dioxide gradient provide an adequate estimation of cardiac index in pulmonary hypertension?
Eur Heart J Acute Cardiovasc Care. 2022 Oct 27. pii: 6775872.
Abstract

DAI Z, Lai G, Chen Z, Li Y, et al
Double Doppler Tei index combined with lung ultrasound to evaluate the right ventricular function and lung condition in neonates with pulmonary hypertension.
J Clin Ultrasound. 2022 Oct 27. doi: 10.1002/jcu.23381.
Abstract

MARTIN DE MIGUEL I, Jain CC, Egbe AC, Hagler DJ, et al
Surgical Repair of Truncus Arteriosus: A Long-Term Hemodynamic Assessment.
World J Pediatr Congenit Heart Surg. 2022;13:716-722.
Abstract

MIHALEK AD, Scott CD, Mazimba S
Evaluating Riociguat in the Treatment of Pulmonary Arterial Hypertension: A Real-World Perspective.
Vasc Health Risk Manag. 2022;18:823-832.
Abstract

BECKMANN T, Shelley P, Patel D, Vorla M, et al
Strategizing Drug Therapies in Pulmonary Hypertension for Improved Outcomes.
Pharmaceuticals (Basel). 2022;15.
Abstract

CHEN YH, Yuan W, Meng LK, Zhong JC, et al
The Role and Mechanism of Gut Microbiota in Pulmonary Arterial Hypertension.
Nutrients. 2022;14.
Abstract

HLAVATA T, Kaldararova M, Klauco F, Drangova E, et al
Congenital Absence of the Portal Vein as a Rare Cause of Portopulmonary Hypertension-A Case Study Series.
Medicina (Kaunas). 2022;58.
Abstract

JANSA P, Ambroz D, Aschermann M, Cerny V, et al
Hospitalisation Is Prognostic of Survival in Chronic Thromboembolic Pulmonary Hypertension.
J Clin Med. 2022;11.
Abstract

EL ALAM S, Pena E, Aguilera D, Siques P, et al
Inflammation in Pulmonary Hypertension and Edema Induced by Hypobaric Hypoxia Exposure.
Int J Mol Sci. 2022;23.
Abstract

YEN TH, Ho WJ, Yeh YH, Lai YJ, et al
Cathepsin S Inhibition Suppresses Experimental Systemic Lupus Erythematosus-Associated Pulmonary Arterial Remodeling.
Int J Mol Sci. 2022;23.
Abstract

TEILLET B, Boukhris MR, Sfeir R, Mur S, et al
Systemic Inflammation Is Associated with Pulmonary Hypertension in Isolated Giant Omphalocele: A Population-Based Study.
Healthcare (Basel). 2022;10.
Abstract

GROEN K, Huitema MP, van der Vis JJ, Post MC, et al
Pulmonary Hypertension Associated Genetic Variants in Sarcoidosis Associated Pulmonary Hypertension.
Diagnostics (Basel). 2022;12.
Abstract

BOXHAMMER E, Scharinger B, Kaufmann R, Brandtner H, et al
Comparability between Computed Tomography Morphological Vascular Parameters and Echocardiography for the Assessment of Pulmonary Hypertension in Patients with Severe Aortic Valve Stenosis-Results of a Multi-Center Study.
Diagnostics (Basel). 2022;12.
Abstract

ANTIGNY F
Role of Ion Channels in the Development of Pulmonary Arterial Hypertension.
Biomolecules. 2022;12.
Abstract

REDEL-TRAUB G, Sampson KJ, Kass RS, Bohnen MS, et al
Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension.
Biomolecules. 2022;12.
Abstract

CHUA WC, Chen IC, Liu YC, Wu YH, et al
Congenital Surfactant C Deficiency with Pulmonary Hypertension-A Case Report.
Children (Basel). 2022;9.
Abstract

SABOURIN J, Beauvais A, Luo R, Montani D, et al
The SOCE Machinery: An Unbalanced Knowledge between Left and Right Ventricular Pathophysiology.
Cells. 2022;11.
Abstract

TANGMAHAKUL N, Sakarin S, Techangamsuwan S, Rungsipipat A, et al
Investigation of Genes and Proteins Expression Associating Serotonin Signaling Pathway in Lung and Pulmonary Artery Tissues of Dogs with Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease: The Preliminary Study.
Vet Sci. 2022;9.
Abstract

OLIVEIRA-JUNIOR SA, Ogura AY, Carvalho MR, Martinez PF, et al
Cardioprotective Effect of Resistance Exercise on Left Ventricular Remodeling Associated with Monocrotaline-Induced Pulmonary Arterial Hypertension.
Arq Bras Cardiol. 2022;119:585-586.
Abstract

SAGAYDAK OV, Danilov NM, Chazova IE
[Rehabilitation in patients with chronic thromboembolic pulmonary hypertension].
Ter Arkh. 2022;94:903-907.
Abstract

VALIEVA ZS, Martynyuk TV
[Chronic thromboembolic pulmonary hypertension: from pathogenesis to the choice of treatment tactics].
Ter Arkh. 2022;94:791-796.
Abstract

MARTYNYUK TV, Shmalts AA, Gorbachevsky SV, Chazova IE, et al
[Optimization of specific therapy for pulmonary hypertension: the possibilities of riociguat].
Ter Arkh. 2021;93:1117-1124.
Abstract

SHMALTS AA, Gorbachevsky SV
[Evidence base for specific pulmonary vasodilators in adults with congenital heart disease].
Ter Arkh. 2021;93:1106-1116.
Abstract

VALIEVA ZS, Martynyuk TV, Nakonechnikov SN, Chazova IE, et al
[Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry].
Ter Arkh. 2021;93:1058-1065.
Abstract

MARTYNYUK TV, Chazova IE
[Pulmonary arterial hypertension: achievements and realities of modern treatment, a look into the future].
Ter Arkh. 2021;93:1009-1017.
Abstract

KASPAROVA AM, Valieva ZS, Martynyuk TV
[A rare clinical case of the patient with pulmonary hypertension associated with hereditary hemorrhagic telangiectasia. Case report].
Ter Arkh. 2022;94:538-543.
Abstract

CHAZOVA IE, Martynyuk TV, Gorbachevskii SV, Gramovich VV, et al
["Guiding lights" for the diagnosis of chronic thromboembolic pulmonary hypertension in the flow of patients with pulmonary embolism].
Ter Arkh. 2022;94:1052-1056.
Abstract

TARAN IN, Valieva ZS, Belevskaya AA, Saidova MA, et al
[Influence of demographic characteristics on the clinical course and results of therapy in patients with precapillary pulmonary hypertension].
Ter Arkh. 2021;93:283-289.
Abstract

EWERT R, Ittermann T, Schmitt D, Pfeuffer-Jovic E, et al
Prognostic Relevance of Cardiopulmonary Exercise Testing for Patients with Chronic Thromboembolic Pulmonary Hypertension.
J Cardiovasc Dev Dis. 2022;9.
Abstract

WANG X, Li Q, He S, Bai J, et al
LncRNA FENDRR with m6A RNA methylation regulates hypoxia-induced pulmonary artery endothelial cell pyroptosis by mediating DRP1 DNA methylation.
Mol Med. 2022;28:126.
Abstract

QIN J, Wang G, Han D
Selexipag in patients with pulmonary hypertension: a systematic review and meta-analysis of randomized controlled trials.
Curr Probl Cardiol. 2022 Oct 22:101466. doi: 10.1016/j.cpcardiol.2022.101466.
Abstract

DURIN L, Noel-Savina E, Heluain V, Mattei P, et al
Impact of pulmonary hypertension on lung cancer management.
Respir Med Res. 2022;82:100964.
Abstract

JIANG X, Zhu YJ, Zhou YP, Peng FH, et al
Clinical features and survival in Takayasu's arteritis-associated pulmonary hypertension: a nationwide study.
Eur Heart J. 2021;42:4298-4305.
Abstract

EL-KHATEEB E, El-Haggar SM, El-Razaky O, El-Shanshory MR, et al
Randomized Clinical and Biochemical Study Comparing the Effect of L-arginine and Sildenafil in Beta Thalassemia Major Children With High Tricuspid Regurgitant Jet Velocity.
J Cardiovasc Pharmacol Ther. 2022;27:10742484221132671.
Abstract

DUSIK M, Fingrova Z, Marek J, Dytrych V, et al
The Impact of Atrial Fibrillation and Atrial Tachycardias on the Hemodynamic Status of Patients with Pulmonary Hypertension.
Physiol Res. 2022 Oct 13. pii: 934941.
Abstract

VIVES M, Gasco I, Pla G, Maciel JL, et al
Inhaled Nitric Oxide in Acute Severe Pulmonary Hypertension and Severe Acute Respiratory Distress Syndrome Secondary to COVID-19 Pneumonia: A Case Report.
Am J Case Rep. 2022;23:e937147.
Abstract

CHEN R, Liao H, Deng Z, He Z, et al
Efficacy of computed tomography in diagnosing pulmonary hypertension: A systematic review and meta-analysis.
Front Cardiovasc Med. 2022;9:966257.
Abstract

ROGULA S, Pomirski B, Czyzak N, Eyileten C, et al
Biomarker-based approach to determine etiology and severity of pulmonary hypertension: Focus on microRNA.
Front Cardiovasc Med. 2022;9:980718.
Abstract

CHENG J, Dou X, Zhao N
The Effects of Sequential Ventilation Therapy on Blood Gas Indexes, Pulmonary Function Indexes, Clinical Efficacy, and Safety in Patients with Severe Cor Pulmonale.
Contrast Media Mol Imaging. 2022;2022:3618592.
Abstract

WANG L, Zhang W, Zhang C, Yan Z, et al
Prognostic effect of pulmonary hypertension in patients with chronic kidney disease: Univariate and multivariate analyses of factors associated with survival.
Front Med (Lausanne). 2022;9:972937.
Abstract

LIU SF, Nambiar Veetil N, Li Q, Kucherenko MM, et al
Pulmonary hypertension: Linking inflammation and pulmonary arterial stiffening.
Front Immunol. 2022;13:959209.
Abstract

GARCIA SM, Yellowhair TR, Detweiler ND, Ahmadian R, et al
Smooth muscle Acid-sensing ion channel 1a as a therapeutic target to reverse hypoxic pulmonary hypertension.
Front Mol Biosci. 2022;9:989809.
Abstract

AVITABILE CM, McBride MG, Harris MA, Whitehead KK, et al
Skeletal muscle deficits are associated with worse exercise performance in pediatric pulmonary hypertension.
Front Pediatr. 2022;10:1025420.
Abstract

SHAO FJ, Guo XL, Xu JX, Liu R, et al
Potential contribution of early endothelial progenitor cell (eEPC)-to-macrophage switching in the development of pulmonary plexogenic lesion.
Respir Res. 2022;23:290.
Abstract

MANZUR-PINEDA K, Martinez L, Alvarez R, Dejman A, et al
Echocardiographic changes after arteriovenous fistula creation in hemodialysis patients.
Clin Nephrol. 2022 Sep 28. pii: 189736. doi: 10.5414/CN110816.
Abstract

NANDULA PS, Shah SD, Damianos A, Kulandavelu S, et al
Neonatal intermittent hypoxia persistently impairs lung vascular development and induces long-term lung mitochondrial DNA damage.
J Appl Physiol (1985). 2022;133:1031-1041.
Abstract

SOARES LL, Leite LB, Ervilha LOG, Silva BAFD, et al
Resistance Exercise Training Mitigates Left Ventricular Dysfunctions in Pulmonary Artery Hypertension Model.
Arq Bras Cardiol. 2022;119:574-584.
Abstract

BALKO J, Havlin J, CasasMendez F, Zajacova A, et al
Mapping of the lung megakaryocytes: A role in pathogenesis of idiopathic pulmonary arterial hypertension?
Pathol Res Pract. 2022;237:154060.
Abstract

DILLER GP, Benesch Vidal ML, Kempny A, Kubota K, et al
A framework of deep learning networks provides expert-level accuracy for the detection and prognostication of pulmonary arterial hypertension.
Eur Heart J Cardiovasc Imaging. 2022;23:1447-1456.
Abstract

MANEK G, Gupta M, Chhabria M, Bajaj D, et al
Hemodynamic indices in pulmonary hypertension: a narrative review.
Cardiovasc Diagn Ther. 2022;12:693-707.
Abstract

LIU J, Li Q, Zeng C, Wang Y, et al
[Role of myelin and lymphocyte protein in regulating pulmonary artery smooth muscle cell proliferation and apoptosis in pulmonary hypertension].
Nan Fang Yi Ke Da Xue Xue Bao. 2022;42:1572-1577.
Abstract

LI J, Zhang X, Mo Y, Huang T, et al
Urokinase-loaded cyclic RGD-decorated liposome targeted therapy for in-situ thrombus of pulmonary arteriole of pulmonary hypertension.
Front Bioeng Biotechnol. 2022;10:1038829.
Abstract

LI HT, Yuan P, Zhao QH, Gong SG, et al
Sex-specific differences in sleep-disordered breathing and nocturnal hypoxemia in chronic thromboembolic pulmonary hypertension and chronic thromboembolic pulmonary disease.
Front Cardiovasc Med. 2022;9:966973.
Abstract

ZHANG X, Zhao JL, Ding F, Yang J, et al
[Recommendations for the diagnosis and treatment of connective tissue disease associated pulmonary arterial hypertension in China].
Zhonghua Nei Ke Za Zhi. 2022;61:1206-1216.
Abstract

WEATHERALD J, Humbert M
PDE5 to keep them alive: The use of phosphodiesterase type-5 inhibitors in severe pulmonary hypertension associated with interstitial lung disease.
Respirology. 2022 Nov 1. doi: 10.1111/resp.14399.
Abstract

FIKE CD, Avachat C, Birnbaum AK, Aschner JL, et al
Pharmacokinetics of L-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension.
Paediatr Drugs. 2022 Oct 31. pii: 10.1007/s40272-022-00542.
Abstract

LESCANO A, Giacommi G, Botta CE, Soricetti J, et al
Real-world evidence of subcutaneous treprostinil use in pulmonary arterial hypertension in Argentina.
Ther Adv Respir Dis. 2022;16:17534666221132735.
Abstract

BUTANE L, Spilva-Ekerte L, Sablinskis M, Skride A, et al
Individually tailored home-based physiotherapy program makes sustainable improvement in exercise capacity and daily physical activity in patients with pulmonary arterial hypertension.
Ther Adv Respir Dis. 2022;16:17534666221132477.
Abstract

LI M, Zhao XY, Kou Y, Kou JJ, et al
Role of HMGB1 in the formation of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism.
Eur Rev Med Pharmacol Sci. 2022;26:7605-7615.
Abstract

OCAL N, Celik M, Satis NK
Pulmonary hypertension in the elderly. Is it an overdiagnosis or a distinct entity?
Eur Rev Med Pharmacol Sci. 2022;26:7474-7481.
Abstract

SULLIVAN RT, Tandel MD, Bhombal S, Adamson GT, et al
Role of left atrial hypertension in pulmonary hypertension associated with bronchopulmonary dysplasia.
Front Pediatr. 2022;10:1012136.
Abstract

MUNEUCHI J, Ezaki H, Sugitani Y, Watanabe M, et al
Comprehensive assessments of pulmonary circulation in children with pulmonary hypertension associated with congenital heart disease.
Front Pediatr. 2022;10:1011631.
Abstract

CHEN M, Chen Y
Bioinformatics Analysis of Common Genetic and Molecular Traits and Association of Portal Hypertension with Pulmonary Hypertension.
J Healthc Eng. 2022;2022:9237701.
Abstract

MARES A, Mukherjee D, Lange RA, Nickel NP, et al
Targeted Therapies in Patients with Pulmonary Arterial Hypertension Due to Congenital Heart Disease.
Curr Vasc Pharmacol. 2022;20:341-360.
Abstract

CLAPHAM KR, Mesbah Uddin M, Honigberg M, Gilliland T, et al
Venous Thromboembolism Polygenic Risk Score Associates With Pulmonary Hypertension in the UK Biobank.
Circ Genom Precis Med. 2022 Nov 9:e003797. doi: 10.1161/CIRCGEN.122.003797.
Abstract

ROLPH KE, Cavanaugh SM
Feline pulmonary hypertension: are we overlooking an important comorbidity?
J Feline Med Surg. 2022 Nov 9:1098612X221127233. doi: 10.1177/1098612X221127233.
Abstract

LACHANCE L, Conversy B, Wiggen K, Pavard C, et al
No evidence of pulmonary hypertension revealed in an echographic evaluation of right-sided hemodynamics in hyperthyroid cats.
J Feline Med Surg. 2022 Nov 9:1098612X221127102. doi: 10.1177/1098612X221127102.
Abstract

YAMASAKI Y, Abe K, Kamitani T, Hosokawa K, et al
Efficacy of Dynamic Chest Radiography for Chronic Thromboembolic Pulmonary Hypertension.
Radiology. 2022 Nov 8:220908. doi: 10.1148/radiol.220908.
Abstract

BAO C, Liang S, Han Y, Yang Z, et al
The Novel Lysosomal Autophagy Inhibitor (ROC-325) Ameliorates Experimental Pulmonary Hypertension.
Hypertension. 2022 Nov 8. doi: 10.1161/HYPERTENSIONAHA.122.19397.
Abstract

MORAN-GARRIDO M, Munoz-Escudero P, Garcia-Alvarez A, Garcia-Lunar I, et al
Optimization of sample extraction and injection-related parameters in HILIC performance for polar metabolite analysis. Application to the study of a model of pulmonary hypertension.
J Chromatogr A. 2022;1685:463626.
Abstract

AINSCOUGH AJ, Smith TJ, Haensel M, Rhodes CJ, et al
An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis.
Commun Biol. 2022;5:1192.
Abstract

JIANG Y, Guo Y, Feng X, Yang P, et al
Iron metabolism disorder regulated by BMP signaling in hypoxic pulmonary hypertension.
Biochim Biophys Acta Mol Basis Dis. 2022 Nov 4:166589.
Abstract

BINBRAIK Y, Wang MK, Riekki T, Conen D, et al
Pulmonary hypertension and associated outcomes in noncardiac surgery: A systematic review and meta-analysis.
Heart Lung. 2022;58:21-27.
Abstract

VIJAY KUMAR JR, Natraj Setty HS, Jayaranganath M, Manjunath CN, et al
Efficacy, safety and tolerability of bosentan as an adjuvant to sildenafil and sildenafil alone in persistant pulmonary hypertension of newborn (PPHN).
Interv Med Appl Sci. 2021;11:216-220.
Abstract

HUTCHISON D, Juhasz M, Smith J, Lee B, et al
The "Flolan Rash": An Impressively Asymptomatic and Non-Inflammatory Eruption Following Long-Term Epoprostenol Therapy.
J Drugs Dermatol. 2022;21:1249-1251.
Abstract

TU S, Chu M
The Match of Electrocardiogram and Artificial Intelligence Confers an Opportunity for Pulmonary Hypertension Screening.
JACC Asia. 2022;2:271-272.
Abstract

LIAN TY, Liu JZ, Guo F, Zhou YP, et al
Prevalence, Genetic Background, and Clinical Phenotype of Congenital Thrombophilia in Chronic Thromboembolic Pulmonary Hypertension.
JACC Asia. 2022;2:247-255.
Abstract

WANG A, Su H, Duan Y, Jiang K, et al
Pulmonary Hypertension Caused by Fibrosing Mediastinitis.
JACC Asia. 2022;2:218-234.
Abstract

LIU CM, Shih ESC, Chen JY, Huang CH, et al
Artificial Intelligence-Enabled Electrocardiogram Improves the Diagnosis and Prediction of Mortality in Patients With Pulmonary Hypertension.
JACC Asia. 2022;2:258-270.
Abstract

HUMBERT M
The Long March to a Cure for Pulmonary Hypertension.
JACC Asia. 2022;2:215-217.
Abstract

TAMURA Y, Kumamaru H, Inami T, Matsubara H, et al
Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in Japan.
JACC Asia. 2022;2:273-284.
Abstract

FAHIMI F, Pourdowlat G, Behzadnia N, Mostofi SS, et al
Clinical evaluation of nebulized verapamil in out-patients with pulmonary hypertension secondary to chronic obstructive pulmonary disease.
Clin Respir J. 2022 Nov 6. doi: 10.1111/crj.13551.
Abstract

CAI D, Chen SY
Nanoparticle endothelial delivery of PGC-1alpha attenuates hypoxia-induced pulmonary hypertension by attenuating EndoMT-caused vascular wall remodeling.
Redox Biol. 2022;58:102524.
Abstract

NORDERFELDT J, Liliequist A, Eksborg S, Frostell C, et al
Severe Covid-19 and Acute Pulmonary Hypertension: 24-month follow-up regarding mortality and relationship to initial echocardiographic findings and biomarkers.
Acta Anaesthesiol Scand. 2022 Nov 4. doi: 10.1111/aas.14168.
Abstract

ZAPATA L, Suarez-Montero JC, Flores-Orella MN, Morales-Alarcon EM, et al
Acute cor pulmonale in patients with acute respiratory distress syndrome due to COVID-19.
Med Intensiva (Engl Ed). 2022;46:645-647.
Abstract

AMANO T, Yamamura A, Fujiwara M, Hirai S, et al
Upregulated ClC3 Channels/Transporters Elicit Swelling-Activated Cl(-) Currents and Induce Excessive Cell Proliferation in Idiopathic Pulmonary Arterial Hypertension.
Biol Pharm Bull. 2022;45:1684-1691.
Abstract

ZHAO J, Wang Q, Deng X, Qian J, et al
The treatment strategy of connective tissue disease associated pulmonary arterial hypertension: Evolving into the future.
Pharmacol Ther. 2022;239:108192.
Abstract

CUETO-ROBLEDO G, Jurado-Hernandez MY, Camacho-Delgado FR, Roldan-Valadez E, et al
Pulmonary Thromboendarterectomy in Klinefelter Syndrome. Literature Review.
Curr Probl Cardiol. 2022;47:101003.
Abstract

DE ALMEIDA GC, Pereira MC, Moreira MM, Souza JRM, et al
Lung function and stress echocardiography in pulmonary arterial hypertension: a cross-sectional study.
Sao Paulo Med J. 2021;139:505-510.
Abstract

CANSU DU, Korkmaz C
Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
Clin Rheumatol. 2022 Nov 17. pii: 10.1007/s10067-022-06446.
Abstract

DUAN A, Huang Z, Hu M, Zhao Z, et al
The comorbidity burden and disease phenotype in pre-capillary pulmonary hypertension: The contributing role of obstructive sleep apnea.
Sleep Med. 2022;101:146-153.
Abstract

XU SL, Liu J, Xu SY, Fan ZQ, et al
Circular RNAs Regulate Vascular Remodelling in Pulmonary Hypertension.
Dis Markers. 2022;2022:4433627.
Abstract

QUINN LA, Gilley SP, Ta AD, Frank BS, et al
Case report: Pulmonary hypertensive crisis leading to cardiac arrest during endoscopic evaluation in a 6-year-old boy with autism, severe malnutrition, and undiagnosed scurvy.
Front Pediatr. 2022;10:1008507.
Abstract

ZHOU H, Gong K, Yang Y, Wu Q, et al
MKI67 as a potential diagnostic biomarker in pulmonary hypertension.
Front Pediatr. 2022;10:1016889.
Abstract

HANSEN TS, Bubb KJ, Schiattarella GG, Ugander M, et al
High-Resolution Transthoracic Echocardiography Accurately Detects Pulmonary Arterial Pressure and Decreased Right Ventricular Contractility in a Mouse Model of Pulmonary Fibrosis and Secondary Pulmonary Hypertension.
J Am Heart Assoc. 2022 Nov 16:e018353. doi: 10.1161/JAHA.120.018353.
Abstract

DHONT S, Zwaenepoel B, Vandecasteele E, Brusselle G, et al
Pulmonary hypertension in interstitial lung disease: an area of unmet clinical need.
ERJ Open Res. 2022;8.
Abstract

KUMBHARE U, Yelne P, Tekale S
Therapeutic Use of an Inhaled Drug Delivery in Pulmonary Hypertension: A Review.
Cureus. 2022;14:e30134.
Abstract

STUBBS H, Brewis M, Church C, Johnson M, et al
Towards telemedicine in pulmonary hypertension: Assessing the feasibility of remote quality of life and exercise capacity assessment.
Pulm Circ. 2022;12:e12144.
Abstract

EVERS PD, Quinn P, Critser PJ, Frank BS, et al
Prognostic value of longitudinal vasoreactivity in pediatric pulmonary hypertension.
Pulm Circ. 2022;12:e12152.
Abstract

MCLAUGHLIN VV, Channick R, Kim NH, Frantz RP, et al
Safety of macitentan for the treatment of pulmonary hypertension: Real-world experience from the OPsumit(R) USers Registry (OPUS) and OPsumit(R) Historical USers cohort (OrPHeUS).
Pulm Circ. 2022;12:e12150.
Abstract

DELGADO V, Pascual D
Comments to the 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension.
Rev Esp Cardiol (Engl Ed). 2022 Nov 12. pii: S1885-5857(22)00293.
Abstract

FAYAD FH, Sellke FW, Feng J
Pulmonary hypertension associated with cardiopulmonary bypass and cardiac surgery.
J Card Surg. 2022 Nov 15. doi: 10.1111/jocs.17160.
Abstract

HIBINO M, Dhingra NK, Verma R, Yanagawa B, et al
Cardiopulmonary bypass and cardiac surgery associated pulmonary hypertension: The need for proactivity and reactivity.
J Card Surg. 2022 Nov 15. doi: 10.1111/jocs.17161.
Abstract

HEISS J, Grun K, Tempel L, Matasci M, et al
Targeted Interleukin-9 delivery in pulmonary hypertension: comparison of immunocytokine formats and effector cell study.
Eur J Clin Invest. 2022 Nov 15:e13907. doi: 10.1111/eci.13907.
Abstract

CHEN Y, Zhou D, Xiong M, Xi X, et al
Prediction and prognosis of adverse maternal and foetal/neonatal outcomes in pulmonary hypertension: an observational study and nomogram construction.
Respir Res. 2022;23:314.
Abstract

ZHANG Y, Li X, Jin Q, Luo Q, et al
The original and two new derivative versions of the COMPERA 2.0 risk assessment model: useful tools for guiding balloon pulmonary angioplasty.
Respir Res. 2022;23:312.
Abstract

MILARA J, Roger I, Montero P, Artigues E, et al
IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis.
Respir Res. 2022;23:313.
Abstract

SUN Z, Xu Z, Sun J, Liu J, et al
Frontometaphyseal dysplasia 2 associated with thoracic deformity, and pulmonary arterial hypertension: a case report and review of literature.
Arch Argent Pediatr. 2022;120:e278-e282.
Abstract

LU Y, Li D, Shan L
MicroRNA153 induces apoptosis by targeting NFATc3 to improve vascular remodeling in pulmonary hypertension.
Clin Exp Hypertens. 2022 Nov 14:1-12. doi: 10.1080/10641963.2022.2140810.
Abstract

DONG ML, Azarine A, Haddad F, Amsallem M, et al
4D flow cardiovascular magnetic resonance recovery profiles following pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension.
J Cardiovasc Magn Reson. 2022;24:59.
Abstract

ZHOU YP, Lian TY, Zhu YJ
Keep minds opening for chronic thromboembolic pulmonary hypertension: More data, less clarity.
J Thromb Haemost. 2022;20:2751-2753.
Abstract

JACOB C, Kitagawa A, Signoretti C, Dzieciatkowska M, et al
Mediterranean G6PD variant mitigates expression of DNA methyltransferases and right heart pressure in experimental model of pulmonary hypertension.
J Biol Chem. 2022 Nov 10:102691. doi: 10.1016/j.jbc.2022.102691.
Abstract

CANTRES-FONSECA O, Kennedy JLW
Where's the Easy Button? The Many Barriers to Care for Patients With Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2022;11:e027967.
Abstract

SCHIKOWSKI EM, Swabe G, Chan SY, Magnani JW, et al
Association Between Copayment and Adherence to Medications for Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2022;11:e026620.
Abstract

KALDARAROVA M, Simkova I, Bohacekova M, Reptova A, et al
Central versus Peripheral CTEPH-Clinical and Hemodynamic Specifications.
Medicina (Kaunas). 2022;58.
Abstract

FUKUI S, Shirota Y, Nakano T, Sato T, et al
Balloon Pulmonary Angioplasty for Takayasu Arteritis and Peripheral Pulmonary Artery Stenosis Mimicking Chronic Thromboembolic Pulmonary Hypertension.
Life (Basel). 2022;12.
Abstract

ANIS M, Gonzales J, Halstrom R, Baig N, et al
Non-Muscle MLCK Contributes to Endothelial Cell Hyper-Proliferation through the ERK Pathway as a Mechanism for Vascular Remodeling in Pulmonary Hypertension.
Int J Mol Sci. 2022;23.
Abstract

HUNDT N, Apel C, Bertsch D, Cerfontaine C, et al
Variables Influencing the Pressure and Volume of the Pulmonary Circulation as Risk Factors for Developing High Altitude Pulmonary Edema (HAPE).
Int J Environ Res Public Health. 2022;19.
Abstract

SIKIRIC P, Udovicic M, Barisic I, Balenovic D, et al
Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation.
Biomedicines. 2022;10.
Abstract

NEVEU J, Cano A, Hoebeke C, Acquaviva-Bourdain C, et al
Hyperglycinemia in a 5-Week-Old Boy with Pulmonary Arterial Hypertension.
Clin Chem. 2022;68:604-606.
Abstract

CRUZ-UTRILLA A, Del Cerro Marin MJ, Sarnago Cebada F, Velazquez Martin M, et al
Total Occlusion of the Left Main Coronary Artery in Pulmonary Arterial Hypertension.
JACC Cardiovasc Interv. 2022;15:e225-e226.
Abstract

WANG T, Xing Y, Peng B, Yang K, et al
Respiratory Microbiome Profile of Pediatric Pulmonary Hypertension Patients Associated With Congenital Heart Disease.
Hypertension. 2022 Nov 10. doi: 10.1161/HYPERTENSIONAHA.122.19182.
Abstract

LI J, Li A, Zhai Y, Li L, et al
Prevalence and risk prediction value of tricuspid regurgitation by echocardiography in precapillary pulmonary hypertension.
BMC Pulm Med. 2022;22:409.
Abstract

WOO JL, DiLorenzo MP, Rosenzweig E, Pasumarti N, et al
Correlation Between Right Ventricular Echocardiography Measurements and Functional Capacity in Patients With Pulmonary Arterial Hypertension.
Tex Heart Inst J. 2022;49.
Abstract

GUO J, Wang L, Wang J, Wan K, et al
Prognostic Value of Hepatic Native T1 and Extracellular Volume Fraction in Patients with Pulmonary Arterial Hypertension.
J Am Heart Assoc. 2022;11:e026254.
Abstract

HONG L, Davies M, Whitfield K
Noradrenaline use for neonatal circulatory support.
J Paediatr Child Health. 2022 Sep 23. doi: 10.1111/jpc.16226.
Abstract

YILDIZ BOLUKBASI E, Karolak JA, Szafranski P, Gambin T, et al
High-level gonosomal mosaicism for a pathogenic non-coding CNV deletion of the lung-specific FOXF1 enhancer in an unaffected mother of an infant with ACDMPV.
Mol Genet Genomic Med. 2022;10:e2062.
Abstract

ORNSTOVA E, Tuzil J, Chadimova K, Mlcoch T, et al
Indirect treatment comparison and cost-minimization analysis of riociguat versus selexipag in patients with pulmonary arterial hypertension.
Expert Rev Pharmacoecon Outcomes Res. 2022;22:1269-1275.
Abstract

LU GF, Geng F, Deng LP, Lin DC, et al
Reduced CircSMOC1 Level Promotes Metabolic Reprogramming via PTBP1 (Polypyrimidine Tract-Binding Protein) and miR-329-3p in Pulmonary Arterial Hypertension Rats.
Hypertension. 2022 Aug 23:101161HYPERTENSIONAHA12219183.
Abstract

HLAVATY A, Roustit M, Montani D, Chaumais MC, et al
Identifying new drugs associated with pulmonary arterial hypertension: A WHO pharmacovigilance database disproportionality analysis.
Br J Clin Pharmacol. 2022;88:5227-5237.
Abstract

YURTTUTAN S, Gullu UU
The Effect of Dual (Combined) Treatment in Late Preterm Infants with Patent Ductus Arteriosus.
Am J Perinatol. 2022;39:1633.
Abstract

JUNG MH, Jung HO, Kwon SJ, Chang S, et al
Clinical Presentations and Multimodal Imaging Diagnosis in Chronic Thromboembolic Pulmonary Hypertension.
J Clin Med. 2022;11:6678.
Abstract

CHANG Z, Liu J, Wang B, Zhang H, et al
Clinicopathological Correlation of Chronic Thromboembolic Pulmonary Hypertension: A Retrospective Study.
J Clin Med. 2022;11:6659.
Abstract

KARIYASU T, Machida H, Yamashiro T, Fukushima K, et al
Correlation between CT Value on Lung Subtraction CT and Radioactive Count on Perfusion Lung Single Photon Emission CT in Chronic Thromboembolic Pulmonary Hypertension.
Diagnostics (Basel). 2022;12:2895.
Abstract

KRASA K, Vajnerova O, D Uris Ova J, Minarikova M, et al
Simvastatin and Dehydroepiandrosterone Sulfate Effects Against Hypoxic Pulmonary Hypertension Are Not Additive.
Physiol Res. 2022.
Abstract

PARMITA PD, Thool AR
Comprehensive Review of Pulmonary Hypertension and Treatment Options in the Paediatric Population.
Cureus. 2022;14:e30622.
Abstract

LIN CC, Wu CK, Kuo PH
Pulmonary hypertension complicating unilateral absence of pulmonary artery and coronary-pulmonary artery fistula: Report of a case and review of the literature.
Pulm Circ. 2022;12:e12160.
Abstract

CLAEYS M, Petit T, Bogaert J, La Gerche A, et al
Dynamic aspects of ventricular interaction during exercise in HFpEF and in pre-capillary pulmonary hypertension.
ESC Heart Fail. 2022 Nov 24. doi: 10.1002/ehf2.14216.
Abstract

BALISTRIERI A, Makino A, Yuan JX
Pathophysiology and Pathogenic Mechanisms of Pulmonary Hypertension: Role of Membrane Receptors, Ion Channels and Ca(2+) Signaling.
Physiol Rev. 2022 Nov 24. doi: 10.1152/physrev.00030.2021.
Abstract

CAI G, Zhang Y, Wang X, Li S, et al
Comparison of hypoxia-induced pulmonary hypertension rat models caused by different hypoxia protocols.
Exp Lung Res. 2022 Nov 24:1-11. doi: 10.1080/01902148.2022.2148016.
Abstract

KUMATA S, Hashimoto Y, Okada H, Kawasaki T, et al
Pulmonary Hypertension Associated With Hyperthyroidism: A Case Report.
Cureus. 2022;14:e30567.
Abstract

XU JH, Liang JP, Zhu CJ, Lian YJ, et al
Mesenchymal Stem Cell-Derived Extracellular Vesicles Therapy for Pulmonary Hypertension: A Comprehensive Review of Preclinical Studies.
J Interv Cardiol. 2022;2022:5451947.
Abstract

LI N, Gao L, Zhou Q, Liu J, et al
Association Between Body Mass Index and 30-Day Mortality in Patients with Pulmonary Hypertension Undergoing Non-cardiothoracic, Non-obstetric Surgery.
Obes Surg. 2022 Nov 22. doi: 10.1007/s11695-022-06320.
Abstract

POURMODHEJI R, Jiang Z, Tossas-Betancourt C, Dorfman AL, et al
Computational modelling of multi-temporal ventricular-vascular interactions during the progression of pulmonary arterial hypertension.
J R Soc Interface. 2022;19:20220534.
Abstract

CHEN X, Wei X, Ma S, Xie H, et al
Cysteine and glycine rich protein 2 exacerbates vascular fibrosis in pulmonary hypertension through the nuclear translocation of yes-associated protein and transcriptional coactivator with PDZ-binding motif.
Toxicol Appl Pharmacol. 2022 Nov 19:116319. doi: 10.1016/j.taap.2022.116319.
Abstract

LI X, Zhang Y, Jin Q, Luo Q, et al
Predictors of early response to balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension.
Ther Adv Respir Dis. 2022;16:17534666221138001.
Abstract

BERGER MM, Bailey DM
On the mechanisms underlying activation and reversal of high altitude-induced pulmonary hypertension in humans - Another piece in the pulmonary puzzle.
Exp Physiol. 2022 Nov 21. doi: 10.1113/EP090967.
Abstract

LI JF, Chen YQ, Wang L, Cao YS, et al
Editorial: Calcium and pulmonary hypertension.
Front Physiol. 2022;13:1019158.
Abstract

YAMASHITA K, Kurosaki M, Nakanishi H, Tanaka Y, et al
Simple algorithm to narrow down the candidates to receive echocardiography in patients with chronic liver disease for suspected pulmonary hypertension.
JGH Open. 2022;6:774-781.
Abstract

LI J, Zhao J, Yang XY, Shi J, et al
Successful treatment of pulmonary hypertension in a neonate with bronchopulmonary dysplasia: A case report and literature review.
World J Clin Cases. 2022;10:11898-11907.
Abstract

GARCIA-ALVAREZ A, Blanco I, Garcia-Lunar I, Jorda P, et al
beta3-adrenergic agonist treatment in chronic pulmonary hypertension associated with heart failure (SPHERE-HF): a double blind, placebo-controlled, randomized clinical trial.
Eur J Heart Fail. 2022 Nov 20. doi: 10.1002/ejhf.2745.
Abstract

SUN Y, Jiang R, Hu X, Gong S, et al
CircGSAP alleviates pulmonary microvascular endothelial cells dysfunction in pulmonary hypertension via regulating miR-27a-3p/BMPR2 axis.
Respir Res. 2022;23:322.
Abstract

POLA K, Bergstrom E, Toger J, Radegran G, et al
Increased biventricular hemodynamic forces in precapillary pulmonary hypertension.
Sci Rep. 2022;12:19933.
Abstract

ROSSI ML, Escobar-Diaz MC, Hadley SM, Randanne PC, et al
Echocardiographic Markers of Mild Pulmonary Hypertension are not Correlated with Worse Respiratory Outcomes in Infants with Bronchiolitis.
Pediatr Cardiol. 2022 Nov 19. doi: 10.1007/s00246-022-03043.
Abstract

VADAKKAN DEVASSY T, Ps N, Sharma D, Thomas AM, et al
Sleep disorders in elderly population suffering from TB and respiratory diseases.
Indian J Tuberc. 2022;69 Suppl 2:S272-S279.
Abstract

LAI YK, Kwo PY
Portopulmonary Hypertension.
Clin Liver Dis. 2023;27:71-84.
Abstract

SCHORK A, Fliedner A, Artunc F
[65-year-old patient with pulmonary involvement of systemic sclerosis and creatinine elevation].
Dtsch Med Wochenschr. 2022;147:1511-1512.
Abstract

KALRA SS, Jaber JF, Alzghoul B, Jansen B, et al
Hypersensitivity Pneumonitis With and Without Autoimmune Features: A Clinical Comparative Analysis.
Lung. 2022;200:763-771.
Abstract

VOELLER J, DeNapoli T, Griffin TC
Two pediatric oncologic cases of hypereosinophilic syndrome and review of the literature.
Cancer Rep (Hoboken). 2022;5:e1710.
Abstract

SUGIURA A, Kavsur R, Spieker M, Iliadis C, et al
Impact of right ventricular-pulmonary arterial coupling on clinical outcomes of tricuspid regurgitation.
EuroIntervention. 2022;18:852-861.
Abstract

MENDEL B, Christianto C, Angellia P, Holiyono I, et al
Reversed Potts Shunt Outcome in Suprasystemic Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
Curr Cardiol Rev. 2022;18:e090522204486.
Abstract

OTERO-FERNANDEZ P, Negreira-Caamano M, Moreno-Flores A, Calvo-Alonso M, et al
Pulmonary arterial hypertension due to ventriculoatrial shunts: A case report and literature review.
Neurochirurgie. 2022;68:684-687.
Abstract

LATIF A, Ahsan MJ, Lateef N, Kapoor V, et al
Is Methamphetamine-Linked Cardiomyopathy an Emerging Epidemic for New Generation?
Curr Probl Cardiol. 2023;48:101042.
Abstract

LIU J, Chang Z, Zhang Z, Wang B, et al
Clinical features and metabolic reprogramming of atherosclerotic lesions in patients with chronic thromboembolic pulmonary hypertension.
Front Cardiovasc Med. 2022;9:1023282.
Abstract

NIKLAS K, Niklas A, Mularek-Kubzdela T, Puszczewicz M, et al
Relationship between changes observed in nailfold capillaroscopy and serological profile, lung fibrosis, and elevated risk of pulmonary hypertension in patients with systemic sclerosis and mixed connective tissue disease.
Postepy Dermatol Alergol. 2022;39:880-886.
Abstract

LOPEZ HORMIGA DF, Combarros Mendez DM, Keituqwa Yanez I
Bronchial compression due to dilatated pulmonary artery without pulmonary hypertension.
Med Intensiva (Engl Ed). 2022 Nov 28:S2173-5727(22)00302.
Abstract

WIELAND I, Diekmann F, Carlens J, Hinze L, et al
Acquired von Willebrand syndrome (AVWS) type 2, characterized by decreased high molecular weight multimers, is common in children with severe pulmonary hypertension (PH).
Front Pediatr. 2022;10:1012738.
Abstract

CHEN Q, Luo H, Li Y
The role of tolvaptan in pulmonary hypertension: A retrospective study.
Medicine (Baltimore). 2022;101:e31587.
Abstract

ZHAO X, Leng S, Tan RS, Chai P, et al
Right ventricular energetic biomarkers from 4D Flow CMR are associated with exertional capacity in pulmonary arterial hypertension.
J Cardiovasc Magn Reson. 2022;24:61.
Abstract

TUNTHONG R, Salama AA, Lane CM, Fine NM, et al
Right ventricular systolic strain in patients with pulmonary hypertension: clinical feasibility, reproducibility, and correlation with ejection fraction.
J Echocardiogr. 2022 Nov 30. doi: 10.1007/s12574-022-00593.
Abstract

VELIOGLU Y, Yuksel A, Topal D, Korkmaz UTK, et al
Does pulmonary hypertension affect early-term outcomes of off-pump coronary artery bypass surgery?
Rev Assoc Med Bras (1992). 2022 Nov 25:S0104-42302022005012218.
Abstract

ASSAF RR, Siembieda J, Recto MR, Doniger SJ, et al
Point-of-Care Ultrasound and the Discovery of Pulmonary Arterial Hypertension in a Teenager.
Pediatr Emerg Care. 2022;38:702-704.
Abstract

GHIO S, Bossone E, Mercurio V, Rudski L, et al
Echocardiographic assessment and clinical implication of functional tricuspid regurgitation in heart failure with reduced or preserved ejection fraction (ECLIPSE-HF) : Rationale and design of the study.
Int J Cardiovasc Imaging. 2022;38:2581-2591.
Abstract

LEE HW, Jung JW, Kim AY, Park HK, et al
Heart Transplantation in a Patient with Complex Congenital Heart Disease, Physiologic Single Lung, and Severe Pulmonary Hypertension.
Yonsei Med J. 2022;63:1144-1146.
Abstract

TAKASHIMA Y, Shinagawa N, Morinaga D, Nakamura J, et al
Risk of bleeding associated with transbronchial biopsy using flexible bronchoscopy in patients with echocardiographic or chest CT evidence of pulmonary hypertension.
BMC Pulm Med. 2022;22:449.
Abstract

QIN L, Jiang B, Zsebo K, Duckers HJ, et al
Multiple Intravenous Bolus Dosing and Invasive Hemodynamic Assessment in a Hypoxia-Induced Mouse Pulmonary Artery Hypertension Model.
J Vis Exp. 2022;.
Abstract

CHIU YW, Huang WC
Cardiopulmonary Exercise Test and Rehabilitation for Pulmonary Hypertension Patients.
Acta Cardiol Sin. 2022;38:663-666.
Abstract

MIAO R, Dong X, Gong J, Li Y, et al
Single-cell RNA-sequencing and microarray analyses to explore the pathological mechanisms of chronic thromboembolic pulmonary hypertension.
Front Cardiovasc Med. 2022;9:900353.
Abstract

LI JL, Xiao F, Liu HT, Li HT, et al
Long-term outcomes in health-related quality of life influence chronic disease management in patients with pulmonary hypertension.
Front Cardiovasc Med. 2022;9:1008253.
Abstract

LYLE MA, Bhatia S, Fenstad E, Schroeder D, et al
Association of Pulmonary Hypertension and Monoclonal Gammopathy of Undetermined Significance.
Adv Hematol. 2022;2022:8918959.
Abstract

SUETOMI T, Shimokawahara H, Sugiyama Y, Miyagi A, et al
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension concomitant with Klippel-Trenaunay-Weber syndrome.
Pulm Circ. 2022;12:e12155.
Abstract

SIRAJUDDIN A, Mirmomen SM, Henry TS, Kandathil A, et al
ACR Appropriateness Criteria(R) Suspected Pulmonary Hypertension: 2022 Update.
J Am Coll Radiol. 2022;19.
Abstract

MARRA AM, Sherman AE, Ameri P, Bossone E, et al
Challenges in Pulmonary Hypertension.
Heart Fail Clin. 2023;19:xv-xvi.
Abstract

DEMELO-RODRIGUEZ P, Galeano-Valle F, Proietti M
Use of Oral Anticoagulant Drugs in Patients with Pulmonary Hypertension.
Heart Fail Clin. 2023;19:97-106.
Abstract

EICHSTAEDT CA, Benjamin N, Cao D, Paleviciute E, et al
Genetics of High-Altitude Pulmonary Edema.
Heart Fail Clin. 2023;19:89-96.
Abstract

MEI JY, Channick RN, Afshar Y
Pregnancy and Pulmonary Hypertension: From Preconception and Risk Stratification Through Pregnancy and Postpartum.
Heart Fail Clin. 2023;19:75-87.
Abstract

JOSE A, Jones CR, Elwing JM
Struggling Between Liver Transplantation and Portopulmonary Hypertension.
Heart Fail Clin. 2023;19:55-65.
Abstract

LEWIS C, Sanderson R, Vasilottos N, Zheutlin A, et al
Pulmonary Arterial Hypertension in Connective Tissue Diseases Beyond Systemic Sclerosis.
Heart Fail Clin. 2023;19:45-54.
Abstract

SHERMAN AE, Saggar R
Cardiopulmonary Exercise Testing in Pulmonary Arterial Hypertension.
Heart Fail Clin. 2023;19:35-43.
Abstract

PARENTE YDM, Fernandes da Silva N, Souza R
Unusual Forms of Pulmonary Hypertension.
Heart Fail Clin. 2023;19:25-33.
Abstract

BERNARDI N, Bianconi E, Vecchi A, Ameri P, et al
Noncoding RNAs in Pulmonary Arterial Hypertension: Current Knowledge and Translational Perspectives.
Heart Fail Clin. 2023;19:137-152.
Abstract

MARRA AM, D'Agostino A, Salzano A, Basili S, et al
Impact of Hormonal-Anabolic Deficiencies in Idiopathic Pulmonary Arterial Hypertension.
Heart Fail Clin. 2023;19:115-123.
Abstract

D'AGOSTINO A, Guindani P, Scaglione G, Vincenzo AD, et al
Sex- and Gender-Related Aspects in Pulmonary Hypertension.
Heart Fail Clin. 2023;19:11-24.
Abstract

FARMAKIS IT, Giannakoulas G
Management of COVID-19 in Patients with Pulmonary Arterial Hypertension.
Heart Fail Clin. 2023;19:107-114.
Abstract

MARRA AM, Attanasio U, Cuomo A, Rainone C, et al
Mildly Elevated Pulmonary Hypertension: Gray Zone or Already a Disease?
Heart Fail Clin. 2023;19:1-9.
Abstract

HUANG N, Wang D, Zhu TT, Ge XY, et al
Plasma Exosomes Confer Hypoxic Pulmonary Hypertension by Transferring LOX-1 Cargo to Trigger Phenotypic Switching of Pulmonary Artery Smooth Muscle Cells.
Biochem Pharmacol. 2022 Nov 23:115350. doi: 10.1016/j.bcp.2022.115350.
Abstract

RE F, Halasz G, Moroni F, Beltrami M, et al
Exercise-induced pulmonary hypertension in hypertrophic cardiomyopathy: a combined cardiopulmonary exercise test-echocardiographic study.
Int J Cardiovasc Imaging. 2022;38:2345-2352.
Abstract

LI N, Shi Y, Yin J, Sun L, et al
Impact of ATP synthase/coupling factor 6 in hypoxic pulmonary arterial hypertension: An experimental rat model.
Turk J Med Sci. 2022;52:1468-1477.
Abstract

ILIUTA L, Andronesi AG, Diaconu CC, Moldovan H, et al
Diastolic versus Systolic Left Ventricular Dysfunction as Independent Predictors for Unfavorable Postoperative Evolution in Patients with Aortic Regurgitation Undergoing Aortic Valve Replacement.
Medicina (Kaunas). 2022;58:1676.
Abstract

MAQHUZU PN, Schwarzkopf L, Markart P, Behr J, et al
Costs of Pharmacological and Non-Pharmacological Interventions in Interstitial Lung Disease Management in Germany.
Respiration. 2022;101:1015-1023.
Abstract

YEO Y, Jeong H, Kim M, Choi Y, et al
Crosstalk between BMP signaling and KCNK3 in phenotypic switching of pulmonary vascular smooth muscle cells.
BMB Rep. 2022;55:565-570.
Abstract

TOKGOZ HC, Akbal OY, Karagoz A, Kultursay B, et al
Maternal and Fetal Outcomes in Pregnant Women with Pulmonary Arterial Hypertension: A Single-Center Experience and Review of Current Literature.
Anatol J Cardiol. 2022;26:902-913.
Abstract

OTTO M, McGiffin D, Whitford H, Kure C, et al
Survival and left ventricular dysfunction post lung transplantation for pulmonary arterial hypertension.
J Crit Care. 2022;72:154120.
Abstract

WEINMAN JP, Mong DA, Malone LJ, Ivy DD, et al
Chest computed tomography findings of ground-glass nodules with enhancing central vessel/nodule in pediatric patients with BMPR2 mutations and plexogenic arteriopathy.
Pediatr Radiol. 2022 Jun 11. pii: 10.1007/s00247-022-05413.
Abstract

OE K, Matsuda S, Kotani T, Takeuchi T, et al
Comment on: Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD.
Rheumatology (Oxford). 2022;61:e381-e382.
Abstract

ZANATTA E, Huscher D, Ortolan A, Avouac J, et al
Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort.
Rheumatology (Oxford). 2022;61:4786-4796.
Abstract

TODOROKI Y, Kubo S, Nakano K, Miyazaki Y, et al
Nailfold microvascular abnormalities are associated with a higher prevalence of pulmonary arterial hypertension in patients with MCTD.
Rheumatology (Oxford). 2022;61:4875-4884.
Abstract

EREWELE EO, Castellon M, Loya O, Marshboom G, et al
Hypoxia-induced pulmonary hypertension upregulates eNOS and TGF-beta contributing to sex-linked differences in BMPR2 (+/R899X) mutant mice.
Pulm Circ. 2022;12:e12163.
Abstract

CHEN A, Wu W, Lin S, Xie L, et al
Bioinformatic Exploration of Hub Genes and Potential Therapeutic Drugs for Endothelial Dysfunction in Hypoxic Pulmonary Hypertension.
Comput Math Methods Med. 2022;2022:3677532.
Abstract

DEICKE M, Alhuneafat L, Obaid O, Adeniyi A, et al
Rapidly progressive pulmonary hypertension and right ventricular failure in a heart and kidney transplant recipient.
Clin Case Rep. 2022;10:e6631.
Abstract

ABDUL-GHAFFAR F, Md Redzuan A, Makmor-Bakry M, Muhamad Nor MA, et al
Drug-Related Problems in Pulmonary Hypertension with Valvular Heart Disease.
Ther Clin Risk Manag. 2022;18:1069-1079.
Abstract

VOLEVSKI LA, Ben Taieb O, Talipov I, Vasiloi I, et al
Differentiated impact of pulmonary hypertension on outcome after left ventricular assist device implantation and tricuspid valve repair.
Int J Artif Organs. 2022 Dec 8:3913988221140423. doi: 10.1177/03913988221140423.
Abstract

BHATTARAI P, Lu W, Gaikwad AV, Dey S, et al
Arterial remodelling in smokers and in patients with small airway disease and COPD: implications for lung physiology and early origins of pulmonary hypertension.
ERJ Open Res. 2022;8:00254-2022.
Abstract

BUDHRAM S, Krishundutt P
A three-year audit of pregnancy outcomes in women with pulmonary hypertension admitted to the high-risk obstetric unit at Inkosi Albert Luthuli Central Hospital, KwaZulu-Natal, South Africa.
Cardiovasc J Afr. 2022;33:1-8.
Abstract

BARRIOS L, Delcroix M, Dymarkowski S, Bennett J, et al
Left Main Coronary Artery Compression in Pulmonary Hypertension: Value of Multimodality Imaging in Diagnosis and Treatment.
J Invasive Cardiol. 2022;34:E892.
Abstract

KENNEDY MK, Kennedy SA, Tan KT, de Perrot M, et al
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review and Meta-analysis.
Cardiovasc Intervent Radiol. 2022 Dec 6. doi: 10.1007/s00270-022-03323.
Abstract

SHEN Y, Goncharov DA, Pena A, Baust J, et al
Cross-talk between TSC2 and the extracellular matrix controls pulmonary vascular proliferation and pulmonary hypertension.
Sci Signal. 2022;15:eabn2743.
Abstract

TOFOVIC SP, Bilan VP, Rafikova O, Schneider F, et al
Dimethyl Sulfoxide Induces Hemolysis and Pulmonary Hypertension.
Pril (Makedon Akad Nauk Umet Odd Med Nauki). 2022;43:5-20.
Abstract

ALHWIESH AK, Abdul-Rahman IS, Alshehri A, Alhwiesh A, et al
The problem of pulmonary arterial hypertension in end-stage renal disease: can peritoneal dialysis be the solution.
BMC Nephrol. 2022;23:386.
Abstract

ROHLFING AB, Bischoff KE, Kolaitis NA, Kronmal RA, et al
Palliative care referrals in patients with pulmonary arterial hypertension: The Pulmonary Hypertension Association Registry.
Respir Med. 2022;206:107066.
Abstract

ZHANG R, Li T, Shao Y, Bai W, et al
Efficacy evaluation of pulmonary hypertension therapy in patients with portal pulmonary hypertension: A systematic review and meta-analysis.
Front Pharmacol. 2022;13:991568.
Abstract

HU J, Lv S, Zhou T, Chen H, et al
Identification of Pulmonary Hypertension Animal Models Using a New Evolutionary Machine Learning Framework Based on Blood Routine Indicators.
J Bionic Eng. 2022 Nov 28:1-20. doi: 10.1007/s42235-022-00292.
Abstract

WANG Y, Guo D, Liu M, Zhang X, et al
Assessment of right ventricular remodeling in chronic thromboembolic pulmonary hypertension by 2D-speckle tracking echocardiography: A comparison with cardiac magnetic resonance.
Front Cardiovasc Med. 2022;9:999389.
Abstract

ZHAO N, Chen J, Zhang M, Zhou L, et al
PAH-specific therapy for pulmonary hypertension and interstitial lung disease: A systemic review and meta-analysis.
Front Cardiovasc Med. 2022;9:992879.
Abstract

SUN S, Li JF, Liu L, Miao R, et al
Long-term Outcomes and Predictors of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Endarterectomy.
Clin Appl Thromb Hemost. 2022;28:10760296221140882.
Abstract

MAIA PD, Gien J, Kinsella JP, Zablah J, et al
Hemodynamic Characterization of Neonates with Congenital Diaphragmatic Hernia-Associated Pulmonary Hypertension by Cardiac Catheterization.
J Pediatr. 2022 Dec 1:S0022-3476(22)01086-1. doi: 10.1016/j.jpeds.2022.
Abstract

MULAREK-KUBZDELA T, Wojnarski J, Kaminski K, Ochman M, et al
Lung transplantation in patients with pulmonary arterial hypertension: The opinion of the Polish Cardiac Society Working Group on Pulmonary Circulation.
Kardiol Pol. 2022;80:1167-1179.
Abstract

WANG P, Feng H, Guo Y, Wu N, et al
Efficacy and safety of non-prostanoid prostacyclin receptor agonist for pulmonary hypertension: A meta-analysis.
Pulm Pharmacol Ther. 2022;78:102182.
Abstract

SAID SM, Marey G
Bilateral branch pulmonary arterial reconstruction in the Alagille syndrome: The technique and its pitfalls.
Multimed Man Cardiothorac Surg. 2022;2022.
Abstract

WINKLER T, Kohli P, Kelly VJ, Kehl EG, et al
Perfusion imaging heterogeneity during NO inhalation distinguishes pulmonary arterial hypertension (PAH) from healthy subjects and has potential as an imaging biomarker.
Respir Res. 2022;23:325.
Abstract

VALIZADEH L, Raffiei Jelodar H, Taghavi S, Amin A, et al
Hemodynamic Profile of Patients with ESKD Referred to Heart Failure Department of Rajaie Heart Center, A Data from Right Heart Catheterization Registry.
Iran J Kidney Dis. 2022;16:7105.
Abstract

MARTINO A, Lista G, Guner YS
Management of the CDH patient on ECLS.
Semin Fetal Neonatal Med. 2022;27:101407.
Abstract

CAJIGAS HR, Burger CD, Cartin-Ceba R, DuBrock H, et al
Portopulmonary Hypertension in Nontransplanted Patients: Results of the Largest US Single-Institution Registry.
Mayo Clin Proc. 2022;97:2236-2247.
Abstract

D'ALTO M, Naeije R
Pulmonary artery pressure-directed therapies in pulmonary arterial hypertension?
Vascul Pharmacol. 2022;147:107124.
Abstract

TURA-CEIDE O
Blood Flow Disturbances in Congenital Heart Disease: Is Neuroblastoma Suppressor of Tumorigenicity 1 a Target for Preventing Pulmonary Vascular Remodeling?
Am J Respir Cell Mol Biol. 2022;67:615-616.
Abstract

SEVILLA-MONTERO J, Munar-Rubert O, Pino-Fadon J, Aguilar-Latorre C, et al
Cigarette smoke induces pulmonary arterial dysfunction through an imbalance in the redox status of the soluble guanylyl cyclase.
Free Radic Biol Med. 2022;193.
Abstract

WEN B, Peng R, Kong P, Li Z, et al
Neuroblastoma Suppressor of Tumorigenicity 1 Mediates Endothelial-to-Mesenchymal Transition in Pulmonary Arterial Hypertension Related to Congenital Heart Disease.
Am J Respir Cell Mol Biol. 2022;67:666-679.
Abstract

TRIANTAFYLLIDI H, Iordanidis D, Montani D, Samiotis E, et al
Pulmonary veno-occlusive disease associated with long-term occupational exposure to chemical solvents and pesticides. A case report.
Respir Med Res. 2022;82:100943.
Abstract

ZHOU JJ, Yang J, Li L, Quan RL, et al
Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt-related pulmonary arterial hypertension.
ESC Heart Fail. 2022;9:3407-3417.
Abstract

MONTANE B, Tonelli AR, Arunachalam A, Bhattacharyya A, et al
Hemodynamic Responses to Provocative Maneuvers during Right Heart Catheterization.
Ann Am Thorac Soc. 2022;19:1977-1985.
Abstract

ZHOU J
Synemin promotes pulmonary artery smooth muscle cell phenotypic switch in shunt-induced pulmonary arterial hypertension.
ESC Heart Fail. 2022;9:3221-3231.
Abstract

WISSMULLER M, Xanthouli P, Benjamin N, Grunig E, et al
Profiles and treatment patterns of patients with pulmonary arterial hypertension on monotherapy at experienced centres.
ESC Heart Fail. 2022;9:2873-2885.
Abstract

HAHN LD, Papamatheakis DG, Fernandes TM, Poch DS, et al
Multidisciplinary Approach to Chronic Thromboembolic Pulmonary Hypertension: Role of Radiologists.
Radiographics. 2023;43:e220078.
Abstract

ZHAO C, Guo Y, Wang Y, Wang L, et al
The efficacy and safety of Sacubitril/Valsartan on pulmonary hypertension in hemodialysis patients.
Front Med (Lausanne). 2022;9:1055330.
Abstract

TAMURA H, Hosokawa S, Yuba K
Emergent balloon pulmonary angioplasty in a patient with central-type chronic thromboembolic pulmonary hypertension with cardiac shock.
Clin Case Rep. 2022;10:e6738.
Abstract

LUO Z, Qian H, Zhang X, Wang Y, et al
Effectiveness and safety of inspiratory muscle training in patients with pulmonary hypertension: A systematic review and meta-analysis.
Front Cardiovasc Med. 2022;9:999422.
Abstract

GOEL K, Egersdorf N, Gill A, Cao D, et al
Characterization of pulmonary vascular remodeling and MicroRNA-126-targets in COPD-pulmonary hypertension.
Respir Res. 2022;23:349.
Abstract

CRNKOVIC S, Rittchen S, Jandl K, Gindlhuber J, et al
Divergent Roles of Ephrin-B2/EphB4 Guidance System in Pulmonary Hypertension.
Hypertension. 2022 Dec 15. doi: 10.1161/HYPERTENSIONAHA.122.19479.
Abstract

DODSON MW, Cirulis MM, Elliott CG
Analysis of family histories suggests shared genetic risk for chronic thromboembolic pulmonary hypertension and venous thromboembolism.
Pulm Circ. 2022;12:e12170.
Abstract

XU J, Liang C, Li J
A signal recognition particle-related joint model of LASSO regression, SVM-RFE and artificial neural network for the diagnosis of systemic sclerosis-associated pulmonary hypertension.
Front Genet. 2022;13:1078200.
Abstract

GILLMEYER KR, Johnson SW, Bolton RE, McCullough MB, et al
Organization of pulmonary hypertension care in non-expert care settings: lessons learned from a multi-site study.
Health Serv Res. 2022 Dec 14. doi: 10.1111/1475-6773.14114.
Abstract

YANG Y, Yang B, Li X, Xue L, et al
Higher circulating Trimethylamine N-oxide levels are associated with worse severity and prognosis in pulmonary hypertension: a cohort study.
Respir Res. 2022;23:344.
Abstract

KAMIYA C, Odagiri K, Inui N, Suda T, et al
A Case of Pulmonary Hypertension Associated with Diffuse Panbronchiolitis that Improved with Erythromycin and Home Oxygen Therapy.
Intern Med. 2022 Dec 14. doi: 10.2169/internalmedicine.0929.
Abstract

COLGLAZIER E, Stevens L, Parker C, Nawaytou HM, et al
Hemodynamic assessment of transitioning from parenteral prostacyclin to selexipag in pediatric pulmonary hypertension.
Pulm Circ. 2022;12:e12159.
Abstract

WANG C, Liu Y, Zhang W, Huang J, et al
circ-BPTF serves as a miR-486-5p sponge to regulate CEMIP and promotes hypoxic pulmonary arterial smooth muscle cell proliferation in COPD.
Acta Biochim Biophys Sin (Shanghai). 2022;55:fpage-lpage.
Abstract

WU W, Chen A, Lin S, Wang Q, et al
The identification and verification of hub genes associated with pulmonary arterial hypertension using weighted gene co-expression network analysis.
BMC Pulm Med. 2022;22:474.
Abstract

QAISER KN, Sahay S, Tonelli AR
Pulmonary hypertension due to high cardiac output.
Respir Med. 2022 Oct 31:107034. doi: 10.1016/j.rmed.2022.107034.
Abstract

DESMARAIS T, Yang J, Narezkina A, Fernandes T, et al
Etiology of pulmonary hypertension in multiple myeloma: A case series and literature review.
Respir Med. 2022;206:107071.
Abstract

BARNETT CF, De Marco T, Galie N
Where we came from and where we are going: A perspective on the practice changing recommendations from the 2022 ESC/ERS pulmonary hypertension guidelines.
Eur Heart J Acute Cardiovasc Care. 2022.
Abstract

CORBOZ MR, Plaunt AJ, Malinin VS, Li Z, et al
Assessment of Inhaled Treprostinil Palmitil, Inhaled and Intravenous Treprostinil, and Oral Selexipag in a Sugen/Hypoxia Rat Model of Pulmonary Arterial Hypertension.
J Pharmacol Exp Ther. 2022;383:103-116.
Abstract

ZAFAR M, Patel A, Ashraf M, Tibble J, et al
Shortness of breath due to portopulmonary hypertension and hepatopulmonary syndrome: diagnostic challenges and complex management approach in frail patients.
Clin Med (Lond). 2022;22:485-489.
Abstract

YAN X, Cen J, Luo X, Chen J, et al
Surgical repair of unilateral absence of pulmonary artery in children with pulmonary hypertension: a single-center retrospective study.
Transl Pediatr. 2022;11:1813-1822.
Abstract

CHEN J, Lockett A, Zhao S, Huang LS, et al
Sphingosine Kinase 1 Deficiency in Smooth Muscle Cells Protects against Hypoxia-Mediated Pulmonary Hypertension via YAP1 Signaling.
Int J Mol Sci. 2022;23:14516.
Abstract

FACCIOLI E, Verzeletti V, Perazzolo Marra M, Boscolo A, et al
Pulmonary Endarterectomy for Chronic Thromboembolic Pulmonary Hypertension: A Systematic Review of the Most Updated Literature.
J Clin Med. 2022;11:6976.
Abstract

DEVENDRAN A, Kar S, Bailey R, Trivieri MG, et al
The Role of Bone Morphogenetic Protein Receptor Type 2 (BMPR2) and the Prospects of Utilizing Induced Pluripotent Stem Cells (iPSCs) in Pulmonary Arterial Hypertension Disease Modeling.
Cells. 2022;11:3823.
Abstract

PAN Z, Wu X, Zhang X, Hu K, et al
Phosphodiesterase 4B activation exacerbates pulmonary hypertension induced by intermittent hypoxia by regulating mitochondrial injury and cAMP/PKA/p-CREB/PGC-1alpha signaling.
Biomed Pharmacother. 2022;158:114095.
Abstract

NELSON EJ, Cook E, Pierce M, Nelson S, et al
Preventative practices and effects of the COVID-19 pandemic on caregivers of children with pediatric pulmonary hypertension.
BMC Public Health. 2022;22:2305.
Abstract

ZHOU CY, Sahay S, Shlobin O, Soto FJ, et al
Effects of COVID-19 pandemic on the management of pulmonary hypertension.
Respir Med. 2022;206:107061.
Abstract

LEOPOLD JA
Pulmonary Artery Denervation: A New Therapeutic for Pulmonary Arterial Hypertension?
JACC Cardiovasc Interv. 2022;15:2424-2426.
Abstract

DE LEON N, Tse WH, Ameis D, Keijzer R, et al
Embryology and anatomy of congenital diaphragmatic hernia.
Semin Pediatr Surg. 2022;31:151229.
Abstract

GUPTA R, Zheng M, Gangemi AJ, Zhao H, et al
Predictors of lung transplant waitlist mortality for sarcoidosis.
Respir Med. 2022;205:107008.
Abstract

UPTON P, Richards S, Bates A, Niederhoffer KY, et al
A rare homozygous missense GDF2 (BMP9) mutation causing PAH in siblings: Does BMP10 status contribute?
Am J Med Genet A. 2023;191:228-233.
Abstract

EGBE AC, Miranda WR, Jain CC, Anderson JH, et al
Risk of pulmonary artery dissection in adults with congenital heart disease.
Int J Cardiol. 2023;370:186-190.
Abstract

XIA X, Huang L, Zhou S, Han R, et al
Hypoxia-induced long non-coding RNA plasmacytoma variant translocation 1 upregulation aggravates pulmonary arterial smooth muscle cell proliferation by regulating autophagy via miR-186/Srf/Ctgf and miR-26b/Ctgf signaling pathways.
Int J Cardiol. 2023;370:368-377.
Abstract

ZHANG H, Wei Y, Zhang C, Yang Z, et al
Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomized PADN-CFDA Trial.
JACC Cardiovasc Interv. 2022;15:2412-2423.
Abstract

SEMAAN D, Phillips AR, Reitz K, Sridharan N, et al
Improved long-term outcomes with catheter directed therapies over medical management in patients with submassive pulmonary embolism - a retrospective matched cohort study.
J Vasc Surg Venous Lymphat Disord. 2022 Oct 6. pii: S2213-333X(22)00420.
Abstract

HU Y, Wang X, Xiao S, Wu H, et al
Development and validation of a risk nomogram model for predicting pulmonary hypertension in patients with stage 3-5 chronic kidney disease.
Int Urol Nephrol. 2022 Dec 23. doi: 10.1007/s11255-022-03431.
Abstract

ELBARDISY B, Boraie N, Galal S
Tadalafil Nanoemulsion Mists for Treatment of Pediatric Pulmonary Hypertension via Nebulization.
Pharmaceutics. 2022;14:2717.
Abstract

DZIKOWSKA-DIDUCH O, Kurnicka K, Lichodziejewska B, Dudzik-Niewiadomska I, et al
Electrocardiogram, Echocardiogram and NT-proBNP in Screening for Thromboembolism Pulmonary Hypertension in Patients after Pulmonary Embolism.
J Clin Med. 2022;11:7369.
Abstract

MADONNA R, Ridolfi L, Morganti R, Biondi F, et al
Impact of Exercise-Induced Pulmonary Hypertension on Right Ventricular Function and on Worsening of Cardiovascular Risk in HIV Patients.
J Clin Med. 2022;11:7349.
Abstract

TOMASZEWSKI M, Malkowska P, Sierawska O, Hrynkiewicz R, et al
CTLA-4 Expression Is a Promising Biomarker of Idiopathic Pulmonary Arterial Hypertension and Allows Differentiation of the Type of Pulmonary Hypertension.
Int J Mol Sci. 2022;23:15910.
Abstract

KARPOV AA, Mihailova AM, Shilenko LA, Vaulina DD, et al
Inhibition of JAK1,2 Prevents Fibrotic Remodeling of Pulmonary Vascular Bed and Improves Outcomes in the Rat Model of Chronic Thromboembolic Pulmonary Hypertension.
Int J Mol Sci. 2022;23:15646.
Abstract

ILIODROMITI Z, Tsaousi M, Kitsou K, Bouza H, et al
Neonatal Sepsis Caused by Streptococcus gallolyticus Complicated with Pulmonary Hypertension: A Case-Report and a Systematic Literature Review.
Diagnostics (Basel). 2022;12:3116.
Abstract

MACERA F, Dewachter C, Stefanidis C, Vanden Eynden F, et al
Lung diffusion capacity correlates with pre-implant pulmonary hypertension and predicts outcome after LVAD implantation.
ESC Heart Fail. 2022 Dec 22. doi: 10.1002/ehf2.14256.
Abstract

WANG D, Mo Y, Zhang D, Bai Y, et al
Analysis of m(7)G methylation modification patterns and pulmonary vascular immune microenvironment in pulmonary arterial hypertension.
Front Immunol. 2022;13:1014509.
Abstract

LEMMERS JMJ, Vonk MC, van den Ende CHM
Patient-reported outcomes to assess dyspnoea in interstitial lung disease and pulmonary hypertension: a systematic literature review of measurement properties.
Eur Respir Rev. 2022;31:220091.
Abstract

ZHANG Y, Zhang Z, Sun Z, Xie Y, et al
Added value of contrast echocardiography for the evaluation of multiple giant coronary artery aneurysms with coronary to pulmonary arterial fistulas.
Cardiol J. 2022;29:1043-1044.
Abstract

DUBROCK HM, Burger CD, Bartolome SD, Feldman JP, et al
Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypertension Association Registry.
Pulm Circ. 2022;12:e12172.
Abstract

OHIRA H, deKemp R, Kadoya Y, Renaud J, et al
Evaluation of Lung Glucose Uptake with Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/CT in Patients with Pulmonary Arterial Hypertension and Pulmonary Hypertension Due to Left Heart Disease.
Ann Nucl Cardiol. 2022;8:21-29.
Abstract

RAWLINGS GH, Thompson AR, Armstrong I, Beail N, et al
What is the psychosocial burden of COVID-19 on people with pulmonary hypertension?
Clin Respir J. 2022 Dec 20. doi: 10.1111/crj.13570.
Abstract

BAKER CE, Chalmers BP, Taunton MJ, Amundson AW, et al
Primary and Revision Total Hip Arthroplasty in Patients with Pulmonary Hypertension: High Perioperative Mortality and Medical Complications.
J Arthroplasty. 2022 Dec 16:S0883-5403(22)01103.
Abstract

DAVIS-HALL D, Thomas E, Pena B, Magin CM, et al
3D-bioprinted, phototunable hydrogel models for studying adventitial fibroblast activation in pulmonary arterial hypertension.
Biofabrication. 2022;15.
Abstract

LUO X, Hang C, Zhang Z, Le K, et al
PVECs-Derived Exosomal microRNAs Regulate PASMCs via FoxM1 Signaling in IUGR-induced Pulmonary Hypertension.
J Am Heart Assoc. 2022;11:e027177.
Abstract

YANG JZ, Mokhlesi B, Mesarwi OA
Obstructive sleep apnea and pulmonary hypertension: the pendulum swings again.
J Clin Sleep Med. 2022 Dec 19. doi: 10.5664/jcsm.10454.
Abstract

RAWLINGS GH, Thompson AR, Armstrong I, Novakova B, et al
Cognitive and behavioral processes predict anxiety and depression in patients with pulmonary hypertension.
Pulm Circ. 2022;12:e12174.
Abstract

NASRI A, Dupuis J, Carrier M, Racine N, et al
Thirty-year trends and outcome of isolated versus combined group 2 pulmonary hypertension after cardiac transplantation.
Front Cardiovasc Med. 2022;9:841025.
Abstract

TAN R, You Q, Yu D, Xiao C, et al
Novel hub genes associated with pulmonary artery remodeling in pulmonary hypertension.
Front Cardiovasc Med. 2022;9:945854.
Abstract

KLYMENKO TM, Kononovych MI
Clinical significance of correlation between persistent pulmonary hypertension and 8-hydroxy-2-desoxyguanosine level in premature newborns.
J Neonatal Perinatal Med. 2022 Dec 13. doi: 10.3233/NPM-221005.
Abstract

KOGAN E, Didden EM, Lee E, Nnewihe A, et al
A machine learning approach to identifying patients with pulmonary hypertension using real-world electronic health records.
Int J Cardiol. 2022 Dec 14:S0167-5273(22)01890.
Abstract

HU S, Wang L, Xu Y, Li F, et al
Disulfiram attenuates hypoxia-induced pulmonary hypertension by inhibiting GSDMD cleavage and pyroptosis in HPASMCs.
Respir Res. 2022;23:353.
Abstract

BENZA RL, Franco V, Aras MA, Spikes L, et al
Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design.
Respir Res. 2022;23:355.
Abstract

CALE R, Caldeira D
Direct oral anticoagulants in chronic thromboembolic pulmonary hypertension: More high-quality and multinational trials are needed!
Rev Port Cardiol. 2022 Dec 14:S0870-2551(22)00523.
Abstract

LI M, Ying M, Gu S, Zhou Z, et al
SIRT6 inhibits hypoxia-induced pulmonary arterial smooth muscle cells proliferation via HIF-1alpha/PDK4 signaling.
Life Sci. 2023;312:121192.
Abstract

ERDEM K, Duman A
Pulmonary artery pressures and right ventricular dimensions of post-COVID-19 patients without previous significant cardiovascular pathology.
Heart Lung. 2023;57:75-79.
Abstract

OWEIS J, Leamon A, Al-Tarbsheh AH, Goodspeed K, et al
Influence of right ventricular structure and function on hospital outcomes in COVID-19 patients.
Heart Lung. 2023;57:19-24.
Abstract

SIGOWSKA P, Zimoch M, Baska A, Kazik J, et al
Genistein in the Treatment of Hypertension: A Review.
Endocr Metab Immune Disord Drug Targets. 2022;22:1367-1377.
Abstract

CHANG SA, Lee SH, Choi JH, Chung WJ, et al
Real-world practice patterns and characteristics of adverse events with selexipag in Korean patients with pulmonary arterial hypertension.
Expert Opin Drug Saf. 2022;21:1423-1432.
Abstract

WIEDENROTH CB, Bandorski D, Ariobi K, Ghofrani HA, et al
Does Age Matter? Pulmonary Endarterectomy in the Elderly Patient with CTEPH.
Thorac Cardiovasc Surg. 2022;70:663-670.
Abstract

ERTAN O, Aslan GK, Akinci B, Bilge AK, et al
Effect of Ground-Based Walk Training in Pulmonary Hypertension.
Am J Cardiol. 2022 Apr 23. pii: S0002-9149(22)00344.
Abstract

BUTCHER SC, Feloukidis C, Kamperidis V, Yedidya I, et al
Right Ventricular Myocardial Work Characterization in Patients With Pulmonary Hypertension and Relation to Invasive Hemodynamic Parameters and Outcomes.
Am J Cardiol. 2022 Jun 9. pii: S0002-9149(22)00535.
Abstract

KASSIS N, Layoun H, Goyal A, Dong T, et al
Mechanistic Insights into Tricuspid Regurgitation Secondary to Pulmonary Arterial Hypertension.
Am J Cardiol. 2022 May 18. pii: S0002-9149(22)00407.
Abstract

TIAN S, Cai Z, Sen P, van Uden D, et al
Loss of lung microvascular endothelial Piezo2 expression impairs NO synthesis, induces EndMT and is associated with pulmonary hypertension.
Am J Physiol Heart Circ Physiol. 2022 Sep 23. doi: 10.1152/ajpheart.00220.2022.
Abstract

FRIED ND, Whitehead A, Lazartigues E, Yue X, et al
Ovarian hormones do not mediate protection against pulmonary hypertension and right ventricular remodeling in female mice exposed to chronic, inhaled nicotine.
Am J Physiol Heart Circ Physiol. 2022 Oct 7. doi: 10.1152/ajpheart.00467.2022.
Abstract

MAARMAN GJ
Reviewing the suitability of mitochondrial transplantation as therapeutic approach for pulmonary hypertension in the era of personalised medicine.
Am J Physiol Lung Cell Mol Physiol. 2022 Mar 23. doi: 10.1152/ajplung.00484.2021
Abstract

CHEN J, Rodriguez M, Miao J, Liao J, et al
Mechanosensitive channel Piezo1 is required for pulmonary artery smooth muscle cell proliferation.
Am J Physiol Lung Cell Mol Physiol. 2022;322:L737-L760.
Abstract

LU M, Chen LY, Gairhe S, Mazer AJ, et al
Mineralocorticoid receptor antagonist treatment of established pulmonary arterial hypertension improves interventricular dependence in the SU5416-hypoxia rat model.
Am J Physiol Lung Cell Mol Physiol. 2022;322:L315-L332.
Abstract

LEE MH, Sanders L, Kumar R, Hernandez-Saavedra D, et al
Contribution of Fatty Acid Oxidation to the Pathogenesis of Pulmonary Hypertension.
Am J Physiol Lung Cell Mol Physiol. 2022 Jun 28. doi: 10.1152/ajplung.00039.2022
Abstract

CAMPBELL NV, Mickael C, Kumar S, Zhang H, et al
Single-cell RNA sequencing and binary hierarchical clustering define lung interstitial macrophage heterogeneity in response to hypoxia.
Am J Physiol Lung Cell Mol Physiol. 2022;323:L58-L68.
Abstract

OSHITA H, Sawada H, Mitani Y, Tsuboya N, et al
Perinatal hypoxia aggravates occlusive pulmonary vasculopathy in SU5416/hypoxia-treated rats later in life.
Am J Physiol Lung Cell Mol Physiol. 2022;323:L178-L192.
Abstract

SURESH K
Sex as a biologic variable: evidence from isolated lung endothelial cells.
Am J Physiol Lung Cell Mol Physiol. 2022;323:L646-L647.
Abstract

MINHAS J, Baird G, Appleby D, McClelland R, et al
Terminal Digit Preference in Pulmonary Hypertension Endpoints.
Am J Respir Crit Care Med. 2022 Apr 5. doi: 10.1164/rccm.202108-2015.
Abstract

VIZZA CD, Lang IM, Badagliacca R, Benza RL, et al
Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
Am J Respir Crit Care Med. 2022;205:751-760.
Abstract

TELLO K, Kremer N, Richter MJ, Gall H, et al
Inhaled Iloprost Improves Right Ventricular Load-Independent Contractility in Pulmonary Hypertension.
Am J Respir Crit Care Med. 2022 Apr 15. doi: 10.1164/rccm.202201-0095.
Abstract

EVRARD B, Goudelin M, Vaidie J, Fedou AL, et al
Severe Acute Cor Pulmonale in COVID-19 ARDS Patients: Caution with Left Turn.
Am J Respir Crit Care Med. 2022 Feb 4. doi: 10.1164/rccm.202107-1568.
Abstract

CUNNINGHAM CM, Li M, Ruffenach G, Doshi M, et al
Y-Chromosome Gene, Uty, Protects Against Pulmonary Hypertension by Reducing Proinflammatory Chemokines.
Am J Respir Crit Care Med. 2022 May 3. doi: 10.1164/rccm.202110-2309.
Abstract

SINGH N, Ventetuolo CE
Prime Time for Proteomics in Pulmonary Arterial Hypertension Risk Assessment?
Am J Respir Crit Care Med. 2022;205:988-990.
Abstract

RHODES CJ, Wharton J, Swietlik EM, Harbaum L, et al
Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2022;205:1102-1111.
Abstract

ALBA GA
Double Jeopardy: Precapillary Pulmonary Hypertension Increases the Risk of Hospitalization and Death from COVID-19.
Am J Respir Crit Care Med. 2022 May 18. doi: 10.1164/rccm.202205-0884.
Abstract

CONSTANTINE A, Dimopoulos K, Haworth SG, Muthurangu V, et al
Twenty-year experience and outcomes in a National Pediatric Pulmonary Hypertension Service.
Am J Respir Crit Care Med. 2022 May 17. doi: 10.1164/rccm.202110-2428.
Abstract

MONTANI D, Certain MC, Weatherald J, Jais X, et al
COVID-19 in Patients with Pulmonary Hypertension: A National Prospective Cohort Study.
Am J Respir Crit Care Med. 2022 May 12. doi: 10.1164/rccm.202112-2761.
Abstract

RAO R, Chan SY
A dUTY to Protect: Addressing "Y" We See Sex Differences in Pulmonary Hypertension.
Am J Respir Crit Care Med. 2022 May 12. doi: 10.1164/rccm.202204-0653.
Abstract

JIN Q, Guan L, Pan W, Zhang X, et al
Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That's the Question.
Am J Respir Crit Care Med. 2022;205:1250-1251.
Abstract

LAPATRA T, Baird GL, Goodman R, Pinder D, et al
Reply to: Remote 6-minute Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
Am J Respir Crit Care Med. 2022 May 24. doi: 10.1164/rccm.202205-0867.
Abstract

HELGESON SA, Burger CD, Moss JE, Zeiger TK, et al
Remote 6-minute Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
Am J Respir Crit Care Med. 2022 May 24. doi: 10.1164/rccm.202204-0762.
Abstract

PRZEBINDA AS, El Haj Chehade A, Farooqui SM, Youness HA, et al
Assessment of Pulmonary Vascular Disease: Pulmonary Vascular Resistance, Exercise Hemodynamics, and Ventriculovascular Coupling.
Am J Respir Crit Care Med. 2022;205:1349.
Abstract

PROVENCHER S, Potus F, Blais-Lecours P, Bernard S, et al
BET Protein Inhibition for Pulmonary Arterial Hypertension: A Pilot Clinical Trial.
Am J Respir Crit Care Med. 2022;205:1357-1360.
Abstract

SOBRANO FAIS R, Lahm T
Misbehaving Guests in the Right Ventricle: Macrophage NLRP3 Activation in Pulmonary Hypertension.
Am J Respir Crit Care Med. 2022 Jun 15. doi: 10.1164/rccm.202205-0977.
Abstract

ABMAN SH, Mullen MP
Of Registries and Disease Classification: Unmasking the Challenges of Pediatric Pulmonary Hypertension.
Am J Respir Crit Care Med. 2022 Jun 23. doi: 10.1164/rccm.202206-1180.
Abstract

OKAZAKI A, Kinuya K, Fujimoto M
Diffuse Decreased Blood Flow in the Right Lung: Mitral Regurgitation-Induced Pulmonary Hypertension.
Am J Respir Crit Care Med. 2022 Jun 23. doi: 10.1164/rccm.202110-2339.
Abstract

SIMPSON CE, Hassoun PM
Promises and Pitfalls of Multiomics Approaches to Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2022;205:1377-1379.
Abstract

HARBAUM L, Rhodes CJ, Wharton J, Lawrie A, et al
Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2022;205:1449-1460.
Abstract

HERSI K, Elinoff JM
Pulmonary Hypertension due to Interstitial Lung Disease: A New iNKlinig into Disease Pathobiology.
Am J Respir Crit Care Med. 2022 Jun 30. doi: 10.1164/rccm.202206-1186.
Abstract

JANDL K, Marsh LM, Mutgan AC, Crnkovic S, et al
Impairment of the NKT-STAT1-CXCL9-axis Contributes to Vessel Fibrosis in Pulmonary Hypertension Due to Lung Fibrosis.
Am J Respir Crit Care Med. 2022 Jun 28. doi: 10.1164/rccm.202201-0142.
Abstract

WERTHEIM BM
New Tricks for an Old Drug: Prostacyclins and Right Ventricular Contractility in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2022;206:12-13.
Abstract

FRECH TM, Austin ED
Is It Still "Idiopathic"? Features of Autoimmunity in Idiopathic Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2022;206:8-10.
Abstract

JONES RJ, De Bie EMDD, Groves E, Zalewska KI, et al
Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2022;206:81-93.
Abstract

Erratum: Prediction of Health-related Quality of Life and Hospitalization in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry.
Am J Respir Crit Care Med. 2022;206:362-363.
Abstract

YUAN P, Li J, Liu J, Liu H, et al
Cognitive Dysfunction in Patients with Pulmonary Hypertension.
Am J Respir Crit Care Med. 2022 Jul 29. doi: 10.1164/rccm.202204-0726.
Abstract

COTTIN V, Selman M, Inoue Y, Wong AW, et al
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement.
Am J Respir Crit Care Med. 2022;206:e7-e41.
Abstract

AL-QAZAZI R, Lima PDA, Prisco SZ, Potus F, et al
Macrophage-NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2022;206:608-624.
Abstract

BELHAJ A, Dewachter L, Hupkens E, Remmelink M, et al
Tacrolimus Prevents Mechanical and Humoral Alterations in Brain Death-induced Lung Injury in Pigs.
Am J Respir Crit Care Med. 2022;206:584-595.
Abstract

MONTANI D, Weatherald J, Humbert M, Sitbon O, et al
Reply to: Effect of Covid-19 Infection in Pulmonary Hypertension.
Am J Respir Crit Care Med. 2022 Oct 17. doi: 10.1164/rccm.202210-1889.
Abstract

JHA AK
Effect of Covid-19 Infection in Pulmonary Hypertension.
Am J Respir Crit Care Med. 2022 Oct 17. doi: 10.1164/rccm.202209-1790.
Abstract

TAYLOR S, Isobe S, Cao A, Contrepois K, et al
Endogenous Retroviral Elements Generate Pathologic Neutrophils in Pulmonary Arterial Hypertension.
Am J Respir Crit Care Med. 2022;206:1019-1034.
Abstract

GENTLE SJ, Travers CP, Clark M, Carlo WA, et al
Patent Ductus Arteriosus and Development of Bronchopulmonary Dysplasia with Pulmonary Hypertension.
Am J Respir Crit Care Med. 2022 Nov 15. doi: 10.1164/rccm.202203-0570.
Abstract

GENTLE SJ, Travers CP, Nakhmani A, Indic P, et al
Intermittent Hypoxemia and Bronchopulmonary Dysplasia with Pulmonary Hypertension in Preterm Infants.
Am J Respir Crit Care Med. 2022 Nov 30. doi: 10.1164/rccm.202203-0580.
Abstract

DOUSCHAN P, Avian A, Foris V, Sassmann T, et al
Prognostic Value of Exercise as Compared to Resting Pulmonary Hypertension in Patients with Normal or Mildly Elevated Pulmonary Arterial Pressure.
Am J Respir Crit Care Med. 2022;206:1418-1423.
Abstract

GEUBE MA, Hsu A, Skubas NJ, Liang C, et al
Incidence, Outcomes, and Risk Factors for Preincision Cardiac Arrest in Cardiac Surgery Patients.
Anesth Analg. 2022 May 13. pii: 00000539-990000000-00367.
Abstract

KANJEE Z, Freed JA, Carroll BJ, Reynolds EE, et al
How Would You Treat This Patient With Pulmonary Embolism? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
Ann Intern Med. 2022 Aug 9. doi: 10.7326/M22-0989.
Abstract

CHIN CW, Bichell DP
Misclassification of pulmonary hypertension in partial anomalous pulmonary venous return.
Ann Thorac Surg. 2022 Feb 26. pii: S0003-4975(22)00281.
Abstract

LIANG M, Yao J, Wang Z, Wu Z, et al
Endarterectomy for Pulmonary Embolism in a Woman with Unilateral Absence of Pulmonary Artery.
Ann Thorac Surg. 2021 May 25. pii: S0003-4975(21)00894.
Abstract

AL-KHALDI A, Momenah T, Alsahari A, Alotay A, et al
Late Outcomes After Pulmonary Arterial Reconstruction in Patients With Arterial Tortuosity Syndrome.
Ann Thorac Surg. 2022;113:1569-1574.
Abstract

CZAPLA J, Claus I, Martens T, Philipsen T, et al
Midterm comparison between different annuloplasty techniques for functional tricuspid regurgitation.
Ann Thorac Surg. 2021 Aug 25. pii: S0003-4975(21)01465.
Abstract

NOVICK WM, Golovenko OS, Lazorhyshynets VV, Dedovich VV, et al
Sildenafil's Early, Late Impact on Ventricular Septal Repair: Older Children Using the Double Patch.
Ann Thorac Surg. 2022;114:818-825.
Abstract

YANARTAS M, Karakoc AZ, Zengin A, Tas S, et al
Multimodal Approach of Isolated Pulmonary Vasculitis: A Single-Institution Experience.
Ann Thorac Surg. 2022;114:1253-1261.
Abstract

ERKILINC A, Ermerak NO, Zengin A, Olgun Yildizeli S, et al
Is There Any Role of Pulmonary Endarterectomy in Pulmonary Arterial Hydatidosis?
Ann Thorac Surg. 2022;114:2093-2099.
Abstract

MARRA AM, Sherman AE, Salzano A, Guazzi M, et al
Right Heart-Pulmonary Circulation Unit Involvement in Left-sided Heart Failure: Diagnostic, Prognostic and Therapeutic Implications. From the Forgotten Chamber to the Chamber of Secrets.
Chest. 2021 Sep 27. pii: S0012-3692(21)04062-9. doi: 10.1016/j.chest.2021.
Abstract

GENTY T, Wirth C, Humbert M, Fadel E, et al
Pulmonary Endarterectomy in Patients With Myeloproliferative Neoplasms.
Chest. 2022;161:552-556.
Abstract

KHIRFAN G, Melillo CA, Al Abdi S, Lane JE, et al
Impact of Esophageal Pressure Measurement on Pulmonary Hypertension Diagnosis in Obese Patients.
Chest. 2022 Apr 8. pii: S0012-3692(22)00592-X. doi: 10.1016/j.chest.2022.
Abstract

CONDON DF, Agarwal S, Chakraborty A, Auer N, et al
Novel Mechanisms Targeted by Drug Trials in Pulmonary Arterial Hypertension.
Chest. 2022;161:1060-1072.
Abstract

VANDERPOOL RR, Hunter KS, Insel M, Garcia JGN, et al
The Right Ventricular-Pulmonary Arterial Coupling and Diastolic Function Response to Therapy in Pulmonary Arterial Hypertension.
Chest. 2022;161:1048-1059.
Abstract

HADDAD F, Contrepois K, Amsallem M, Denault AY, et al
The Right Heart Network and Risk Stratification in Pulmonary Arterial Hypertension.
Chest. 2022;161:1347-1359.
Abstract

SCHWIENING M, Swietlik EM, Pandya D, Burling K, et al
Different Cytokine Patterns in BMPR2-Mutation-Positive Patients and Patients With Pulmonary Arterial Hypertension Without Mutations and Their Influence on Survival.
Chest. 2022;161:1651-1656.
Abstract

MCCARTHY BE, McClelland RL, Appleby DH, Moutchia JS, et al
BMI and Treatment Response in Patients With Pulmonary Arterial Hypertension: A Meta-analysis.
Chest. 2022;162:436-447.
Abstract

YARLAS A, Mathai SC, Nathan SD, DuBrock HM, et al
Considerations when Selecting Patient-Reported Outcome Measures for Assessment of Health-Related Quality of Life in Patients with Pulmonary Hypertension: A Narrative Review.
Chest. 2022 Aug 20. pii: S0012-3692(22)03649.
Abstract

CHANNICK R, Robert Naeije
A Right Heart Catheterization for the Diagnosis of Pulmonary Hypertension: Yes, But How?
Chest. 2022;162:511-513.
Abstract

SHELBURNE NJ, Frantz RP
The Oracle of the Auricle?: Optimizing Serial Risk Stratification of Patients With Pulmonary Arterial Hypertension.
Chest. 2022;162:509-510.
Abstract

SHAH T, Manthena P, Patel C, Chuah A, et al
Prognostic Value of Echocardiographic Variables Prior to and Following Initiation of Parenteral Prostacyclin Therapy: An Observational Study.
Chest. 2022;162:669-683.
Abstract

NATHAN SD, Deng C, King CS, DuBrock HM, et al
Inhaled Treprostinil Dose in Pulmonary Hypertension Associated with Interstitial Lung Disease and Its Effects on Clinical Outcomes.
Chest. 2022 Sep 14. pii: S0012-3692(22)03725-4. doi: 10.1016/j.chest.2022.
Abstract

MA X, Yu D, Jie B, Li LL, et al
Endovascular Treatment of Central Pulmonary Arterial Pseudoaneurysms in the Context of Silicosis Combined with Pulmonary Tuberculosis.
Chest. 2022 Apr 28. pii: S0012-3692(22)00880-7. doi: 10.1016/j.chest.2022.
Abstract

MARON BA, Kleiner DE, Arons E, Wertheim BM, et al
Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy with Pulmonary Hypertension.
Chest. 2022 Oct 12. pii: S0012-3692(22)03912-5. doi: 10.1016/j.chest.2022.
Abstract

WU S, Hoang HB, Yang JZ, Papamatheakis DG, et al
Drug-Drug Interactions in the Management of Patients With Pulmonary Arterial Hypertension.
Chest. 2022;162:1360-1372.
Abstract

LACHANT D, Kennedy E, Derenze B, Light A, et al
Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension.
Chest. 2022;162:1340-1348.
Abstract

CULLEY MK, Chan SY
Endothelial Senescence: A New Age in Pulmonary Hypertension.
Circ Res. 2022;130:928-941.
Abstract

HUSTON JH, Shah SJ
Understanding the Pathobiology of Pulmonary Hypertension Due to Left Heart Disease.
Circ Res. 2022;130:1382-1403.
Abstract

RHODES CJ, Sweatt AJ, Maron BA
Harnessing Big Data to Advance Treatment and Understanding of Pulmonary Hypertension.
Circ Res. 2022;130:1423-1444.
Abstract

SINGH N, Dorfmuller P, Shlobin OA, Ventetuolo CE, et al
Group 3 Pulmonary Hypertension: From Bench to Bedside.
Circ Res. 2022;130:1404-1422.
Abstract

BOUCHERAT O, Agrawal V, Lawrie A, Bonnet S, et al
The Latest in Animal Models of Pulmonary Hypertension and Right Ventricular Failure.
Circ Res. 2022;130:1466-1486.
Abstract

ALDRED MA, Morrell NW, Guignabert C
New Mutations and Pathogenesis of Pulmonary Hypertension: Progress and Puzzles in Disease Pathogenesis.
Circ Res. 2022;130:1365-1381.
Abstract

KUDRYASHOVA TV, Dabral S, Nayakanti S, Ray A, et al
Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival.
Circ Res. 2022;130:760-778.
Abstract

ALENEZI F, Covington TA, Mukherjee M, Mathai SC, et al
Novel Approaches to Imaging the Pulmonary Vasculature and Right Heart.
Circ Res. 2022;130:1445-1465.
Abstract

WANG C, Xing Y, Zhang J, He M, et al
MED1 Regulates BMP/TGF-beta in Endothelium: Implication for Pulmonary Hypertension.
Circ Res. 2022 Oct 14. doi: 10.1161/CIRCRESAHA.122.321532.
Abstract

KUDRYASHOVA TV, Goncharova EA
MonOrail to Cure? Targeting Orai1 to Reverse Pulmonary Arterial Hypertension.
Circ Res. 2022;131:728-730.
Abstract

MASSON B, Le Ribeuz H, Sabourin J, Laubry L, et al
Orai1 Inhibitors as Potential Treatments for Pulmonary Arterial Hypertension.
Circ Res. 2022;131:e102-e119.
Abstract

NANDULA PS, Shah SD, Park CS, Kim SH, et al
Sox17 Deficiency Promotes Pulmonary Arterial Hypertension via HGF/c-Met Signaling.
Circ Res. 2022;131:792-806.
Abstract

LECHUGA-VIECO AV, Latorre-Pellicer A, Calvo E, Torroja C, et al
Heteroplasmy of Wild Type Mitochondrial DNA Variants in Mice Causes Metabolic Heart Disease With Pulmonary Hypertension and Frailty.
Circulation. 2022 Mar 3. doi: 10.1161/CIRCULATIONAHA.121.056286.
Abstract

STEWART RH, Cox CS Jr, Allen SJ, Laine GA, et al
Myocardial Edema Provides a Link Between Pulmonary Arterial Hypertension and Pericardial Effusion.
Circulation. 2022;145:793-795.
Abstract

BRITTAIN EL, Thenappan T, Huston JH, Agrawal V, et al
Elucidating the Clinical Implications and Pathophysiology of Pulmonary Hypertension in Heart Failure With Preserved Ejection Fraction: A Call to Action: A Science Advisory From the American Heart Association.
Circulation. 2022 Jul 11:101161CIR0000000000001079.
Abstract

STEFFES LC, Cheng P, Quertermous T, Kumar ME, et al
von Willebrand Factor Is Produced Exclusively by Endothelium, Not Neointima, in Occlusive Vascular Lesions in Both Pulmonary Hypertension and Atherosclerosis.
Circulation. 2022;146:429-431.
Abstract

JIN Q, Guan L, Zhou D
Letter by Jin et al Regarding Article, "SPARC, A Novel Regulator of Vascular Cell Function in Pulmonary Hypertension".
Circulation. 2022;146:e14-e15.
Abstract

VEITH C, Ghofrani HA, Weissmann N
Response by Veith et al to Letter Regarding Article, "SPARC, A Novel Regulator of Vascular Cell Function in Pulmonary Hypertension".
Circulation. 2022;146:e16-e17.
Abstract

TREMBLAY E, Gosselin C, Mai V, Lajoie AC, et al
Assessment of Clinical Worsening End Points as a Surrogate for Mortality in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Circulation. 2022 Jul 8:101161CIRCULATIONAHA121058635.
Abstract

Correction to: Nanoparticle Delivery of STAT3 Alleviates Pulmonary Hypertension in a Mouse Model of Alveolar Capillary Dysplasia.
Circulation. 2022;146:e168.
Abstract

ZHONG Y, Yu PB
Decoding the Link Between Inflammation and Pulmonary Arterial Hypertension.
Circulation. 2022;146:1023-1025.
Abstract

YAKU A, Inagaki T, Asano R, Okazawa M, et al
Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages.
Circulation. 2022 Aug 23:101161CIRCULATIONAHA122059435.
Abstract

BRUSCA SB, Elinoff JM, Zou Y, Jang MK, et al
Plasma Cell-Free DNA Predicts Survival and Maps Specific Sources of Injury in Pulmonary Arterial Hypertension.
Circulation. 2022 Aug 25:101161CIRCULATIONAHA121056719.
Abstract

RUFFENACH G, Medzikovic L, Aryan L, Li M, et al
HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension.
Circulation. 2022 Aug 22:101161CIRCULATIONAHA122059591.
Abstract

JHA AK
Letter by Jha Regarding Article, "Latent Pulmonary Vascular Disease and Therapeutic Atrial Shunt".
Circulation. 2022;146:e242-e243.
Abstract

BORLAUG BA, Shah SJ
Response by Borlaug and Shah Regarding Article, "Latent Pulmonary Vascular Disease and Therapeutic Atrial Shunt".
Circulation. 2022;146:e244-e245.
Abstract

ZHOU W, Liu K, Zeng L, He J, et al
Targeting VEGF-A/VEGFR2 Y949 Signaling-Mediated Vascular Permeability Alleviates Hypoxic Pulmonary Hypertension.
Circulation. 2022 Nov 17. doi: 10.1161/CIRCULATIONAHA.122.061900.
Abstract

BORN E, Lipskaia L, Breau M, Houssaini A, et al
Eliminating Senescent Cells Can Promote Pulmonary Hypertension Development and Progression.
Circulation. 2022 Dec 14. doi: 10.1161/CIRCULATIONAHA.122.058794.
Abstract

XUE L, Yang YC, Zhao Q, Zhao ZH, et al
The spectrum and prevalence of arrhythmia in different clinical pulmonary hypertension groups in Chinese population.
Clin Cardiol. 2022 Mar 7. doi: 10.1002/clc.23803.
Abstract

RAZA F, Dharmavaram N, Hess T, Dhingra R, et al
Distinguishing exercise intolerance in early-stage pulmonary hypertension with invasive exercise hemodynamics: Rest VE /VCO2 and ETCO2 identify pulmonary vascular disease.
Clin Cardiol. 2022 Apr 14. doi: 10.1002/clc.23831.
Abstract

SONG W, Zhu J, Zhong Z, Song Y, et al
Long-term outcome prediction for chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy.
Clin Cardiol. 2022 Sep 7. doi: 10.1002/clc.23900.
Abstract

SEMEN KO, Bast A
Senescence in pulmonary arterial hypertension: is there a link?
Curr Opin Pulm Med. 2022;28:303-306.
Abstract

GARCIA AR, Piccari L
Emerging phenotypes of pulmonary hypertension associated with COPD a field guide.
Curr Opin Pulm Med. 2022 Jul 16. pii: 00063198-990000000-00012.
Abstract

KENNEDY JLW, Mihalek AD
Update in approaches to pulmonary hypertension because of left heart disease.
Curr Opin Pulm Med. 2022 Jul 16. pii: 00063198-990000000-00013.
Abstract

LANG IM
Update on balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension.
Curr Opin Pulm Med. 2022;28:369-374.
Abstract

DE PERROT M
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism.
Curr Opin Pulm Med. 2022;28:384-390.
Abstract

KOLAITIS NA, Saggar R, De Marco T
Methamphetamine-associated pulmonary arterial hypertension.
Curr Opin Pulm Med. 2022;28:352-360.
Abstract

MEDREK S, Melendres-Groves L
Evolving nonvasodilator treatment options for pulmonary arterial hypertension.
Curr Opin Pulm Med. 2022;28:361-368.
Abstract

TRAVIN N, Dalinin V, Salimov D
Thoracic bilateral sympathectomy as a new method of pulmonary arterial hypertension treatment: gaps of evidence.
Eur J Cardiothorac Surg. 2022;61:1346-1347.
Abstract

GOLOVENKO O, Lazorhyshynets V, Prokopovych L, Truba Y, et al
Early and Long-term Results of Ventricular Septal Defect Repair in Children with Severe Pulmonary Hypertension and Elevated Pulmonary Vascular Resistance by Double or Traditional Patch Technique.
Eur J Cardiothorac Surg. 2022 Jun 29. pii: 6619555. doi: 10.1093.
Abstract

NISHIKAWA H, Yamashita K, Niwa K, Taniguchi S, et al
Coronary-pulmonary arterial fistula with anomalous origin and aneurysms of the coronary arteries.
Eur J Cardiothorac Surg. 2022;62.
Abstract

SU AY, Vinogradsky A, Wang AS, Ning Y, et al
Impact of sex, race and socioeconomic status on survival after pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension.
Eur J Cardiothorac Surg. 2022;62.
Abstract

LOTTO AA
Children Presenting Late with Ventricular Septal Defect and Pulmonary Hypertension: "Prevention is better than cure" (Desiderius Erasmus 1500 Circa).
Eur J Cardiothorac Surg. 2022 Sep 2. pii: 6687128. doi: 10.1093.
Abstract

OPITZ I
No "Great divide" in chronic thromboembolic pulmonary hypertension patients undergoing pulmonary endarterectomy?
Eur J Cardiothorac Surg. 2022 Sep 13. pii: 6696713. doi: 10.1093.
Abstract

POVEDA D, Fadel E, Lorenzi W, Menager JB, et al
A bilateral lung transplant and giant pulmonary artery aneurysm reconstruction with an aortic graft in a woman with pulmonary hypertension.
Eur J Cardiothorac Surg. 2022;62:ezac538.
Abstract

TOSHNER M, Church C, Harbaum L, Rhodes C, et al
Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension.
Eur Respir J. 2022;59.
Abstract

AZZO L, Ali YS, Vaqar S, Dauriat G, et al
Severe pulmonary hypertension associated with chronic obstructive pulmonary disease Long-term results of a prospective French multicenter cohort.
Eur Respir J. 2022 May 20. pii: 13993003.02897-2021.
Abstract

NEDER JA, Phillips DB, O'Donnell DE, Dempsey JA, et al
Excess ventilation and exertional dyspnoea in heart failure and pulmonary hypertension.
Eur Respir J. 2022 May 26. pii: 13993003.00144-2022.
Abstract

BENATTIA A, Bugnet E, Walter-Petrich A, de Margerie-Mellon C, et al
Long-term outcomes of adult pulmonary Langerhans cell histiocytosis: a prospective cohort.
Eur Respir J. 2022;59.
Abstract

CERTAIN MC, Baron A, Turpin M, Ebstein N, et al
Outcomes of cirrhotic patients with pre-capillary pulmonary hypertension and pulmonary vascular resistance between 2 and 3 Wood Units.
Eur Respir J. 2022 Jun 9. pii: 13993003.00107-2022.
Abstract

ALI MK, Schimmel K, Zhao L, Chen CK, et al
The role of circular RNAs in pulmonary hypertension.
Eur Respir J. 2022 Jun 9. pii: 13993003.00012-2022.
Abstract

BOUCLY A, Humbert M, Sitbon O
To be or not to be... treated with initial combination therapy, that is the (PAH) question.
Eur Respir J. 2022;59.
Abstract

HOEPER MM, Pausch C, Grunig E, Staehler G, et al
Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry.
Eur Respir J. 2022;59.
Abstract

ZELT JGE, Sugarman J, Weatherald J, Partridge ACR, et al
Mortality trends in pulmonary arterial hypertension in Canada: a temporal analysis of survival per ESC/ERS guideline era.
Eur Respir J. 2022;59.
Abstract

VAN DER HAVE O, Westoo C, Ahrne F, Tian X, et al
Shunt-type plexiform lesions identified in the Sugen5416/hypoxia rat model of pulmonary arterial hypertension using synchrotron-based phase-contrast micro-CT.
Eur Respir J. 2022;59.
Abstract

NAEIJE R, Richter MJ, Rubin LJ
The physiological basis of pulmonary arterial hypertension.
Eur Respir J. 2022;59.
Abstract

WESSELS JN, Mouratoglou SA, van Wezenbeek J, Handoko ML, et al
Right atrial function is associated with right venticular diastolic stiffness: RA-RV interaction in pulmonary arterial hypertension.
Eur Respir J. 2022;59.
Abstract

LIU B, Peng Y, Yi D, Machireddy N, et al
Endothelial PHD2 deficiency induces nitrative stress via suppression of caveolin-1 in pulmonary hypertension.
Eur Respir J. 2022 Jul 7. pii: 13993003.02643-2021.
Abstract

STUBBS H, Lua S, Brewis M, Johnson M, et al
COMPERA 2.0 risk stratification in medically-managed chronic thromboembolic pulmonary hypertension.
Eur Respir J. 2022 Jul 7. pii: 13993003.00313-2022.
Abstract

JUTANT EM, Tu L, Thuillet R, Picard V, et al
Erythrocytes are altered in pulmonary arterial hypertension.
Eur Respir J. 2022;59.
Abstract

GHOFRANI HA
Selexipag for inoperable CTEPH: why meeting a primary endpoint simply isn't enough.
Eur Respir J. 2022;60.
Abstract

DU M, Jiang H, Liu H, Zhao X, et al
Single-cell RNA sequencing reveals that BMPR2 mutation regulates right ventricular function via ID genes.
Eur Respir J. 2022;60.
Abstract

HOEPER MM, Pausch C, Olsson KM, Huscher D, et al
COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.
Eur Respir J. 2022;60.
Abstract

MADOUN S, Piliero N, Guillien A, Salvat M, et al
Improved ventilatory efficiency to evidence haemodynamic improvement after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
Eur Respir J. 2022 Jul 27. pii: 13993003.00762-2022.
Abstract

SWINNEN K, Bijnens E, Casas L, Nawrot TS, et al
Health effects of exposure to residential air pollution in patients with pulmonary arterial hypertension: a cohort study in Belgium.
Eur Respir J. 2022;60.
Abstract

VAN DE VEERDONK MC, Vonk-Noordegraaf A, Vachiery JL
Unbowed, unbent, unbroken: predicting pulmonary hypertension using echocardiography.
Eur Respir J. 2022;60.
Abstract

OLSSON KM, Richter MJ, Kamp JC, Gall H, et al
Refined risk stratification in pulmonary arterial hypertension and timing of lung transplantation.
Eur Respir J. 2022 Feb 10. pii: 13993003.03087-2021.
Abstract

HUMBERT M, Kovacs G, Hoeper MM, Badagliacca R, et al
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.
Eur Respir J. 2022 Aug 25. pii: 13993003.00879-2022.
Abstract

LECHARTIER B, Girerd B, Eyries M, Beurnier A, et al
Screening for pulmonary veno-occlusive disease in heterozygous EIF2AK4 variant carriers.
Eur Respir J. 2022;60.
Abstract

RAI N, Sydykov A, Kojonazarov B, Wilhelm J, et al
Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension.
Eur Respir J. 2022;60.
Abstract

HASSAN HJ, Naranjo M, Kazzi B, Housten-Harris T, et al
Risk assessment of systemic sclerosis-associated pulmonary arterial hypertension: cardiac index versus stroke volume index.
Eur Respir J. 2022;60.
Abstract

RIOU M, Canuet M, Ghigna MR, Eyries M, et al
First histological description of pulmonary and vascular abnormalities of pulmonary hypertension associated with KDR pathogenic variant.
Eur Respir J. 2022 Sep 30. pii: 13993003.01197-2022.
Abstract

DOUSCHAN P, Tello K, Rieth AJ, Wiedenroth CB, et al
Right ventricular-pulmonary arterial coupling and its relationship to exercise haemodynamics in a continuum of patients with pulmonary vascular disease due to chronic thromboembolism.
Eur Respir J. 2022;60.
Abstract

MICKAEL C, Lee MH, Graham BB
The COVID-19 pandemic and pulmonary arterial hypertension in Italy: adaptation, outcomes and valuable lessons learned.
Eur Respir J. 2022;60.
Abstract

BADAGLIACCA R, Papa S, D'Alto M, Ghio S, et al
The paradox of pulmonary arterial hypertension in Italy in the COVID-19 era: is risk of disease progression around the corner?
Eur Respir J. 2022;60.
Abstract

ADNOT S, Lipskaia L, Bischof O
What is hidden behind a pulmonary hypertensive, fibrotic and inflammatory phenotype?
Eur Respir J. 2022;60.
Abstract

SHU T, Zhang J, Zhou Y, Chen Z, et al
Eosinophils Protect Against Pulmonary Hypertension through 14-HDHA and 17-HDHA.
Eur Respir J. 2022 Nov 24:2200582. doi: 10.1183/13993003.00582-2022.
Abstract

GALKIN A, Sitapara R, Clemons B, Garcia E, et al
Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension.
Eur Respir J. 2022;60:2102356.
Abstract

TAKAYA Y, Akagi T, Sakamoto I, Kanazawa H, et al
Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension.
Heart. 2022;108:382-387.
Abstract

OTTO CM
Heartbeat: right ventricular remodelling in pulmonary hypertension.
Heart. 2022;108:1331-1333.
Abstract

D'ALTO M, Badagliacca R
The importance of right ventricular remodelling in pulmonary arterial hypertension.
Heart. 2022;108:1338-1339.
Abstract

GOH ZM, Balasubramanian N, Alabed S, Dwivedi K, et al
Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response.
Heart. 2022;108:1392-1400.
Abstract

HENDRIKS PM, Kauling RM, Geenen LW, Eindhoven JA, et al
Role of the electrocardiogram in the risk stratification of pulmonary hypertension.
Heart. 2022 Sep 28. pii: heartjnl-2022-321475. doi: 10.1136/heartjnl-2022-321475
Abstract

YAN C, Wan L, Li H, Wang C, et al
First in-human modified atrial septostomy combining radiofrequency ablation and balloon dilation.
Heart. 2022;108:1690-1698.
Abstract

SERA F, Ohtani T, Tamaki S, Yano M, et al
Pulmonary hypertension with a precapillary component in heart failure with preserved ejection fraction.
Heart. 2022 Dec 21:heartjnl-2022-321565. doi: 10.1136/heartjnl-2022-321565.
Abstract

BARTNIK A, Pepke-Zaba J, Hoole SP, White P, et al
Right ventricular-pulmonary artery coupling in chronic thromboembolic pulmonary hypertension.
Heart. 2022 Dec 22:heartjnl-2022-321770. doi: 10.1136/heartjnl-2022-321770.
Abstract

HUANG S, Vignon P, Mekontso-Dessap A, Tran S, et al
Echocardiography findings in COVID-19 patients admitted to intensive care units: a multi-national observational study (the ECHO-COVID study).
Intensive Care Med. 2022 Apr 21. pii: 10.1007/s00134-022-06685.
Abstract

ARVANITAKI A, Gatzoulis MA, Opotowsky AR, Khairy P, et al
Eisenmenger Syndrome: JACC State-of-the-Art Review.
J Am Coll Cardiol. 2022;79:1183-1198.
Abstract

OLIN JW, Johnston-Cox H
Angioplasty to Treat Pulmonary Hypertension in Takayasu Arteritis: An Uncommon Treatment for an Uncommon Disease.
J Am Coll Cardiol. 2022;79:1489-1491.
Abstract

ZHOU YP, Wei YP, Yang YJ, Xu XQ, et al
Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension.
J Am Coll Cardiol. 2022;79:1477-1488.
Abstract

WILKINS MR
Pulmonary Hypertension: Dissecting a Complex Phenotype.
J Am Coll Cardiol. 2022;80:719-721.
Abstract

HEMNES AR, Leopold JA, Radeva MK, Beck GJ, et al
Clinical Characteristics and Transplant-Free Survival Across the Spectrum of Pulmonary Vascular Disease.
J Am Coll Cardiol. 2022;80:697-718.
Abstract

GENEREUX P
Pulmonary Hypertension and Aortic Stenosis: A Piece of the Puzzle.
J Am Coll Cardiol. 2022;80:1614-1616.
Abstract

MIYAMOTO J, Ohno Y, Kamioka N, Ikari Y, et al
Impact of Periprocedural Pulmonary Hypertension on Outcomes After Transcatheter Aortic Valve Replacement.
J Am Coll Cardiol. 2022;80:1601-1613.
Abstract

HENKE VG
Inhaled Selective Pulmonary Vasodilator Use After Cardiac Surgery: Broader Insights From a Study Describing Significant Changes in Drug Utilization and Savings After Implementation of a Guideline Favoring Inhaled Epoprostenol.
J Cardiothorac Vasc Anesth. 2022 Jan 23. pii: S1053-0770(22)00055.
Abstract

SIEGRIST KK, Woolard AA, Hillenbrand KD, Shah AS, et al
An Unusual Finding in a Patient Presenting for Pulmonary Thromboendarterectomy: Pulmonary Venous Thrombosis.
J Cardiothorac Vasc Anesth. 2022;36:2046-2050.
Abstract

TULL CM, Abraham AM, MacArthur JW, Vanneman MW, et al
Intraoperative Considerations in a Patient on Intravenous Epoprostenol Undergoing Minimally Invasive Cardiac Surgery.
J Cardiothorac Vasc Anesth. 2022 Apr 22. pii: S1053-0770(22)00282.
Abstract

SONG W, Chu S, Yang K, Sun X, et al
Perinatal Management and Long-Term Follow-up of a Primipara With Severe Pulmonary Arterial Hypertension Associated With Systemic Lupus Erythematosus.
J Cardiothorac Vasc Anesth. 2022;36.
Abstract

RICHARDSON A, Scott JP, White J, Labovsky K, et al
Isolated Left Upper Extremity Desaturation and Pulmonary Hypertension: What is the Diagnosis?
J Cardiothorac Vasc Anesth. 2022 Jul 8. pii: S1053-0770(22)00517.
Abstract

KRICHEVSKIY LA
Reduction of Pulmonary Arterial Blood Flow as a Possible Mechanism for Bronchospasm During Cardiopulmonary Bypass.
J Cardiothorac Vasc Anesth. 2022;36:4228.
Abstract

NGUYEN R, Murra A, Capdeville M
Chronic Thromboembolic Pulmonary Hypertension Due to a Rare Anterior Mediastinal Venous Malformation.
J Cardiothorac Vasc Anesth. 2022 Nov 22:S1053-0770(22)00820.
Abstract

CAI H, Fan S, Cai L, Zhu L, et al
Dihydroartemisinin attenuates hypoxia-induced pulmonary hypertension through the ELAVL2/miR-503/PI3K/AKT axis.
J Cardiovasc Pharmacol. 2022 May 5. pii: 00005344-990000000-00028.
Abstract

ZIP12 Contributes to Hypoxic Pulmonary Hypertension by Driving Phenotypic Switching of Pulmonary Artery Smooth Muscle Cells: Erratum.
J Cardiovasc Pharmacol. 2022;79:758.
Abstract

IMAM SS, El-Farrash RA, Taha AS, Saleh GA, et al
Milrinone Versus Sildenafil in Treatment of Neonatal Persistent Pulmonary Hypertension: A Randomized Control Trial.
J Cardiovasc Pharmacol. 2022 Jul 12. pii: 00005344-990000000-00081.
Abstract

KANG L, Liu X, Li Z, Li X, et al
Sildenafil improves pulmonary vascular remodeling in a rat model of persistent pulmonary hypertension of the newborn.
J Cardiovasc Pharmacol. 2022 Oct 1. pii: 00005344-990000000-00118.
Abstract

HANSMANN G, Diekmann F, Chouvarine P, Ius F, et al
Full recovery of right ventricular systolic function in children undergoing bilateral lung transplantation for severe PAH.
J Heart Lung Transplant. 2021 Oct 29. pii: S1053-2498(21)02568.
Abstract

HUMBERT M, Simonneau G, Pittrow D, Delcroix M, et al
Oral anticoagulants (NOAC and VKA) in chronic thromboembolic pulmonary hypertension.
J Heart Lung Transplant. 2022 Feb 11. pii: S1053-2498(22)01804.
Abstract

BENZA RL, Boucly A, Farber HW, Frost AE, et al
Change in REVEAL Lite 2 risk score predicts outcomes in patients with pulmonary arterial hypertension in the PATENT study.
J Heart Lung Transplant. 2022;41:411-420.
Abstract

VAN WEZENBEEK J, Groeneveldt JA, Llucia-Valldeperas A, van der Bruggen CE, et al
Interplay of sex hormones and long-term right ventricular adaptation in a Dutch PAH-cohort.
J Heart Lung Transplant. 2022;41:445-457.
Abstract

WEATHERALD J, Thakrar MV, Varughese RA, Kularatne M, et al
Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial.
J Heart Lung Transplant. 2022;41:563-567.
Abstract

BADAGLIACCA R, Rischard F, Giudice FL, Howard L, et al
Incremental value of cardiopulmonary exercise testing in intermediate-risk pulmonary arterial hypertension.
J Heart Lung Transplant. 2022;41:780-790.
Abstract

ABDELNOUR-BERCHTOLD E, Donahoe L, McRae K, Asghar U, et al
Central venoarterial extracorporeal membrane oxygenation as a bridge to recovery after pulmonary endarterectomy in patients with decompensated right heart failure.
J Heart Lung Transplant. 2022;41:773-779.
Abstract

SUN QW, Sun Z
Stem cell therapy for pulmonary arterial hypertension: An update.
J Heart Lung Transplant. 2022;41:692-703.
Abstract

GAIOTTO FA, Bacal F, Steffen SP, Marcondes-Braga FG, et al
A modified heterotopic heart transplant technique to bridge patients with "fixed" pulmonary hypertension: A case report.
J Heart Lung Transplant. 2022 May 1. pii: S1053-2498(22)01917.
Abstract

WIEDENROTH CB, Deissner H, Adameit MSD, Kriechbaum SD, et al
Complications of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: Impact on the outcome.
J Heart Lung Transplant. 2022 May 20. pii: S1053-2498(22)01944.
Abstract

REDDY SA, Nethercott SL, Teh W, De Bie EM, et al
Prevalence and clinical significance of conduction disease in patients with idiopathic pulmonary arterial hypertension.
J Heart Lung Transplant. 2022;41:861-865.
Abstract

HOEPER MM, Pausch C, Olsson KM, Huscher D, et al
Prognostic value of improvement endpoints in pulmonary arterial hypertension trials: A COMPERA analysis.
J Heart Lung Transplant. 2022;41:971-981.
Abstract

KIANZAD A, van Wezenbeek J, Celant LR, Oosterveer FPT, et al
Idiopathic pulmonary arterial hypertension patients with a high H2FPEF-score: Insights from the Amsterdam UMC PAH-cohort.
J Heart Lung Transplant. 2022;41:1075-1085.
Abstract

BONTA PI, Tramper J, Eberl S, Tepaske R, et al
Endobronchial blocker use for massive, focal pulmonary hemorrhage during pulmonary endarterectomy for CTEPH.
J Heart Lung Transplant. 2022;41:1130-1133.
Abstract

GULATI G, Grandin EW, DeNofrio D, Upshaw JN, et al
Association between postoperative hemodynamic metrics of pulmonary hypertension and right ventricular dysfunction and clinical outcomes after left ventricular assist device implantation.
J Heart Lung Transplant. 2022 Jul 23. pii: S1053-2498(22)02029.
Abstract

HALPERN SE, Wright MC, Madsen G, Chow B, et al
Textbook outcome in lung transplantation: Planned venoarterial extracorporeal membrane oxygenation versus off-pump support for patients without pulmonary hypertension.
J Heart Lung Transplant. 2022 Jul 21. pii: S1053-2498(22)02041.
Abstract

MCGLOTHLIN DP, Granton J, Klepetko W, Beghetti M, et al
ISHLT consensus statement: Perioperative management of patients with pulmonary hypertension and right heart failure undergoing surgery.
J Heart Lung Transplant. 2022;41:1135-1194.
Abstract

VICAIRE H, Pavec JL, Mercier O, Montani D, et al
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation.
J Heart Lung Transplant. 2022 Jun 6. pii: S1053-2498(22)01974.
Abstract

GARRY JD, Kolaitis NA, Kronmal R, Thenappan T, et al
Anticoagulation in pulmonary arterial hypertension - association with mortality, healthcare utilization, and quality of life: The Pulmonary Hypertension Association Registry (PHAR).
J Heart Lung Transplant. 2022 Aug 28. pii: S1053-2498(22)02085.
Abstract

WIEDENROTH CB, Rolf A, Steinhaus K, Adameit MSD, et al
Riociguat and balloon pulmonary angioplasty improve prognosis in patients with inoperable chronic thromboembolic pulmonary Hypertension.
J Heart Lung Transplant. 2022 Aug 23. pii: S1053-2498(22)02077.
Abstract

WEATHERALD J, Iqbal H, Mielniczuk L, Syed AR, et al
Priorities for pulmonary hypertension research: A James Lind Alliance priority setting partnership.
J Heart Lung Transplant. 2022 Oct 3. pii: S1053-2498(22)02160.
Abstract

BENZA RL, Gomberg-Maitland M, Farber HW, Vizza CD, et al
Contemporary risk scores predict clinical worsening in pulmonary arterial hypertension - An analysis of FREEDOM-EV.
J Heart Lung Transplant. 2022;41:1572-1580.
Abstract

UKITA R, Stokes JW, Wu WK, Patel YJ, et al
Large animal preclinical investigation into the optimal extracorporeal life support configuration for pulmonary hypertension and right ventricular failure.
J Heart Lung Transplant. 2022 Nov 6:S1053-2498(22)02205.
Abstract

KRIECHBAUM SD, Birmes J, Wiedenroth CB, Adameit MSD, et al
Exercise MR-proANP unmasks latent right heart failure in CTEPH.
J Heart Lung Transplant. 2022;41:1819-1830.
Abstract

FAUVEL C, Raitiere O, Boucly A, De Groote P, et al
Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment.
J Heart Lung Transplant. 2022;41:1761-1772.
Abstract

ZI-YANG Y, Hezhi L, Nanshan X, Yin Z, et al
Model for screening adult congenital heart disease surgery eligibility with echocardiography parameters.
J Heart Lung Transplant. 2022;41:1831-1838.
Abstract

SALLMON H, Koestenberger M, Avian A, Reiterer F, et al
Extremely premature infants born at 23-25 weeks gestation are at substantial risk for pulmonary hypertension.
J Perinatol. 2022 Apr 1. pii: 10.1038/s41372-022-01374.
Abstract

DILLARD J, Pavlek LR, Korada S, Chen B, et al
Worsened short-term clinical outcomes in a cohort of patients with iNO-unresponsive PPHN: a case for improving iNO responsiveness.
J Perinatol. 2022;42:37-44.
Abstract

MEMON N, Griffin I
Correspondence: "Patent ductus arteriosus shunt elimination results in a reduction in adverse outcomes: a post hoc analysis of the PDA RCT cohort".
J Perinatol. 2022;42:692.
Abstract

AVITABILE CM, Zhang X, Ampah SB, Wang Y, et al
Factors associated with discontinuation of pulmonary vasodilator therapy in children with bronchopulmonary dysplasia-associated pulmonary hypertension.
J Perinatol. 2022 Jun 8. pii: 10.1038/s41372-022-01421.
Abstract

CARPENTER RJ, Srdanovic N, Rychlik K, Sen SK, et al
The association between pulmonary vascular disease and respiratory improvement in infants with type I severe bronchopulmonary dysplasia.
J Perinatol. 2022 Apr 9. pii: 10.1038/s41372-022-01386.
Abstract

PARK L, Donohue L, Lakshminrusimha S, Sankaran D, et al
Intravitreal bevacizumab injection for retinopathy of prematurity and pulmonary hypertension.
J Perinatol. 2022 Aug 15. pii: 10.1038/s41372-022-01489.
Abstract

DE CARVALHO NUNES G, Wutthigate P, Simoneau J, Dancea A, et al
The biventricular contribution to chronic pulmonary hypertension of the extremely premature infant.
J Perinatol. 2022 Aug 25. pii: 10.1038/s41372-022-01497.
Abstract

GIEN J, Kinsella JP, Behrendt NJ, Zaretsky MV, et al
Improved survival for infants with severe congenital diaphragmatic hernia.
J Perinatol. 2022 Apr 23. pii: 10.1038/s41372-022-01397.
Abstract

EL-KHUFFASH A, McNamara PJ, Breatnach C, Bussmann N, et al
The use of milrinone in neonates with persistent pulmonary hypertension of the newborn - a randomised controlled trial pilot study (MINT 1).
J Perinatol. 2022 Nov 16. pii: 10.1038/s41372-022-01562.
Abstract

STEFLIK HJ, Brinton DL, Corrigan C, Wagner CL, et al
Costs associated with acute kidney injury in critically Ill neonates with patent Ductus arteriosus: pediatric health information system (PHIS) analysis.
J Perinatol. 2022 Sep 7. pii: 10.1038/s41372-022-01499.
Abstract

MURPHY C, Bussmann N, Staunton D, McCallion N, et al
The effect of patent ductus arteriosus treatment with paracetamol on pulmonary vascular resistance.
J Perinatol. 2022;42:1697-1698.
Abstract

DE PERROT M, Donahoe L, McRae K, Thenganatt J, et al
Outcome after pulmonary endarterectomy for segmental chronic thromboembolic pulmonary hypertension.
J Thorac Cardiovasc Surg. 2022 Mar 1. pii: S0022-5223(22)00205.
Abstract

CHARLES EJ, Wertheim BM
Commentary: Small packages, big questions: Mitochondrial transplantation in a preclinical model of pulmonary arterial hypertension.
J Thorac Cardiovasc Surg. 2022;163:e379-e380.
Abstract

HSU CH, Roan JN, Fang SY, Chiu MH, et al
Transplantation of viable mitochondria improves right ventricular performance and pulmonary artery remodeling in rats with pulmonary arterial hypertension.
J Thorac Cardiovasc Surg. 2022;163:e361-e373.
Abstract

GIULINI L, Mittal SK, Masuda T, Razia D, et al
Factors associated with esophageal motility improvement after bilateral lung transplant in patients with an aperistaltic esophagus.
J Thorac Cardiovasc Surg. 2022;163:1979-1986.
Abstract

BICHELL DP
Commentary: The illogic of oversizing donor hearts for pulmonary hypertension.
J Thorac Cardiovasc Surg. 2022 May 11. pii: S0022-5223(22)00536.
Abstract

GOLDSTONE AB, Bacha EA, Rosenzweig EB
Commentary: Keeping the reversed Potts shunt reversed: Insights from the fourth dimension.
J Thorac Cardiovasc Surg. 2022;164:342-343.
Abstract

SCHAFER M, Frank BS, Grady RM, Eghtesady P, et al
Monitoring and evaluation of the surgical Potts shunt physiology using 4-dimensional flow magnetic resonance imaging.
J Thorac Cardiovasc Surg. 2022;164:331-341.
Abstract

AHMED EA, Schaff HV, Al-Lami HS, Lahr BD, et al
Prevalence and influence of pulmonary hypertension in patients with obstructive hypertrophic cardiomyopathy undergoing septal myectomy.
J Thorac Cardiovasc Surg. 2022 Sep 7. pii: S0022-5223(22)00915.
Abstract

HIRJI SA, Shin B, Aranki S
Commentary: Pulmonary hypertension and survival in hypertrophic cardiomyopathy: A predictor or a surrogate?
J Thorac Cardiovasc Surg. 2022 Oct 8. pii: S0022-5223(22)01046.
Abstract

SCHAFF HV
Commentary: Does pulmonary hypertension change the management of patients undergoing septal myectomy for obstructive hypertrophic cardiomyopathy?
J Thorac Cardiovasc Surg. 2022 Nov 1:S0022-5223(22)01161.
Abstract

WEATHERALD J, Boucly A, Peters A, Montani D, et al
The evolving landscape of pulmonary arterial hypertension clinical trials.
Lancet. 2022;400:1884-1898.
Abstract

JOSE A, Shah SA, Anwar N, Jones CR, et al
Pulmonary Vascular Resistance Predicts Mortality and Graft Failure in Transplantation Patients With Portopulmonary Hypertension.
Liver Transpl. 2021;27:1811-1823.
Abstract

DUBROCK HM, Del Valle KT, Krowka MJ
Mending the Model for End-Stage Liver Disease: An in-depth review of the past, present, and future portopulmonary hypertension Model for End-Stage Liver Disease exception.
Liver Transpl. 2022;28:1224-1230.
Abstract

VALETTE K, Bermudez J, Habert P, Puech B, et al
[Computed tomography lung density and small vessel quantification in pulmonary hypertension associated with progressive fibrosing interstitial lung disease (PF-ILD)].
Rev Mal Respir. 2022 Feb 24. pii: S0761-8425(21)00414.
Abstract

VALENTIN S, Maurac A, Mandry D, Selton-Suty C, et al
[The role of cardiac magnetic resonance imaging in pulmonary arterial hypertension and chronic thrombo-embolic pulmonary hypertension].
Rev Mal Respir. 2022 Mar 16. pii: S0761-8425(22)00132.
Abstract

WAJDA-POKRONTKA M, Nadziakiewicz P, Krauchuk A, Ochman M, et al
Incidence and Perioperative Risk Factors of Acute Kidney Injury Among Lung Transplant Recipients.
Transplant Proc. 2022;54:1120-1123.
Abstract

LIVINGSTONE J, Raveh Y, Souki F, Shatz V, et al
Multivisceral Transplant in a Patient With Portopulmonary Hypertension: A Case Report.
Transplant Proc. 2022;54:1664-1670.
Abstract

ABLONCZY L, Mayer Z, Somoskovi O, Berkes A, et al
Assessment of Quality of Life in Children With Pulmonary Hypertension Using Parent and Self-report Questionnaires.
Transplant Proc. 2022 Nov 15:S0041-1345(22)00721.
Abstract

LOPEZ-VILELLA R, Paniagua-Martin MJ, Gonzalez-Vilchez F, Donoso Trenado V, et al
Prevalence of Tricuspid Regurgitation After Orthotopic Heart Transplantation and Its Evolution in the Follow-up Period: A Long-Term Study.
Transplant Proc. 2022 Oct 26:S0041-1345(22)00600.
Abstract

LOPEZ-VILELLA R, Gomez Bueno M, Gonzalez Vilchez F, Sole Jover A, et al
Evolving Indications for Heart-Lung Transplant in Spain.
Transplant Proc. 2022;54:2500-2502.
Abstract

COLEBANK MJ, Chesler NC
An in-silico analysis of experimental designs to study ventricular function: A focus on the right ventricle.
PLoS Comput Biol. 2022;18:e1010017.
Abstract

BOLOURANI S, Sari E, Brenner M, Wang P, et al
The role of eCIRP in bleomycin-induced pulmonary fibrosis in mice.
PLoS One. 2022;17:e0266163.
Abstract

HAYASHI R, Kogiso T, Kikuchi N, Yamamoto K, et al
Portopulmonary hypertension and the risk of high right ventricular systolic pressure in liver transplant candidates.
PLoS One. 2022;17:e0267125.
Abstract

VICENZI M, Caravita S, Rota I, Casella R, et al
The added value of right ventricular function normalized for afterload to improve risk stratification of patients with pulmonary arterial hypertension.
PLoS One. 2022;17:e0265059.
Abstract

REZENDE CF, Mancuzo EV, Correa RA
Heart rate recovery in 1 minute after the 6-minute walk test predicts adverse outcomes in pulmonary arterial hypertension.
PLoS One. 2022;17:e0268839.
Abstract

TSEGA T, Tesfaye T, Dessie A, Teshome T, et al
Nutritional assessment and associated factors in children with congenital heart disease-Ethiopia.
PLoS One. 2022;17:e0269518.
Abstract

CARDOSO NL, de Sa JF, do Nascimento LFE, Mendes LA, et al
Psychometric properties of the sit-to-stand test for patients with pulmonary hypertension: A systematic review protocol.
PLoS One. 2022;17:e0275646.
Abstract

JASINSKA-STROSCHEIN M
Training programs in preclinical studies. The example of pulmonary hypertension. Systematic review and meta-analysis.
PLoS One. 2022;17:e0276875.
Abstract

RAMSEY SD, Bender MA, Li L, Johnson KM, et al
Prevalence of comorbidities associated with sickle cell disease among non-elderly individuals with commercial insurance-A retrospective cohort study.
PLoS One. 2022;17:e0278137.
Abstract

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.

;